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Abstract 
This thesis describes the development and the application of three different [3+3] 
annelation strategies for the formation of functionalised piperidines. Initially, the 
scope of the [3+3] cycloaddition reaction of Pd-trimethylenemethane and 
aziridines towards functionalised piperidines was investigated for its application 
to silyl ether substituted aziridines. These substrates appeared to be very 
challenging, undergoing the cycloaddition only under very rigorous conditions. 
Since this methodology was not trivial to repeat, a two-step strategy was explored 
that involved the addition of a Grignard reagent to the aziridines followed by ring-
closure to the corresponding piperidines. These two procedures were found to be 
enantiospecific, providing good routes for the synthesis of enantiopure 
piperidines. The functionalisation of the exo-alkene group of these piperidines 
was also investigated with particular regard to the reaction diastereoselectivity. A 
third [3+3] annelation reaction towards the synthesis of the piperidine core has 
also been employed, which invoked the addition of the Bilchi Grignard reagent to 
the enantiopure silyl ether substituted aziridine (R)-139 to provide the 
corresponding acetal 263 in good yield. Acid catalysed cyclisation of the acetal 
produced the corresponding enantiopure tetrahydropyridine 264. The last section 
of this work focused on the applicability of these methods for the synthesis of 
natural products and highlights our attempts towards the synthesis of quinolizidine 
alkaloid (-)217A. 
4 
Acknowledgements 
Firstly, I would like to thank Prof. Joe Harrity for giving me the opportunity to do 
this PhD, for encouraging and helping me in any circumstances, even when times 
were hard! I know it was not always easy but I really appreciated the help and the 
encouragement you gave me throughout my PhD. 
Thank you Wengard for welcoming me in your lab and for your help with my 
chemistry. 
Next thank you to everyone who made the group such a nice place to work in: 
Olivier, thank you for giving me so much advice at the beginning of my PhD, for 
always being ready to give me all the help I needed and for all the efforts you put 
into entertaining your labmates. 
Neil, thank you for your patience when I asked you a thousand questions a day, 
for making me discover English pop music and for those Friday nights spent in 
the cinema watching crap movies (whatever you do, don't go to Bratislava to a 
place called Hoste!!). 
Matt and Si, thank you for always trying to communicate with me even though I 
struggled to understand half of what you were saying! 
Paddy, thank you for supporting me as your housemate In our first year. 
Katharine, thank you for allowing me to inherit your fume hood; I was hoping it 
would boost my results but I think it was not a matter of fume hoods! 
Fabienne, thank you for making things so easy when I first arrived and for making 
me feel comfortable in the group. 
Carl, thank you for being a good friend and for your great taste in music! I am 
missing our Tuesday nights in Flares and the following fights: one day I will beat 
you at judo! 
Thank you Dune for being such a good laugh in the lab. 
Clare, I have known you for 4 years now and we have shared so much: thank you 
for letting me crash at your place so many times, for all the meals you cooked for 
5 
me, for our nights out, for chats about life and my immaturity ... You've been 
such a good friend! 
Nicole, since the beginning you have been so lovely, so nice, and so caring with 
me, that I sometimes feel like you are my little (or big, depending on whether you 
consider the mental or physical age!) sister! You have got such a lovely 
personality, don't change in any way but try not to bully the guys in the lab too 
much! 
Jeje and Damien, I have only known you for a few months but I feel like we have 
been mates for years! Good luck boys with everything but I think you will have to 
put up with me for a few more years. Make sure you always have a spare room for 
me at home! 
Calum, thank you for welcoming me so many times at yours and for all the Guitar 
Hero sessions (mainly at 4am after Pop Tarts!). I am going to work on my skills 
and one day I will match you! 
Juju, thank you for all the discussions about chemistry, for being so supportive, 
for making me believe in my chemistry skills and for having taught me so much. 
You have been a reliable friend and a brilliant housemate! 
Hey Pattenden! First, I think I have to apologise for stealing your scissors and for 
putting the music on too loud in the lab! I know we argued a couple (!) of times 
but I really enjoyed working alongside you and I had so much fun winding you 
up! I am missing you as a labmate and a friend. 
Thank you Ads for being such a clown and keep persevering, you will match me 
at football one day! 
Thank you Pierro, Mentxu, Guille, Jame, Raffa and all the Spanish and Italian 
guys for being so friendly and for all the random parties! 
6 
To everyone else that was involved in the Harrity group and in the department 
(particularly Pete and Nick in stores) for their presence and help over the years. 
Thank you to all the guys in E26 it has been a real pleasure to share the office 
with you guys! 
Thank you to all the football lads and go on 2008 double winners' Ecclesia FC! 
Dava, Dave, John, thank you for your friendship guys and for all the fun I had in 
Reflex and Flares! 
Nick, thank you for the banter and for your jokes about The Office; now that I 
have watched the series, I get them and I can be involved! It's hilarious! Fact! 
Alex, tu es la depuis le debut, j'ai toujours pu compter sur toi, merci pour m'avoir 
introduit a la vie sheffieldienne, de m'avoir remonte le moral dans les moments 
difficiles et d'avoir essaye de m'apprendre ajouer de la guitare! 
Dam Dam, merci pour tous les debats footballistiques et pour etre mon ami : je 
sais que je pourrais toujours compter sur toL Ton amitie est precieuse. 
Ju de chatte, merci pour les pauses cafe, les grandes discussions existentielles et 
pour etre aussi sensible aux sentiments des autres. 
Tops, mon "meilleur homme", merci d'etre mon meilleur pote, de partager tous 
les moments importants de ma vie, tout ne serait pas aussi genial sans toi mec. 
T'es le meilleur! 
I'd like to thank my parents and my brother; you have always been very 
supportive and encouraging about all I have done throughout my life. 
And finally my thanks go to "mon petit lapin", Camille, for supporting and 
encouraging me throughout my PhD and for all the love you give me. I know it 
has been a long process, especially these last few months, but thank you for your 
patience and for being such a great wife. Tu es merveilleuse! 
7 
Ac 
Acac 
ADDP 
aq. 
Ar 
Atm 
9-BBN 
Bn 
Boc 
b.p. 
Br 
nBu 
tBu 
C 
calcd. 
cat. 
Cbz 
Chloramine-T 
Cl 
COSY 
Cp 
d 
D 
8 
Dba 
DBU 
DCM 
DEAD 
DIAD 
DIBAL 
DMAP 
Abbreviations 
Acetyl 
acetylacetonate 
1,1' -(Azodicarbonyl)dipiperidine 
aqueous 
Aryl 
Atmosphere (pressure) 
9-Borabicyclo[3.3.1 ]nonane 
Benzyl 
tert-Butyloxycarbonyl 
Boiling point 
Broad 
n-Butyl 
tert-Butyl 
Concentration 
Calculated 
Catalyst or catalytic 
Carboxybenzyloxy 
N-Chloro-4-toluenesulfonamide sodium salt 
Chemical Ionisation 
Correlated spectroscopy 
Cyclopentadienyl 
Doublet (NMR); day(s) (reaction time) 
Dextrorotatory 
Chemical shift 
Dibenzy lideneacetone 
1,8-Diazabicyclo[ 5 A.O]undec-7 -ene 
Dichloromethane 
Diethylazodicarboxylate 
Diisopropylazodicarboxylate 
Di-iso-butylaluminium hydride 
4-[N,N-Dimethylamino ]pyridine 
8 
DMDO 
DME 
DMF 
DMS 
DMSO 
ee 
El 
eq. or eqUlv. 
ES 
Et 
EhO 
EWO 
FTIR 
o 
h or hrs 
HMPT 
HRMS 
Hz 
IR 
J 
L 
L 
LDA 
LO 
LiAIH4 or LAH 
Lit. 
M 
M 
mCPBA 
Me 
Min 
Mol. Sieves or MS 
m.p. 
Dimethyldioxirane 
1,2-Dimethoxyethane 
N ,N-Dimethylformamide 
Dimethylsulfide 
Dimethylsulfoxide 
Enantiomeric excess 
Electron impact 
Equivalent(s) 
Electrospray (mass spectroscopy) 
Ethyl 
Diethyl ether 
Electron-withdrawing group 
Fourier transform infra-red 
gram(s) 
Hour(s) 
Hexamethylphosphorotriamide 
High resolution mass spectrometry 
Hertz 
Infra-red 
Coupling constant 
Litre, ligand 
Laevorotatory 
Lithium di-iso-propylamide 
Leaving group 
Lithium aluminium hydride 
Literature 
Molar, metal 
Multiplet (NMR); medium (FTIR) 
meta-Chloroperbenzoic acid 
Methyl 
Minute(s) 
Molecular sieves 
Melting point 
9 
Ms or mesyl 
NaOH 
NBS 
NMO 
NMR 
NOE 
NOESY 
Ns 
Nu 
P 
Pd-TMM 
Pent. 
Ph 
PMBS 
ppm 
ipr 
nPr 
Pyr 
Q 
RCM 
Rt 
S 
S 
SM 
t 
TBAF 
TBS 
TBDPS 
Temp 
Tf or triflate 
TFA 
THF 
TLC 
Methanesulfonyl 
Sodium hydroxide 
N-Bromosuccinimide 
N-Methylmorpholine-N-oxide 
Nuclear magnetic resonance 
Nuclear Overhauser enhancement 
Nuclear Overhauser enhancement spectroscopy 
4-Nitrobenzenesulfonyl 
Nucleophile 
Protecting group 
Palladi um-trimethy le ne methane 
n-Pentyl 
Phenyl 
para-Methoxybenzenesulfonyl 
Parts per million 
iso-Propyl 
n-Propyl 
Pyridine 
Quartet 
Ring closing metathesis 
Room temperature 
Singlet (NMR); strong (IR) 
Solvent 
Starting material 
Triplet 
Tetra-n-butylammonium fluoride 
tert-Butyldimethylsilyl 
tert-Butyldiphenylsilyl 
Temperature 
Trifluoromethanesulfonate 
Trifluoroacetic acid 
Tetrahydrofuran 
Thin layer chromatography 
10 
TMEDA 
TMM 
TMS 
Ts or tosyl 
w 
w/v 
N,N,N,N-Tetramethylethylenediamine 
Trimethylenemethane 
Trimethylsilyl 
4-Toluenesulfonyl 
Weak (IR) 
Weight per volume 
11 
Chapter I - Introduction 
The formation of five- and six-membered rings constitutes a great area of interest 
to the organic chemist due to their presence in a huge variety of natural products. 
Indeed, an abundance of natural products contain a core of cyclopentane skeleta 
such as prostaglandins and triquinanes. The power of cycloadditions for ring 
formation derives from the potential for chemo-, regio-, and enantioselectivity. 
Cycloaddition strategies have been employed in the formation of five-membered 
rings, using reactions such as the 1,3-dipolar cycloaddition, but although this 
method was successful in the synthesis of certain heterocycles it could not be 
extended to carbocyclic systems. The Diels-Alder reaction is an established way 
to form six-membered rings and in close analogy to it, a [3+2] strategy for 
formation of five-membered rings is conceivable. 
l.Trimethylenemethane Complexes 
The trimethylenemethane (TMM) unit and its equivalents are very reactive 
organic species. They are potentially interesting four-carbon fragments for 
cycloadditions and could provide an efficient route towards five-membered rings. 
TMM can be represented in either a zwitterionic or a diradical form (Figure 1): 
Figure 1 
The TMM synthon can be stabilized by coordination of a metal complex. 
Emerson et all were the first researchers to report the synthesis of one of these 
complexes, Fe[114-C(CH2)3](CO)3. Since this time, some other TMM complexes 
have been synthesised with molybdenum and chromium2, as well as complexes of 
iridium, rhodium, osmium and ruthenium3• Although the possible use of metal 
complexed TMM systems in organic syntheses appeared promising, their poor 
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reactivity in cycloadditions make them less interesting for that purpose. The 
reactivity had been lowered so much that these species would not undergo 
cycloaddition reactions. As highlighted in Schemes 1 and 2, even when the Fe-
TMM complex 1 was reacted with a very much activated alkene, only a low yield 
of cycloadduct 2 was obtained2,4. 
t<~ 
NC)=<CN NC~CN NC CN 4% .. Fe(COh Ce(IV) 
NC CN 
1 2 
Scheme 1 
'0 Fe:~:~+_o_ . [,6] 
60 DC, benzene 
+ 
.. 
Scheme 2 
1.1.Palladium-Trimethylenemethane (Pd-TMM) complexes 
In 1979, Trost and Chan4• 5 reported that 2-acetoxymethyl-3-allyltrimethylsilane 3 
served as a novel annulating agent with oIetins bearing electron withdrawing 
groups in the presence of a palladium(O) catalyst to generate cycIopentanes 4 
(Scheme 3). 
.. 
y 
+~ Pd(O) 
3 
Scbeme3 
13 
9-19% 
Their reasoning was based on the fact that, to be reactive in cycloadditions, the 
TMM equivalent must exist in a zwitterionic form with synthons for a carbocation 
and carbanion that do not self-annihilate. In the case above, silyl group serves as 
carbanion equivalent and carboxylate as carbocation equivalent (Scheme 4). 
11 = AeO 11 SiMe3 
<±)/'....e ~ 
3 
Scheme 4 
Other groups can also be considered as illustrated in Scheme 5. 
= ==e.MR3 MR3 = Si(CH3h. Sn(CH3h. SnBu3 
X X = OAe, OC02CH3, OS02CH3, I 
Scheme 5 
However, all of these synthons need an activator: palladium (0) complexes serve 
as such activators because they can readily effect the ionization of even poor 
leaving groups. In the presence of a palladium (0) catalyst, a 7l"-allyl palladium 
species 6 is formed via the oxidative insertion of Pd(O) into the carbon-oxygen 
bond of 3. The proximal positive charge weakens the carbon - silicon bond and 
facilitates the loss of SiMe3, forming the palladium-TMM complex as a reactive 
intermediate6• This complex contains both the required nucleophilic and 
electrophilic centres (Scheme 6). 
--.rSiMe3+ PdL
n 
-_.. [;.c:~:1 ~OAe . le 
PdLn 
3 5 
Scheme 6 
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1. 1. 1. Synth esis of TMM and conjunctive reagents 
In 1983, Trost and co-workers 7 described a convenient two-step route to 2-
(hydroxymethyl)allyltrimethylsilane 7 using inexpensive reagents (Scheme 7). A 
similar route can be used to make the stannyl derivate 8. Firstly methallyl alcohol 
9 was doubly deprotonated with butyllithium in the presence of TMEDA. The 
efficiency of this process appeared to be very dependant on the polarity of the 
reaction medium, in that when the reaction was run in hexane, a significant 
amount (up to 50%) of an isomeric alkene was produced, thought to be 13, as 
judged by IH NMR spectroscopy. In the non-polar solvent, complexation of the 
lithium alkoxide with the lithiating agent (10) increases the acidity of the syn 
proton of the alkene and this internal activation leads to the by-product 13. 
Indeed, changing to a more polar solvent (Le. removing the hexane from the 
butyllithium solution and replacing this with ether or THF) did lead to a 
significant decrease in the amount of by-product 13 formed, presumably due to 
suppression of the internal coordination. Use of ether gave -15% 13 and 60-70% 
of the desired vinyl silane 12. In THF, conversion was low but only the exo-
methylene product 12 was formed, probably due to the instability of THF in the 
presence of strong base, so in practise a -1.5: 1 ratio of ether:THF was used. AI: 1 
ratio of BuLi:TMEDA was also found to be optimal. The dianion 11 was 
quenched with TMSCI, and then selective hydrolysis of the TMS-ether using 
dilute sulphuric acid yielded the allylic alcohol 7. This allylic alcohol can then be 
functionalised with various groups. 
15 
~ c ~ • ~ Me3Si OSiMe3 Me3Si OH Me3Si X 
~ ~ / 12 a • 
9 OH Li OLi 
j 11 ~ A c 
Me3Sn OSnMe3 
,.--.... 
A A --C ~U I Li 
-
• I 
0 Li OLi Me3Si OSiMe3 
10 13 
a: 2.6 eq. BuLi, 3 eq. TMEDA, THF, Et20 
b: TMSCI 
c: 1M H2S04 
Scheme' 
7 
·A Me3Sn OH .~ Me3Sn X 
8 
Alternatively, two routes from diethyl malonate using (chloromethyl)- or 
(iodomethyl)trimethylsilane also provide reagents of type , (Scheme sl' 9. 
a 
• 
~A 
Me3Si OS02CH3 
a, 1. NaOEtlEtOH, L\; 2. Me3SiCH21 or Me3SiCH2CI, L\; 
b, 1. NaH, C6H6; 2. CH2Br2, L\; 
C, 1. KOH/H20, L\, EtOH; 2. LiAIH4; 
d, 1. NaH/LiAIH4' ..:\, THF; 2. CH3S02Cl/collidine, 0 °C, DMF 
Scheme 8 
Ethyl acrylate also serves as a readily available starting material in a route where 
the silicon source is again the inexpensive chlorotrimethylsilane. Scheme 9 
outlines this route to a l,l-dideutero analogue of ,IO.ll. 
16 
~COOEt 
a, Me3SiCIlLi; 
a. ('COO Et b 
SiMe3 
44% 
SbM ~ I e30H d .. 
70% 
[1,1]-D2]-7 
OMs 
/COOEI 
SiMe3 
1 c 40% 
!COOEI 
SiMe3 
80% 
b, 1. LiN(iPr)2, THF; 2. (CH20)n, 3. CH3S02CI/Et3N; 
c, 1 ,8-diazabicyclo[S.4.0]undec-7-ene (DBU), RT Et20; 
d, LiAID4' -25°C, Et20 
Scheme 9 
Various 1,3-disubstituted TMM precursors (Scheme 10) can be synthesised thanks 
to the ready availability of the aldehyde 14, prepared by Swem oxidation of the 
alcohol 712,13. 
Scheme 10 
The Grignard reagent, 1-[(trimethylsilyl)methyl]ethenylmagnesium bromide 16, 
synthesised starting from the isopropenyl bromide 15 can also be used to create 
17 
the 1,3-bifunctional units required for cycloaddition (Scheme 11)14-16. The 
Orignard reagent 16 shows good chemoselectivity in its addition to aldehydes and 
ketones. 
;:Br 
Br 
15 
(SiMe3 
~Li 
(SiMe3Y I 
a • ~ ~ MgBr2 
Br ~ (SiMe3 
~MgBr 
16 
a, (2 Me3SiLi + 3 CuCN), ODC, THF/HMPA or 1. HSiCI3/Et3N, CuCl, 2. 3 CH3MgBr, Et20; 
b, tBuLi, -78 °C, Et20 
C, Mg turnings 
Scheme 11 
2.[3+2J Cycloadditions with unsubstituted TMM reagents 
The TMM unit 3 is able to undergo a [3+2] cyc1oaddition with electron deficient 
alkenes in the presence of palladium-catalyst to give methylenecyclopentanes 17 
(Scheme 12)10. 
Pd 
Z = electron withdrawing group 
Scheme 12 
The acceptor requires an electron-withdrawing group, similar to a dienophile in a 
Die1s Alder reaction. Various electron-withdrawing groups (EWG) such as ester lO, 
cyan06• 10 and sulfone6• 10 groups in addition to a ketone carbonyl group can be 
used as activators of the olefinic bond (Scheme 13). Any EWO that activates an 
olefin in terms of a Michael reaction should function similarly. 
18 
ACO~SiMe3 ~C02Me Q 18 68% 
• C02Me 
3 8.5% Pd(PPh3)4 19 
Toluene, 90 QC 
ro o 0 0 
20 56% 3 • 
3.5% Pd(PPh3)4 
1.5% dppe, THF, 65 QC 
~CN 
22 35% 3 • 
6% Pd(PPh3)4 
Toluene, 60 QC 
Q Ot,Ph S02Ph 58% 24 3 .. 
5% Pd(PPh3)4 
1.5% dppe, THF, 65 QC 25 
Scheme 13 
2.1.Mechanistic studies on the cycloaddition reaction 
The cycloaddition reaction is proposed to proceed via a Michael addition of 6 to 
the double bond followed by palladium catalysed intramolecular allylation of the 
subsequent carbanion (Scheme 14). 
@ 
LnPd')l_ ~ + ~EWG 
6 
@ h LnPd,JI 
----.. ~EWG ----. 
e EWG 
Scheme 14 
Trost and Chan14 performed some experiments to study the mechanism of this 
[3+2] cycloaddition. They tested susbtrates that possessed both electron rich and 
electron deficient olefins to see if any chemoselectivity could be achieved. 
19 
electron ~n deficient ~ 
o Me3Si OAc 
26 3 
electron deficient 
electron ric~ r.-~C02CH3 
'?L-{ 
27 C02CH3 
Scheme 15 
THF 
THF 
o 
52% 
The ambident traps 26 and 27 chemoselectively led to products derived from 
exclusive reaction at the electron-deficient double bond. Cycloadducts resulting 
from attack of Pd-TMM 5 at the electron rich alkene were not observed. 
2.2.Mechanistic studies on the nature of Pd-TMM complexes 
The Pd-TMM complex 6 is described as a ,,3 -allyl palladium fragment. A series of 
experiments were performed by Trost and Chan 17 to provide evidence for the 
existence of this moiety. Sodium salts of nu~leophiles 29 were generated with 1 
equivalent of the conjugate acid 28 and 0.8 equivalent NaH. These anions 29 were 
then treated with 3 in the presence of a Pd(O) catalyst (Scheme 16). 
NuH NaH. 
28 THF 
Scheme 16 
NU~ 
31 
20 
Entry Nu Temp Yield 30 Yield 31 
1 e 25°C ;""".... 72% Ph02S C02Me 
29a 
2 A Me02C C02Me 25 73% 
29b 
3 Ph02S
A S02Ph 65 54% 18% 
29c 
e 
4 Ph02S;"""....S02Ph 25 17% 
29c 
o e 
5 ~C02Me 25 44% 
29d 
6 °VO 25 74% 
2ge 
Table 1 
For strong nucleophiles (Table 1, entries 1 and 2), the expected alkylation product 
30 is isolated in good yield. However, if more stabilised anions are used 
(generally pKa less than 12, entries 3-6), desilylated alkylation product 31 is 
instead obtained. These results can be explained as follows in Scheme 17: more 
reactive 29a and 29b react with the n--allylpalladium moiety very quickly, and 
thus the n-alIylpalIadium species 5 is trapped to produce silylated product 30. The 
use of less reactive nucleophiles 29c, 29d and 2ge means that intermediate 5 is not 
trapped as quickly and therefore has a longer lifetime and can undergo 
desilylation with acetate anion to produce Pd-TMM complex 6. Pd-TMM 
complex 6 can be protonated by any conjugate acid of the nucleophile 28 that is 
presenta• The nucleophilic anion 29 now reacts with the n-alIylpalladium moiety 
of32 in this case, and desilylated product 31 is observed. 
• Trost considers that Pd-TMM complex 6 has a pKa included between 21 and 25, since it can 
abstract a proton from acetophenone but not from esters. 
21 
cD e 
PdL2~OAC PdLn ,) 
==:=::. .:? SiMe3 
5 
NU~SiMe3 
30 
Scheme 17 
• 
-TMSOAc 
j NuH 
$ 
PdL2~H 
32 
J~ 
NU~ 
31 
The existence of a proton transfer step was confirmed by the use of 95% 
deuterium labelled 33 which provided deuterated product 34 in excellent yield 
with 91 % deuterium incorporation (Scheme 18). 
A 
OAc SiMe3 
3 
Scheme 18 
PdL~D 
1) 0 
Ph02sXC02Me 
2) chromatography 
Alkylation of a deuterium labelled TMM precursor d2-3 with 29a shows that the 
deuterium label is incorporated in two of the carbons of the product 35. A 
symmetrical 7l'-allyl palladium species must be present, which is attacked equally 
at either terminus by reactive nucleophiles (Schemes 19). 
22 
ACO~SiMe, 
D D 
d2-3 
• 
5% Pd(PPh3)4 
2.5% dppe 
THF, 65 QC 
Scheme 19 
However, with less reactive nucleophiles, an equal distribution of labels is found 
in the product. This implies that the palladium-TMM is unsymmetrical but 
capable of symmetrising at a rate comparable to that of cycloaddition reaction 
with the nuc1eophile (Scheme 20). 
ACO~SiMe3 
D D 
d2-3 
~ ~oAo 
36 
Scheme 20 
While d6 metals tend to form TJ4-TMM complexes I, 3, theoretical calculations have 
shown that a ,,3-TMM species is more likely for d8 metals l8, 19, Indeed, a crystal 
structure of Pd[,,3-CH2C«C02Me)2)CH2](PPh3)2 has been published by Chen20 
that provides evidence of this bonding pattern. 
Scheme 21 
23 
2.3.Stereoselectivity of Pd-TMM Cycloaddition 
The stereoselectivity of the cycloaddition normally is very high; the geometry of 
(E)-olefins is retained in the product, as illustrated in Scheme 227, 17: 
[(Ph3P)4Pd] / DPPE, )l 
Ll, 12h, THF L-Z ~COOCH3 + 
;
- \,\., COOCH
3 
51% 
Scheme 22 
A comparison of isomeric cinnamate was carried out as highlighted in Scheme 23. 
From E-olefin, E-adduct was mainly obtained. On the other hand, Z-olefin 
produced a mixture of E- and Z-methylenecyclopentanes. 
11 2.1% dppe 
3.3%Pd(PPh3)4 Q 
Ph~ + AcO~SiMe3 -
C02Me THF, 65°C Ph"" 
70% C02Me 
trans/cis 95:5 
6.3%Pd(PPh3)4  
2.3% dppe 
• 
THF, 65°C Ph C0
2
Me 
55% trans/cis 1: 1.3 
Scheme 23 
Partial loss of stereochemistry in the case of Z-olefinic acceptors arises from 
isomerization of the zwitterionic intermediate under the reaction conditions 
(Scheme 24). 
24 
Scheme 24 
~hn,C02Me 
-PdL2 Y 
trans-41 
cis-41 
This provides good evidence that the cycloaddition reaction proceeds via a 
stepwise, non-concerted addition mechanism. Zwitterionic intermediate 39 is 
formed from reaction of Pd-TMM 6 with frans-alkene 38a, and ring closure to 
frans-41 is rapid due to the neutralisation of charges providing a strong driving 
force for the normally slow 5-endo-trig ring c1osure21 and thus stereochemistry is 
maintained from 38a to the product frans-41 b. In the case of eis-alkene 38b, the 
mechanism goes through the intermediate 40: here the bond rotation of 40 to 39 
competes with cyclisation to cis-41, resulting in a loss of stereospecificity. 
The difficulty in designing a catalyst for the asymmetric Pd-TMM cyc1oaddition 
reaction is illustrated by the following stepwise mechanism proposed by Trost and 
co-workers22 (Scheme 25). 
ACO~SiMe3 + R\ \ 
EWG 
LnPd .JZ 
SOlvent- RH 
EWG 
b According to Baldwin's rules, 5-endo-trig ring closure is disfavoured 
25 
TMS~OAC 
o 
cyclisation 
o 
Y 
H--
R o 
Isomerisation 
Scheme 25 
nucleophilic 
addition 
The formation of the zwitterionic intermediate is generated by insertion of LnPd 
into the C-O bond followed by attack of the displaced acetate anion onto the 
trimethylsilyl group, which deposits its electrons onto the TMM fragment. The 
enantiodetermining step is most likely the initial nucleophilic attack. This step 
occurs distal to the set of coordinated chiral ligands. Nonetheless, Trost and his 
collaborators examined the reaction of 3 with methyl cinnamate 42 in the presence 
of 5 mol% of Pd( dba)2 and 10 mol% of various chiral phosphoramidites as ligands 
in toluene at 23°C. As highlighted in Scheme 26, these conditions provided an 
asymmetric catalytic cycloaddition reaction, providing cyclopentane 43 with 
modest enentioselectivity. 
26 
ACO~SiMe3 + Ph~O 
5 mol% Pd(dba)2.. ;!) 
10 mol% L _ 
43 toluene, 23°C Ph ~ 
L 1-(R) 
0% yield 
3 42 0, 
L2-(R, R, R)-78%, 29% ee 
L3-(rac, R, R)-77%, 4% ee 
o 
L6-( S, S, S) 80%, 58% ee 
Scheme 26 
~O/ 
° o 
I ~ 'P-N 0=0 . ~ d 
L4-(rac, S, S) 0% 
Using the optimized catalytic conditions, they investigated the scope of the TMM 
accepting olefin. All cyc10pentane products were formed in > 19: 1 trans:cis 
selectivity, with good enantiocontrol (Scheme 27, Table 2). 
5 mol% Pd( dba)2. If 
10 mol% L6 .. 
toluene, T °C R1 '; 
(see Table 2) R2 
Scheme 27 
27 
Entry Substrate Product Temp (C) Yield (%) ee (%) 
0 
pP)ro, Ph~O/ 23 80 58 1 0 81 62 
0 
0 pP,y Ph~ 23 76 72 2 
-25 63 82 
0 
0 i:,y ~ 23 72 73 3 4 -25 79 84 
0 
0 
PhP'r, Ph~ 23 84 73 4 -25 72 83 
0 
0 
PhP '7rPh 5 
Ph~Ph 
-25 83 80 
0 
° P a: -25 73 72 Ph~Ar 6 
a: Ar = C6H4-4-0CH3 Ph ')rAr b: -25 80 74 
b: Ar = C6H4-4-F 0 
7 Ph~CN PhP.CN 0 78 58 
Table 2 
The reaction of 3 was also tested with various tetralone derivatives in the presence 
of Pd(dba)2 and L6 with success, as the corresponding exo-
28 
methylenecyclopentanes were obtained in high yields and enantiomeric excesses 
(Scheme 28). 
o 
ACO~SiMe3 + ~R 
5 mol% Pd(dba)2 
10 mol% L6 
R= 
toluene, T °C 
;s< 0 
'[) 
C>-~­
;s< D 
Scheme 28 
• 
3.[3+2) Cycloaddition with substituted TMM reagents 
53-99% yields 
73-92% ee 
Substituted TMM precursors can also be used in cycloadditions but since the 
reaction proceeds via a 7l'-allyl intermediate, questions of regiochemistry arise. If 
we combine the three possible regioisomers with the two diastereoisomers that are 
possible in each case, we obtain a total of six possible products (Scheme 29). 
~SiMe3 + ~z~ 
,,/OAC 
R 
Z = electron-withdrawing group 
Z=<r 
=<;J andlor Z 
R Z 
and/or FU 
R 
Scheme 29 
In Scheme 30, all the various possible products that can be obtained from the 
different mesomeric forms of the Pd-substituted TMM complex are shown: 
29 
Scheme 30 
Trost and co-workers decided to carry out some experiments to see if any 
chemoselectivity is observed during cyc1oadditions with substituted TMM-Pd 
precursors6, 14-16 (Scheme 31, Table 3). 
Reagent Product 
44 SOa 
45 SOb 
46 SOe 
47 50d 
48 50e 
49 sor 
a yield not reported 
~SiMe3 
r-OAc 
R 
44-49 
Scheme 31 
R 
CN 
COEt 
Ph 
cyc1opropyl 
CH=CH2 
OAc 
Table 3 
Yield % 
54 trans 
59 trans 
a cis + trans 
61 cis + trans 
89 cis + trans 
86 cis + trans 
30 
As can be seen from Table 3, when R is an electron withdrawing group, only the 
trans isomer is obtained, although this selectivity is not observed with other R-
groups. The formation of only five-membered ring products with the vinyl 
derivative 48 suggests that the kinetically favored 7T-allylpalladium cation 51, 
which should produce seven membered-ring products via the zwitterion 52, is not 
a product-determining intermediate. All intermediates funnel through 53, which is 
presumably the product-determining intermediate (Scheme 27). 
Scheme 32 
~ .h ~zVz 
-.~ ~z' L{ 
z 
These experiments suggested that the unsymmetrical TMM complexes equilibrate 
faster than they undergo cycloaddition. To investigate this, Trost23• 24 and co-
workers used two isomeric methyl-TMM precursors 54 and 55 with a view to 
trapping them with the appropriate olefin acceptors (Scheme 33 and Table 4). 
First they used 2-cyclopentenone 58 and both precursors gave identical product 
mixtures, in which 61 predominated over 60. On the other hand, they used 
dimethyl benzylidenemalonate 59 as a trapping agent, and observed that, even if a 
slightly larger amount of adduct 62 was formed from 54 than from 55, in both 
cases adducts derived from 57 were favoured. The results indicate that the 
regioselectivity of the cycloaddition is independent of the regiochemistry of the 
precursors. 
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0 
ACJy 6 0 b Cfr 58 55 a • SiMe3 e> I 57 PdL2 61 
+ 
0 
ACX ~ 6 58 ~ 54 a 
SiMe3 PdL2 
60 56 
AJy 
Me02CrC02Me 
b Ph 59 Me02C 55 a Me02ct(= a 
SiMe3 e> I 57 Ph 
PdL2 63 
+ 
~ Me02C ACX Me02C~ a 54 Ph 
SiMe3 
PdL2 Me02Cr.C02Me 62 e> 
56 
Ph 59 
Scheme 33 
Reactants Products Yield Selectivity 
54+58 60+61 52% <5:>95 
55+58 60+61 45% <5:>95 
54+59 62+63 82% 23:77 
55+59 62+63 90% 13:87 
Table 4 
32 
The example below confirms the previous results: only a single regioisomer is 
obtained (Scheme 34)13-16. 
~ + Ac0)LSiMe3 
~oAO Ph Toluene 110 QC 
76% 
Scheme 34 
70:30 
The regioselectivity of these reactions is remarkable. All substituents tested to 
date, electron donating or electron withdrawing, end up preferentially at the 
carbon in the product that becomes bonded to the p carbon of the acceptor i.e. all 
the substituted TMM precursors lead to the same methylenecycIopentane, as 
shown in Scheme 35. 
Scheme 35 
The regioselectivity can be rationalised as being due to nucleophilic attack of the 
most negatively charged carbon atom. This implies that the negative charge 
prefers to sit on the more substituted carbon atom of the TMM species: this is 
quite surprising when R is a methyl group or an electron-donating group but it can 
33 
be explained by invoking a strong interaction between the HOMO of the TMM 
carbanion and the LUMO of the Pd-7r-allyl moiety (Scheme 36). 
Most stable dipole 
Scheme 36 
In their efforts to develop an efficient asymmetric process to make enantiopure 
cyc10pentanes using the transition metal-catalyzed [3+2] trimethylenemethane 
cyc1oaddition, Trost and co-workers2s recently investigated the reactivity of 3-
alkylidene-oxindoline-2-ones 65 toward Pd-TMM complexes. They chose the 
cyano-substituted TMM-precursor 64, thinking it could enhance the asymmetric 
induction. 
Initial experiments with hexarnethylphosphorus triamide (HMPT) as ligand for 
palladium showed that the desired cycloadduct formed in excellent yield as a 
eis/trans mixture (Scheme 37, Table 5 and Figure 2). 
34 
(TMS 
~CN 
OAc 64 
j Pd(O)L*n -TMSOAc 
eN 
+ 
trans-66 cis-67 
conditions: 2.5% Pd2dba3.CHCI3,10% L*, toluene 12h 
Scheme 37 
Ligand Temp (DC) Yield (%) 66/67 66 ee (%) 67 ee (%) 
HMPT 
Lt 
L3 
L2 
23 
o 
o 
-20 
HMPT 
99 
93 
97 
97 
2:1 
1:3 
4.3:1 
1:6.2 
Table 5 
Figure 2 
L1 
80 
92 
96 
o 
97 
95 
99 
As highlighted in Table 5, Lt gave mainly the cis-cyclopentane X. This contrasts 
the reaction with HMPT as ligand, where a 2: 1 ratio favouring the corresponding 
trans product 66 was observed. Attempts to optimize the conditions for the 
formation of both diastereoisomers resulted in good diastereo- and excellent 
35 
enantioselectivities for either trans-66 (92% ee and 4.3: 1 dr with L3) and cis-67 
(99% ee and 1 :6.2 dr with L2). 
si, si si, re 
(R, R, R)-L3 (R, R, R)-L2 
r---------------------~-l----------------------~ 
... R'~R' \\ ~R' \ 
• \. • • R" • \ \\ " \ ~ \ 
'0 :;;.- • • I -.;;: · 
. I " , 
I '\ ~ 0,
" N::-- "" N " ,I , , ' \ 
\ R 68 ... ... 68 R ... 
\ , , , 
~---------------------~-~----------------------~ 
J j 
eN 
trans-66 eis-67 
Scheme 38 
The bulky I-naphthyl-substituents of L3 preferentially orient the aromatic 
oxindole part of the substrate 68 under the BINOL portion of the ligand. The 2-
naphthyl-substituents of L2 are shielding an area closer to the phosphorus centre 
of the ligand, favouring an orientation of the oxindole benzene ring away from the 
BINOL portion of the ligand (Scheme 38). Notably, variation of the substituents 
of the oxindole portion had little influence on the ee. 
In the same paper, Trost and his collaborators also explored the influence of an 
unsymmetrical substitution pattern on both sides of the double bond of the 
oxindole. The cycloaddition proceeds under mild conditions generating the 
36 
corresponding cycloadducts with up to three stereo genic centres in excellent 
yields and enantiomeric excesses, especially when L2 was used. 
Whilst palladium-trimethylenemethane is a good reagent for [3+2] cycloadditions 
to alkenes to form methylenecyc1opentanes, but it has also been successfully used 
in addition to aldehydes, ketones and imines. These processes will be described in 
the following section. 
4.0ther types of cycloadditions 
4.1.Addition to aldehydes and ketones26• 27 
In theory, the palladium-TMM complex can act as a nucleophile towards a ketone 
or aldehyde leaving an oxyanion 70, which would then cyclise to form the 
methylene tetrahydrofuran 72. In practice, however, this cycloaddition with 
aldehydes and ketones occurs only under specific conditions 
A e + [Pd] • MR3 0Ac G pdL2 
3: MR3 = SiMe3 6 
69: MR3 = SnBu3 
R3MOAc 
R' R' 
- 0 MMe3 ~ R'CHO £81B £ OMR3 ~ 8 0Ac 
G PdL2 M=Si 70a 
M=Sn 70b 
M=Sn ~ 
72 
Scheme 39 
~ G pdL2 
71 
~ M=Si 
R' 
~OMR3 
A-OAc 
73 
As shown in Scheme 39, Pd-TMM complex 6 is formed from precursor 3 or 69 in 
the presence of a Pd(O) catalyst with associated Me3SiOAc or Me3SnOAc. 
Addition of Pd-TMM 6 to aldehyde provides 70 and the product 72 or 73 and this 
37 
is determined by the nature of the Me3M+ counter-anion. The alkoxide 70a is a 
poor nucleophile for the 1l'-allylpalladium moiety, and hence ring closure to 72 is 
slow and competitive reaction with acetate generates 73. 
A rationale for the effect of tin cocatalysis is described in Scheme 40. The stannyl 
ether is a more long-lived species than alkoxide and reacts very well with the 1l'-
allyl palladium cation whereas alkoxides are poor nucleophiles for these 
electrophiles. This means that formation of the stannyl ether intermediate 
promotes the cyclisation reaction to the methylene tetrahydrofuran since this 
cyclises quickly in comparison to the alkoxide. 
TMS~OAC--
3 
\ 
RCHO 
Me3SnOAc 
e Me3S~PdL2 
R 
70b 
L J fast 
! ~9~ 
decamp ...J.-./ 
R 
72 
Scheme 40 
A summary of this reactivity profile is given in Scheme 41. 
decomposition • 
Pd(OAc)2. 
PPh3. THF 
Scheme 41 
75 
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Since it has been shown that [3+2] cycloaddition on aldehydes occurs in presence 
of tin, Trost and co-workers had the idea to use tin acetate as a co-catalyst in 
presence of TMM. 
In an experiment to further establish the origin of this tin effect, 3 and 10-20 
mol% trialkyltin acetate were used in reaction with various aldehydes 76, 78, and 
80 and cycloaddition to form the desired tetrahydrofurans 77, 79 and 81 was 
accomplished in high yields in all cases (Scheme 42). 
3 
20-40% 5-10% 
5% Pd(OAc)2 ~ BU3SnOAc Me3SnOAc Ph~CHO 30% PPh3 0 89% 95% 
78 
.. Ph ~ 
3 79 
5% Pd(OAc)2 
Ph~CHO 30%PPh3 .. ~ 71% 99% 
80 Ph 
3 81 
~CHO 5% Pd(OAc)2 30%PPh3 ~ 80% 
.. ~ 
76 
77 
Scheme 42 
Notably, this method can also be applied to ketones. a,~-Unsaturated ketones 
undergo cyc1oaddition preferentially on the olefin forming a 2: 1 mixture of 83:84 
(Scheme 43). Rapid decomposition was seen without the tributyltin acetate 
cocatalyst. In the absence of the olefin moiety, the cyc1oaddition takes place 
smoothly at the carbonyl of ketone 85, forming isomers 86 and 87. This occurs in 
much enhanced yield when trimethyltin acetate (84%) is used in comparison to 
tributyltin acetate (52%). 
39 
2% Pd2(dbah 0 0 24% PPh3 (0=. Y 24% BU3SnOAc .. (0 (0 (0 
Ph Ph Ph 
82 83 2:1 84 
54% 
0 7% Pd(PPh3)4 n Q 15% PPh3 Q 17% Me3SnOAc + .. (0 (0 (0 
Ph 
85 Ph Ph 86 2:1 81 
84% 
Scheme 43 
As well as tin compounds, the use of electropositive indium complexes as co-
catalysts has also shown application for the [3+2] cycloaddition to aldehydes, and 
these can even undergo addition to the carbonyl moiety of enones such as 88 
(Scheme 44). Without 1n(acac)3, the reaction proceeds via an almost exclusive 
1 ,4-addi tion 9028• 
o 
Ph~ 
88 
3, 5% Pd(OAch, 
DIBAL-H, 40% PPh3 , _ 9~ 
10% In(acach, toluene.. Ph~~ 
89 
Scheme 44 
j)-z 
24:1 90 
82% 
Trost proposed that 1n3+ co-ordinates to the carbonyl in order to increase the 
electrophilicity of the carbonyl group and promote attack at this site. 1n3+ may also 
modulate the activity of the alkoxide nucleophile onto the 7l'-allylpalladium moiety 
as for the stannyl ether. 
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4.2.Addition to imines 
In 1993, Trost's investigations29 on cycloadditions to imines via Pd-catalyzed 
TMM reactions led to the conclusion that, whereas simple imines fail to react, 
imines possessing an electron-withdrawing group at either the carbon or nitrogen 
enhance the electrophilicity of the imine sufficiently to make it an excellent 
acceptor. This represents a good way to synthesize pyrrolidines. For a variety of 
aromatic groups, yields of95-98% were achieved (Scheme 45). 
< ~ 1'N-TS + 
Cl 
91 
10% Pd(OAch, 
50% PPh3 
11 20% nBuLi 
AcO~TMS -----
3 97% 
Scheme 45 
I~T:t)= 
lXCI 
92 
The reaction also worked for aliphatic tosylimines as long as they were derived 
from non-enolisable aldehydes or ketones, an example of which is shown below 
in Scheme 46. The sterically hindered, non-enolisable 'butyl imine gave a high 
yield of methylene pyrrolidine. 
NTs 
t-Bu 
} 
93 
310% Pd(OAch 
60% P(Oiprh 
.. 
90% 
Scheme 46 
TSx>= 
t-Bu 
94 
Other activating groups were also used (Scheme 47). The electron withdrawing 
nitro group was effective as an alternative to a tosyl group on nitrogen for 
hindered imines such as the bis iso-propyl substituted example 95 but was 
unsuccessful with less hindered imines, due to possible enolisation. 
41 
95 
10% Pd(OACh.. J?=~02 
60% P(O/Prh, _ 
3 
87% 96 
Scheme 47 
Activating groups were also used effectively on the carbon of the imine, 
demonstrated by the diester 97 which underwent cyc1oaddition easily, forming a 
pyrrolidine armed with two ester groups 98 (Scheme 48). 
Ph"" Ny C02Et 
C02Et 
97 
Scheme 48 
In 2007, Trost and co-workers3o reported their work on an asymmetric [3+2] 
cyc1oaddition with imines. Initial studies focused on the reaction of benzylidene 
aniline 99 under the previously developed conditions (5 mol% Pd(dba)2, 10 mol% 
ligand, 1.6 equiv TMS propenyl acetate) at 45°C (Scheme 49). 
42 
(1.6 equiv) 
L1 = 71% conv, 3% ee 
(1.0 equiv) 
99 
5 mol% Pd(dbah J 
10 mol% L 
• 
L2 = 44% conv, 56% ee L3 = 76% conv, 84% ee 
Scheme 49 
Ligand Lt gave only 3% ee at 71% conversion but adjusting the nature of the 
chiral space by increasing the size of the aryl groups led to replacement of one 
phenyl group with a 2-naphthyl group (L2), which did increase the ee. Bis-2-
naphthyl ligand L3 gave the best results with a 76% conversion and 84% ee. 
Using the optimized ligand L3, they determined the best class of imine for this 
reaction. Keeping in mind that they wanted to use a group which could provide 
high enantiomeric excess but would be easy to remove, they screened benzyl, 
phosphonyl, Fmoc and Cbz imines but it turned out that the use of the N-Boc 
imine gave excellent results with the protected pyrrolidine being obtained in 98% 
yield and 87% ee (Scheme 50). 
TMS~OAC+ 
(1.6 equiv) 
5 mol% Pd(dbah J 
10 mol% L3 
Ph~N~Boc • 
toluene, 45 °C, 4h Ph NB (1.0 equiv) oc 
Scheme 50 
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The reaction using both N-Boc and N-aryl imines was also investigated. The 
reaction worked well when the N-bound aryl ring bore electron donating groups or 
withdrawing groups (80-87% yields, 83-84% ee). On the C-bound ring, electron 
withdrawing groups significantly enhanced reactivity. However, the use of Boc-
imines provided a broader reaction scope, this class being more reactive than the 
substituted benzylidene anilines. 
4.3.[4+3] Cycloadditions 
The TMM-precursor 3 can also be used in a [4+3] cycloaddition with dienes to 
form seven-membered rings31,32. The diene 100 can either react at one alkene only 
in a [3+2] cycloaddition giving cyclopentane 101 or in a [4+3] reaction to give 
cycloheptene 102 (Scheme 51). 
3 
Scheme 51 
In the event, little selectivity was seen between [3+2] and [4+3] cycloadducts, 
with a 1.1: 1 ratio of 101 to 102 being obtained. The proposed solution to this was 
to restrict the diene to a cisoid conformation thus promoting the opportunity for 
seven-membered ring formation. 
For example, the diene 103 was formed by a palladium-catalysed enyne 
cycloisomerisation reaction and a subsequent palladium catalysed [4+3] 
cycloaddition reaction gave the seven-membered ring 104 as the only product. 
Increased steric hindrance by increased substitution on the ring of the diene 
enhanced the selectivity for seven-membered ring formation (Scheme 52). 
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A 
OAc TMS 
~C02Me 5 mol% OTBS 35 mol% P(Oiprh ~TBSO C02Me- ----------.. ~!. TBSO ~ Pd(OAc~ ~02Me 5 mol% Pd(OAc)2 ~ 71% 87% 
103 104 
Scheme 52 
This approach was successful for highly substituted substrates and moderately 
successful for less substituted substrates but it was still limited to geometrically 
constrained molecules and so is far from being general. 
4.4.[3+3] Cycloadditions 
4.4.1.{3+3} Cyc/oaddition with Azometlline imines 
Although a (3+3] cycloaddition strategy is a legitimate approach toward the 
formation of six-membered rings, it has been much less studied than the 
corresponding [4+2] approach33-36 and only a few examples of transition-metal-
catalyzed (3+3] cycIoadditions have been reported to date37-4s. 
In 2006, Shintani and Hayashi46 described the development of a new palladium-
catalyzed [3+3] cycloaddition of TMM with azomethine imines 105 to produce 
highly functionalized hexahydropyridazine derivatives 106 under simple and mild 
conditions (Scheme 53). 
105 
o 
Pd(PPh,). (8 mol~) IN) 
CH2CI2• 40°C '--< 
R 
up to 92% yield 
106 
Scheme 53 
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l-Alkylidene-3-oxopyrazolidin-l-ium-2-ides 105 developed by Dorn and Otto in 
196847, 48, are isolable and stable azomethine imines and have been used as 1,3-
dipoles in the context of [3+2] cycloadditions, giving five-membered nitrogen-
containing heterocycles 49-52. 
Initially, they examined the reaction of 3 with azomethine imine 107 in the 
presence of a catalytic amount of Pd(PPh3)4 at 40 DC and found that the choice of 
solvent has a significant impact on the reaction progress (Scheme 54). Thus, 
desired [3+3] cycloadduct 108 was obtained in high yield by the use of 
dichloromethane (82% yield). 
o 
TMS-JLOAc + e~ 
~v 
PhAH 
(2.0 equiv) (1.0 equiv) 
107 
Scheme 54 
108 
With respect to the substituents on the alkylidene portion, a variety of aryl groups 
as well as heteroaryl and alkenyl groups can be tolerated, furnishing [3+3] 
cycloadducts in high yield (70-92% yield). However, substrates with an alkyl 
substituent are less effective for this [3+3] cycloaddition. 
They also investigated the reactions using substituted TMM precursors (Scheme 
55). Compound 109 mainly furnished two different products 110 and 111, with 
traces of a third compound 112 (77 : 20 : 3). 
=<=OAC 
0 Pd(PPh3)4 ;=Q~ ~~ ==Q~ eh (8 mol%) .. + + 
SiMe3 + ~<±> DCM,40oC 
PhAH Ph Ph Ph 
109 
72% yield 77 20 3 
110 111 112 
Scheme 55 
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In contrast, the use of structural isomer 113 generated 114 as the major product 
(Scheme 56). 
===r-
0AC 
r SiMe; 
113 66% yield 12 
114 
Scheme 56 
These results showed that the substitution pattern of the TMM precursor is 
reflected in the product distribution in the [3+3] cyc1oaddition with azomethine 
imine 107, indicating that the cyc1oaddition occurs without significant 
equilibration between intermediates 115 and 116 (Scheme 57). 
eh ~ =Q~ =C0AC e ~(f) Pd(PPh3)4 lnPY<e )( 10~ Ph H • • . - + SiMe3 115 - fast 
0 Ph Ph 109 
slow Il e~ ~» L = PPh3 (±J Jt+ 107 =}-OAC Pd(PPh3)4 LnP~ Ph H • 116~ .. SiMe3 fast Ph 
113 
Scheme 57 
This observation contrasts to the palladium-catalyzed [3+2] cyc1oadditions of 109 
or 113 with electron-deficient olefins described by Trost, which preferentially 
afford five-membered cyclic compounds derived from intermediate 116 regardless 
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of the starting TMM precursor (109 or 113) due to the fast equilibration between 
115 and 116 prior to the cycloaddition23 , 
4.4.2.{3+3J Cycloaddition with Nitrones 
[3+3] cycloadditions can also be extended to the couplings with nitrones as shown 
by Shintani and Hayashi46 (Scheme 58). 
8(f) Pd(PPh3)4 ~OAC 0, +,Ar2 (10 mol%) ~N-Ar2 N SiMe3 + Ar1Y--H DCM,40oC 
Ar1 
(2.5 equiv) (1.0 equiv) Ar1 = 4-CF3C6H4 91% yield 
Ar2 = 4-Et02CC6H4 
Scheme 58 
More recent work by the same group proved that trimethylenemethane derivatives 
could be used in a palladium-catalyzed asymmetric [3+3] cyc1oaddition with 
nitrones to produce six-membered heterocycles with high stereoselectivity53. 
In an initial investigation, they performed a reaction of the TMM precursor 117 
with nitrone 118 in the presence of 5 mol % [CpPd(113-C3Hs)] and 10 mol % PPh3 
at 40°C, and found that product 119 was obtained in 86% yield as a mixture of 
two diastereoisomers (d.r...... 1: 1). with almost no formation of the structural 
isomers 120 and 121 (Scheme 59). 
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=< OAc SiMe3 + 
(2.0 equiv) 
117 
[CpPd(1l3_C3H5)] 
6(±) (5 mol%) 
0, .Ar2 PPh3 (1 0 mol%) ~ .. Ar1 H DCM, 40 cC, 48 h 
(1.0 equiv) Ar1 = 4-CF3C6H4 
118 Ar2 = 4-Et02CC6H4 
(0't:I,Ar2 PhXXo'N,Ar2 Ph~ :4.r 1 Ar1 
120 121 
Scheme 59 
~ - Ar2 Ph Ar1 119 
86% yield 
(d.r. - 1:1) 
The observed high selectivity to form 119 over isomers 120 or 121 proves that the 
initially formed Pd-TMM intermediate 122 rapidly isomerizes to Pd-TMM 
intermediate 123, which bears a more stable benzylic anion, leading to the product 
119 (Scheme 60). 
Ph ~OAC Pd(O) .. 
Scheme 60 
After having investigated different ligands used in varIOUS transition metal-
catalyzed cyc1oadditions such as (S)-MeO-mop54, 55, (S)-binap56 or 
phosphoramiditesS7, they investigated the scope of this asymmetric [3+3] 
cyc1oaddition reaction using {S,S,S)-124 as the ligand (Scheme 61). 
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Ar 
o )""1 , 
P-N 
0/ r-
Ar 
(2.0 equiv) (1.0 equiv) 
Ar = 2-naphthyl 
124 
Scheme 61 
It was found that various aryl groups can be tolerated on the electrophilic carbon 
atom of the nitrone, with the corresponding 1,2-oxazines obtained in excellent 
yield (92-99%), relatively high diastereoselectivity (translcis 76:24-89:11) and 
high enantioselectivity (91-92% ee)c. Several TMM precursors with different aryl 
groups can also be used in the [3+3] cycloaddition reaction with similarly high 
efficiency. Unfortunately, the use of unsubstituted TMM precursor 3 gives the 
cycloadduct with almost no enantioselectivity. 
4.4.3.[3+3} Cycloaddition witlt Aziridines 
Prior to work in the Harrity group37-39. 58, there was a single example in the 
li~erature of the use of 2-[(trimethylsilyl)methyl]-2-propen-I-yl acetate 3 in 
reaction with N-tosyl methyl aziridine 125 in a [3+3] cycloaddition reaction in 
order to form a functionaIised piperidine 12640 (Scheme 62). Presumably, as with 
the imines, the presence of the electron withdrawing tosyl group activates the 
aziridine towards nucleophilic attack. Nucleophilic attack took place specifically 
at the less hindered, unsubstituted carbon. The mechanism was assumed to be 
analogous to all those shown above and the route was attractive in that if 
enantiomerically pure aziridines were to be used then the stereochemistry would 
be retained in the product as this centre is not directly affected by the 
C Alkyl-substituted nitrones are not suitable substrates under these reaction conditions; they give 
little or no cycloadducts. 
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cycloaddition reaction. This would be an efficient entry into the formation of 
enantiomerically pure functionalised piperidines. 
Scheme 62 
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Chapter 11 - Palladium-Trimethylenemethane 
complexes and their applications in [3+3] 
Cycloadditions towards the Piperidine nucleus 
The presence of the piperidine nucleus in a myriad of natural products and 
biologically active compounds is reflected in the continued interest in developing 
new and efficient routes to this motif. As described in the introduction, our 
approach to piperidines is based on Trost's [3+2] cycloaddition to five-membered 
rings via trimethylenemethane (TMM) and its equivalentss. 
In 1989, Kemmit and Bambal40 reported the first metal-catalysed cycloaddition of 
2-[(trimethylsilyl)methyl]-2-propen-I-yl acetate 3 to the aziridine ring system 
(Scheme 63). They used the complex [Pd(PPh3)4] to catalyse the cycloaddition of 
trimethylenemethane to activated aziridines to give 5-methylenepiperidines in 
good yields. The mechanism was proposed to proceed via an analogous stepwise 
process to the [3+2] cycloaddition described by Trost. 
YNTS + ACO~SiMe3 
3 
5% Pd(PPh3}4 
THF, 65°C 
75% 
Scheme 63 
• N 
Ts 
The route is attractive in that, if enantiomerically pure aziridines (which are 
readily available) were to be used, then the stereochemistry would be retained in 
the product, as this centre is not directly affected by the cycloaddition reaction. 
This would therefore represent an efficient entry into the formation of 
enantiomerically pure functionalised piperidines. 
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1.Previous studies 
In the Harrity group, the application of TMM-metal complexes in [3+3] 
cycloadditions towards the preparation of enantiomerically pure piperidine 
products has been investigated for the last few years33, 38, 39 (Scheme 64). 
+ 
r:>-R' [3+3] 
RN 
Scheme 64 
A 1,3-dipole 127 was required for this transformation, and Trost's TMM 
precursor 3 was chosen as the synthetic equivalentS (Scheme 65). Not only would 
this result in the construction of the heterocyc1e in a single step from readily 
available starting materials, it would also furnish the product 129 with an 
exocyc1ic methylene group, which can be further functionalised. 
~--------. 
Scheme 65 
o 
L ~ I .. 
CD PdLn 
6 
Via: 0 
~~R' i-, TsN 
LnPd w 
"Pd·TMM" 
The R group attached to the aziridine nitrogen atom has to be a protecting group 
capable of activating the aziridine 128 towards nucleophilic attack, and should be 
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easy to remove. The nature of the palladium species needed for efficient catalysis 
was previously investigated in the group and it turned out that Pd(OAc)2, together 
with P(Oipr)3 and n-BuLi as a reductant, provided the best catalyst for the [3+3] 
cycloaddition. The tosyl group was initially employed because of its electron 
withdrawing nature. Another advantage is that according to the method of Craig59, 
enantiomerically pure tosyl aziridines can be synthesised in high yield from the 
corresponding amino acid. 
Preliminary experiments have demonstrated that this technique permits the 
synthesis of these compounds in enantiomerically pure form from the 
corresponding aziridines. 
1.1.Cycloaddition Reactions of Monosubstituted Aziridines38 
Since ring opening reactions of aziridines require either an electron-withdrawing 
activating group attached to the nitrogen or catalysis by Lewis or protic acids, 
previous studies focused on the p-toluenesulfonyl (Ts) as the N-substituent 
(Scheme 66). The presence of the electron withdrawing tosyl group activates the 
aziridine towards nucleophilic attack. Nucleophilic attack takes place generally at 
the less hindered, unsubstituted carbon. After having tested a range of solvents 
and catalyst systems, optimal conditions were identified for the [3+3] 
cycloaddition reaction and a range of substituted tosylaziridines were screened as 
outlined in Table 6 below. 
10% Pd(OAch 
60% p(Oiprh 
20%nSuLi rY 
YNTS + AcohsiMe3 --T-H-F,-6-S-o-C-"'" RAN) 
R 3 Ts 
Scheme 66 
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Entry Aziridine Product Yield 
1 
,PNTS N 82% Ts 
2 yNTS R 72% 
3 PTS snN 79% Ts 
Bn 
4 
TBDPSOJNTS 
TSDPSOJ:j 62% 
Ts 
5 ~NTS ~ Ts 65% 
Table 6 
We notice that, in all the cases tested, piperidines were obtained in good yields 
and with complete retention of enantiopurity. Groups that could be useful in 
further transformations (OTBDPS and allyl) were tolerated under the reaction 
conditions. All piperidines formed were substituted by an exocyclic methylene, 
which provided further possible functionalisation. 
1.2.Cycloaddition Reactions of 2,2-Disubstituted Aziridines38 
Given that 2,5-disubstituted piperidines were prepared in good yields and in 
excellent enantiomeric purity, the substrate scope was expanded to include 2,2-
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disubstituted aziridines (Scheme 67). This was successful and spiropiperidines 
were obtained in good yields (Table 7). 
Entry 
1 
2 
3 
4 
j::NTS 
O)n 
10% Pd(OAC)2 
60% P(OiPrb c[;! 
20% nSuLi· N 
n Ts THF, 65°C 
Scheme 67 
Aziridine Product 
dNTS rf;! 
dNTS TsN 
Table 7 
Yield 
74% 
54% 
70% 
43% 
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1.3.Cycloaddition Reactions of 2,3-Disubstituted Aziridines38 
A final class of substrates that were investigated were the bicyclic aziridines 
(Scheme 68). The reactions were found to be slow and the yields low. However, 
piperidines with five- and six-membered rings were isolated (Table 8). In contrast, 
the seven-membered ring piperidine could not be isolated. 
ACO~SiMe3+ <.;I:NTS 
10% Pd(OAch 
60% P(OiPrb 
20% nSuLi 
THF. 65°C 
.. 
3 n 
Scheme 68 
Entry Aziridine Product 
H 
1 
ONTS 
<t) 
H Ts 
H 
2 
ONTS 
ay 
H Ts 
H 
3 ONTS a:r H Ts 
Table 8 
Yield 
15% 
29% 
0% 
Thus a wide variety of piperidines could be prepared, mostly in good yields, from 
readily available aziridine substrates. The door was open for the application of 
this technique to the synthesis of various natural products with a piperidine core. 
The possibility of formation of bicyclic or spirocyclic piperidines was especially 
encouraging due to their presence in a wide range of natural products. 
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2.Background 
During the application of this chemistry in target synthesis, a surprisingly 
inefficient [3+3] cyc1oaddition was observed when aziridine 130 was employed 
(Scheme 69). The reaction could not be optimized to any great extent after 
screening many catalyst systems and conditions. 
TBSO 
130 
10% Pd(OAc)~ 
60% P(O/Prh 
20% BuLi 
20% 
Scheme 69 
TBSO 
We decided to further explore this observation, in particular we wished to 
investigate whether there was any particular silylether effect on the [3+3] 
cyc1oaddition. 
That's the reason why part of our project was focused on the silylether-substituted 
aziridines and our investigation led us to the question whether there was any 
particular silylether effect on the [3+3] cyc1oaddition. Specifically, we chose to 
study the effect of the side chain on the cyc1oadditon, using the aziridines 
described below (Figure 3). 
TBDPSO~ 
N 
Ts 
n = 1, 2, 3, 4 
Figure 3 
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3.Synthesis of aziridine precursors 
Two different routes have been considered to synthesise the required aziridines 
(Scheme 70): 
• Aziridination of an alkene via a nitrene addition (Route 1) 
• Dehydration using amino-acids via a Mitsunobu reaction (Route 2) 
Route 1 
RO~ "TsN:" RO~NTS • 
n n 
Route 2 
NHTs 
-H2O RO~NTS RO~OH • 
n 
Scheme 70 
3.1.Aziridination via a nitrene addition 
Various routes towards the aziridine synthesis via a nitrene addition have been 
reported in the literature. Amongst them, chloramine-T coupled with various 
catalysts (phenyltrimethylammonium tribromide PhMeJ + BrJ- or PT AB 60, 
pyridinium hydrobromide perbromide py.HBr/1, N-bromosuccinimide62 NBS) 
have attracted a lot of interest. In our case, we used the route described by Sudalai 
and Thakur62, which is a modification of the Sharpless60 aziridination that uses N-
bromosuccinimide and chloramine-T. 
The mechanism of the aziridination remains unclear but some elements are 
proposed (Scheme 43). Firstly, bromide catalyst acts as a source of Br+. 
Secondly, it is believed that it reacts with chloramine-T to produce 131 which 
then reacts with the olefin to afford the bromonium ion 132. The ion can then 
undergo stereoselective opening by TsNCr species to produce 133 and then 
undergo cyclisation to yield the aziridine and regenerate the species 131 by 
reaction between chloramine-T and Br-Cl. 
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./ TsNCINa + NBS 
TsNCINa /" TsNBrCl + aX f=\ 
'-1 131 R R' 
!-Br 
HR G> 
TS'NA. .""Br L~{ e 
- r ~ + TsNCI Cl R',"H R / R' 
133 ~ 132 
Scheme 71 
We anticipated that we could prepare the desired silyl ether containing aziridines 
from the commercially available hydroxyalkenes 134-136. Initial efforts to 
prepare the aziridine from the unprotected hydroxyalkene failed, therefore, we 
decided to protect the hydroxyl group using tert-butyldiphenylsiIyl (TBDPS) 
group (Scheme 72). We obtained the expected protected hydroxyalkenes 137-139 
in excellent yields (Table 9). 
HO~ 
n 
134-136 
TBDPSCI, Imidazole 
DMF, 0 QC to rt 
n = 2, 3, 4 
Scheme 72 
• 
n Yield 
% 
2 93 
3 99 
4 95 
Table 9 
TBDPSO~ 
n 
137-139 
60 
Then, we proceeded to study the aziridination of the alkenes 137-139 (Scheme 
73). Unfortunately, we only obtained the desired products in poor to moderate 
yields (Table 10). 
TBDPSO~ 
n 
137-139 
TsN(Na)CI, NBS 
MeCN, 4A MS, rt 
n = 2, 3,4 
Scheme 73 
• 
n Yield % 
2 16 
3 25 
4 48 
Table 10 
TBDPS00
TS 
n 
140-142 
We can highlight an effect of the length of the side chain, since the longer the 
chain, the better the yield. It can be explained by the inductive effect of the silyl 
ether group; it makes the alkene less electron rich and therefore makes the 
bromination step slower. Since the closer the silyl ether group to the double bond, 
the stronger the inductive effect, this might explain the increasing of the yields 
when increasing the chain from n=2 to n=4. 
Whilst this route was not especially efficient, the reagents are cheap, easy to use 
and in each case we recover useful quantities of product together with the starting 
material. 
3.2.Amino acid route 
Since the product yields were quite low for compounds 140 and 141, we 
investigated an alternative route to synthesise these aziridines. EnantiomericaUy 
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pure aziridines can be obtained from enantiomerically pure amino acids by the 
method of CraigS9, which uses tosylation of the nitrogen before reduction of the 
acid functionality. Tosylation of the alcohol moiety generates a good leaving 
group, which permits ring closure to furnish the corresponding enantiomerically 
pure aziridine in high yield. The general pathway for the synthesis of aziridines 
starting with an amino alcohol (or amino acid when the alcohol is not available) is 
shown in Scheme 74. 
R R R 
R_ ~OH---. R_ ....lLG ___ J I" - I" ~ · R-<~H 
NH2 NH2 
Scheme 74 
This approach had already been investigated in the group towards the synthesis of 
a siloxymethyl aziridine (Scheme 75). This route started from the enantiopure and 
commercially available (D)-serine. 
HN ..... Ts 
SOCI2 NHTs l' TsCl, 2M N.OH MeOH ~C02Me ~C02H • C02H • 60% OH OH 60% OH 
j TBDPSCI, imidazole, DMF 
96% 
ADDP, BU3P /Ts HN ..... Ts 
(NTS Toluene 
HN LiAIH4' THF 
• ~OH • ~C02Me 
80% 63% OTBDPS OTBDPS OTBDPS 
(R)-143 
Scheme 75 
An advantage of this method is that the first two steps do not reqUIre 
chromatographic purification so aziridine (R)-143 can be easily obtained ona 
large scale. 
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Since this route provided good yields of aziridine, we applied this method to the 
required homologous aziridines. Starting from the racemic (D,L)-aspartic acid, we 
performed the esterification, then the tosylation of the nitrogen and the reduction 
of diester 145 into corresponding dio1146, all these three steps proceeded in very 
good yields (Scheme 76). At this point, we tried to protect one of the two 
hydroxyl groups but unfortunately, we got mainly the diprotected alcohol 147. 
JJ:fH2 SOCI2 HO 0 • MeOH 
OH 0 QC to rt 
~ 7H2.HCI 
Meo~O 
99% OMe 
THF, 48 h 
o QC to rt 
• 
~ 7HTSO Meo~ 
OMe 
(D,L) - aspartic acid 144 87% 145 
I 
NHTs NHTs 
TBDPSO 
I OTBDPS + I . ·OH ~ TBDPSO~ 
TBDPSCI, Imidazole 7HTS 
• ~OH 
48% 23% 
147 
Scheme 76 
DMF HO 
146 
LiAIH4: 60% 
LiBH4 : 86% 
Therefore, we decided to perform the Mitsunobu reaction, which worked better 
using PBU3 and ADDP than using PPh3 and DIAD (Scheme 77). As desired, the 
unprotected aziridine 148 was obtained in good yield. Then, we protected the 
alcohol using TBDPSCI in THF. We noticed a solvent effect for the protection 
step, the use of DMF resulted in addition of water to the aziridine. Finally, using 
THF, the desired aziridine 140 was synthesised in a good overall yield. This route 
is particularly interesting, since it has the potential to access enantiomerically pure 
aziridines. 
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NHTs ~TS PPh3, DIAD, Toluene; 54% HO~OH .. PBu3, ADDP, Toluene; 81% HO 
148 
~Ts TBDPSCI ~TS DMF; 0% .. 
HO Imidazole TBDPSO THF; 90% 
140 
o NH2 
HOJVYO 
OH 
(D,L) - Aspartic acid 
5 steps 
____ ..... TBDPSO~ 
140 NTs 
overall yield = 63% 
Scheme 77 
Based upon these good results, we used this methodology for the homologous 
aziridine, starting from racemic glutamic acid. Unfortunately, we mainly formed 
the five-membered pyrolidine in the final Mitsunobu ring closure step (Scheme 
78). 
o NH2 
HO~O 
OH 
(D,L) - glutamic acid 
~OH 
N 
Ts 
89% 
SOCI2 
MeOH 
+ 
• 
o NH2.HCI Meo~O 
OMe 
99% 
HO~TS 
11% 
Scheme 78 
THF,48 h 
o °C to rt 
• 
PBU3 ADDP 
.. ' 
o NHTs 
Meo~O 
OMe 
98% 
/
liA1H
4 
NHTs 
HO~OH 
51% 
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The previous results have been summarized in Scheme 79: 
./ We used the amino acid route for the synthesis of siloxyethyl aziridine 140, 
which represents a good way of preparing enantiopure aziridines . 
./ We used the nitrene addition route for siloxypropyl and siloxybutyl aziridines 
141 and 142 synthesis, which comprises a cheap and easy route. 
~ 7H2 HO~O 
OH 
(D,L) - Aspartic acid 
5 steps 
TBDPSCI, Imidazole 
• 
TBDPSO~ 
140 NTs 
overall yield = 63% 
HO~ 
n DMF, OOC to rt 
TBDPSO~ 
n 
n=2; 93% 
n=3; 99% 
n=4; 95% 
TBDPSO~ 
TBDPSO~ 
4. [3+ 3J Cycloaddition 
TsN(Na)CI, NBS 
MeCN, 4A MS, rt 
TsN(Na)CI, NBS 
.. TBDPSO~TS 
141 25% 
MeCN, 4A MS, rt NTs 
------------------------------------- TBDPSO~ 
142 48% 
Scheme 79 
Previous work in the group established optimum conditions for the [3+3] 
cycloaddition38, Although this method is capable of giving good results, it is also 
very capricious and to obtain high yields of product requires rigorous drying of 
recrystallised aziridine, distillation of the triisopropylphosphite from sodium and 
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the complete exclusion of air and moisture. Our proposed cycloaddition under 
these optimal conditions is summarized in Scheme 80. 
~NTS 
TBDPSOfJ
n 
140-143 
==(SiMe, 
OAc 
3 
------------~ 
Pd(OAc)2, P(OiPr)3 
n-BuLi, THF I 65°C 
n = 1-4 
Scheme 80 
OTBDPS 
149-152 
Additionally, by consideration of the proposed catalytic cycle for this reaction, 
some deductions can be made about desirable characteristics for the catalyst 
(Scheme 81): 
-/ Initial coordination 
An electron deficient ligand would promote this step as it would decrease the 
electron density at the palladium centre allowing the electron rich olefin to 
coordinate to the alkene; 
-/ Oxidative addition 
This would be promoted with electron donating ligands; 
-/ Desilylation 
An electron withdrawing ligand would make the iT-allyl palladium complex 
formed initially more electrophilic, promoting attack by acetate and thus 
desilylation; 
-/ Nucleophilic attack of Pd-TMM complex 6 on aziridine 
An electron donating group could be conceived to promote this step as it would 
increase the electron density and thus the nucleophilicity of the palladium-TMM 
complex 6; 
-/ Nucleophilic attack of sulfonamide on iT-allyl palladium (ring closure). 
As with desilylation, this could be aided by electron withdrawing ligands, making 
the palladium less electron rich and more electrophilic. 
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Phosphite ligands appear to provide the best balance of desirable electronic 
effects. Notably however, phosphite ligands are poor IT-donors so are less capable 
of stabilising palladium (0), meaning that more equivalents are required to prevent 
the precipitation of palladium black and concomitant loss of catalytic activity. 
Scheme 81 
So, depending on the rate determining step, which must be accelerated in order to 
accelerate the entire reaction, either electron donating or electron withdrawing 
ligands may help increase the rate. 
Another factor is the extent to which the acetate actually removes the TMS group: 
it may be that a pentacoordinate silicon is present in the intermediate 153, again 
changing the electronic requirements for the reaction (Scheme 82). 
Scheme 82 
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We decided to employ the standard conditions used in previous [3+3] 
cyc1oadditions, for the reactions of aziridines substituted by a silyl ether group. 
The results are shown in Table 11. 
PNTS 
TBDPso-ft)n 
==("siMe3 
OAc 
10 % Pd(OAch 'YI ACOl 
60% p(Oiprh· ....... ~:'tl)n TS(H)N~)n 
20% nBuLi Ts OTBDPS OTBDPS 
THF, 16 hrs, reflux 149-152 154-157 
0=1 67% 25% 
0=2 65% 17% 
0=3 20% 25% 
0=4 20% 60% 
Table 11 
AcO 
TSN\)n y OTBOPS 
158-161 
3% 
13% 
9% 
25% 
The first study was carried out in THF. It turns out that not only was the desired 
piperidine formed, but also by-products resulting from the ring opening of the 
aziridine by acetate. The ring opened products are then either just protonated to 
give 154-157 or trapped by the allyl-palladium species to give 158-16l. 
../ n=l: we mainly formed the desired product 149. This reaction was 
reproducible and we were able to repeat the high yields obtained by co-workers 
in the group; 
../ n=2: this reaction was often low yielding (-20% piperidine 150 and -60% 
155). Nevertheless, we once managed to obtain the piperidine 150 in a good 
yield, as shown in Table 11; triisopropylphosphite P(Oipr)3 had been freshly 
distilled and we conducted the reaction on a relatively large scale (-200 mg); 
../ n=3 and n=4: the yields obtained for the desired piperidines 151 and 152 were 
consistently poor and we mainly formed the by-products 156 and 157. 
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These results are quite difficult to rationalise but there does not appear to be any 
particular silyl ether effect. This cyc1oaddition is just very difficult to run and 
quite capricious and it requires rigorous conditions. We believe that, if we run the 
reaction more carefully, the cyc1oaddtion of the aziridines n=3 and n=4 will 
provide the desired piperidines 151 and 152 in reasonable yields. 
However, we wanted to establish if there was a solvent effect, hence we also ran 
the reaction in a less polar solvent, toluene (Table 12). 
,C::NTS 
TSDPso-f1jn 
=<=SiMe3 
OAc 
10 %Pd(OAc)2 ~ AcOj 
60% p(Oiprh· ....... ~s~)n TS(H)N~)n 
20% nSuLi Ts OTSDPS OTSDPS 
Tol., 16 hrs, reflux 149·151 154·157 
n=1 45% 0% 
n=2 49% Trace 
Table 12 
AeOj 
TSN~)n '-~ OTSDPS 
TI 158·161 
7% 
9% 
Toluene did not improve the reaction; we obtained moderate yields for 149 and 
150 and low yield for 151. THF appears to be a better solvent for this 
cycloaddition reaction. 
Inspired by Hayashi's work46 in 2006, we applied the conditions he developed on 
the cycloaddition of his azomethine imines to our silylether substituted aziridines 
(Scheme 83). 
° eQ 
)l.CB 
R H 
Pd(PPh3)4 
(8 mol%) 
• 
DeM, reflux 
Scheme 83 
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Unfortunately, the reaction wasn't really successful, leading to a mixture of by-
products (Scheme 84). 
(""'\7 
TBDPSO ~s 
=("SiMe3 
OAc 
Pd(PPh3)4 (8 mol%) 
DeM, reflux 
""U + OAc l ~S ,JNHTS 
OTBDPS lOTBDPS 
not isolated 40% 
Scheme 84 
OAc 
+ ,,··.eNTS 
TBDPSOJ Y 
51% 
Even though the mechanism of the ring opening by the acetate is unclear, we have 
made the following hypothesis. We assume that the desilylation is the slow step. 
The mechanism for formation of acetate opened product 163 must involve the 
presence of water in the system. The acetate generated from the TMM precursor 
attacks the aziridine 162 to leave an intermediate which can be protonated 
(presumably by the presence of small quantities of water) to provide the observed 
sulphonamide 163, whilst allylation of this species by Pd-TMM 6 generates the 
second by-product 164 and releases palladium (Scheme 85). 
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e 
~ Pd(O) AeO SiMe3 Slow? e • ~ • ~ + TMSOAe PR3 OAc SiMe3 
<±lPd(PR3)n f±)Pd(PR3)n 
o "-""if R • R~AC H2O R 163 
AeO +CN • Ae00NHTS 
Ts TSNG 
J 
162 e +6 
R 
R },Ac
G 
Pd(PR,), 
Aeo~ y1TS .. TS' $:-J 
164 n(R3P)Pd~ 
Scheme 85 
5.Investie;ation of alternative N-protecting groups 
Considering that we were not really successful with the [3+3] cyc1oaddition on 
silylether substituted aziridines, we decided to investigate the scope of this 
cyc1oaddition by screening different N-protecting groups for the aziridine. We 
decided to employ 2-benzyl substituted aziridines as the N-Ts analogue 165 
performed consistently well and could therefore be used as a control in parallel 
with the aziridines under investigation. 
DV 
Ts 
165 
=CSiMe, 
OAc 
3 
• 
Pd(OAe)2. P(Oiprh 
n-BuLi, THF, 65°C 
Scheme 86 
N 
Ph Ts 166 
79% 
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5.1.Aziridine Synthesis 
The synthesis of aziridines did not offer any particular problems. The racemic 
aminoacid phenylalanine 167 was reduced to the aminoalcohol phenylalaninol 
168, which represented a key intermediate for all the aziridines we were interested 
to test (Scheme 87). 
THF. 0 °C to RT 
167 
Scheme 87 
5. J.J.Suljonamide aziridines 
NH2 Ph~OH 
66% 
168 
Starting from the amino alcohol 168, the synthesis of I-sulfonamide aziridines can 
be easily performed using a base and the corresponding sulfonyl chloride, 4-
nitrobenzenesulfonyl chloride 169 for the nosyl group and methanesulfonyl 
chloride 170 for the mesyl group (Scheme 88 and Table 13). 
168 
R-S02CI 
Et3N. DMAP or 
____________ \ 2 Pyridine; KOH rN-SO 
R 
DCM, 0 °c to RT 
Ph 169-170 
R = CH 3• 4-nitrophenyl 
Scheme 88 
R Product 
43% 
4-nitrophenyl 51% 
Table 13 
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To prepare the trifluoromethylsulfonamide aziridine, we used triflic anhydride 
(Scheme 89). We have to mention that aziridine 171 seems not to be very stable, 
and therefore it has to be used reasonably soon after preparation. 
NH2 Ph~OH 
o 0 
11 11 
F C-~-O-~-CF 3 n n 3 
o 0 rN-SO ___________ • , 2 
CF3 Et3N, DCM 
OOC to RT Ph 68% 171 
Scheme 89 
For the synthesis of the Bus-protected aziridine, we had to make the N-chloramine 
salt of the tert-butylsulfonamide 173 from tert-butylsulfinyl chloride 172 (Scheme 
90) and then performed an aziridation according to Sharpless'conditions using 
allylbenzene 174 (Scheme 91). 
e 
9 <±> e 
tBU .... & .. N=N=N 
60% 
Scheme 90 
~ BusN(Na)CI, PTAB 
~--------------~~~ 
174 
MeCN, rt 
37% 
Scheme 91 
<D 
~uOCI ~ e Na 
------.... tBu-~-N .. c 
o I 
NaOH (1 M) 173 
90% 
The aziridination proceeded in poor yield but all the reagents are cheap and easy 
to handle, which makes the reaction easy to set up and easy to scale up. 
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5.J.2.Carhamate aziridines 
We decided to prepare two carbamate-substituted aziridines via a Mitsunobu 
reaction on the aminoalcoho1168 (Scheme 92) followed by protection of the free 
aziridine 176 using the corresponding chloroformate (Scheme 93 and Table 14). 
PPh3• DEAD 
Toluene reflux 
168 
~ V ~. 
H 176 
65% 
Scheme 92 
~H 
176 
R 
'-0 )=0 
Cl 
• 
Scheme 93 
R 
4-nitrophenyl 
2-chlorophenyl 
Table 14 
5.2.[3+3] Cycloaddition 
uv 
oAO/"'--R 
177-178 
Product 
64% 
99% 
With all these aziridines in hand, we turned our attention to the cyc1oaddition 
using the optimum conditions developed in our labs (Scheme 94 and Table 15). 
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V'v R 
==CSiMe, 
OAc 
3 
Or 
Pd(OAch, P(Oiprh 
n-BuLi, THF, 65°C 
N 
Ph R 
Scheme 94 
~OAC 
V (NR 
A 179 
+ 
~OAC 
V NHR 180 
Entry R Product By-product By-
1 
2 
3 
4 
5 
6 
1 product 2 
-S02CH3169 
-S02CF3171 
-S02C(CH3)3 175 
-S02( 4-nitrobenzene) 170 19% (178) 14% (179) 
-C02CH2( 4-nitrobenzene) 177 
-C02CH2(2-chlorobenzene) 178 
Table 15 
Unfortunately, we quickly realized that we mainly recovered the starting material 
in most cases (entries 1, 3 and 5, Table 15). It seems that, as for the sulfonamide 
protecting group, the tosyl group is the protecting group of choice since mesyl and 
Bus groups 169 and 175 returned starting material, whereas the reaction with the 
trifluoromethanesulfonyl protected aziridine 171 resulted in a complex mixture 
with no piperidine having been isolated. We can, however, notice that the TMM 
precursor reacted with the nosyl protected aziridine 170 to give the two by-
products. The carbamate protected aziridines 177 and 178 were not successful 
either, giving mainly recovered starting material. 
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SM 
89% 
100% 
39% 
85% 
42% 
6.Functionalisation 
With the piperidines 150-152 in hand, we opted to study the functionalisation of 
the exo-alkene group on the piperidines. 
6.1.Dihydroxylation 
Using the piperidines (S)-150 and (S)-151, we performed a dihydroxylation 
reaction with a catalytic amount of osmium tetroxide and NMO (Scheme 95). 
(A) 
OS04 cat., NMO OH OH CV U OH U···' ......... OH AcetonelWater (4:1), RT .' + . .. ~ N ~ N Ts l Ts l Ts 
OTBDPS 71% OTBDPS OTBDPS 
(S)-150 dr 5:1 181 182 
(8) 
0504 cat, NMO OH OH 
" .. et AcetonelWater (4:1), RT (j'OH .. U··\' ......... OH ~ ~ ~s + ~ ~s 83% ~ ~s 
dr 6:1 OTBDPS OTBDPS OTBDPS 
(S)-151 183 184 
Scheme 95 
In both cases, two diastereoisomers were formed but we were unable to separate 
them by column chromatography or by recrystallisation. The ratios 1811182 and 
183/184 were determined by IH NMR spectroscopy. However, we have been 
unable to ascertain which of the diastereoisomers is the major, nonetheless we 
obtained a good diastereoselectivity in both cases. 
It is known that in most circumstances, it is energetically more favourable for a 
large alkyl group to occupy an equatorial geometry in cyclohexanes in order to 
avoid unfavourable 1,3-diaxial interactions. However, in the case of piperidines 
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with a tosyl group attached to nitrogen, the silyl ether group present at C2 should 
adopt axial geometry in 185 in order to minimise A I ,3 strain (Scheme 96)63. 
Therefore, any nucleophilic attack should mainly and preferentially occur from 
the bottom face of the alkene away from the N-Ts. This conformation has been 
confirmed by previous work within the group39,64-66. 
(17 
TBOPSO 9~ 0' "0 
~I 
:::-... 
Scheme 96 
~r {~ ~ 
(~n 
OTBOPS 185 
Once we defined the supposed conformation of the piperidines, we could assume 
that in (A) in Scheme 95, 181 should be the major product, whereas, in (B), it 
should be 183. The obtained products are very interesting, since they bear three 
different hydroxyl groups, two primary alcohol (including a protected one) and 
one tertiary alcohol. 
6.2.Hydroboration 
We also considered the hydroboration reaction of the piperidine (S)-150, using 
borane dimethylsulfide, hydrogen peroxide and sodium hydroxide (Scheme 97). 
CV 1) BH3.OMS, THF, RT ccfH 
H ?H U l ' .' 2) H202, NaOH, RT 
~ + 
" 
" N 
Ts 76% Ts l Ts 
OTBOPS OTBOPS OTBOPS 
dr: 5: 1 (S)-150 186 187 
Scheme 97 
Once again, we obtained two diastereoisomers 186 and 187 in a good yield. We 
didn't manage to separate them but we determined the diastereoisomeric ratio (dr) 
77 
by IH NMR spectroscopy. Whilst the diastereoselectivity was encouraging, we 
envisage that this would improve using bulky borane reagents such as 9-BBN. 
As just shown, the [3+3] cycloaddition has been applied to a particular class of 
substituted aziridines, the silylether substituted aziridines. It has been proved to be 
a challenging reaction, difficult to reproduce but good results can be obtained 
under rigorous conditions. 
Since the efficiency of the Pd-TMM technique is quite variable according to the 
substituent used on the aziridines, an alternative approach has been developed 
which may avoid the problems of reduced reactivity and potential by-products; 
this methodology utilised more heavily substituted organomagnesium reagents 
and is described in the next chapter. 
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Chapter III - Introduction to Organomagnesium 
Chemistry 
l.Allylalcohol derived organomaenesiun reagent 
As discussed previously, the [3+3] cycloaddition using Pd-TMM can be a good 
way to form piperidines but unfortunately it doesn't work in all cases; we have 
uncovered several instances where the Pd-TMM reagent fails to add to the 
aziridine or does so with low levels of conversion. We therefore turned our 
attention to a more nucleophilic alternative in an effort to generate the desired 
piperidines in high yields for all substrates (Scheme 98). 
e~ 
0 8 
I ! \/,R. 
: N 
I Ts 
+ 
MR 
OR NHTs 
------------ .... l)R 
Ts 
Scheme 98 
Based on work by Klumpp et a167-72 and within the group, we investigated the use 
of Grignard chemistry for the preparation of piperidines. In practice, we have 
employed Trost's conjunctive reagent (2-[(trimethylsilyl)methyl]-2-propen-l-yl 
acetate) 3, which is prepared from methallyl alcohol 1887• As outlined in Scheme 
99, double deprotonation of methallyl alcohol 188 provides allyllithium 189 
which is quenched by TMSCI to provide allylsilane 190. The TMM-precursor 3 is 
finally generated after hydrolysis of 190 and acylation. It is notable that the first 
step of this sequence furnishes a reactive allyllithium species 189 and we 
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contemplated employing this intermediate as our "strongly nucleophilic" TMM-
equivalent. Accordingly, transmetallation to the corresponding organomagnesium 
compound furnishes a reagent that will add to aziridines that are inert to our Pd-
catalysed [3+3] cycloaddition methodology. 
" 2eq n-BuLi R ~OH • ( 'v'0Li 
188 Li 189 
A ==)l ~ 1. MgBr2 MR .. 
Li OLi e 0 Li OLi 
2. }NTS OH NHTs 189 189 191 
R 
Scheme 99 
Preliminary results in the group58 showed that double deprotonation of methallyl 
alcohol 188 and addition of the organolithium reagent to 165 only succeeded in 
furnishing 192 after a large excess of reagent was employed (Scheme 100 and 
Table 16). Therefore, a transmetallation to the organomagnesium reagent by 
addition of MgBr2 was performed and addition of the Grignard reagent to 165 
provided 192 in moderate yield. Further optimization showed that excellent yields 
of product could be obtained when aziridine 165 was added to 5 equiv of Grignard 
reagent and that the reaction was effectively complete within 2 h. 
~ 
OH 
188 
1. BuLi, TMEDA II _ 
2. Additive. ( ............... "l",Bn 
3. ~NTs OH NHTs 
r 192 
Bn 165 
Scheme 100 
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Equiv of Xi additive conditions yield 
10 25 °C, 2 h 19% 
3 MgBr2 25 °C, 18 h 53% 
5 MgBr2 25 °C, 18 h 88% 
5 MgBr2 25 °C, 2 h 87% 
a Organomagnesium reagent prepared by addition ofTMEDA (2.6 equiv) 
and n-BuLi (3.0 equiv) to 165 followed by MgBr2 (2.6 equiv) 
Table 16 
Following the investigation on the aziridine ring opening with the Grignard 
reagent, work in our group was also focused on developing an efficient method 
for the cyclisation process. Specifically, a transition metal catalysed one-step 
cyclisation reaction was investigated. Hirai and Makabe have reported that Pd(II) 
catalysts mediate the closure of carbamates onto aIIylic aIcohols without need for 
pre-activation of the hydroxyl unit'3 (Scheme 101). Additionally, Yang and Hung 
have performed a Ti-mediated allylation reaction that proceeds through a Pd !r-
allyl intermediate and that has been successfully employed on 1, I-disubstituted 
alkenes74• 
Hirai's process 
re 
R NHR' OH 
cat. • [ ~~'~l R~::R' 
Yang's process 
re cat. • [RJ!f~(-H Pd'j R NHR' OH Ti(OR). 
Scheme 101 
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M··,Bn 
OH NHTs 
166 
--_. l)"Bn 
Ts 
192 
Scheme 102 
conditionsa Yield (%) 
i) 5 mol% of PdCh, THF 
ii) 5 mol% ofPd(OAc)2, 20 moI% ofPBu3, 
60 mol% of Et3B, THF 
o 
75 
iii) 5 mol% ofPd(OAch, 40 mol% ofPPh3, 100 
25 mol% of Ti(Oipr)4, 4A MS, toluene 
a All reactions run at reflux over ISh 
Table 17 
As shown in Table 17, cyclisation of 166 towards the piperidine 192 using PdCh 
was unsuccessful, and starting material was recovered. In contrast, the B-
promoted amination provided the desired piperidine in good yield although 
presence of the alkene isomerisation product was noticed. The Ti-promoted 
reaction proceeded smoothly to give piperidine 192 in high yield with the optimal 
conditions resulting from overnight reflux in toluene. 
In the past, the scope of this 2-step piperidine forming reaction was investigated 
and its efficiency compared with the Pd-TMM cycloaddition process (Scheme 
103). 
10% Pd(OAc)2. 40% PPh3 
25% Ti (Oipr)4' 4A MS ~R3 
.. l..N~R2 
toluene. 110°C Ts R1 
Scheme 103 
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aziridine Grignard Addition Cyclisation Overall Pd-TMM 
yield yield yield yield 
\1' "Bn 87% 100% 87% 79% 
N 
Ts 
\1' "Me 93% 67% 62% 82% 
N 
Ts 
92% 81% 74% 15% 
-\T'l 
~ OTBS 
s 193 
ONTS 76% 77% 58% 0% 
194 
Table 18 
Table 18 highlights that whilst aziridines 193 and 194 had been found to be 
sluggish in the TMM-mediated [3+3] cycloaddition chemistry, the corresponding 
piperidines were formed in excellent overall yield using this modified procedure. 
Encouraged by these excellent results, we decided to apply this methodology to 
our aziridines 140-142, using the pathway outlined in Scheme 104. 
TBDPSOtb 
II 1. BuLi, TMEDA. [ R ] 140-142 ~s. /1 2. MgBr2 (, 
OH BrMg OMgBr 
TBDPSO~ 
NHTs OH 
TBDPSO~ 
NHTs OH 
PdCat. . ~ 
Ti (Oipr)4 ... TBDPSO~t{) 
n Ts 
Scheme 104 
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Starting from commercially available methallyl alcohol, we formed the Grignard 
reagent and then investigated the ring opening of the aziridines (Scheme 105). As 
shown in Table 19, we were delighted to find that the desired ring-opened 
products were formed in good yields. 
~ 
188 OH 
TBDPSO~ 
1. BuLi, TMEDA .. [ ] ] 140-142 ~s .. 
2. MgBr2 (I 
BrMg OMgBr 
195 
TBDPSO~ 
NHTs OH 
196-198 
Scheme 105 
Entry n Producta Yield 
1 2 
TBDPSUX 
NH OH 76% 
196 Ts 
2 3 ~H 73% 
TBDPSO 197 Ts 
3 4 99% 
• Organomagnesium reagent prepared by addition ofTMEUA (3.0 equiv) and n-HuLi (4.0 equiv) to 188 
followed by MgBrz (2.0 equiv). S.O equiv. of this reagent added to aziridine. 
Table 19 
In addition, we were very pleased to see that the cyclisation worked very well and 
that we could synthesize the desired piperidines 150-152 in good yields (Scheme 
106 and Table 20). 
84 
TBDPSO~ 
NHTs OH 
196-198 
Entry n 
1 2 
2 3 
3 4 
10% Pd(OAc)2 
40% PPh3 
25% Ti(Oipr)4 
TBDPsoN 
n Ts 
Scheme 106 
Piperidines 
TBDPSO~ 
150 Ts 
~ 
TSOPSO 151 Ts 
N 
Ts 
OTSOPS 152 
Table 20 
150-152 
Yield 
90% 
84% 
87% 
This method has great potential for the formation of functionalised piperidines, 
since we performed the synthesis of the desired piperidines in only two steps. It 
uses cheap, commercially available reagents and works on the aziridines which 
had proved to be challenging substrates for the TMM-mediated cycloaddition. 
The synthesised piperidines are very interesting in terms of functionalisation, 
since they bear an exo-alkyne group and a protected primary alcohol. 
Motivated by the fact that pyrans are a common motif to many natural products 75, 
76 and in an effort to broaden the scope of this strategy, the use of this allyl-
magnesium reagent in addition to epoxides was also investigated within the group 
by another PhD student and it proved to be also very efficient77 (Scheme 107 and 
Table 21). 
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epoxidea 
VBn 
o 
\7'l 
o OBn 
\7'l 
o OTBDPS 
toluene. 110°C 
Scheme 107 
Grignard Addition Pyran Overall 
yield yield yield 
76% 82% 62% 
74% 85% 63% 
50% 83% 42% 
76% 67% 51% 
• Organomagnesium reagent prepared by addition ofTMEDA (2.1 equiv) and n-BuLi (2.1 equiv) 
to 188 followed by MgBrz (2.1 equiv) 
Table 21 
Although we were pleased that the sequence Grignard reaction-cyclisation had 
been successful with both aziridines and epoxides, a significant drawback of this 
method was the requirement for 5.0 equivalents of the in situ generated Grignard 
reagent 19578• 
One reason for this is that the titration process was not really accurate to assess 
the concentration of 195: we used 4.0 equivalents of n-BuLi and 2.0 equiv of 
MgBr2. meaning that 2.0 equiv of butylmagnesium species remained after 
transmetalation and were also taken into consideration during the titration process. 
Trost used 2.6 equiv of BuLi7 for the double deprotonation of 188 therefore we 
wondered if this could be further reduced without significantly affecting the 
deprotonation process. 
Accordingly, 2.1 equiv each of n-BuLi and TMEDA were used and this resulted 
in formation of a orange gum after stirring at room temperature for 24 h. Removal 
of the ethereal solution by cannula and addition of fresh ether and freshly prepared 
MgBr2{from magnesium turnings and dibromoethane) resulted in the formation of 
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a white precipitate that was removed from the Grignard reagent by cannula 
filtration. Titration of the resulting solution generally provided a concentration of 
active reagent of around 0.1 M (Scheme 108). 
With the Grignard reagent in hand, we turned our attention to the study of its 
addition to our silylether substituted aziridines (Scheme 109). As outlined in 
Table 22, we were delighted to find that the organomagnesium reagent 195 
underwent smooth addition to our aziridine (R)-140. Moreover, only 2.5 
equivalents of reagent were required to achieve complete conversion of each 
aziridine substrate. 
~ 
OH 
(""\7 
TBDPSO ~s 
(R)-140 
2.1 eq BuLi 
A 2.1 eqTMEDA 1. Et20 A .. .. 2.2.1 eq MgBr2 Et20,24 h Li OU BrMg OMgBr 
(CannUla) Orange gum [Filter) 0.1-0.2 M 
Scheme 108 
+ A .. (""M BrMg OMgBr TBDPSO NHTs OH 
195 (5)-196 
Scheme 109 
Equivof Product 
Grignard Yield 
5.0a 76% 
2.5b 85% 
• Organomagnesium reagent prepared by addition of TMEDA 
(3.0 cquiv) and n-BuLi (4.0 cquiv) to 188 followed by MgBrl (2.0 cquiv). 
b Organomagnesium reagent prepared with the improved method: 
TMEDA (2.1 cquiv) and n-BuLi (2.1 cquiv) to 188 followed by MgBrl (2.1 equiv). 
Table 22 
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This improved method to generate the active Grignard reagent 195 was much 
more convenient: 
• it allowed us to use less equivalents of Grignard 195; 
• the set-up of the reaction was straightforward, since the reagent was directly 
added via syringe to a solution of aziridine in THF; 
• the solution could be used several times, as long as it was regularly titrated. 
The only disadvantage was that the solution of 195 had to be used within 3 or 4 
weeks, the molarity decreasing over this period. 
We had assumed in our studies that the organomagnesium reagent had the formula 
195; however, it occurred to us that the reactive reagent could well be the cyclic 
organomagnesium alkoxide 199 formed by the Schlenk equilibrium79 (Scheme 
110). 
~ 
BrMg OMgBr 
~ 
MgO 
195 199 
Scheme 110 
Experiments carried out in our laboratories suggest that MgBr2 is essential for 
successful addition of the doubly deprotonated methallyl alcohol to epoxides 78; 
however, it is not clear whether the reaction involves Grignard reagent 195, or is 
the result of a MgBr2-promoted addition of cyclic magnesium alkoxide 199. 
Inspired by Bartmann's work on the cleavage of tetrahydrofuran by transition-
metal activated magnesium8°(Scheme 111), we tried to clarify this issue by 
preparing cyclic magnesium alkoxide 199 starting from oxetane 202 (Scheme 
112). 
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Q + Mg • Og ~ M9(O"8U'2) 
~~~y200~H20 / 
~ nSuOH 
l..OAO 
201 
Scheme 111 
~ Mgtuming~ Lb c ~ 
MgO 
oxetane 202 199 
Scheme 112 
Bartmann tested a range of transition metal salts (TiCI4, ZrCI4, VCI4, NbCIs, 
CrCh, MnCh, FeCh, CoCh, NiCh) for their catalytic activity in THF cleavage. 
They were usually used in a 10 mole percent ratio to magnesium, in a large excess 
of THF. Three different types of magnesium were used: commercial magnesium 
powder; activated magnesium according to Rieke81 ; activated magnesium 
according to Bogdanovic82• The mixtures were heated to reflux and after a certain 
time the amount of the cyclic organomagnesium compound 200 was determined 
by quenching of the mixtures with dilute acid and GLC analysis of the yield of 
butanol formed. The reaction mixtures were occasionally quenched by 
introduction of carbon dioxide, which converted 200 into o-valerolactone 201 
(Scheme ,.111). The best results obtained by Bartmann (72% butanol; 35% 0-
valerolactone) were when he used TiCl4 as catalyst precursor, with magnesium 
activated by Rieke's method under reflux for 285 h! 
First, we had to focus on the synthesis of the substrate, oxetane 202, which 
appeared to be very challenging. Our first idea was to start from epichlorohydrin 
203 to make oxetanone 204 using conditions developed by Baum and 
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collaborators83 and improved by Kozikowski84; then a Wittig reaction should 
provide us with the desired 3-methylenetrimethylene oxide 202. 
CI~ 
o 
203 
Ob 
--....... 0 • 
204 
Scheme 113 
------ b 
o 
202 
Ring opening of epichlorohydrin by acetic acid, followed by protection of the 
resulting secondary alcohol 205 with ethyl vinyl ether offered compound 206 in a 
good overall yield. No particular purification was made at this stage (Scheme 
114). 
• 
A~'" 
OAc Cl 206 
HOAc ?H CI~ • rl 
° FeCI3• 65-70 °C OAc Cl 
203 205 
p-TsA cat. 
50% ove r 2 steps 
Scheme 114 
Then, aqueous sodium hydroxide hydrolysed the ester and also closed the oxetane 
ring to offer 207. The crude IH NMR spectrum being clean, compound 207 was 
also used without further purification for the next step (Scheme 115). 
0,1.0""" 
~ 
OAc Cl reflux 
206 
Scheme 115 
Still following Baum's procedure, crude 207 was treated with methanol and a 
catalytic amount of p-toluenesulfonic acid. A distillation under reduced pressure 
was carried out in order to purify the desired 3-hydroxyoxetane 208 (Scheme 
116). 
90 
pT sA OH 
MeOH, NaHC03 od 
208 
Scheme 116 
Unfortunately, even after several distillations, no clean product was obtained; 
NMR studies carried out on the different fractions seemed to show that the 
product was decomposed during the distillation, and it probably polymerised. In 
fact, the desired oxetane 208 has been described in the literature as having a 
boiling point around 230°C. Our different distillations were carried out between 
120 and 150 °c under 20 mmHg; this could explain why the product had 
decomposed, or even it polymerised at high temperatures. This sequence of 
reactions was repeated several times, and in each case, the alcohol deprotection 
step appeared to be unsuccessful. 
We then thought that the reaction might fail due to the deprotection conditions; 
therefore, we employed two other acids, CSA and PPTs. Unfortunately, in those 
cases too, we were unable to isolate any desired product 208. 
We then tried to change the protecting group for a silyl ether (TBDPS and TMS). 
This strategy did not make any difference, the isolation and purification of the 
oxetane 207 by distillation still being unsuccessful. 
The purification of 3-hydroxyoxetane 208 by distillation appearing to be very 
challenging, we decided to change our strategy to synthesise oxetane 202 and 
envisaged a more direct method (Scheme 117). 
~ ...... -
OH OH 
~ ..... -~ 
OH Br 0 
209 210 202 
Scheme 117 
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Diol 209 was readily obtained following Wuest's conditions85 starting from 
compound 211 (Scheme 118). 
~ AcOH,DBU r\ NaOMe, Me OH r\ »- »-
Cl Cl Benzene reflux, 72 h OAc OAc o °c to rt 48 h OH OH 
211 96% 212 80% 209 
Scheme 118 
We then submitted diol 209 to bromination conditions, hoping that we could 
obtain the monobromo derivative 210. Unfortunately, no desired product could be 
isolated, only the dibromo derivative was detected by LCIMS spectroscopy 
(Scheme 119). 
A PBr3 (0.5 eq.) ~ ~ .. 
OH OH THF, -50°C Br Br OH Br 
209 mainly not isolated 
210 
Scheme 119 
As we experienced many difficulties to synthesise the starting material 202, we 
were unable to apply Bartmann's methodology and to carry out further studies on 
our Grignard reagent. 
We also investigated the role of TiCfOPr)4 in the cyclisation. Originally, we 
thought that it was there to act as a Lewis acid and it would help to form the Pd-
allyl complex by coordinating to the 0 of the allyl alcohol, making it a better 
leaving group. However, we later realised that it was not necessary for the 
reaction to occur (Scheme 120 and Table 23). 
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10% Pd(OAc)2. ~ 
40% PPh3• l. ) 
4A MS ~ TBDPSO./"......\\\· N 
Toluene reflux Ts 
(S)-196 (S)-150 
Scheme 120 
Lewis acid Product 
Yield 
none 84% 
25 %Ti(OPr)4 90% 
Table 23 
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Chapter IV - Application: Natural Product 
Synthesis 
l.Introduction to the Properties and the Synthesis of the 
Ouinolizidine Alkaloids 
1.1.1ntroduction 
Alkaloids are nitrogen-containing naturally occurring compounds, produced by a 
large variety of organisms, including fungi, plants, animals and bacteria. 
Alkaloids are part of the group of natural products and are chemical derivatives of 
amino acids or other nitrogen-containing compounds, such as polyamines. They 
have many biological activities and are usually active in extremely small 
quantities. Extracts of plants containing alkaloids as the active ingredient have 
been used as poisons, stimulants and medicines. 
Among these alkaloids, we were particularly interested in highly toxic 
quinolizidine and indolizidine alkaloids isolated from the skin of poisonous 
amphibians, since they have been reported to be efficient research tools for 
neurophysiological investigations. For example, quinolizidine alkaloids obtained 
from marine sources have been recently identified as leading compounds for the 
d I f · . . fl d d' I d 86 eve opment 0 antIcancer, antI-m ammatory an car lOvascu ar rugs 
(Scheme121). 
n-Bu '1", 
I~ ~ 
Epiquinamide (+)-Pumiliotoxln 251 D Qulnolizidine (-)-217 A Qulnolizidine 2071 
Scheme 121 
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The quinolizidine moiety is incorporated into a vast range of complex plant 
alkaloids87 t but relatively few quinolizidines (l-azabicyclodecanes) have been 
isolated. Therefore, we would like to exploit the methodology described in the 
previous chapters through its employment in target synthesis. As such, we 
considered to utilise this chemistry to prepare quinolizidine alkaloid (-)217 A, an 
amphibian alkaloid isolated by Daly in 1993 from skin extracts of the Madagascan 
frog Mantella barom.88, 
1.2.Previous syntheses 
The first total synthesis of quinolizidine alkaloid (-)217 A was reported by Pearson 
and Suga in 199889, After investigating several azide-based routes, they outlined 
that the cyclisation of an azide onto an ester-bearing alkene yielded a 3,4,5,6-
tetrahydropyridine that could be stereo selectively reduced to produce a cis-2,6-
disubstituted piperidine (Scheme 122). 
I~ 
Scheme 122 
Accordingly, addition of allyltrimethylsilane to the aldehyde 21390-92 followed by 
cyclisation of the resultant hydroxyester afforded the lactone. After formation of 
the corresponding enolate, lactone 214 was methylated to produce a 1:1 mixture 
of diastereomeric lactones 215 (Scheme 123). 
C02M• ~TMS CC 0 TiCI4 LOA; Mel • • TsOH, PhH, Dean-Stark CHO 1: 1 cis:trans 73% 93% 
213 214 215 
Scheme 123 
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Based on studies carried out by Cha on cycloaddition of ester-bearing 
azidoalkenes for the synthesis of indolizidines93, lactone 215 was then subjected 
to an oxidative cleavage to give the aldehyde, which was protected to give the 
acetal 216; 216 was reduced to the lactol 217 and converted to the alkene 218 
after a Wittig reaction (Scheme 124). 
.. 
DiBAL-H; 
[Ph3P(CH2hC02Et)]Br, 
KHMDS 
52% 
217 
1: 1 cis:trans 
215 
1:1.1 cis:trans 1 :1.2 cis:trans 
216 
218 
1 :1.2 cis:trans 
Scheme 124 
The inseparable 1: 1.2 mixture of diastereoisomers was heated to produce the 
triazoline 219 initially, which decomposed to the imine 220 as a 1: 1.3 mixture of 
diastereoisomers. Inspired by the report of Lhommet and co-workers94 on the 
stereoselective reduction of pyrrolines, Pearson and Suga managed to 
stereoselectively reduce the crude imine with NaBH4IPdCh as an inseparable 
1: 1.3 mixture of the two cis-2,6-disubstituted piperidines 221. The two piperidines 
were separated after saponification of the ester group offering the precursor of 
quinolizidine 217 A 222 in good overall yield (Scheme 125). 
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.. 
.. 
1200C,66h 
1 :1.2 cis:trans 219 1:1.3 cis:trans 
218 
0" ....... ./"0.... " ""'" 'C02H NH 1}NaOH _ EtOH 
.. 
2} separate 
~-Me, 34% from the azide 222 
a-Me, 26% from the azide 
Scheme 125 
yo 1:1.3 cis:trans 
0] 221 
After a 5-step sequence involving reduction of the acid to the alcohol, cyclisation 
to the quinolizidine via an allyl chloride, hydrolysis of the dioxolane to the 
aldehyde followed by olefination using Yamamoto's method9S, they managed to 
synthesise the corresponding silyl enyne quinolizidine, which, after treatment with 
TBAF, afforded the desired quinoIizidine 217 A (Scheme 126). 
Q':lC02H 1) LiAIH4 (84%) Cb 3) aq. THF I~ .. .. 2} PPh3 , CCI4 4} TMSCCCH2SiMe2tBu, NEt3 (75%) tBuLi, Ti(OiPr)4 (42%) ~) (t 5) nBu4NF (90%) (-)217A 
222 
Scheme 126 
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In 2003, Panek and collaborators96 described an alternative route towards 
quinolizidine 217 A. The key step in their synthesis was the fonnation of the 
terahydropyridine core, which relied on an intramolecular imine crotylation. This 
chemistry was based on previous experiments towards the synthesis of 
dihydropyrans via a [4+2] annulation, which highlighted the important role of a 
silicon-bearing centre to control the stereoselectivity97. They applied this 
methodology to initiate the synthesis of the desired quinolizidine, using silane 
22398, 99 and aldehyde 224 to provide Cbz-protected tetrahydropyridine 225 as a 
single diastereoisomer in 60% yield (Scheme 127). 
~H2 
~; C02Me 
223 SiMe2Ph 
+ H~OAC 
224 
1) MgS04, DCM 
----------------~ 
2) TiCI4, DCM 
3) CbzCI, Na2C03, DCM 
Scheme 127 
~.\\~OAc 
L~CbZ 
225 
A 5-step sequence of functional group interconversions afforded the enol-ether 
intennediate 226 (Scheme 128). 
O 3) CBr4, NEt3, .• \\\ PPh3, DCM, rt (93%) NH 4) a. DiBAL-H, Et20 
=. b. Ph3P=CHOMe, THF (67%) 
C02Me OH 
• 
~ 
OMe 
Scheme 128 
Enol-ether 226 was subsequently converted to the corresponding aldehyde, which 
was subjected to Yamamoto's olefination and desilylation (as previously 
discussed) to produce quinolizidine (-)217 A (Scheme 129). 
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226 
~ 226 
OMe 
1) a. 6 N HCI, Et20 
b. TMSCCCH2 TBS, tBuLi, 
Ti(iOPr)4, THF, ZlE 5:1 (60%) 
Scheme 129 
The last and most recent synthesis was reported by Maloney and Danheiser in 
2005100. Their strategy for the synthesis of the azabicyclic core of the 
quinolizidine involved the intramolecular [4+2] cycloaddition of 
iminoacetonitriles101 , 102 227 to afford a-amino nitriIes like compound 228 
(Scheme 130). 
H 9H3 H CH3 CH3 
~I roOSiR, ~OSiR' > > N~CN ; 
-228 CN 227 
Scheme 130 
Starting from commercially available 5-hexenol, Mitsunobu coupling with 
TfNHCH2CN yielded the corresponding sulphonamide, which underwent 
ozonolysis to furnish aldehyde 229. Wittig olefination of aldehyde 229 gave the 
(E)-a,p-unsaturated ketone 230 and its conversion to the desired enol ether 231 
was achieved using the general procedure of Dunogues et al 103 (Scheme 131). 
99 
1) TtNHCH2CN 
~ Ph 3P, DIAD, rt, 2h (89%) GO 
~OH • TNf, 2) 0 3, DCM, -78°C; 
Ph 3P, rt, 18h (92%) 229 CN 
Scheme 131 
o ArPPh,. cfro 
toluene, 700C N, 
7h (85%) 230 CN 
fBuMe2SiCI 
Nal, Et3N 
CH3CN, rt, 18h 
(90%) 
cfr°TBS Tt NI 
CN 231 
The desired reagent used for the cycloaddition, iminoacetonitrile 232, was 
obtained under basic conditions as a mixture of E and Z imine isomers. 
Azobicycle 233 was then formed as a single isomer by heating 232 at 130°C for 
36 h and the addition of BHT (butylated hydroxy toluene) was deemed necessary 
to avoid any decomposition or polymerisation of the product, BHT preventing 
radical formation which can polymerise double bonds (Scheme 132). 
CS2C03 d5 c0roTBS THF c:)rOTBS 130°C, 36 h ~ ~ OTBS Tf .. 
Ni N~CN 
.. 
55°C, 1.5 h BHT, toluene 
= 
CN EIZ 84:16 CN 85% 55% 233 231 232 
Scheme 132 
Alkylation of a-amino nitrile 233 with (Z)-3-bromo-l-chloropropene proceeded 
smoothly and the desired quinolizidine 234 was then obtained by reductive 
decyanation (Scheme 133). Finally, cleavage of the silyl enol ether with TBAF 
generated ketone 235 as a single diastereoisomer with the desired stereochemistry 
at the methyl group. 
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1) LiHMDS 
~~X3/ RBr, THF lJ:r OTBS _-7_8_0_C_,_2_h_ .... 
CN 
233 
2) NaBH3CN 
AcOH, CH3CN 
r~ 2h 234 
Cl 74% 
RBr= ~ 
Br 
Scheme 133 
H ~H3 
TBAF, THF ~:. 0
-780C, rt· N I 
235 
~ 
87% 
Reduction of the ketone to the corresponding alkane was performed using a Wolf-
Kishner reaction, by reducing the tosylhydrazone derivative with NaBH3CN in 
presence of tert-butyl mercaptan (Scheme 134), Then a Sohogashira coupling 
with trimethylsilylacetylene followed by a desilylation reaction to remove the 
TMS group offered quinolizidine (-)217 A. 
QH3 
TsNHNH2 QH3 ~ ~ 0 I:l, N 
c:01 cat TsOH Ct6'NHTS • N I DMF, sulfolane 110 oC,2h ~ 
then NaBH3CN, 
tBuSH, 110°C 
5 h, 63% 
. CH3 1) cat. PdCI2(PhCNh ~I I:l :- cat Cui, piperidine, Ct(jl rt,2 h TMS == 4 2) K2C03, MeOH rt,2 h 
(-)217A 80% 
Scheme 134 
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2.Retrosynthetic analysis of Ouinolizidine Alkaloid (-)217 A 
At the beginning of our investigation, we envisaged that we could obtain 
quinolizidine alkaloid (-)217 A from the lactame 236, following lactam reduction 
and homologation of the pendant alcohol unit following the procedure outlined by 
Panek96 (lactam 236 being itself obtained from the 2,5,6-trisubstituted piperidine 
237) (Scheme 135). 
=
===> .. ~ ~ ~O/ 
.' ""NX  j Ts 
TBDPSO 
Quinolizidine Alkaloid 236 237 
(-)217A 
O~o .<:=: ===TBDPSO .......... ', .. <1 •• !::3) ••• _ ".() 
NTs j TNs OH NH2 
TBDPSO D-aspartic acid 
Scheme 135 
The aim was to employ our cycloaddition strategy (Pd-catalysed or Mg-mediated) 
to access enantiopure piperidine (S)-150 from aziridine (R)-140. In order to go 
from piperidine (S)-150 to the 2,5,6-trisubstituted piperidine 237, we wished to 
exploit a recent observation by our group which showed that piperidine 238 can 
undergo acid-catalysed cyclisation to give bicycle 239 in excellent yield, 
presumably through the intermediacy ofiminium ion 240104 (Scheme 136). 
97% 
~ 
239 
via: ~Me 
ACP.~ Bn N 
Ts 240· 
Cat TsOH 
Scheme 136 
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We anticipated that substrates which cannot undergo intramolecular addition 
reactions would instead be trapped by external nucleophiles and that this may 
provide an alternative strategy for the stereoselective synthesis of 2,6-
disubstituted piperidines. As outlined in Scheme 137 and based on similar 
transformations by Funk, acid catalysed allylation of piperidines should furnish 
the corresponding allylated piperidine productslO5 • 
Proposed Intermolecular Allvlation 
H 
CO.' N : 
TS~ 
Funk et al 
TFA 
.. 
~SiMe3 
70% 
Scheme 137 
H 
" .. CO ~TS~ 
3.Synthesis of the key aziridine intermediate 
As discussed earlier, our synthetic route towards quinolizidine alkaloid 217A 
involves the synthesis of enantiopure aziridine (R)-140, which is the key reagent 
in our cydoaddition strategy (Pd-catalysed or Mg-mediated) to access enantiopure 
piperidine (S)-150. 
D-Aspartic acid was first treated with thionyl chloride in methanol to give the 
diester (R)-144 in excellent yield. The crude diester (R)-144 was subsequently 
tosylated on nitrogen using tosyl chloride and triethylamine to afford product (R)-
145106-108 (Scheme 138). 
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1. SOCI2, MeOH NH2 99% 
H02C0c02H -------
2.TsCI, Et3N 
D-Aspartic acid 87% 
Scheme 138 
NHTs 
Me02C0c02Me 
(R)-145 
The double reduction of the diester (R)-145 was then carried out to form diol (R)-
146 in excellent yield (Scheme 139). 
NHTs 
Me02C0c02Me 
(R)-145 84% 
Scheme 139 
.. 
9H ~HTs 
~OH 
(R)-146 
We next took advantage of the preference for three-membered ring formation over 
four-membered ring closure to form the aziridine (R)_148 1OS (Scheme 140). This 
was achieved via a Misunobu reaction, ADDP and BU3P offering the best yield in 
aziridine after difficult purification by column chromatography109. 
OH NHTs PBU3, ADDP 
(OH 
~OH I, .- "\7 
toluene N 
81% 
Ts 
(R)-146 (R)-148 
Scheme 140 
Treatment of aziridine (R)-148 with TBDPSCI and imidazole provided the 
silicon-protected aziridine product (R)-140 (Scheme 141). 
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(
OH 
TBDPSCI, imididazole 
~ ~ 
"\7 
N 90% 
Ts 
(R)-148 
Scheme 141 
(OTBDPS 
" 
"\7 
N 
Ts 
(R)-140 
Using this route, large quantities (-Sg) of the desired aziridine (R)-140 were 
synthesised. 
4.Synthesis of the desired piperidine 
4.1.[3+3] Cycloaddition 
The desired aziridine (R)-140 was subjected to our standard cycloaddition 
conditions (10% Pd(OAc)2, 60% P(Oipr)3, 20% n-BuLi, THF reflux overnight), 
developed in the group (Scheme 142). However, this unfortunately resulted in 
disappointing and unreliable results (yield of piperidine -15-30% together with 
by-products). 
=('SiMe3 
OAc ~NTs 
;-~ 
TBDPSO 10 %Pd(OAc)2 
60% P(Oiprh 
20% nBuLi 
THF, 16 hrs, reflux 
(R)-140 
Scheme 142 
.. u \\ N l Ts 
OTBDPS 
(S)-150 
15-30% 
As a result, we decided to turn our attention to a more promising method: the 
Grignard approach. 
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4.2.Grignard Reaction 
As discussed in Chapter 3, an alternative approach to the TMM equivalent was 
envisaged involving the use of a Grignard reagent. Encouraged by Klumpp's 
studies36, 67-71, we applied the use of the Grignard chemistry for the preparation of 
our piperidine. 
Double deprotonation of methallyl alcohol 188 followed by transmetallation with 
magnesium bromide and addition of this Grignard reagent 195 to our enantiopure 
silylether substituted aziridine (R}-140 led to the formation of the desired ring-
opened product (S)-196 in high yield. 
OH 
188 
BuLi (4.0 eq) 
TMEDA (3.0eq) A MgBr2 (2.0 eq) 
Li OLi 
Scheme 143 
5.0 eq 
BrMg OMgBr 
195 
j 
(OTBDPS 
""\1 1.0 eq 
~s (R)-140 
COTBDPS 
""M NHTs OH 
76% (S)-196 
Following work previously carried out by Brioche77, 78 on epoxides, this 
methodology was further developed and we were able to make a solution of the 
Grignard reagent in THF, which, after titration, could be added to a solution of 
our aziridine (Scheme 144). Only 2,5 equivalents of reagent were required to 
achieve complete conversion (Scheme 145 and Table 24). 
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~ 
OH 
188 
(""\7 
TBDPSO ~s 
(R)-140 
2.1 eq BuLi 
2.1 eqTMEDA ~ 1. Et20 ~ • • 2.2.1 eq MgBr2 Et2O,24h U OU BrMg OMgBr 
( CannUla) Orange gum (Filter) 0.1-0.2 M 
+ 
195 
Scheme 144 
~ 
BrMg OMgBr (""M TBDPSO N HTs OH 
195 (S)-196 
Scheme 145 
Equivof Product 
Grignard Yield 
5.0a 76% 
2.Sb 85% 
• Organomagnesium reagent prepared by addition of TMEDA 
(3.0 equiv) and n-BuLi (4.0 equiv) to 188 followed by MgBr2 (2.0 equiv). 
b Organomagnesium reagent prepared with by addition of TMEDA 
(2.1 equiv) and n-BuLi (2.1 equiv) to 188 followed by MgBr2 (2.1 equiv). 
Table 24 
To complete the synthesis of the desired piperidine, we considered Yang and 
Hung's work74 on Ti-mediated allylation reactions and a transition metal catalysed 
one-step cyclisation reaction was used (Scheme 146). 
TBDPSO"-""""M 
NHTs OH 
(S)-196 Toluene reflux (S)-150 
Scheme 146 
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We also investigated the role of TieOPr)4 in the cyclisation. Originally, we 
thought that it behaved as a Lewis acid helping to form the Pd-allyl complex by 
coordinating to the 0 of the allyl alcohol, making it a better leaving group. 
However, it was discovered that it was not necessary for the reaction to occur 
(Table 25). 
Lewis Product 
acid Yield 
none 84% 
TieOPr)4 90% 
Table 25 
Using this 2-step methodology, we were able to synthesise the desired piperidine 
on > 1 g scale. 
5.Elaboration of piperidine to key guinolizidine intermediate 
The first challenging step to overcome was the allylation of our piperidine. As 
mentioned earlier in this chapter, we based our reasoning on Funk's studies (see 
Scheme 147). 
The first investigations carried out on the racemIC silyloxyethyl substituted 
piperidine 150, using 2 equivalents of TsOH in toluene under reflux overnight, 
were not conclusive, as no product was observed and only the starting material 
was recovered. 
R 1.Acid ~s -2·---T- M-· S TBDPSO ~ HO~ Ts not observed 
via 
Scheme 147 
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It was decided to isomerise the exo-alkene to the corresponding enamide in the 
hope that this would promote formation of the key iminium intermediate. Work 
carried out by SchmidtllO on the double bond isomerisation, catalyzed by 
ruthenium hydride, provided some ideas on the best conditions to use in our case 
(Scheme 148). 
,.~ 
" IN) j Ts 
TBDPSO (S)-150 
SM 
(±)-lS0 
(±)-IS0 
(±)-lS0 
(±)-lS0 
(S)-lS0 
(S)-IS0 
(S)-lS0 
_R_h_C_I{P_h_3_P}_3_{1_0_m_o_IOIc_o} __ • ,.U + ,.U 
" N ,I N j Ts j Ts 
TBDPSO TBDPSO (S) 242 (S)-241 '-
Reaction conditions 
100% conversion 
Scheme 148 
Reaction % ISO %241 %242 
conditions 
DBU (1.5 eq), EtOH 72 28 
reflux, o.n. 
DBU (1.5 eq), EtOH 67 33 
reflux, 1.5 h 
DBU (1.5 eq), EtOH, 100 
RT,o.n. 
DBU (1.Seq), EtOH, 358 11 
40 °c, 25 min 
DBU (1.5 eq), MeOH 47 23 30 
reflux, o.n. 
DABCO (1.5 eq), SS 30 IS 
EtOH reflux, 2 h 
DBU (1.5 eq), EtOH 67 33 
reflux, 35 min 
• No product 141 was isolated but an unidentilied complex mixture was observed. 
Table 26 
It turned out that Wilkinson's catalyst (10 mol%), in presence of a base under 
reflux of ethanol (or methanol), generally afforded the two isomers, with isomer 
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242 being the only one potentially useful for a further allylation of the piperidine. 
Based on these studies, we considered the following conditions to be optimal: 
10% RhCI(Ph3P)3, DBU (1.5 eq), 4A M.S., EtOH, 40 °c overnight (Table 26). 
The influence of the quantity of the catalyst on the ratio of the two isomers was 
then investigated (Scheme 149 and Table 27). 
, .. (1 j Ts 
TBDPSO 
(5)-150 
.. " .. 0' l Ts 
OTBDPS 
EtOH, 40 DC, o.n., 4A M.S. 
(5)-241 
Scheme 149 
[Rh] Ratio 241:242 
10% 1.3 : 1 
10%1 1 : 2 
20% 1 : 2 
30% 1 : 3.8 
40% 1 : 3.9 
100% 0: 100 
'Wilkinson's catalyst freshly prepared 
Table 27 
+ L'·.(Y 
Ts 
OTBDPS 
(5)-242 
As can be seen in Table 27, the isomerisation provided good yields of the desired 
alkene isomer (S)-242 but at the expense of high catalyst loadings, which is a 
drawback for our synthesis considering the high cost of the catalyst. 
In our attempt to improve the conditions, distilled EtOH, distilled DBU and 
freshly prepared catalyst were used. Under these conditions, a 2: 1 ratio in favour 
of (S)-242 was obtained with only 10% Rh catalyst. 
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Another idea to avoid using the expensive Wilkinson's catalyst and to get the 
desired regioisomer (S)-242 was to functionalise the exo-double bond on (S)-150 
(Scheme 150). 
~ ------------- .. CY \\, .. IN) j\\' N j Ts Ts 
TBDPSO TBDPSO 
Scheme 150 
The first attempt involved the synthesis of the epoxide 243, which was deemed 
successful using DMDO, prepared from acetone and oxone))), at low temperature 
(Schemes 151 and 152). 
Scheme 151 
",et 
DMDO, DCM, 
""et o °c to r.t., 16 h .. , N l Ts 67% l Ts OTBOPS OTBOPS 
(S)-150 243 
Scheme 152 
It was subsequently attempted to open epoxide 243 using a base and deprotonate 
at C6 (Scheme 153). However, with DBU in DMF, the desired product 244 was 
not obtained, instead mainly starting material was isolated (60%). 
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",.et j ~s OBU,OMF ~OH X" """N)J but mainly SM 90°C j Ts 
TBOPSO 243 TBOPSO 244 
Scheme 153 
Alternatively, opening epoxide 243 using a nucleophile such as a halogen was 
investigated. Inspired by the work done by Shiro and collaborators 112, we 
employed Hel as a chloride source and observed the formation of the desired 
product 245 (Scheme 154). 
",.cr HCI.EtzO• ,.&OH Acetone j" N j ~s 
TBOPSO 243 
Ts 
34% TBOPSO 245 
Scheme 154 
The purpose of this strategy was to synthesize product (S)-242 via a 2-step 
sequence starting from compound 245 (Scheme 155). 
, .. &OH ._!l:~!?_ .. ~OH ~ .. !t,o_n:~~_~,!,~~? l ~s (l.~; 
OTSOPS OTSOPS 
245 
Scheme 155 
l",(Y Ts 
OTSOPS 
(S)-242 
Even though this strategy looked potentially promising, we decided not to 
continue our investigations but to carry on the synthesis, judging this multi-step 
sequence too elaborate. 
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Having established good conditions for the isomerisation of the exo double bond 
into the desired endo double bond isomer, we could focus on the allylation step 
itself. This transformation was also found to be challenging. It was envisaged that 
addition of acid to piperidine (S)-242 would form the iminium which could be 
trapped by an appropriate nucleophile (Scheme 156). 
, .. CY via ~ .. le~ j ~s 
TBDPSO (S)-242 
\' N j Ts 
TBDPSO 
Scheme 156 
Unfortunately, after having screened a number of Bwnsted acids, allylation was 
not observed, generally recovering starting material instead. 
The next attempt involved introduction of a methoxy group in C6 position to form 
an aminal so that Lewis acid mediated allylation could be more easily explored. In 
this respect, we were encouraged by Shono and collaborators who described a 
similar transformation in 1987113,114 (Scheme 157). 
0 (XBr Br2/ NaOMe • N MeOH N OMe O~O/ O~O/ 
Scheme 157 
When these conditions were applied to our piperidine (S)-242, the bicycle 246 
was yielded, providing a suitable precursor for the allylation (Scheme 158). 
.. CY \\ N 
) Ts 
TBDPSO 
(S)-242 
1. NalMeOH 
• 
95% 
Scheme 158 
et 
: Ts: 
,-",0 
246 
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The proposed mechanism for this reaction is the following (Scheme 159) 
o Bjr 
,.r;( --" ",[§f-
,\ ~~- , N l Ts l Ts 
OrBDPS OrBDPS 
{S)-242 
Scheme 159 
We firstly decided to remove the bromide and were encouraged to find an 
efficient means to reduce bromohydrins using tributyltin hydride I IS • 
When we applied these conditions for the debromination (AIBN, BU3SnH in 
refluxing benzene) on our substrate 246, the formation of a single crystalline 
product 247 was observed in excellent yield. 
d AIBN, 0\\\ BU3SnH, .' • Benzene ; N ; ~o 80 0e ~6 
246 90% 241 
Scheme 160 
However, X-ray crystallography confirmed that the wrong diastereoisomer had 
been synthesised with regard to the natural product, as the methyl in CS was cis to 
the group at C2 (Figure 4). 
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Figure 4: X-ray structure of compound 247 
5.1.Allylation reaction 
At this stage, the synthesis was continued, turning our attention to the allylation 
reaction (Scheme 161). 
0 ""\\ 
:: N :: 
:: Ts:: 
- 0 ~
Q "\\ ---~~ ---.. . j\\'" ~s I Nu 
HO 
? 
Stereoselectivity? 
Scheme 161 
Based on previous work by Ahman and Somfai 11 6 on the addition of carbon 
nucleophiles to cyclic N-tosyliminium ions, we screened Lewis acids such as 
TMSOTf, BF3.Et20 and TiCI4, but only BF3.EbO afforded encouraging results. 
Only one diastereoisomer 248 was obtained from the reaction in 69% yield 
(Scheme 162). 
0 ·,,\\ 1. BF3.OEt2 ~.,,\\ ~ N ~ .. \\"~N~ 
:: Ts 0 2. AllylTMS j Ts 
~ -78°C to rt HO 248 
DCM 69% 
247 100:0 dr 
Scheme 162 
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The product stereochemistry at C6 was later investigated by NMR spectroscopy to 
confirm the presence of the all cis-diastereoisomer; the expected outcome is 
discussed in Scheme 163. 
... w··"\\ ---.-\\ N l Ts 
O-SF3 
e 
Scheme 163 
~ ... ,\\ 
\\,··l..NiNU l Ts 
OH Nu = AllylTMS 
N-Ts piperidines tend to place substituents at C2 in an axial geometry in order to 
minimise Al,3 strain (Scheme 163)63. Therefore, the reaction should go via the 
pathway on the left hand side and lead to the cis product. 
Initially, although the wrong stereochemistry in at the C5-methyl was observed, 
the synthesis of lactam 236 was still sought after. Therefore, the cross-metathesis 
onto the 2,5,6-substituted piperidine 248 was performed using methyl acrylate and 
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Grubbs second generation catalyst. The methyl ester 249 was obtained in good 
yield (Scheme 164). 
0"\ 
,,-- N ::.,~ 
) Ts 
HO 248 
Scheme 164 
Instead of using an expenSIve 2-step strategy to make compound 249 via 
allylation and then cross-metathesis, we proposed that we could run the allylation 
step directly, using diene 250 as a nucleophile. Diene 250 is readily available 
from methyl crotonate l17 (Scheme 165). 
1. LOA 
2. TMSCI 
39% 
Scheme 165 
Allylation with 247 showed the formation of only one compound 249 in good 
yield. 
0"'\\ 
~ N ~ 
~o 
247 
BF3,oEt2 
DCM, -78 DC to RT 
75% 
This compound was characterised and the NMR data were shown to be identical 
to the data obtained via the 2-step strategy. NOESY and COSY experiments 
(Figure 5) were also undertaken to confirm the stereochemistry at the C6 position: 
both groups in C2 and C6 were indeed cis (see Appendix 6.3). 
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NOESY 
Figure 5 
o 
The allylation of the bromo-substituted bicycle 246 was also attempted. The two 
nucleophiles previously tested were used (namely allyltrimethylsilane and diene 
250) and we were delighted to realise that in both cases we obtained one single 
diastereoisomer 251 and 252 in very good yield (Schemes 166 and 167). These 
results confirmed earlier results concerning the stereoselectivity of the allylation: 
the same model can be applied to the bromo-substituted bicycle 246. 
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Once synthesised, the substituted piperidines 251 and 252 were investigated under 
the conditions of dehydrobromination. In 1938, Renshaw and Conn118 developed 
the dehydrobromination of bromopiperidine derivatives under basic conditions. 
118 
This method was then successfully utilised on halogenopiperidines over the past 
few years l14, 119, 120, with the most commonly used base being DBU heated in N,N-
dimethylformamide. 
These conditions were tested on bromopiperidine 246 and the desired product 253 
was obtained in quantitative yield (Scheme 168). The crystalline compound 253 
was characterised by X-ray crystallography, confirming the eis-stereochemistry at 
C2 and C6 positions (Figure 6). 
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Figure 6: X-ray structure of compound 253 
When the dehydrobromination reaction was carried out with piperidine 251 , the 
formation of compound 254 was observed as expected, in good yield (Scheme 
169). The product was characterised by NOESY and COSY experiments, 
confirming the stereoselectivity in C2 and C6 positions. 
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Scheme 169 
Cross-metathesis on piperidine 254 was then carried out offering compound 255 
in good yield (Scheme 170), 
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Surprisingly, the dehydrobromination performed on 252 afforded the opposite 
regioisomer 256 to the one we expected (Scheme 171). This is attributed to the 
presence of the ester group in C6 position, rendering the hydrogen at C-6 more 
acidic. 
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5.2.N-Tosyl deprotection 
The next challenge was to deprotect the tosyl amine of the 2,5,6-substituted 
piperidines 249, 252 and 255. Even though many methods have been previously 
reported \21, the removal of the tosyl group appeared to be a very difficult step in 
our case. Nevertheless, we first tried the most commonly used method, inspired 
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by Alonso and Andersson's works, using magnesium turnings in methanol 121 
(Scheme 172). 
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At the first glance, the results appeared encouraging, as we obtained a product, 
which looked like the tosyl-free piperidine 257 according to the NMR data 
(Scheme 172). The reaction was low yielding and no starting material was 
recovered. However, this result was found to be irreproducible. 
Other substrates were also trialled, resulting in the loss of the starting materials 
and no desired product was isolated (Scheme 173). 
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Scheme 173 
Even though previo~s work in the group37 using the same conditions on similar 
substrates gave the desired lactam, the conditions were inefficient with our 
piperidines. Other metal-based conditions were also screened for the deprotection, 
but they also revealed themselves to be unsuccessful. 
Systems investigated involved sodium metal in liquid ammonia122, sodium metal 
and naphthalene in DME122 and sodium bis(2-methoxyethoxy)aluminium hydride 
121 
(Red-AI) in THp123; all of these methods resulted in the loss of the starting 
material with no evidence of any traces of product by NMR or GCIMS (Scheme 
174). 
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Scheme 174 
We also investigated two other methods, samarium (II) iodide in THP121 and a 
sodium-mercury amalgam in methanol 124. Both conditions were revealed to be 
inefficient. 
The difficulties observed with Ts-deprotection together with the problems 
encountered in controlling C-5 methyl stereochemistry prompted us to explore an 
alternative approach. 
6.An alternative route towards the synthesis of guinolizidine 
alkaloid 217 A: Biichi Grignard 
We have seen two different methods developed in our group to access 
functionalized piperidines. A third has also been investigated: a stepwise [3+3] 
annelation sequence to tetrahydropyridines via addition of the Biichi Grignard to 
aziridines l2S. The key strategy that has been applied involves the formation of a 
six-membered ring through the reaction between two compatible three-atom 
containing fragments (Scheme 175). 
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This work is based on Craig's studies, which have shown that a sulfone-based 
three-carbon homologating agent can be used to synthesise piperidines and deliver 
functionalization around the heterocycle6S, 66, 126-128. Three carbon-homologating 
agents are not commonly used in organic synthesis. As synthons, these reagents 
bear an electrophilic motif and a nucleophilic unit in a 1,3-relationship. A specific 
and much studied class of three carbon-homologating reagents are 
propionaldehyde homoenolate equivalents. Propionaldehyde homoenolate 
equivalents come in various forms. Two examples of these equivalents are 
described below, allyl anions 259. and an acetal masked homoenolate 260 
(Scheme 176). 
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In 2006, Pattenden reported the addition of propionaldehyde homoenolate 
equivalent 260129 to aziridines and the employment of this methodology in the 
synthesis of a cis 2,6-disubstituted piperidine alkaloid. 
Based on studies by Biichi130, who showed that 1,3-dioxolane based reagent 261 
represented a competent propionaldehyde homoenolate equivalent, our group 
investigated the efficiency of the addition of 261 to readily available Bn-
substituted aziridine 165 and observed that the addition of 20 mol% CuBr.DMS 
improved the efficiency of the Grignard addition to the aziridine to afford the 
desired product 262 in high yield (Scheme 177). 
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Scheme 177 
They then focused on the piperidine-forming reaction and opted to perform an in 
situ acid-catalysed deprotection-cyclisation protocol. This process was found to 
proceed efficiently to give the corresponding tetrahydropyridine 263 (Scheme 
178). 
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The scope of the stepwise annelation of aziridines was studied: the Grignard 
addition reaction was found to proceed in good to excellent yield in all cases 
examined, and the cyclisation reactions afforded the desired dihydropyridines in 
high yield, although they were generally found to be more sluggish in the 
formation of bicyclic and spirocyclic products (Scheme 179). 
Il Rn ~) o 0 ,17 20 mol% CuBr.DMS HCI ORn '(,M9B~ N .. .. R-Z THF, 16 h n 'NHZ Acetone, RT N 
-78°C to RT Z 2.0 equiv 1.0 equiv 62% - 98% 54% - 98% 
Scheme 179 
We decided to apply this chemistry to aziridine (R)-140. The Grignard addition 
afforded the desired product 264 in excellent yield. Subsequently, the 
corresponding tetrahydropyridine 265 was obtained in high yield, using TF A for 
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the acid-promoted cyclisation; acetic acid was deemed too weak, as the reaction 
resulted in the recovery of the starting material (Scheme 180). From this substrate, 
a new strategy for the synthesis of quinolizidine alkaloid (-)217 A was envisaged. 
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The first concern was the introduction of the methyl group in C5 position. 
Inspired by extensive work on the functionalisation of tetrahydropyridines, the 
epoxidation of the endo double bond was investigated in an attempt to 
functionalise compound 265 at both the C5 and C6 positions in two steps. 
6.1.Epoxidation of tetrahydropyridines 
In the past few years, much work has been done on the epoxidation of 
tetrahydropyridines131 -133 and has been of particular interest by two groups, Hu 
and collaborators134 and Burgess and co-workers135• They highlighted two 
different and efficient methods for the epoxidation: dimethyldioxirane (DMDO) 
in dichloromethane and m-CPBA in dichloromethane. We decided to apply both 
methods to our tetrahydropyridine. 
6. 1. l.m-CPBA 
Following Hu's protocol, the addition of m-CPBA was carried out at -10 °c and 
the reaction left at room temperature overnight (Scheme 181). After work-up, the 
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product 266 was not further purified, as epoxides derived from 
tetrahydropyridines are known for their instability on silica. The crude product 
was used in the next step, namely the epoxide ring opening. The stereochemistry 
of the epoxide 266 at CS and C6 has been established by additional experiments 
and is discussed later. 
\\\0 m-CPBA, DCM .J)o .. \ N 
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Scheme 181 
Once the epoxy-piperidine had been synthesised, we could then focus on the ring 
opening, using the same conditions as those used earlier with bicycle 247. 
Influenced by Burgess' work135 and the promising results obtained in earlier 
studies, we decided to employ BF3.0Et2 as a Lewis acid. The conditions were 
deemed successful as the allylated-piperidine 267 was obtained in a good yield 
(Scheme 182). 
.... C)o ss: 1. BF3.OEt2, DCM • C~T~~PS~ l Ts 2. ~TMS OTBDPS 
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Scheme 182 
6.1.2.DMDO 
Another epoxidation method was also investigated: DMDO. First, a solution of 
DMDO was synthesised using acetone and oxoneI36 (Scheme 183). 
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Scheme 183 
This solution was added to a solution of compound 265 in dichloromethane at low 
temperature (Scheme 184). For the same reason as above, the crude product was 
used directly in the subsequent epoxide ring opening reaction. 
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For the allylation reaction, we applied the same conditions as earlier and the 
corresponding allylated-piperidine was also obtained in a good yield (Scheme 
185). 
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Scheme 185 
Formation of the desilylated alcohol 268 was also noticed in small quantities. The 
amount of desilylated product was shown to increase when a large excess of 
Lewis acid was used. However, decreasing the amount of Lewis acid from 4 
equivalents to 2 equivalents had no effect on the efficiency of the reaction. The 
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use of another Lewis acid such as TiCl4 resulted in the fonnation of more 
desilylated alcohol. 
To confinn that the desilylated product 268 fonned during the allylation reaction 
came from the deprotection of compound 267, this was submitted to standard 
desilylation conditions (TBAF in THF) and the product obtained was identical to 
that characterised during the allylation reaction (Scheme 186). 
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The fonnation of this desilylated product was not a main issue since we were able 
to resubmit 268 to the protection conditions, following Robertson's protocol137, 
and to selectively protect the primary alcohol (Scheme 187) . 
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The order of addition the Lewis acid and allylsilane had a slight influence on the 
efficiency of the reaction: the reaction was much cleaner when we first added the 
Lewis acid to a solution of substrate in DCM, left the reaction stir for 10-15 min 
at -78 °c and then added the nucleophile at the same temperature. 
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6.2.1nvestigation on the stereoselectivity of the allylation reaction 
With regard to the stereoselectivity of the epoxidation and/or the allylation, we 
noticed that we only obtained one diastereoisomer in each case, and the same 
isomer was observed when we used the epoxide generated from DMDO and the 
one made with m-CPBA, suggesting that we formed only one and identical 
epoxide with both methods. 
To clear things up, we decided to carry out additional experiments. First, we 
oxidised the free secondary alcohol in compound 267 resulting from the opening 
of the epoxide 266, using Swern conditions (Scheme 188). 
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With the 5-piperidinone 269 in hand, we decided to submit it to reduction 
conditions138, thinking that we would get the 2 diastereoisomers in C5 position 
and that we would be able to separate them (Scheme 189). 
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As envisaged, the 2 diastereoisomers were formed in a 2.5 to 1 ratio in favour of 
compound 267b. The diastereoisomers were partially separated and subsequently 
characterized by NOESY experiment to identify the stereochemistry at C5 and C6 
for both compounds 267a and 267b. The product made during the epoxidation 
and the allylation was revealed to be compound 267a. This result allowed us to set 
a model for the epoxidation and the nucleophilic addition, which could be used to 
rationalise the stereoselectivity of these reactions. 
As discussed, the product 267a after allylation has an exo-hydroxyl group at the 
CS position trans to the groups at C2 and C6. Since the nucleophilic addition has 
no effect on the stereochemistry of the group at C6, the stereochemistry of the 
group in C5 must have been set during the epoxidation (Scheme 190). 
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The explanation for the stereoseIectivity of the reaction is highlighted in Scheme 
191. 
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The exo-hydroxyl group at CS suggested epoxidation takes place at the more open 
face of the alkene with the C2 substituent in the more favoured axial position. 
As highlighted earlier in this chapter, the allylation on piperidine 266 goes via an 
iminium intermediate and this proceed via a chair-like transition state (and not a 
twist boat-like transition state) (Scheme 192). 
e 
~<±Je 
",,1..~Y3-BF3 _____ • 
l Ts 
c;;rOBF3 '+' 1.Nu 
\' '\!:,)/! • 
" N l Ts 2. W 
OTBDPS 
266 
~q ~ ~f 
OP I Nu 
OP 
"' 
OTBDPS 
Scheme 192 
(X0H 
"" N ""~ l Ts 
OTBDPS 
"' 
Once again, the preference for an axial group at C2 favoured the pathway on the 
left hand side and leads to the cis product, which was confirmed by the NOESY 
and COSY experiments. 
131 
To avoid usmg the expenSIve Grubbs'catalyst for the cross-metathesis, the 
allylation step was performed directly with diene 250 as a nudeophile. But, unlike 
the reaction carried out with bicycle 247, we were unable to obtain the desired 
product, as the reaction led to an unidentified, complex mixture. The synthesis 
was subsequently continued on the 2,5,6-substituted piperidine 267a. 
After carrying out Swem oxidation on 267a, leading to piperidine 269 in a good 
yield (Scheme 193), 269 underwent a cross-metathesis using methyl acrylate and 
Grubbs' second generation catalyst (Scheme 194). The reaction using the first 
generation catalyst afforded lower yields139• 
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The two separable isomers trans and eis, 270b and 270a, were obtained in good 
yield, with the trans diastereoisomer 270a being the major product. 
We then could continue with the envisaged strategy towards the natural product. 
To install the exo double bond at the C5 position, it was initially believed that a 
Wittig reaction on piperidine 270a could methylenate the carbonyl group, leading 
to the desired compound. However, when piperidine 270a was submitted to the 
Wittig conditions 140, the main product that formed during the reaction was the free 
amine piperidine 271 (Scheme 195). 
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The formation of this compound is attributed to a deprotonation at the a position 
of the nitrogen; therefore eliminating the tosyl group to give the imine 272. 
Tautomerisation then yields the most stable enamine 271 (Scheme 196). 
7 
Scheme 196 
Even though this method was interesting and represented an efficient way to 
remove the tosyl group, it led to the loss of the stereocenter in a position of the 
nitrogen. Therefore, another method for the methylenation of carbonyl groups was 
sought after. Another obvious strategy was to use Nysted's reagent141 • The 
methylenation was carried out with our two isomers 270a and 270b to 
successfully obtain the desired piperidines 273a and 273b with the exo double 
bond (Schemes 197 and 198). The yields were moderate but some starting 
material was recovered in both cases. 
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The synthesis led to the 2,S,6-substituted piperidines 273a and 273b, overcoming 
some problems along the way to allow inexpensive, yet efficient chemistry to be 
employed. 
6.3.Tosyl deprotection 
The tosyl deprotection step, which had proven to be troublesome in the previous 
synthesis, was the next step to be encountered. Although previously deemed to be 
challenging, it was decided to use the same method as employed earlier (Le. 
magnesium in methanol). 
Initially, our investigations was based on the work previously done by Backvall 
on the synthesis of ferruginine 142, where magnesium was used in methanol with 
ultrasound to free his amine from the tosyl group. These conditions were applied 
to our piperidine 273a (Scheme 199); adding powdered magnesium to a solution 
of 273a in methanol and the resulting suspension was sonicated at room 
temperature for 40 minutes. Additional powdered magnesium was then added and 
sonicated for a further 30 min. Formation of the deprotected piperidine 274 was 
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observed in a moderately good yield. The hydrogenated ester 275 was also 
obtained but the corresponding lactam could not be isolated. 
.... (t.~C02Me l Ts 
OTBDPS 
273a 
_M_9,_M_e_O_H_. ""UN ""jco2:e 
so nication l 
Ts 275 
OTBDPS 
16% 
Scheme 199 
.".(XjC02Me 
l H 274 
OTBDPS 
52% 
Although successful, another method was developed to improve the synthetic 
protocol. Magnesium turnings were flame dried and subsequently methanol (1 
mL) was added, followed by dropwise addition of a solution of the ester 273a in 
methanol (Scheme 200). The solution was left stirring for 16 hours. Additional 
magnesium was then added and the reaction mixture was heated at reflux for 3 
hours. With this modified method, the free amine 274, the hydrogenated ester 275 
and the corresponding lactam 276 were all isolated, 
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An interesting point to note was that these conditions were successful in 
deprotecting piperidine 273a and affording the desired lactam 276, whereas they 
were unsuccessful when applied to piperidine 249, which has a similar structure. 
The only difference between the two methods is that the successful reaction was 
done under reflux on a larger scale. Bringing the reaction to reflux for few hours 
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appeared to help the reaction to occur, especially for the formation of the lactam. 
The reaction appeared to be more efficient and easier to run, particularly for the 
isolation and the purification of the different compounds when performed on a 
larger scale. Work done by Lisa Pattenden in the group on the desulfonylation of 
piperidines led to the same conclusions143• 
6.4.Quinolizidine ring formation 
We envisaged that two routes were viable to obtain the bicycle 277 (Scheme 201): 
• Starting from deprotected piperidine 274, ester reduction and alkylation 
should lead us to the desired bicycle 277; 
• Starting from lactam 276, a simple reduction should lead to 277. 
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Accordingly, piperidine 274 was subjected to LAH reduction to provide the 
corresponding alcohol 278 in excellent yield (Scheme 202). 
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Cyclisation of 278 using CBr4-PPh3 conditions proceeded without difficulty, 
offering bicycle 277 (Scheme 203). 
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Bicycle 277 was also obtained by LiAIH4-reduction in a very good yield144 
(Scheme 204). 
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The next part was the final challenging step of the total synthesis, namely the 
diastereoselective reduction of the exo double bond (Scheme 205). With only few 
milligrams of bicycle 277 to work with, various conditions could not be screened 
to optimise the hydrogenation. As a result, the most commonly used method, 
palladium on charcoal in methanol145, was employed. 
OTBOPS 
Scheme 205 
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Unfotunately, hydrogenation of bicycle 277 gave a 1:1 mixture of the two 
diastereoisomers 279a and 279b in quantitative yield, which were unable to be 
separated by column chromatography (Scheme 206). 
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The mixture of both diastereoisomers was, however, submitted to TBAF-
deprotection, offering an inseparable mixture of the two piperidines in a good 
yield (Scheme 207). The mass balance after column chromatography was not 
ideal which is attributed to the small scale of the reaction, with a very polar 
product, which increased the risk of loss of material. 
" .. o;~ Cd j -0 + , ••. N 
TBDPSO TBDPSO
j 
279a 279b 
TBAF,THF. ,,··0~ + J~ 
69% HO) '0 HO '0 
280a 280b 
mixture 1: 1 mixture 1:1 
Scheme 207 
6.5.1nvestigations on the last step towards the natural product 
After this stage, only 10 mg of product had been isolated with only two steps 
remaining to reach the natural product quinoIizidine alkaloid (-)217 A and its 
diastereoisomer. The sequence was theoretically simple and consisted of oxidation 
of the alcohol followed by olefination, using either Wittig conditions or 
Yamamoto's method95.146. 
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6. 5. l.Model substrate 
A model substrate was used for the remaining sequence in an attempt to optimise 
reaction conditions before using the quinolizidine intermediates 280 (a and b). 
The structure of the model substrate had to reflect that of our key intermediate. 
The first choice for the model substrate was 3-piperidin-I-yl-propan-I-ol 281, 
which was readily available from piperidine and 3_propan_l_oI147, 148 (Scheme 
208). 
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Initially, the oxidation (Swem) and the olefination using Wittig conditions were 
trialled in a one-pot synthesis (Scheme 209). Unfortunately, this attempt appeared 
to be unsuccessful, as desired product 282 was not isolated. 
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As a result, both reactions were run separately and attempts to isolate the aldehyde 
resulting from the oxidation were made. Two methods were tested for the 
oxidation, Swern's conditions and Dess-Martin's reagent. Neither method was 
successful: a side reaction appeared to occur, preventing isolation of the aldehyde. 
Specifically, unusual peaks in the IH NMR spectrum were observed at around 5.5-
6 ppm, potentially due to vinyl protons, but no peak appeared at 10-11 ppm, 
indicating that the aldehyde had not formed. A potential reason for this is that the 
product undergoes p-elimination (Scheme 210). 
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Having been unsuccessful with model substrate 281, another alternative was 
envisaged, starting from commercially available 2-piperidin-2-yl-ethanol 283 
(Scheme 211). Substrate 284 could be synthesised via a theoretically simple 
reductive amination, and subsequently be used as a model substrate to test the 
conditions for the oxidation and the olefination. Importantly, elimination of the 
aldehyde would be reversible in this case. 
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Inspired by work carried out by Lin and RajanBabul49, the reductive amination of 
2-piperidin-2-yl-ethanol 283 was performed with an unexpected result: only 
bicycle 285 was obtained instead of the desired piperidine 284 (Scheme 212). 
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A stronger reducing agent was added to speed up the reaction, but the same 
compound 285 was obtainedl5o (Scheme 213). 
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This result was not a major issue, since it was overcome by submitting the bicycle 
to a LiAII-4 reduction 151, leading to the desired piperidine 284 (Scheme 214). 
LiAIH4 c9 ~ THF, reflux 85% 284 285 
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Work carried out by Rouden and collaborators l52 in 2004 offered another 
alternative for the synthesis of the desired model substrate: protection of the free 
amine of compound 283 with a Boc-group following by reducing 28 6 using 
LiAIH4 (Scheme 215). Indeed, both steps were successful and piperidine 284 was 
accessed very easily and in large quantities. 
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~ 600,0, ElaN. ~ 
HO ~ DCM. OOC to rt HO ! J( 
283 98% 286 0 0 
LiAIH. e .. THF. reflux 
85% 
286 284 
Scheme 215 
The new model substrate, piperidine 284, was subsequently oxidised, using 
Swern's method (Scheme 216). Following workup, the crude IH NMR spectrum 
displayed a broad singlet at 9.8 ppm and a signal at 201 ppm, in the crude l3C 
NMR spectrum, both characteristic of an aldehyde. The material was not further 
purified to avoid any decomposition on silica. 
c9 
OH 284 
1. (COClh. DMSO 
DCM.-78
D
C R 
.. NI 2. Et3N 
H 0 287 
Scheme 216 
The crude aldehyde was subjected to the Wittig conditions (Scheme 217). Initial 
crude IH NMR studies showed a doublet of triplets at 5.14 ppm, a multiplet at 
5.75 ppm and a singlet at 2.23 ppm, potentially matching the 2 vinyl protons and 
the terminal alkyne proton, respectively. Unfortunately, a clean product could not 
be isolated following purification by column chromatography, as the product 
appeared to decompose on silica. However, the 2-step sequence was repeated on a 
smaller scale and the 1 H NMR studies led to the same conclusions: product 288 
was formed using these conditions. 
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~(±) srG 
PPh3 
B 
H 0 287 
tSuOK 
THF,RT ~ 
288 
Scheme 217 
With proof of concept of the final two steps, bicycles 280 (a and b) were finally 
employed and with only 7 mg of the mixture of the 2 diastereoisomers, there was 
only enough material for one attempt (Scheme 218). Unfortunately, as the 
reaction was performed on such a small scale, the NMR data were not very 
encouraging after oxidation. Potential peaks between 9 and 11 ppm, which would 
suggest that we formed the two aldehydes, were not clearly visible. 
1. (COCI)2, DMSO C(j'" C(j 
DCM, -78 QC • f'" N "H + f"" N H 
2.EbN O~ O~ 
280a 280b 289a 289b 
mixture 1:1 
Scheme 218 
However, the crude products 289a and 289b from the oxidation reaction were 
subjected to the olefination conditions. The conditions developed by Yamamot095• 
146 were employed, since this process was known and was previously used 
efficiently during previous syntheses of quinolizidine alkaloid (-)217 A by Panek96 
and Pearson89• First, the silyl alkyne 290 had to be synthesised, which would then 
react with the aldehyde to form the desired enyne (Scheme 219). 
1. tSuLi, ether, -5°C 
• 
I \/ 
-$i--=----' J'-
, Si 
/ \ 290 2. TSSel, rt, on 
50% 
Scheme 219 
143 
Finally, we reacted silyl alkyne 290 with the crude products from the oxidation 
reaction, in an attempt to obtain the silyl derivative of quinolizidine alkaloid (-)-
217 A and its epimer (Scheme 220). Unfortunately, after a careful column 
chromatography, the desired products 291a and 291h could not be isolated with 
neither the NMR data nor the GelMS analysis being conclusive. Neither of them 
gave us the necessary evidence that we made the desired natural product or even 
its epimer. 
TMS \ TMS~ (,0~ 
TSS ~-O 
fsuLi, Ti(iOPr)4 291a 
• 
THF TMS~~"'C6 289a 289b 
291b 
Scheme 220 
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Conclusions 
The very effective route towards functionalised, enantiomerically pure piperidines 
previously developed in the group has been investigated further. The [3+3] 
cycloaddition has been applied to a range of substituted aziridines, namely the 
silylether substituted aziridines (Scheme 221). The reaction has been proven to be 
a challenging and difficult to reproduce, however good results can be obtained 
under rigorous conditions. 
~NTS 
TSOPso-f)n 
==('SiMe3 
OAc 
10 %Pd(OAc)2 ~ AcOl 
60% P(Oiprh •. ......~:'tl)n TS(H)N~)n 
20% nSuLi OTSOPS OTSOPS 
THF, 16 hrs, reflux 
n=1-4 20-67% 0-60% 9-25% 
Scheme 221 
The Grignard route from aziridines to piperidines, which has been developed in 
the group, was found to be a good alternative to the cycloaddition reaction for this 
particularly challenging substrate (Schemes 222 and 223). 
1. BuLi, TMEOA 
2. MgSr2 
OH 
TBOPScU 
NH OH 
Ts 
76% 
.. 
TSOPSO~ 
N 
Ts 
THF 
~H 
TSOPSO Ts 
73% 
Scheme 222 
.. {H 
NHTs OH 
99% 
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H 
NHTs OH 
10% Pd(OAch, 
40% PPh3, 
25% Ti(Oipr)4 
4AMS 
Toluene reflux 
TBDPSW ~ 
Ts TBDPSO Ts 
90% 84% 
Scheme 223 
TBDPSOn 
n Ts 
87% 
The addition of the Biichi Grignard reagent 261 to enantiopure silyl ether 
substituted aziridine (R)-140 was also investigated and afforded the corresponding 
acetal 264 in good yield. Subsequently, the corresponding tetrahydropyridine 265 
was obtained in excellent yield, using TF A for the acid-promoted cyclisation 
(Scheme 224). 
(
OTBDPS /""l 25% CuBr.DMS (OTBDPS 
o 0 THF, r.t., 16 h 
""\7 + y'" · II"~O) 
N ~MgBr 80% NHTs 0-.1 
Ts 
(R)-140 261 
Scheme 224 
2M 1 TF A, Acetone 
r.t.,20h 
88% 
,.0 
.' N l Ts 265 
OTSDPS 
As shown before, the [3+3] cycloaddition route is an effective way to synthesise 
natural products with a piperidine core, therefore the applicability of the three 
146 
different [3+3] annelation strategies developed in the group was highlighted by 
the attempts to synthesise quinolizidine alkaloid (-)217 A. Unfortunately, due to . 
the complexity of the route and a lack of material for the last two steps, the 
synthesis could not be completed. However, it is envisaged that with more time 
and material, the desired natural product could be obtained by similar 
methodology described herein. 
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Chapter V - Experimental 
I.General Considerations 
All reactions were conducted in oven or flame-dried glassware under an inert 
atmosphere of dry nitrogen. Flash chromatography was performed on silica gel 
(Davisil) according to the method ofW.C. StillIS3. The solvent system used was a 
gradient of petroleum ether, increasing in polarity to ethyl acetate. Thin layer 
chromatography (TLC) was performed on aluminium backed plates pre-coated 
with silica (0.2 mm, Merck DC-alufolien Kieselgel 60 F254) which were 
developed using standard visualizing agents: Ultra Violet light or potassium 
permanganate 
IH NMR spectra were recorded on a Bruker AC-250 (250 MHz) or AMX-400 
(400 MHz) or Avl-250 instruments or AMX-400 or AVl-400 instruments 
supported by an Aspect 3000 data system, unless otherwise stated. Chemical 
shifts are reported in ppm with the solvent resonance as the internal standard 
(CHCh: 07.27 ppm). Data are reported as follows: chemical shift, integration, 
mUltiplicity (s=singlet, d=doublet, t=triplet, q=quartet, br=broad, m=multiplet), 
coupling constants (.1) in Hz, and assignment. 
I3C NMR spectra were recorded on a Bruker AC-250 (62.9 MHz) or AMX-400 
(100.6 MHz) with complete proton decoupling. Chemical shifts are reported in 
ppm with the solvent resonance as the internal standard (CDCh: 077.0 ppm). 
Infrared (FTIR) spectra were recorded on a Perkin Elmer Paragon 100 FTIR 
spectrophotometer, Vmax in cm-I. Bands are characterized as broad (br), strong (s), 
medium (m) and weak (w). Samples were recorded as thin films from a DCM 
solution using sodium chloride plates. 
Low resolution mass spectra were recorded on Micromass Autospec, operating in 
E.!., C.I. or F AB mode; or a Perkin-Elmer Turbomass Benchtop GC-MS 
operating in either E.I. or C.I mode. High-resolution mass spectra (HRMS) 
148 
recorded for accurate mass analysis, were performed on either a MicroMass LCT 
operating in Electrospray mode (TOF ESl or a MicroMass Pro spec operating in 
either F AB (F AB+), El (EI+) or Cl (Cll mode. 
Elemental microanalysis performed using a Perkin-Elmer 2400 CHNS / 0 Series 
11 Elemental Analyser. 
Melting points, performed on recrystallised solids, were recorded on a 
Gallenkamp melting point apparatus and are uncorrected. 
2.Purification of solvents and reagents 
All solvents and reagents were purified using standard laboratory techniques 
according to methods published in "Purification of Laboratory Chemicals" by 
Perrin, Armarego, and Perrin (Pergamon Press, 1966). 
Solvents and reagents were used either as received from commercial suppliers or, 
when necessary, purified in accordance with standard procedures as outlined 
below. 
Grubb's Solvent System 
The departmental dry solvent is a Grubbs type one manufactured by Innovative 
Technology. In an individual solvent line the untreated solvent is contained within 
a lined metal reservoir and, using nitrogen gas pressure, forced through a pair of 
metal columns each containing either activated alumina or molecular sieve. If 
oxygen removal is also required one of the cylinders contains a catalyst instead. 
The water and oxygen removal occurs as the solvent passes over the drying 
agents. The dried solvent is then dispensed to a suitable collection vessel under 
vacuum via a Schlenk line system. Water content of the solvents is routinely 
monitored by coulometric Karl Fischer titration. 
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Acetone was distilled from Drierite. 
Acetonitrile was collected from Grubb's solvent system. 
Dichloromethane was freshly distilled from calcium hydride immediately prior 
to use. 
Diethyl ether (anhydrous grade) was distilled from sodium metal / benzophenone 
ketyl immediately prior to use. 
Diisopropylamine was distilled from potassium hydroxide and stored over 4A 
molecular sieves. 
DME was distilled from calcium sulphate immediately prior to use. 
DMSO was distilled from calcium hydride immediately prior to use. 
Methanol was distilled from Magnesium turnings immediately prior to use. 
N,N-Dimethylformamide was distilled under reduced pressure from potassium 
hydroxide and stored over 4 A molecular sieves. 
Petroleum ether refers to 40-60 °c petroleum distillates, which was distilled 
prior to use. 
Tetrahydrofuran (anhydrous grade) was distilled from sodium metal / 
benzophenone ketyl immediately prior to use. 
Toluene was freshly distilled from calcium hydride immediately prior to use. 
Triethylamine was distilled from potassium hydroxide and stored over 4 A 
molecular sieves. 
Triisopropylphosphite was distilled from sodium under reduced pressure. 
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3.Aziridina tion 
Synthesis of 4-(tert-butyldiphenylsiloxy)-1-butene 137154 
HO~ 
134 
TBDPSCI, Imidazole, DMF, 
o °C to rt '+ < >-6i-O~ 
I 137 
~ 
3-Buten-l-01 134 (0.5 g, 6.93 mmol, 1.0 eq), was dissolved in distilled 
dimethylfonnamide (IQ mL) and the solution was cooled to 0 QC. Tert-
butylchlorodiphenylsilane (2.25 mL, 8.66 mmol, 1.25 eq) and imidazole (1.41 g, 
20.79 mmol, 3.0 eq) were added. The reaction mixture was allowed to reach room 
temperature and stirred overnight. The reaction mixture was partitioned between 
diethyl ether and water and the aqueous phase was extracted with Et20, dried over 
magnesium sulphate and concentrated by rotary evaporation to give a colourless 
liquid. Purification of the resulting liquid by silica gel chromatography (20/1, 
petroleumlEtOAc) provided 4-(tert-butyldiphenylsiloxy)-I-butene 137 (2.0 g, 
93%). 111 NMR (250 Mllz, CDCh): 81.06 (9H, s, C(CH3)3), 2.33 (2H, dtt, J=1.5, 
6.5, 6.5 Hz, CH2-C=), 3.72 (2H, t, J=6.5 Hz, CH2-0), 4.98-5.06 (2H, m, H2C=), 
5.74-5.88 (IH, m, C=C-H), 7.31-7.47 (6H, m, ArH), 7.67-7.79 (4H, m, Arl!). lJC 
NMR (62.9 MHz, CDCh): 819.3, 26.9, 37.2, 63.5, 116.4, 127.6, 129.6, 134.0, 
135.5, l35.6. 
Synthesis of 3-(tert-butyl-diphenyl-silanyloxyethyl)-1-(toluene-4-
sUlfonyl)-aziridine 140 
TsN(Na)CI, NBS 
o 
MeCN, 4A MS, rt 
TBDPSO~ ______ ...... 
137 
-0-" <i? ,Na TsN(Na)CI = '/ \ ~-N, 
- 8 Cl 
151 
A 50 ml round-bottomed-flask was charged with 4A molecular sieves and flame 
dried. A solution of 4-(tert-butyldiphenylsiloxy)-I-butene 137 (500 mg, 1.61 
mmol, 1.0 eq) in acetonitrile (10 mL) was transferred via cannula. Then 
chloramine-T (367 mg, 1.61 mmol, 1.0 eq) and N-bromosuccinimide (57 mg, 0.32 
mmol, 0.2 eq) were added. The resulting solution was stirred at room temperature 
for 48 h. The reaction mixture was diluted with EtOAc and washed with brine. 
The organic layer was dried over magnesium sulphate, concentrated in vacuo to 
give a yellow oil. Purification of the resulting liquid by silica gel chromatography 
(lOll, petroleumlEtOAc) provided 3-(tert-butyl-diphenyl-silanyloxyethyl)-I-
(toluene-4-sulfonyl)-aziridine 140 (100 mg, 13%). IH NMR (250 MHz, CDCh): 
80.96 (9H, s, C(CHj)j), 1.42-1.74 (2H, m, CH]), 2.05 (IH, d, J=4.5 Hz, CHH 
aziridine), 2.32 (3H, s, ArCHj), 2.60 (1H, d, J=7.0 Hz, CHH aziridine), 2.76-2.88 
(1H, m, CH aziridine), 3.49 (2H, dd, J=5.5, 7.0 Hz, CH]OTBDPS), 7.18 (2H, d, 
J=8.0 Hz, Arlf), 7.25-7.41 (6H, m, Arlf), 7.48-7.57 (4H, m, Arlf), 7.74 (2H, d, 
J=8.0 Hz, Arlf). 13C NMR (62.9 MHz, CDCh): 819.1, 21.6, 26.8, 33.5, 34.4, 
38.0, 61.2, 127.7, 128.0, 129.6, 129.7, 133.5, 135.5, 142.3, 144.4. FTIR (thin 
film): 3071 (w), 2930 (m), 2857 (m), 1598 (w), 1472 (w), 1428 (m), 1326 (s), 
1164 (s), 1093 (s) cm-I. mlz (TOF ES): 502 (MNa+). HRMS (TOF ES) caIcd. 
for C2,H33N03NaSiS (MNa+): 502.1848. Found: 502.1870. 
Synthesis of 5-(terl-butyldiphenylsiloxy)-1-pentene 138155 
HO~ 
135 
TBDPSCI, Imidazole, DMF, 
o °C to rt 'Y 
.. <~oi-O~ 
I 138 
~ 
5-Penten-l-01 135 (1.0 g, 11.61 mmol, 1.0 eq), was dissolved in distilled 
dimethylformamide (17 mL) and the solution was cooled to 0 QC. Tert-
butylchlorodiphenylsilane (3.8 mL, 14.51 mmol, 1.25 eq) and imidazole (2.37 g, 
34.83 mmol, 3.0 eq) were added. The reaction mixture was allowed to reach room 
temperature and stirred overnight. The reaction mixture was partitioned between 
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diethyl ether and water and the aqueous phase was extracted with Et20, dried over 
magnesium sulphate and concentrated by rotary evaporation to give a colourless 
liquid. Purification of the resulting liquid by silica gel chromatography (20/1, 
petroleumlEtOAc) provided 5-(tert-butyldiphenylsiloxy)-I-pentene 138 (3.83 g, 
99%). III NMR (250 Mllz, CDCI3): 01.03 (s, 9H, C(CH3)3), 1.64 (tt, 2H, J=6.5, 
7.5 Hz, CH2), 2.13 (dt, 2H, J=7.0, 7.5 Hz, CH2-C=), 3.65 (t, 2H, J=6.5 Hz, CH2-
0),4.90 (dd, IH, J=1.5, 10.0 Hz, CHH-C=), 4.98 (dd, IH, J=1.5, 15.5 Hz, CHH-
C=), 5.78 (ddt, IH, J=7.0, 10.0, 15.5 Hz, C=C-H), 7.42-7.32 (m, 6H, ArH), 7.66-
7.63 (m, 4H, ArH). BC NMR (62.9 Mllz, CDCh): 019.2,26.9,30.0,31.8,63.3, 
114.5, 127.6, 129.5, 134.1, 135.6, 138.6. 
Synthesis of 4-(tert-butyl-diphenyl-silanyloxypropyl)-1-(toluene-4-
sulfonyl)-aziridine 141 
TBDPSO~ 
138 
TsN(Na)CI, NBS ~ ) 
MeCN,4A MS, rt TBDPSO O"S ~ y"o 
141 
A 50 ml round-bottomed-flask was charged with 4A molecular sieves and flame 
dried. A solution of 5-(tert-butyldiphenylsiloxy)-I-pentene 138 (1.51 g, 4.66 
mmol, 1.0 eq) in acetonitrile (73 mL) were transferred via cannula. Then 
chloramine-T (1.06 g, 4.66 mmol, 1.0 eq) and N-bromosuccinimide (166 mg, 0.93 
mmol, 0.2 eq) were added. The resulting solution was stirred at room temperature 
for 48 h. The reaction mixture was diluted with EtOAc and washed with brine. 
The organic layer was dried over magnesium sulphate, concentrated in vacuo to 
give a yellow oil. Purification of the resulting liquid by silica gel chromatography 
(10/1, petroleumlEtOAc) provided 4-(tert-butyl-diphenyl-silanyloxypropyl)-1-
(toluene-4-sulfonyl)-aziridine 141 (572 rng, 25%). III NMR (250 Mllz, CDCh): 
01.01 (9H, s, C(CH3)3), 1.33-1.58 (2H, m, CH2), 1.63-1.78 (2H, rn, CH2), 2.06 
(IH, d, J=4.5 Hz, CHH aziridine), 2.42 (3H, s, ArCH3), 2.62 (IH, d, J=7.0 Hz, 
CHH aziridine), 2.66-2.78 (lH, m, CH aziridine), 3.57 (2H, t, J=6.0 Hz, 
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CH;OTBDPS), 7.30 (2H, d, J=8.0 Hz, Ar/!), 7.35-7.43 (6H, m, Ar/!), 7.56-7.65 
(4H, m, Arlf), 7.80 (2H, d, J=8.0 Hz, Ar/!). l3C NMR (62.9 MHz, CDCh): 
819.1, 21.6, 26.8, 27.8, 29.6, 38.0,40.2,62.9, 127.6, 128.0, 129.6, 129.8, 133.4, 
135.5, 143.8, 144.3. FTIR (thin film): 3059 (w), 2930 (m), 2856 (m), 1598 (w), 
1471 (w), 1428 (m), 1325 (s), 1162 (s), 1093 (s) cm-I. mlz (TOF ES): 494 (MH). 
HRMS (TOF ES) calcd. for C2sH36N03SiS (MH+): 494.2185. Found: 
494.2206. 
Synthesis of 6-(tert-butyldiphenylsiloxy)-1-hexene 139156 
TBDPSCI, Imidazole, DMF, ......... I ./ 
HO~ 
136 
QOCtort o-~ T 
.. -6i-O~ 
I 139 
~ 
6-Hexen-l-01 136 (2.0 g, 19.97 mmol, 1.0 eq), was dissolved in distilled 
dimethylformamide (29 mL) and the solution was cooled to 0 cC. Tert-
butylchlorodiphenylsilane (6.5 mL, 24.96 mmol, 1.25 eq) and imidazole (4.08 g, 
59.91 mmol, 3.0 eq) were added. The reaction mixture was allowed to reach room 
temperature and stirred overnight. The reaction mixture was partitioned between 
diethyl ether and water and the aqueous phase was extracted with Et20, dried over 
magnesium sulphate and concentrated by rotary evaporation to give a colourless 
liquid. Purification of the resulting liquid by silica gel chromatography (20/1, 
petroleumlEtOAc) provided 6-(tert-butyldiphenylsiloxy)-I-pentene 139 (6.4 g, 
95%). IH NMR (250 MHz, CDCh): 81.05 (9H, s, C(CH3h), 1.40-1.63 (4H, m, 
CH;), 2.04 (21-1, br d, J=7.0 Hz, CH;), 3.66 (2H, t, J=6.0 Hz, CH2-0), 4.90-5.03 
(2H, m, CHrC), 5.79 (lH, tdd, J=7.0, 10.0, 17.0 Hz, H-C=C), 7.33-7.46 (6H, m, 
Arll), 7.63-7.70 (4H, m, Arll). I3C NMR (62.9 MHz, CDCh): 819.2,25.1,26.9, 
32.0,33.5,63.8, 114.3, 127.6, 129.5, 134.0, 135.6, 138.9. 
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Synthesis of 5-(tert-butyl-diphenyl-silanyloxybutyl)-1-(toluene-4-
sulfonyl)-aziridine 142 
TBDPSO~ 
139 
TsN(Na)CI, NBS 
o 
MeCN, 4A MS, rt TBDPSO~ 
• N 
142 090 
A 50 ml round-bottomed-flask is charged with molecular sieves and flame dried. 
A solution of 6-(tert-butyldiphenylsiloxy)-1-hexene 139 (1 g, 2.95 mmol, 1.0 eq) 
in acetonitrile (50 mL) was transferred via cannula. Then chloramine-T (673 mg, 
2.950 mmol, 1.0 eq) and N-bromosuccinimide (105 mg, 0.59 mmol, 0.2 eq) were 
added. The resulting solution was stirred at room temperature for 48 h. The 
reaction mixture was diluted with EtOAc and washed with brine. The organic 
layer was dried over magnesium sulphate, concentrated in vacuo to give a yellow 
oil. Purification of the resulting liquid by silica gel chromatography (10/1, 
petroleum/EtOAc) provided 5-(tert-butyl-diphenyl-silanyloxybutyl)-I-(toluene-4-
sulfonyl)-aziridine 142 (420 mg, 48%). III NMR (250 Mllz, CDCh): 01.04 (9H, 
S, C(CHJ)J), 1.22-1.60 (6H, m, CH]), 2.04 (1H, d, J=4.S Hz, CHH aziridine) 2.39 
(3H, S, ArCHJ), 2.62 (IH, d, J=7.0 Hz, CHH aziridine), 2.66-2.78 (IH, m, CH 
aziridine), 3.57 (2H, t, J=6.S Hz, CH]OTBDPS), 7.29 (2H, d, J=8.0 Hz, ArH), 
7.33-7.49 (6H, m, ArH), 7.61-7.69 (4H, m, ArH), 7.81 (2H, d, J=8.0 Hz, ArH). 
I3C NMR (62.9 MHz, CDCh): 019.2, 21.6, 23.1, 26.9, 31.0, 31.9, 39.3, 40.3, 
63.4, 127.6, 128.0, 129.6, 129.7, 134.0, 135.5, 143.2, 144.5. FTIR (thin film): 
3070 (w), 2932 (m), 2858 (m), IS98 (w), 1472 (w), 1428 (m), 1325 (s), 1163 (s), 
1093 (s) cm-I. mlz (TO~ ES): S08 (MH+). IIRMS (TOF ES) calcd. for 
C29HJsNOJSiS (MH+): 508.2342. Found: 508.2333. 
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4.Amino acid route 
Synthesis of (S)-3-phenyl-2-(toluene-4-sulfonylamino)-propionic acid 
292157 
• 
NaOH, acetone 
To a solution of (S)-phenylalanine (5.0 g, 30 mmol, 1.0 eq.) in aqueous 2 M 
NaOH (15 ml, 30 mmol, 1.0 eq.) at 0 cC, was added 4-toluenesulfonyl chloride 
(6.0 g, 31 mmol, 1.04 eq.), followed by N-ethyldiisopropylamine (5.8 ml, 33 
mmol, 1.1 eq.) and acetone (15 ml). The homogeneous yellow mixture obtained 
was stirred for 6 hours at room temperature. The reaction mixture was washed 
with 2 portions of EhO and the combined organic washings extracted with 
NaOHaq• The combined basic aqueous layers were cooled to 0 °c and acidified 
(PH 1) by the addition of concentrated hydrochloric acid. The mixture was 
extracted with ethyl acetate and the combined extracts washed with brine, dried 
over MgS04 and concentrated under reduced pressure to give 292 as a white solid, 
8.0 g (86%). m.p.=150-151 °c (lit. m.p.=158-159 oC)158 [aJD=-2.1 (c=1.4, 
acetone), (lit. [aJD=-1.34 (c=10.0, acetone) 1 58). lu NMR (250 MUz CDCh): 
02.38 (3H, s, ArCH3), 2.97 (lH, dd, J=6.5, 14.0 Hz, CHH), 3.09 (IH, dd, J=5.0, 
14.0 Hz, CHl-I), 4.20 (IH, m, Cl-I), 5.15 (lH, d, J=8.0 Hz, NH), 5.28 (IH, br s, 
C02l-I), 7.01-7.13 (2H, m, Arl-I), 7.15-7.34 (5H, m, Phl-I), 7.57 (2H, d, J=8.0 Hz, 
Arl-I). 
Synthesis of (S)-N-(1-benzyl-2-hydroxy-ethyl)-4-methyl-
benzenesulfonamide 293159 
I'::JHTs 
Ph~C02H 
292 
I'::JHTs 
LiAIH4 ~ Ph~OH 
Et20, THF 293 
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To a stirred suspension oflithium aluminium hydride (1.07 g, 28.30 mmol, 3 eq.) 
in diethyl ether (70 ml) at room temperature was added a solution of 292 (4.0 g, 
14.70 mmol, 1.0 eq.) in 1:1 diethyl ether-tetrahydrofuran (70 ml) dropwise. Upon 
completion of addition the mixture was heated under reflux for 30 min. The 
reaction mixture was cooled to 0 °c and water added cautiously, followed by 
aqueous 1 M NaOH and then water. The resulting colourless suspension was 
filtered through Celite®, and the filtrate was concentrated under reduced pressure 
to give 293 as a colourless oil, 2.63 g (92%). The material was carried through to 
the next step without further purification (see below). IH NMR (250 MHz 
CDCb): 52.06 (lH, br s, OH), 2.41 (3H, s, ArCH3), 2.62 (IH, dd, J=7.0, 14.0 Hz, 
CHH), 2.78 (lH, dd, J=7.0, 14.0 Hz, CHH), 3.36-3.70 (3H, m, CH + CH20), 4.41 
(lH, br s, NH), 6.91-7.02 (2H, m, ArH), 7.10-7.31 (SH, m, PhH), 7.57 (2H, d, 
J=8.0 Hz, ArH). 13C NMR (62.9 MHz, CDCb): 521.5, 37.8, 56.6, 63.9, 126.7, 
127.0, 128.6, 129.2, 129.7, 136.8, 137.0, 143.3. 
Synthesis of (S)-2-benzyl-1-(toluene-4-sulfonyl)-aziridine 165159 
t::JHTs ADDP, PBU3 
Ph~OH ~ 
293 Toluene, OOC to RT 165 
ADDP (2.66 g, 10.53 mmol, 1.5 eq) was added to a solution of 293 (2.14 g, 7.02 
mmol, 1.0 eq) and tributylphosphine (2.80 mL, 11.23 mmol, 1.6 eq) in toluene (66 
mL) at 0 °C and the reaction was stirred for 2 h at this temperature, before 
warming to room temperature overnight. The reaction mixture was then 
partitioned between Et20 and water, and the layers were separated. The aqueous 
layer was extracted with a further 2 portions of Et20. The combined organic 
fractions were dried over MgS04, concentrated and then purified by flash 
chromatography (10: 1, 40-60 petroleum ether/ethyl acetate) gave 165 as a 
colourless solid 1.44 g (71%). m.p.=91-92 °c (lit. m.p.=91-92 CC) [a]o=+9.l 
(c=1.0~ DCM), (lit. [a]o=+ 10.1 (c=1.0, DCM»59. III NMR (250 MlIz CDCiJ): 
52.16 (IH, d, J=4.5 Hz, CHH-N), 2.42 (3H, s, ArCH3), 2.67 (lH, dd, J=7.0, 15.0 
Hz, CHHPh), 2.72 (IH, d, J=7.0 Hz, CHH-N) , 2.80 (IH, dd, J=5.0, 15.0 Hz, 
157 
CHHPh) , 2.89-3.00 (lH, m, CHN), 6.99-7.17 (SH, m, PhH), 7.21 (2H, d, J=8.S 
Hz, ArH), 7.67 (2H, d, J=8.S Hz, ArH). 
Synthesis of N-(1-benzyl-2-hydroxy-ethyl)-4-methyl-
benzenesulfonamide 168 
NH2 Ph~OH 
168 
To a stirred suspension oflithium aluminium hydride (1.03 g, 27.0 mmol, 2.2 eq.) 
in THF (70 ml) at 0 cC, was added 167 (2.03 g, 12.3 mmol, 1.0 eq.).The mixture 
was heated under reflux overnight. The reaction mixture was cooled to 0 °C and 
potassium carbonate was added cautiously. The resulting colourless suspension 
was filtered through Celite®, and the filtrate was concentrated under reduced 
pressure to give 168 as a yellow oil, 1.23 g (66%). The material was carried 
through to the next step without further purification. IH NMR (250 MHz CDCh): 
82.06 (IH, br s, OH), 2.62 (HI, dd, J=7.0, 14.0 Hz, CHHPh), 2.78 (lH, dd, J=7.0, 
14.0 Hz, CHHPh), 3.36-3.70 (3H, m, CH + CH20), 4.41 (2H, br s, NH2), 7.10-
7.31 (5H, m, PhH). BC NMR (62.9 MHz, CDCh): 837.8, 56.6, 63.9, 127.0, 
128.6, 137.0, 143.3. 
Synthesis of 2-benzyl-1-methanesulfonyl-aziridine 169 
H3C-S02CI 
Et3N, DMAP ( N-SO ________________ \ 2 
DCM, OOC to RT CH3 
Ph 169 168 
To a solution of racemic 168 mixed with triethylamine (1.9 mL, 13.40 mmol, 3.5 
eq) in dry DCM (6 mL), were slowly added methanesulfonylchloride (650 JlL, 
8.43 mmol, 2.2 eq) and DMAP (94 mg, 0.77 mmol, 0.2 eq) at 0 °c and the 
resulting solution was stirred for 30 min. The solution was left at room 
temperature overnight. The solvent was removed under reduced pressure and 
158 
diluted with EtOAc. The organic layer was washed twice with brine and was dried 
over MgS04. The solution was then filtered, concentrated under reduce pressure 
and purified by flash chromatography (3: 1, petroleum ether/ethyl acetate) to 
provide the product 169 as an oil (350 mg, 43%). III NMR (400 Mllz, CDCh): 
82.19 (lH, d, J=4.5 Hz, CHHN), 2.63-2.78 (2H, m, CHN + CHHN), 2.72 (3H, m, 
CH3), 2.87-3.03 (2H, m, CH2Ph), 7.22-7.39 (5H, m PhH). BC NMR (62.9 Mllz, 
CDCh): 836.5, 37.9, 39.6, 41.7, 127.5, 129.1, 130.0, 137.7. FTIR (thin film): 
3063 (w), 3029 (m), 2933 (m), 2854 (w), 1604 (m), 1497 (m), 1455 (m), 1393 
(w), 1315 (s), 1235 (m), 1151 (s), 969 (s), 948 (s), 857 (s), 796 (s), 745 (s), 673 (s) 
cm-I. HRMS (TOF ES) calcd. for ClOII14N02S (MII+): 212.0745. Found: 
212.0748. 
Synthesis of 2-benzyl-1-trifluoromethanesulfonyl-aziridine 171 160 
168 
o 0 
11 11 
F C-~-O-~-CF 3 "IT T1 3 
o 0 rN-SO ____________ ~ ,2 
CF3 Et3N, DCM 
o °c to RT Ph 171 
Triflic anhydride (630 J.1L, 3.75 mmol, 2.2 eq) was added dropwise to a solution of 
racemic 168 (260 mg, 1.71 mmol, 1.0 eq) and triethylamine (760 J.1L, 5.46 mmol, 
3.2 eq) in dry DCM (7 mL) at -78°C, where after the mixture was kept at -30 °c 
overnight. The reaction mixture was diluted with DCM and washed twice with 0.1 
M Hel and twice with Na2C03(aq)' The organic layer was dried over MgS04. The 
solution was then filtered, concentrated under reduce pressure and purified by 
flash chromatography (6:1, petroleum ether/ethyl acetate) to provide the product 
171 as an oil (310 mg, 68%). III NMR (250 Mllz, CDCh): 82.39 (lH, d, J=5.0 
Hz, CIUl), 2.78-3.03 (3H, m, CH2Ph + CHHN), 3.03-3.18 (IH, m, CHN), 7.10-
7.33 (5H, m, PhH). lJC NMR (62.9 MHz, CDCh): 838.4, 39.0, 39.1, 118.2 (q, 
J=280 Hz), 127.7, 129.2, 129.8, 136.4. FTIR (thin film): 3029 (m), 2926 (m), 
2864 (w), 1606 (m), 1483 (m), 1425 (m), 1393 (w), 1315 (s), 1235 (m), 1151 (s), 
969 (s), 948 (s), 857 (s) cm-I. HRMS (TOF ES) calcd. for CloHIIF3N02S 
(MH+): 266.2432. Found: 266.2463. 
159 
Synthesis of tert-butylsulfonamide 161 
e 
9 NaN3 
t ..... 5... 11 
Bu Cl MeCN/H20 
172 (10/1) 
9 <±> e 
tBU .... & .. N=N=N 
Sodium azide (1.4 g, 21.15 mmol, 1.75 eq) was suspended in acetonitrile (8.5 mL) 
and water (850 ilL). The mixture was heated to just below the boiling point of 
acetonitrile, the source of heat was removed, and tert-butylsulfinyl chloride 172 
(1.5 mL, 12.09 mmol, 1.0 eq) was added slowly to the vigorously stirred mixture. 
The reaction is highly exothermic, and the addition rate was adjusted to maintain 
gentle reflux of acetonitrile. After the addition was complete, the reaction mixture 
was allowed to cool to room temperature. Ethyl acetate and water were added, and 
the layers were separated. The aqueous layer was extracted once with ethyl 
acetate, and the combined organic layers were washed with water and dried with 
MgS04• After the solvents were evaporated in vacuo, the residue was mixed with 
ether and the crystals were filtered and washed with ether. The product was 
recrystallized from acetone to afford 1.0 g (60%) of tert-butylsulfonamide as 
colourless crystals (m.p.=162-163 °C, lit. m.p.=162-165 oC)162. The compound 
was used directly without further characterisation. 
Synthesis of tert-butyl hypochlorite 163,164 
tSuOH 
NaOCI • tSuOCI 
AcOH 
Reaction conducted in the dark. A 5% aqueous solution of sodium hypochlorite 
(75 mL, 5% available chlorine) was cooled to 0 cc. To this was added a solution 
of glacial acetic acid (7.5 mL) and tert-butanol (11.25 mL) in one portion and the 
resulting mixture was stirred for 3 mins. The organic layer was separated and 
washed successively with sodium carbonate (10% solution) and water. The 
product was dried over calcium chloride and filtered to yield the title compound 
160 
as a yellow liquid. The product was stored below 4 °C in the dark over calcium 
chloride. 
Synthesis of the N-chloramine salt of terf-butylsulfonamide 173161 
o 
~uOCI ~ 0 Na 
-
--__ tBu-~-N 
iT "'CI 
NaOH (1M) 0 
173 
'BuOCI (267 mg, 2.47 mmol, 1.0 eq) was added slowly to a stirred solution of 
tert-butylsulfonamide (338 mg, 2.47 mmol, 1.0 eq) in an aqueous solution of 
NaOH (1 M, 2.5 mL, 2.47 mmol, 1.0 eq) at room temperature. The resulting 
solution was stirred for 1 h. The solution was then concentrated to dryness in 
vacuum. The solid was triturated with ether, filtered and dried in drying pistol (80 
QC) overnight to afford the product 173 as a white powder (430 mg, 90%). 
Synthesis of 2-benzyl-1-(2-methyl-propane-2-sulfonyl)-aziridine 175165 
~ BusN(Na)CI. PTAB ~----------~~~ 
MeCN. rt 
174 
To a mixture of 174 (125 mg, 1.06 mmol, 1.0 eq) and the N-chloramine salt of 
tert-butylsulfonamide 173 (246 mg, 1.27 mmol, 1.2 eq) in 17 mL of CH3CN were 
added phenyltrimethylammonium tribromide (40 mg, 0.11 mmol, 0.1 eq) at 25°C. 
After 12h of vigorous stirring, the reaction mixture was concentrated and purified 
by flash chromatography (5: 1, petroleum ether/ethyl acetate) to provide the 
product 175 as an oil (100 mg, 37%). IH NMR (250 MHz, CDCiJ): 81.43 (9H, s, 
C(CH3)3), 2.09 (IH, d, J=4.5 Hz, CHH aziridine), 2.58-2.61 (1H, d, J=7.0 Hz, 
CHH aziridine), 2.72-2.85 (IH, m, CH aziridine), 2.92-3.07 (2H, m, CH2Ph), 
7.18-7.36 (5H, m ArH). 13C NMR (62.9 MHz, CDCh): 824.1,32.9, 37.4, 39.3, 
59.3, 126.9, 128.6, 129.1, 136.5. 
161 
Synthesis of 2-benzyl-1-(4-nitro-benzenesulfonyl)-aziridine 170166. 167 
1. NsCI. Pyridine 
DCM 
2.2 M KOH 
()'<1, 
1709 " ~~I 
~ 
N02 
4-nitrobenzenesulfonyl chloride (3.34 g, 15.06 mmol, 3.0 eq) was added in one 
portion to a suspension of 168 (759 mg, 5.02 mmol, 1.0 eq) in DCM (4.2 mL) and 
pyridine (2.1 mL) and stirred at rt for 4 hours. This was then diluted with DCM 
and washed with 2 portions aqueous 1 M HCI, and the aqueous washings 
extracted with DCM. The combined organic extracts were then carefully shaken 
with 6 successive portions of aqueous 2 M KOH. The aqueous washings were 
further extracted with DCM and the combined organics were dried over MgS04, 
filtered, concentrated in vacuo, and the resulting residue purified by flash 
chromatography (2: 1, petroleum ether/ethyl acetate) to give aziridine 170 (810 
mg, 51 %) as a colorless oil. tu NMR (250 MUz, CDCh): 82.30 (lH, d, J=4.5 
Hz, CHHN), 2.48 (IH, m, CHHN), 2.91 (3H, m, CRN + CH2Ph), 6.90-7.12 (5H, 
m, PhH), 7.87 (2H, d, J=9.0 Hz, ArH), 8.15 (2H, d, J=9.0 Hz, ArH). 13C NMR 
(62.9 MHz, CDCh): 833.1, 37.2, 42.4, 124.3, 127.0, 128.3, 128.6, 129.0, 136.5, 
143.8, 150.4. 
Synthesis of 2-benzyl-aziridine 176106.168 
Toluene reflux V¥ 176 
The amino alcohol 168 (1.48 g, 9.76 mmol, 1.0 eq) was dissolved in toluene (IS 
mL) and was added to a solution oftriphenylphosphine (2.69 g, 10.25 mmol, 1.05 
eq) and diethylazodicarboxylate (1.6 mL, 10.25 mmol, 1.05 eq) in toluene (22 
mL). After refluxing overnight, the mixture was poured into water and diluted 
162 
with diethyl ether. Drying over MgS04, filtration, and concentration gave a 
residue, which was diluted with diethyl ether and left in the freezer overnight. 
Precipitated triphenylphosphine oxide was filtered off, and the filtrate was 
concentrated and subjected to column chromatography (10:1, DCMlMeOH) to 
give aziridine 176 (850 mg, 65%) as a colorless oil. IH NMR (250 MHz, CDCh): 
81.45 (1H, d, J=3.5 Hz, CHHN), 1.82 (1H, d, J=5.5 Hz, CHHN), 2.16-2.25 (IH, 
m, CHN), 2.65 (1H, dd, J=6.0 Hz, J=14.5 Hz, CHHPh), 2.80 (IH, dd, J=6.0 Hz, 
J=14.S Hz, CHHPh), 7.20-7.35 (5H, m, PhH). I3C NMR (62.9 MHz, CDCIJ): 
825.0,31.0,40.2, 126.4, 128.5, 128.8, 139.4. 
Synthesis of 2-benzyl-aziridine-1-carboxylic acid 4-nitro-benzyl ester 
177 
• ~H 4-n itrobenzylch loroformate 
176 
To a solution of amino alcohol 176 (80 mg, 0.60 mmol, 1.0 eq) dissolved in DCM 
(3 mL) at 0 °c were added triethylamine (126 JlL, 0.90 mmol, 1.5 eq) and 4-
nitrobenzylchloroformate (155 mg, 0.72 mmol, 1.2 eq). After stirring overnight at 
rt, the mixture was concentrated and subjected to column chromatography (2: 1, 
petroleum ether/ethyl acetate) to give aziridine 177 (120 mg, 64%) as a colorless 
oil. In NMR (400 MHz, CDCh): 82.15 (IH, d, J=4.S Hz, CHHN), 2.48 (IH, d, 
J=6.0 Hz, CHHN), 2.70-2.97 (3H, rn, CH2Ph + CHN), 5.20 (2H, s, CH20), 7.25-
7.33 (5H, m, PhH), 7.45 (2H, d, J=9.0 Hz, ArH), 8.20 (2H, d, J=9.0 Hz, ArH). IJC 
NMR (400 MHz, CDCh): 831.8, 38.4, 39.0, 66.4, 123.8, 126.8, 128.0, 128.6, 
128.9, 137.6, 143.0, 147.7, 162.8. mlz (TOF ES): 312 (M+). 
163 
Synthesis of 2-benzyl-aziridine-1-carboxylic acid 2-chloro-benzyl 
ester 178 
• V<1H 2-chlorobenzylchloroformate 
176 
To a solution of amino alcohol 176 (80 mg, 0.60 mmol, 1.0 eq) dissolved in DCM 
(3 mL) at 0 °c were added triethylamine (130 !-lL, 0.90 mmol, 1.5 eq) and 2-
chlorobenzylchlorofonnate (110 !-lL, 0.72 mmol, 1.2 eq). After stirring overnight 
at rt, the mixture was concentrated and subjected to column chromatography (2:1, 
petroleum ether/ethyl acetate) to give aziridine 178 (180 mg, 99%) as a colorless 
oil. 111 NMR (400 MlIz, CDCh): 82.12 (lH, d, J=4.5 Hz, CHHN), 2.42 (lH, d, 
J=6.0 Hz, CHHN), 2.67-2.80 (2H, m, CH2Ph), 2.88-3.02 (IH, m, CHN), 5.20 (2H, 
s, CH20), 7.20-7.33 (5H, m, PhH), 7.37-7.40 (3H, m, ArH), 7.42-7.50 (lH, m, 
ArH). BC NMR (400 Mllz, CnCIJ): 831.7, 38.3, 38.7, 43.6, 65.4, 126.6, 126.9, 
127.2, 128.5, 129.5, 129.9, 130.9, 133.5, 137.7, 163.0. mlz (TOF ES): 301 (M+). 
Synthesis of (R)-2-(tert-butyl-diphenyl-silanoxymethyl)-1-(toluene-4-
sulfonyl)-aziridine 143 
~HTs 
TBDPSO~OH ------... -
Toluene, 0 OC to rt 
JNTS 
TBDPSO 
(R)-143 
ADDP (877 mg, 3.47 mmol, 1.2 eq) was added to a solution of starting material 
(1.40 g, 2.89 mmol, 1.0 eq) and tributylphosphine (1.07 mL, 4.34 mmol, 1.5 eq) in 
toluene (20 mL) at 0 °C and stirred for 2 h at this temperature, and then warmed to 
room temperature overnight. The reaction mixture was then partitioned between 
EhO and water, and the layers were separated. The aqueous layer was extracted 
with a further 2 portions of Et20. The combined organic fractions were dried over 
MgS04, concentrated and then purified by flash chromatography to provide (R)-
164 
143 as a colourless oil (1.07 g, 80%). IH NMR (250 MHz, CDCh): 00.96 (9H, s, 
C(CH3)3), 2.15 (IR, d, J=5.0 Hz, CHH aziridine), 2.40 (3R, s, ArCH3), 2.65 (lH, 
d, J=I1.0 Hz, CHH aziridine), 2.94-3.04 (lH, m, CH aziridine), 3.60 (lH, dd, 
J=I1.5, 5.5 Hz, CHHOTBDPS), 3.70 (lH, dd, J=I1.5, 4.0 Hz, CHHOTBDPS), 
7.25-7.47 (8R, m, ArH), 7.54-7.62 (4H, m, ArH), 7.85 (2H, d, J=8.0 Hz, ArH). 
BC NMR (62.9 MHz, CDCh): 819.1,21.6,26.6, 30.4, 40.9, 63.1, 127.7, 128.0, 
129.7, 129.8, 135.1, 135.5, 143.2, 144.4. FTIR (thin film): 3071 (w), 2931 (m), 
2858 (m), 1598 (w), 1472 (w), 1428 (m), 1327 (s), 1164 (s), 1093 (s) cm-I. m/z 
(TOF ES): 466 (MH+). HRMS (TOF ES) caIcd. for C26H32N03SiS (MH1: 
466.1872. Found: 466.1851. 
Synthesis of 2-Amino-succinic acid dimethyl ester 144107, 108, 169 
o ' NH2 
HO~ 
OH 
(D.L) - aspartic acid 
MeOH 
o °C to rt 
o NH2.HCI Meo~ 
OMe 
144 
Thionyl chloride (3.1 ml, 42.07 mmol, 1.4 eq) was added dropwise to a solution 
of (D.L)-aspartic acid (4.0 g, 30.05 mmol, 1.0 eq) in dry methanol (40 mL) at 0 
°c, the reaction was allowed to warm to room temperature and stirred for 48 h. 
The reaction was evaporated under reduced pressure to give a light yellow oil and 
then triturated with diethylether and filtered to give 144 as a white solid (5.90 g, 
99% crude). rn.p.=I13-114 °c (lit. rn.p.=116-117 °C)I07, 108. JHNMR (250 MHz, 
CDCh): 02.73 (lH, dd, J=7.5, 16.5 Hz, CHH), 2.82 (IH, dd, J=4.5, 16.5 Hz, 
CHH), 3.71 (3H, s, CH3), 3.75 (3H, s, CH3), 3.85 (IH, dd, J=4.5, 7.5 Hz, CH-N). 
Synthesis of 2-(toluene-4-sulfonylamino)-succinic acid dimethyl ester 
145 37,170 
o NH2 HCI Meo~ 
144 OMe 
THF,48h 
o °C to rt 
o NHTs 
Meo~ 
145 OMe 
165 
A flask was charged with diester 144 (5.80 g, 29.36 nunol, 1.0 eq) and THF (22 
mL) and cooled to 0 QC. Distilled triethylamine (18 mL, 129.18 nunol, 4.4 eq) and 
then p-toluenesulfonylchloride (6.1 g, 32.23 nunol, 1.1 eq) were added and the 
mixture stirred at room temperature for 72 h. The reaction mixture was acidified 
with HCI (32%) to pH 3 and extracted with ethyl acetate. The organic layer was 
washed with saturated aqueous sodium hydrogencarbonate solution then dried 
over MgS04 and evaporated under reduce pressure to give 145 as an oily yellow 
residue (8.05 g, 87% crude). IHNMR (250 MHz, CDCh): 82.41 (3H, m, CH3), 
2.84 (1H, dd, J=5.0, 17.0, HCH-C=O), 2.97 (1H, dd, J=5.0, 17.0, HCH-C=O), 
3.59 (3H, s, CH3), 3.66 (3H, s, CH3), 4.06-4.18 (IH, m, CH-N), 5.60 (IH, d, J=8.0 
Hz, NH), 7.30 (2H, d, J=8.0 Hz, ArH), 7.73 (2H, d, J=8.0 Hz, ArH). FTIR (thin 
film): 3849 (br), 3061 (m), 2956 (m), 1748 (s), 1599 (m), 1440 (s), 1346 (s). 
Synthesis of N-(3-hydroxy-1-hydroxymethyl-propyl)-4-methyl-
benzenesulfonamide 146171 
~ ~HTSO 
MeO~ 
145 OMe 
• 
THF, 48 h 
NHTs 
HO~ 
146 OH 
A solution of the diester 145 (1 g, 3.17 mmol, 1.0 eq) in THF (15 ml) was added 
dropwise via cannula to a solution of lithium borohydride (152 mg, 6.80 nunol, 
2.2 eq) in THF (23 rnL) at 0 °c and stirred for 48 h. Aqueous potassium carbonate 
solution and water were added to quench the reaction and the resulting mixture 
was extracted with ethyl acetate. The organic layer was dried over MgS04, 
evaporated under reduced pressure and then purified by flash chromatography to 
provide 146 as a white powder (1.37 g, 84%). m.p.=88 QC. IHNMR (250 MHz, 
CDCh): 81.59-1.77 (2H, rn, CH2), 1.91 (IH, br s, OH), 2.43 (3H, s, CH3), 3.37-
3.87 (5H, m, CH2 + CH-N), 7.36 (2H, d, J=8.5 Hz, ArH), 7.66 (2H, d, J=8.5 Hz, 
ArH). 13C NMR (62.9 MHz, CDCh): 821.6, 34.4, 53.0, 58.7, 64.6, 127.1, 129.8, 
140.5, 143.7. 
166 
Synthesis of 2-hydroxyethyl-1-(toluene-4-sulfonyl)-aziridine 148 via 
Mitsunobu reaction 
NHTs BU3P, ADDP HO~OH ------.... 
Toluene, 0 CC to rt 
146 
/~S 
HO 148 
A 50 mL round-bottomed-flask was charged with 146 (548 mg, 2.11 mmol, 1.0 
eq), distilled tributylphosphine (840 )lL, 3.38 mmol, 1.6 eq) and toluene (20 mL) 
at room temperature. The reaction mixture was cooled to 0 cC. Then, 1,1'-
azodicarbonyldipiperidine (ADDP) (800 mg, 3.17 mmol, 1.5 eq) was added in 
small portions. The reaction mixture was stirred 2 h at 0 °c, then it was allowed to 
reach rt and stirred overnight. The reaction mixture was evaporated under reduced 
pressure, dissolved in a mixture DCMlMeOH (10:1), dried on silica and purified 
by flash column chromatography (1:1 petroleum etherlEtOAc) to provide a 
colourless oil, 148 (411 mg, 81%). III NMR (250 Mllz, CDCh): 81.36-1.53 (IH, 
m, HCH), 1.89-2.10 (IH, m, HCH), 2.14 (1H, d, J=4.5 Hz, CHH aziridine) 2.44 
(3H, s, ArCHj ), 2.64 (IH, d, J=7.0 Hz, CHH aziridine), 2.83-2.97 (1H, m, CH 
aziridine), 3.55-3.74 (2H, CH20H), 7.34 (2H, d, J=8.0 Hz, ArH), 7.82 (2H, d, 
J=8.0 Hz, ArH). I3C NMR (62.9 MHz, CDCh): 825.8, 29.6, 42.1, 55.3, 68.2, 
128.3, 131.8, 132.0, 133.3. FTIR (thin film): 3527 (br), 2925 (w), 1597 (w), 1320 
(m), 1232 (w), 1160 (s), 1092 (w) cm-I. mlz (TOF ES): 264 (MNa+). HRMS 
(TOF ES) calcd. for ClIHISN03NaS (MNa+): 264.0670. Found: 264.0666. 
Synthesis of (R)-2-(tett-butyl-diphenyl-silanoxyethyl)-1-(toluene-4-
sulfonyl)-aziridine 140 
/~S TBDPSCI, Imida~le 
HO 148 THF, 0 °C to rt, 3 h 
/NTS 
TBDPSO 140 
Substrate 148 was dissolved in THF (2.5 mL) and the solution was cooled to 0 °C. 
TBDPSCl (552 mL, 2.12 mmol, 1.25 eq) and imidazole (347 mg, 5.10 mmol, 3.0 
eq) were added. The reaction mixture was allowed to reach rt and stirred for 3 h. 
167 
The reaction mixture was diluted with EtOAc and washed with brine. The organic 
layer was dried over magnesium sulphate, concentrated in vacuum. Purification of 
the resulting liquid by silica gel chromatography (l0/1, petroleumlEtOAc) 
provided 140 as a yellow oil (734 mg, 90%). Characterisation data for this 
compound has been described earlier. 
Synthesis of 2-amino-pentanedioic acid dimethyl esterl07, 108, 169 
o NH2 
HOv'yO 
2 OH 
(O,L) - glutamic acid 
MeOH 
o °C to rt 
o NH2.HCI Meo~O 
OMe 
Thionyl chloride (1.24 mL, 16.95 mmol, 1.4 eq) was added dropwise to a solution 
of (D,L)-glutamic acid (2.0 g, 12.11 mmol, 1.0 eq) in dry methanol (16 mL) at 0 
QC, the reaction was allowed to warm to room temperature and stirred for 48 h. 
The reaction was evaporated under reduced pressure to give a light yellow oil and 
then triturated with diethyl ether and filtered to give 2-amino-pentanedioic acid 
dimethyl ester as a white solid (2.53 g, 99% crude). ]HNMR (250 MHz, DMSO): 
81.94-2.11 (2H, m, CH]), 2.39-2.62 (2H, m, CH]-C=O), 3.62 (IH, s, CH3), 3.75 
(lH, s, C1IJ), 4.08 (lII, t, J=6.5 Hz, CH-N). FTIR (thin film): 3852 (br), 3058 
(m), 2957 (m), 1750 (s), 1595 (m), 1442 (s), 1343 (s). 
Synthesis of 2-(toluene-4-sulfonylamino)-pentanedioic acid dimethyl 
ester 172 
o NH2.HCI Meo~O 
OMe 
TsCl, Et3N 
• THF, 48 h 
o °c to rt 
o NHTs 
Meo~O 
OMe 
A flask was charged with the dimethyl ester (2.53 g, 11.96 mmol, 1.0 eq) and 
TIIF (10 ml) and cooled to 0 QC. Distilled triethylamine (7.3 ml, 52.62 mmol, 4.4 
eq) and then p-toluenesulfonylchloride (2.51 g, 13.16 mmol, 1.1 eq) were added 
and the mixture was stirred at room temperature for 72 h. The reaction mixture 
168 
was acidified with HCI (32%) to pH 3 and extracted with ethyl acetate. The 
organic layer was washed with saturated aqueous sodium hydrogenocarbonate 
solution then dried over MgS04 and evaporated under reduce pressure to give 2-
(toluene-4-sulfonylamino )-pentanedioic acid dimethyl as an oily yellow residue 
(3.85 g, 98% crude). I HNMR (250 MHz, CDCh): 81.82 (lH, m, CHH), 2.00 
(lH, m, CHH), 2.37 (3H, m, CH3), 2.41 (2H, m, CH]-C=O), 3.41 (3H, s, CH3), 
3.56 (3H, s, CH3), 3.90 (IH, m, CH-N), 5.60 (lH, d, J=9.5 Hz, NH), 7.20 (2H, d, 
J=8.0 Hz, Ar/{), 7.63 (2H, d, J=8.0 Hz, Ar/{). FTIR (thin film): 3852 (br), 3050 
(m), 2963 (m), 1749 (s), 1612 (m), 1440 (s), 1342 (s). 
Synthesis of N-(4-hydroxy-1-hydroxymethyl-butyl)-4-methyl-
benzenesulfonamide 
o NH2.HCI 
Meo~O 
OMe 
THF, 24 h 
• 
NHTs 
HO~ 
OH 
A solution of the diester (3.85 g, 11.69 mmol, 1.0 eq) in THF (56 mL) was added 
dropwise via cannula to a solution of lithium borohydride (976 mg, 25.72 mmol, 
2.2 eq) in THF (85 mL) at 0 °c and stirred for 24 h. Aqueous potassium carbonate 
solution and water were added to quench the reaction and the resulting mixture 
was extracted with ethyl acetate. The organic layer was dried over MgS04, and 
the solvent removed in vacuo. The solid residue was recrystallised in DCMlPetrol, 
providing the diol as a white powder, 1.62 g (51 %). m.p.=83-85 0c. IHNMR (250 
Mllz, CnCb): 01.35-1.63 (4H, m, CH]), 1.90 (211, br s, OH), 2.42 (3H, s, Clh), 
3.18-3.31 (IH, m, CH-N), 3.41-3.63 (4H, m, CH]-O), 7.30 (2H, d, J=8.0 Hz, 
ArH), 7.77 (2H, d, J=8.0 Hz, Ar/{). I3C NMR (62.9 MHz, cncIJ): 021.5,28.0, 
28.4, 42.1, 55.3, 62.3, 64.6, 127.1, 129.7, 135.6, 138.4. FTIR (thin film): 3476 
(br), 3294 (s), 2946 (m), 2875 (m), 1718 (w), 1436 (w), 1321 (m), 1157 (s), 1093 
(m), 1047 (m) cm-I. mlz (TOF ES): 274 (MH+). HRMS (TOF ES) calcd. for 
C12H20N4S: 274.1113. Found: 274.1113. 
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Synthesis of 2-hydroxypropyl-1-(toluene-4-sulfonyl)-aziridine 173 
NHTs PP~, DIAD ~NTS 1\ HO~OH - _____ .. + \~,~OH 
Toluene, 0 QC to rt H ~s 
A 50 mL round-bottomed-flask was charged with the diol (300 mg, 1.10 mmol, 
1.0 eq), triphenylphosphine (460 mg, 1.76 mmol, 1.6 eq) and toluene (10 mL) at 
room temperature. The reaction mixture was cooled to 0 QC. Then, diisopropyl 
azodicarboxylate (DIAD) (324 J..lL, 1.65 mmol, 1.5 eq) was added. The reaction 
mixture was stirred 2 h at 0 QC, then it was allowed to reach rt and stirred 
overnight. Water was added and the reaction mixture was extracted with 
diethylether, dried over MgS04 and purified by flash column chromatography 
(1:2 petroleumetherlEtOAc) to provide the hydroxy-aziridine as a white solid (30 
mg, 11 %), and the pyrrolidine as a yellow oil (250 mg, 89%). 
Hydroxy-aziridine: m.p.=120-121 QC. III NMR (250 Mllz, CDCh): 01.31-1.45 
(IH, m, HCH), 1.47-1.60 (2H, m, CH2), 1.65-1.82 (lH, m, HCll), 2.05 (IH, d, 
J=4.50 Hz, CHH aziridine) 2.43 (3H, s, ArCH;), 2.60 (IH, d, J=7.0 Hz, CHH 
aziridine), 2.72-2.84 (lH, m, CH aziridine), 3.60 (2H, t, J=6.0 Hz, CH20H), 7.32 
(2H, d, J=8.0 Hz, Arll), 7.81 (2H, d, J=8.0 Hz, Arll). I3C NMR (62.9 Mllz, 
CDCh): 025.8, 28.3, 29.6, 55.3, 68.2, 128.3, 131.8, 132.0, 133.3. FTIR (thin 
film): 3430 (br), 3056 (w), 2923 (w), 2359 (m), 1437 (m), 1327 (w), 1182 (m), 
1119 (s) cm-I, 
Pirrolidinelo: III NMR (250 Mllz, CDCh): 01.29-1.46 (IH, m, CH2), 1.52-1.81 
(3H, m, HCH + CH2), 2.37 (3H, s, ArCH;), 3.11-3.24 (IH, m, CHH-N), 3.31-3.45 
(llI, rn, HCH-N) 3.50-3.68 (3H, m, CHN + CH2-0), 7.27 (2H, d, J=8.0 Hz, Arll), 
7.67 (2H, d, J=8.0 Hz, Arll). I3C NMR (62.9 Mllz, CDCh): 021.5, 21.9, 24.3, 
28.9,50.1,61.8,65.9, 127.6, 129.8, 143.8. 
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5.[3+3] Cycloaddition 
Synthesis of (R)-2-(tett-butyl-diphenyl-silanoxymethyl)-5-methylene-
1-(toluene-4-sulfonyl)-piperidine 149 
TBOPSO 
JNTS 
~SiMe, 
OAc 
10 %Pd(OAc)2 ~ AcO') AcO,) 
60% P(OiPrh· ....... ~:I + TS(H)NI + TSNI 
143 
20% n-BuLi Ts OTBOPS OTBOPS ............ ) OTBOPS 
THF,16 hrs, reflux 149 154 IT 158 
A solution of 143 (88 mg, 0.19 mmol, 1.5 eq) in THF (1.2 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solutiond (90 JlL, 0.012 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (27 JlL, 0.126 mmol, 1.0 
eq) and the reaction mixture heated at reflux for 16 h. Solvent was removed in 
vacuo and the residue purified by flash chromatography (12:1 petroleum 
etherlEtOAc) to give mainly the desired piperidine 149 (45mg, 67%). 
149: IH NMR (250 MHz, CDCh): 81.06 (9H, s, C(CH3)3), 1.34-1.52 (1H, m, 
CH2), 1.79-1.98 (2H, m, CH2), 2.02-2.23 (IH, m, CH2), 2.40 (3H, s, ArCH3), 3.62 
(Ill, d, J=15.5 Hz, C6-l/), 3.72-3.86 (2H, m, CH20TBDPS), 3.96-4.08 (IH, m, 
C2-1l), 4.20 (lH, d, J=15.5 Hz, C6-Hj, 4.66 (lH, br s, C=CHH), 4.75 (1H, br s, 
C=CHl/), 7.20 (2H, d, J=8.0 Hz, Arl/), 7.35-7.48 (6H, m, Arl/), 7.60-7.69 (6H, 
m, Arl/). JJC NMR (62.9 MHz, CDCIJ): 819.2,21.5,24.6,26.9,27.1,47.7,53.6, 
62.9, 110.3, 127.2, 127.8, 129.4, 129.8, 133.3, 135.6, 137.7, 141.2, 142.9. FTIR 
(CH2Ch): 3072 (w), 2931 (m), 2858 (m), 1598 (w), 1428 (m), 1342 (s), 1162 (s), 
1113 (s) cm>l. mlz (TOF ES): 542 (MNa+). HRMS (TOF ES) calcd. for 
CJOHJ7NOJNaSiS (MNa+): 542.2161. Found: 542.2138. 
d Representative procedure for 0.14 M Pd catalyst used in cycloaddition reactions: 
To a suspension ofPd(OAc)2 (50 mg, 0.22 mmol, 1.0 eq.) in THF (1.61 mL) was added P(O/prh 
(0.33 mL, 1.34 mmol, 6.0 eq.), and then n-butyllithium (2.5 M in hexane, 0.18 mL, 0.44 mmol, 2.0 
eq) was added and the resultant solution was stirred for 15 min before use. 
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154: IH NMR (250 MHz, CDCh): 00.98 (9H, s, C(CH3)3), 1.81 (3H, S, CH3-
C=O), 2.34 (3H, s, ArCH3), 3.28-3.59 (3H, m, CH-N + CH20), 3.89-4.17 (2H, m, 
CH2-O), 4.89 (1H, d, J=8.0 Hz, NH), 7.16 (2H, d, J=8.0 Hz, Arl!), 7.26-7.43 (6H, 
m, Arl!), 7.46-7.56 (4H, m, Arl!), 7.66 (2H, d, J=8.0 Hz, Arl!). 13C NMR (62.9 
MHz, CDCh): 019.0, 20.7, 21.5, 26.8, 53.3, 61.5, 63.0, 127.0, 127.8, 129.7, 
130.0, 132.9, 135.5, 137.8, 143.4, 170.7. FTIR (CH2Ch): 3282 (br), 2931 (m), 
2857 (m), 1744 (s), 1428 (m), 1337 (m), 1238 (m), 1163 (s), 1111 (s) cm-I. mlz 
(TOF ES): 548 (MNa+). HRMS (TOF ES) caled. for C2SHJsNOsNaSiS (MNa+) 
548.1903. Found: 548.1884. 
158: mlz (TOF ES): 602 (MNa). HRMS (TOF ES) ca led. for CJ2H41NOsNaSiS 
(MNa+): 602.2372. Found: 602.2347. 
Synthesis of 2-( tert-butyl-diphenyl-si lanoxyethyl)-5-methylene-1-
(toluene-4-sulfonyl)-piperidine 150 via [3+3] Cycloaddition 
~SjMe3 
OAc 
JNTS 10%Pd(OAc), YI AcO) AcO) 
TBDPSO)2 60% p(Oiprh" '~:'tl)2 TS(H)N~)2 yTSN~)2 
140 20% nBuLi OTBDPS OTBDPS OTBDPS 
THF, 16 hrs, reflux 150 155 159 
A solution of 140 (208 mg, 0.43 mmol, 1.5 eq) in THF (2.8 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (206 JlL, 0.029 mrnol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (61 JlL, 0.29 mrnol, 1.0 eq) 
and the reaction mixture heated at reflux for 16 h. Solvent was removed in vacuo 
and the residue purified by flash chromatography (12:1 petroleum etherlEtOAc). 
150: (65%) III NMR (250 MHz, CDCIJ): 01.05 (9H, s, C(CH3)3), 1.30-1.49 (2H, 
m, CH2), 1.65-1.82 (2H, m, CH2), 1.83-2.04 (2H, m, CH2), 2.37 (3H, s, ArCH3), 
3.52 (IH, d, J=15.0 Hz, C6-l!), 3.57-3.77 (2H, m, CH]OTBDPS), 4.05-4.15 (IH, 
m, C2-l!), 4.21 (IH, d, J=15.0 Hz, C6-H), 4.67 (IH, br, C=CHH), 4.76 (IH, br, 
C=CHl!), 7.18 (2H, d, J=8.0 Hz, Arl!), 7.32-7.47 (6H, m, Arl!), 7.59-7.70 (6H, 
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m, ArH). I3C NMR (62.9 MHz, CDCiJ): 019.2,21.5,26.9,27.3,28.0,32.9,46.5, 
50.0, 61.1, 110.3, 127.4, 127.7, 129.4, 129.6, 133.6, 135.6, 136.8, 142.3, 144.4. 
FTIR (CH2Ch): 3060 (w), 2931 (m), 2847 (m), 1466 (w), 1428 (m), 1341 (s), 
1160 (s), 1111 (s) cm·l. mlz (TOF ES): 556 (MNa+). HRMS (TOF ES) calcd. 
for C31H39N03NaSiS (MNal: 556.2318. Found: 556.2330. 
155: (17%) IH NMR (250 MHz, CDCiJ): 00.98 (9H, s, C(CH3)3), 1.54-1.62 (2H, 
m, CH2), 1.89 (3H, s, CH3-C=O), 2.33 (3H, s, ArCH3), 3.38-3.71 (3H, m, CH-N + 
CH20), 4.0 (2H, app ddd, J=5.5, 11.5, 17.5, CH2-0), 5.30 (1H, d, J=7.5 Hz, NH), 
7.16 (2H, d, J=8.0 Hz, ArH), 7.26-7.43 (6H, m, ArH), 7.46-7.56 (4H, m, ArH), 
7.66 (2H, d, J=8.0 Hz, ArH). I3C NMR (62.9 MHz, CDCiJ): 019.0, 20.7, 21.5, 
26.8,33.9,51.0,60.7,65.5, 127.1, 127.8, 129.7, 129.9, 132.9, 135.5, 137.8, 143.3, 
170.7. FTIR (CH2Ch): 3282 (br), 2931 (m), 2860 (m), 1744 (s), 1428 (m), 1235 
(m), 1162 (s), 1111 (s) cm"l. mlz (TOF ES): 562 (MNal. IIRMS (TOF ES) 
calcd. for C29H37NOsNaSiS (MNal: 562.2059. Found: 562.2059. 
Synthesis of 2-( tert-butyl-d iphenyl-silanoxypropyl)-5-methylene-1-
(toluene-4-sulfonyl)-piperidine 151 via [3+3] Cycloaddition 
[::NTS 
TBDPSO-f!) 3 
141 
~SiMe3 
OAc 
AcO AcO 
10%Pd(OAch ~ 1 'I 
60% p(Oiprh· '~~b TS(H)N~)3 yTSN~)3 
20% nBuLi Ts OTBDPS OTBDPS OTBDPS 
THF, 16 hrs, reflux 151 156 160 
A solution of 141 (249 mg, 0.51 mmol, 1.5 eq) in THF (3.3 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (240 ilL, 0.034 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (71.5 ilL, 0.34 mmol, 1.0 
eq) and the reaction mixture heated at reflux for 16 h. Solvent was removed in 
vacuo and the residue purified by flash chromatography (12:1 petroleum 
etherlEtOAc ). 
151: (20%) III NMR (250 MlIz, CDCiJ): 01.03 (9H, s, C(CH3h), 1.27-1.43 (2H, 
m, CH2) , 1.49-1.67 (2H, m, CH2), 1.73-1.86 (2H, m, CH2), 1.89-2.02 (2H, m, 
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CH2) , 2.38 (3H, s, ArCH3), 3.60 (lH, br, C6-H), 3.63-3.71 (2H, m, 
CH20TBDPS), 3.84-3.95 (IH, m, C2-H), 4.23 (lH, d, J=15.0 Hz, C6-H), 4.64 
(lH, br, C=CHH), 4.75 (IH, br, C=CHH), 7.20 (2H, d, J=8.0 Hz, ArH), 7.33-7.44 
(6H, m, ArH), 7.61-7.69 (6H, m, ArH). l3C NMR (62.9 l\1Hz, CDCh): 319.2, 
21.4, 26.2, 26.9, 27.3, 28.4, 31.4,48.2, 52.5, 63.6, 110.4, 127.3, 127.6, 129.4, 
129.6, 133.4, 135.6, 137.8, 142.4, 143.5. FTIR (CH2Ch): 3071 (w), 2932 (m), 
2857 (m), 1472 (w), 1428 (m), 1340 (s), 1159 (s), 1111 (s) cm-I. mlz (TOF ES): 
548 (MH+). HRMS (TOF ES) caled. for C32H42N03SiS (MH+): 548.2655. 
Found: 548.2634. 
156: (25%) IH NMR (250 MHz, CDCh): 31.02 (9H, s, C(CH3)3), 1.35-1.58 (4H, 
m, CH2), 1.93 (3H, s, CHrC=O), 2.38 (3H, s, ArCH3), 3.38-3.65 (4H, m, CH20), 
3.90 (lH, ddd, J=4.5, 11.5, 12.5, CH-N), 4.71 (IH, d, J=8.5 Hz, NH), 7.24 (2H, d, 
J=8.0 Hz, ArH), 7.32-7.47 (6H, m, ArH), 7.57-7.65 (4H, m, ArH), 7.71 (2H, d, 
J=8.0 Hz, ArH). l3C NMR (62.9 MHz, CDCh): 319.2, 20.6, 21.5, 26.8, 28.2, 
28.8, 52.6, 63.1, 65.8, 127.0, 127.7, 129.7, 132.9, 133.7, 135.5, 138.1, 143.4, 
170.8. FTIR (CH2Ch): 3275 (br), 2931 (m), 2858 (m), 1744 (s), 1428 (m), 1237 
(m), 1161 (s), 1093 (s) cm-I. mlz (TOF ES): 576 (MNa+). HRMS (TOF ES) 
ca led. for C30HJ9NOsNaSiS (MNal: 576.2216. Found: 576.2202. 
Synthesis of 2-(tert-butyl-diphenyl-silanoxypropyl)-5-methylene-1-
(toluene-4-sulfonyl)-piperidine 152 via [3+3] Cycloaddition 
~NTS 
TBDPSO-fl) 4 
!(SiMe3 
OAc 
10 %Pd(OAch ~ Ae0'l Ae0'l 
20% nBuU Ts OTBDPS OTBDPS OTBDPS 142 
60% p(Oiprh· '~~}4 TS(H)N9}4 yTSN9}4 
THF,16hrs,reflux 152 157 161 
A solution of 142 (100 mg, 0.20 mmol, 1.5 eq) in THF (1.3 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (95 ~L, 0.013 mmol, 0.1 eq), 
and 2-[(trimethylsiJyl)methyl]-2-propen-l-yl acetate 3 (28 ~L, 0.13 mmol, 1.0 eq) 
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and the reaction mixture heated at reflux for 16 h. Solvent was removed in vacuo 
and the residue purified by flash chromatography (12:1 petroleum etherlEtOAc). 
152: (20%) IH NMR (250 MHz, CDCh): 01.04 (9H, s, C(CH3)3), 1.30-1.48 (4H, 
m, CH2), 1.49-1.61 (2H, m, CH2), 1.63-1.78 (2H, m, CH2), 1.88-2.0 (2H, m, CH2), 
2.37 (3H, s, ArCH3), 3.64 (3H, m, CH20TBDPS + C6-H), 3.83-3.95 (1H, m, C2-
H), 4.22 (IH, d, J=15 Hz, C6-H'), 4.64 (1H, br s, C=CHH), 4.74 (1H, br s, 
C=CHH), 7.21 (2H, d, J=8.0 Hz, ArH), 7.32-7.43 (6H, m, ArH), 7.61-7.70 (6H, 
m, ArH). 13C NMR (62.9 MHz, CDCh): 019.3,21.5,22.6,26.9,27.2,27.9,29.8, 
32.3, 46.5, 52.7, 63.7, 110.3, 127.3, 127.6, 129.4, 129.5, 133.4, 135.6, 137.6, 
141.1, 142.6. FTIR (CH2CIz): 3071 (w), 2930 (m), 2856 (m), 1467 (w), 1428 
(m), 1340 (s), 1159 (s), 1111 (s), 900 (m), 822 (m), 703 (s) cm-I. mlz (TOF ES): 
562 (MH+). HRMS (TOF ES) calcd. for C33H44N03SiS (MHl: 562.2811. 
Found: 562.2833. 
157: (60%) IH NMR (250 MHz, CDCIJ): 01.02 (9H, s, C(CH3)J), 1.33-1.52 (6H, 
m, CH2), 1.93 (3H, s, CHrC=O), 2.38 (3H, s, ArCH3), 3.38-3.61 (4H, m, CH20 ), 
3.90 (IH, ddd, J=5.0, 11.5, 12.5, CH-N), 4.71 (IH, d, J=8.5 Hz, NH), 7.24 (2H, d, 
J=8.0 Hz, ArH), 7.32-7.47 (6H, m, ArH), 7.57-7.65 (4H, m, ArH), 7.71 (2H, d, 
J=8.0 Hz, ArH). 13C NMR (62.9 Mllz, CDCh): 019.2, 21.5, 22.8, 26.9, 28.2, 
30.9,32.1,52.8,63.4,65.8, 127.0, 127.7, 129.6, 133.9, 135.5, 137.5, 143.3, 143.6, 
170.8. FTIR (CII2Ch): 3283 (br), 2931 (m), 2858 (m), 1743 (s), 1428 (s), 1331.4 
(s), 1234(s), 1161 (s), 1092 (s) cm-I. mlz (TOF ES): 590 (MNa+). IIRMS (TOF 
ES) calcd. for C31H41NOsNaSiS (MNa+): 590.2372. Found: 590.2389. 
Synthesis of 2-benzyl-5-methylene-1-(toluene-4-sulfonyl)-piperidine 
166 via [3+3] Cycloaddition 
~NTS 
< ~ / 
165 
:CSiMe, 
OAc 
10 %Pd(OACh • U.", 
60% P(O/prb N I 
Ts 
20% nBuLi 166 Ph 
THF, 16 hrs, reflux 
175 
A solution of 165 (79 mg, 0.28 mmol, 1.5 eq) in THF (1.8 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (130 ilL, 0.018 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (39 ilL, 0.18 mmol, 1.0 eq) 
and the reaction mixture heated at reflux for 16 h. Solvent was removed in vacuo 
and the residue purified by flash chromatography (5:1 petroleum etherlEtOAc) to 
give piperidine 166 (55 mg, 59%). IU NMR (250 MHz, CDCh): 81.21-1.54 (2H, 
m, CH]), 1.98 (lH, dt, J=4.0, 14.5 Hz, CHH), 2.26-2.45 (IH, m, CHH), 2.38 (3H, 
s ArCH3), 2.94 (2H, d, J=7.5 Hz, CH]Ph ), 3.74 (IH, d, J=15.0 Hz, C6-H), 4.08-
4.20 (IH, m, C2-H), 4.25 (lH, d, J=15.0 Hz, C6-H), 4.71 (lH, s, C=CHH), 4.81 
(lH, s, C=CHH), 7.12-7.37 (7H, m, PhH + ArH), 7.63 (2H, d, J=8.0 Hz, ArH). 
l3C NMR (62.9 MHz, CDCh): 821.5, 26.4, 27.1, 36.9, 46.8, 54.3, 110.6, 126.5, 
127.3, 128.6, 129.2, 129.5, 137.7, 138.2, 141.0, 143.0. 
Ph 
Synthesis of 2-benzyl-5-methylene-1-(4-nitro-benzenesulfonyl)-
piperidine via [3+3] Cycloaddition 
~SiMe3 ~ OAc AcO AeO JNNS 10 %Pd(OAch NS(H)N\ NSN\ • rQPh 60% P(Oiprh ~I y Ph 
170 20% nSuLi 
Ph 
~ 
THF, 16 hrs, reflux 0% 14% 19% 
N02 
A solution of 170 (202 mg, 0.64 mmol, 1.5 eq) in THF (4.2 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (302 ilL, 0.042 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (88 ilL, 0.42 mmol, 1.0 eq) 
and the reaction mixture heated at reflux for 16 h. Solvent was removed in vacuo 
and the residue purified by flash chromatography (3: 1 petroleum etherlEtOAc) to 
give mainly the starting material back (79 mg, 39%) and what could be the two 
by-products (179 34 mg, 19% and 180 23 mg, 14%; structures confirmed by IH 
NMR and LCIMS) but no trace of the desired piperidine. 
180: 14% III NMR (500 MHz, DMSO): 81.88 (3H, s, CH3), 2.50-2.78 (2H, m, 
CH]), 3.60-3.68 (UI, m, CH-N), 3.85-3.98 (2H, m, CH]OCO), 7.03-7.12 (5H, m, 
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PhH), 7.80 (2H, d, J=9.0 Hz, Arll), 8.20 (2H, d, J=9.0 Hz, Arll). mlz (TOF ES): 
379 (MH). 
179: 19% lH NMR (500 MHz, DMSO): 51.67 (3H, s, CHj ), 1.78 (3H, s, CHj ), 
2.70-2.80 (2H, m, CH2), 3.88-4.06 (4H, m, CH2C=C + CH20CO), 4.19-4.29 (IH, 
m, CHN), 5.0 (2H, br s, CHrC), 7.10-7.27 (5H, m, PhH), 8.03 (2H, d, J= 9.0 Hz, 
Arll), 8.33 (2H, d, J = 9.0 Hz, Ar/{). mlz (TOF ES): 433 (MH). 
Synthesis of 2-benzyl-1-methanesulfonyl-5-methylene-piperidine via 
[3+3] Cycloaddition 
JNMS 
Ph 
169 
~SiMe3 
OAc 
10 %Pd(OAc)2 
• 
60% P(Oiprh 
20% nSuLi 
THF, 16 hrs, reflux 
A solution of 169 (235 mg, 1.11 mmol, 1.5 eq) in THF (7.4 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (530 J..LL, 0.074 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (154 J..LL, 0.74 mmol, 1.0 
eq) and the reaction mixture heated at reflux for 16 h. Solvent was removed in 
vacuo and the residue purified by flash chromatography (2: 1 petroleum 
etherlEtOAc) to give mainly the starting material back (210 mg, 89%) but no trace 
of the desired piperidine. 
Synthesis of 2-benzyl-5-methylene-1-(propane-2-sulfonyl)-piperidine 
via [3+3] Cycloaddition 
JNSUS 
Ph 
175 
~SiMe3 
OAc 
10 %Pd(OAc)2 
• 
60% P(Oiprh 
20% nSuLi 
THF, 16 hrs, reflux 
~ ~Ph 
177 
A solution of 175 (63 mg, 0.25 rnrnol, 1.5 eq) in THF (1.6 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (119 JlL, 0.017 rnrnol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (35 JlL, 0.17 rnrnol, 1.0 eq) 
and the reaction mixture heated at reflux for 16 h. Solvent was removed in vacuo 
and the residue purified by flash chromatography (5:1 petroleum etherlEtOAc) to 
give only the starting material back but no trace of the desired piperidine. 
Synthesis of 2-benzyl-5-methylene-1-trifluoromethanesulfonyl-
piperidine via [3+3] Cycloaddition 
171 
~SiMe3 
OAc 
10 %Pd(OAch 
• 
60% P(Oiprh 
20% nSuLi 
THF, 16 hrs, reflux 
A solution of 171 (96 mg, 0.36 rnrnol, 1.5 eq) in THF (1.6 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (172 JlL, 0.024 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-1-yl acetate 3 (50 JlL, 0.24 mmol, 1.0 eq) 
and the reaction mixture heated at reflux for 16 h. Solvent was removed in vacuo. 
The purification of the residue by flash chromatography resulted to a big mess 
since we were not able to characterize any compounds but no trace of the desired 
piperidine. 
178 
Synthesis of 2-benzyl-5-methylene-piperidine-1-carboxylic acid 4-
nitro-benzyl ester via [3+3] Cycloaddition 
~SiMe, 
OAc ~ 
O!~ _1_0_o/c_oP_d_{O_A_C)_2__ '11 
60% P{Oiprh 0 0 Ph 
I ~ 20% nSuLi » 
177 ~ THF, 16 hrs, reflux I ~ 
N02 / // N0
2 
A solution of177 (123 mg, 0.39 mmol, 1.5 eq) in THF (2.6 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (188 JlL, 0.026 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (55 JlL, 0.26 mmol, 1.0 eq) 
and the reaction mixture heated at reflux for 16h. Solvent was removed in vacuo 
and the residue purified by flash chromatography (5:1 petroleum etherlEtOAc) to 
give only the starting material back (105 mg, 85%) but no trace of the desired 
piperidine. 
Synthesis of 2-benzyl-5-methylene-piperidine-1-carboxylic acid 2-
chloro-benzyl ester via [3+3] Cycloaddition 
!(SiMe, 
OAc ~ 
10 %Pd{OAc)2 '~1 
-6-0-%-P-{-O-ip-rh-· O~O Ph 
20%nSuLi )0 I ~ THF, 16 hrs, reflux 
Cl ~ 
A solution of 178 (102 mg, 0.34 mmol, 1.5 eq) in THF (2.3 mL) was treated with 
freshly prepared 0.14 M palladium catalyst solution (161 JlL, 0.023 mmol, 0.1 eq), 
and 2-[(trimethylsilyl)methyl]-2-propen-l-yl acetate 3 (47 JlL, 0.23 mmol, 1.0 eq) 
and the reaction mixture heated at reflux for 16 h. Solvent was removed in vacuo 
179 
and the residue purified by flash chromatography (3: 1 petroleum etherlEtOAc) to 
give only the starting material back (51 mg, 42%) but no trace of the desired 
piperidine. 
6.Grignard route 
Synthesis of N-(1-[2-(t-butyl-diphenyl-silanyloxy)-1-ethyl]-4-
hydroxymethyl-pent-4-enyl)-4-methyl-benzenesulfonamide 196 
TBDPSO~ 
N 
140 Ts 
r\ 
BrMgO MgBr ~ 
----------~ TBDPSO OH 
195 
196 NHTs 
Preparation of Grignard Reagent: 
A 100 mL two-necked flask was charged with 2.0 M n-butyllithium (5.96 mL, 
11.93 mmol, 4.0 eq.). Diethyl ether (8.5 mL) was added and the pale yellow 
reaction mixture was cooled to 0 cC. This was followed by addition of TMEDA 
(1.44 mL, 8.95 mmol, 3.0 eq.) and 2-methyl-2-propen-l-01 (0.25 mL, 2.98 mmol, 
1.0 eq.) was added dropwise resulting in a bright yellow homogenous solution. 
The reaction mixture was stirred at 0 °C for 2 h then allowed to warm to room 
temperature generating a bright orange solution. The solution was cooled to 0 °C 
and dried magnesium bromide (1.11 g, 5.96 mmol, 2.0 eq.) was added generating 
a cloudy solution. The resulting suspension was stirred at room temperature for 1 
hour. 
Titration of the Grignard Reagent solution: 
The titrateion was carried out usmg (D,L)-menthol (20 mg) and 1,10-
phenanthroline in THF (1.0 mL). The Grgnard Reganet solution was added to the 
menthol solution until a red-purple colour persisted. The molarity of the solution 
was then calculated by dividing the number of mmol of menthol used by the 
180 
volume in mL of Grignard solution used to achieve the colour change. This gave a 
concentration between 0.1 and O.2M. 
Reaction with aziridine: 
3-(Tert-butyl-diphenyl-silanyloxyethyl)-I-(toluene-4-sulfonyl)-aziridine 140 (270 
g, 0.56 mmol, 1.0 eq) in THF (8.5 mL) was added to the solution of Grignard 
reagent 195 prepared above via cannula. The reaction mixture was stirred at room 
temperature for 16 h. The reaction was quenched with saturated aqueous 
ammonium chloride then extracted with ethyl acetate and the combined organic 
extracts were washed with brine. The solution was dried over MgS04 and solvent 
was removed in vacuo. The residue was purified by column chromatography in 
2:1 petroleum ether/ethyl acetate to give 196 as a clear oil, 235 mg (76%). III 
NMR (250 MHz, CDCh): 51.05 (9H, s, C(CHJ)J), 1.41-1.72 (4H, m, CH2), 2.0-
2.11 (2H, m, =C-CH2), 2.40 (3H, s, ArCHJ), 3.38-3.55 (2H, m, TBDPSOCH2), 
3.60-3.72 (IH, m, CH-N), 4.02 (2H, S, CH2-0), 4.80 (lH, br s, C=CH), 5.01 (lH, 
br s, C=CH), 5.42 (IH, d, J=7.5 Hz, NH), 7.22 (2H, d, J=8.0 Hz, ArH), 7.32-7.50 
(6H, m, ArH), 7.54-7.62 (4H, m, ArH), 7.70 (2H, d, J=8.0 Hz, ArH). 13C NMR 
(125 MHz, CDCIJ): 519.0, 21.5, 26.9, 28.6, 29.3, 30.9, 52.4, 61.2, 66.0, 105.9, 
109.8, 127.1, 129.9, 132.9, 133.0, 135.5, 135.6, 143.1, 148.2. FTIR (CH2Ch): 
3475 (br), 3276 (br), 2929 (s), 2851 (m), 1657 (w), 1423.1 (m), 1323 (m), 1157 
(s), 1112 (s). mlz (TOF ES): 574 (MNa+). HRMS (TOF ES) calcd. for 
C31H41N04NaSiS (MNa j: 574.2423. Found: 574.2396. 
Synthesis of 2-( tert-butyl-di phenyl-silanoxyethyl)-5-methylene-1-
(toluene-4-sulfonyl)-piperidine 150 via Grignard 
1-..\ ~ II 10% Pd(OAc)2 
T8DPSO"¥~1 -40%P~h3~ 
NHTs OH 25% Ti(O'Pr)4 
196 Toluene, reflux, 16 h 
TBDPSOn 
2 Ts 
150 
A flask containing 4A molecular sieves (115 mg) was flame dried in vacuo. After 
cooling, palladium acetate (14 mg, 0.065 mmol, 0.1 eq) and triphenylphosphine 
181 
(68 mg, 0.26 mmol, 0.4 eq) were added together with toluene (2.9 mL). To the 
resulting yellow reaction mixture was added a solution of 196 (356 mg, 0.65 
mmol, 1.0 eq) in toluene (3.9 mL) via cannula followed by titanium isopropoxide 
(48 J.lL, 0.16 mmol, 0.25 eq). The reaction mixture was placed under reflux for 16 
h. The reaction was quenched with 1 M HCI from pH-6 to pH-2 and extracted 
with EtOAc. The aqueous layer were basified with 1 M NaOH from pH-2 to 
pH-6-7 and further extracted with EtOAc. The combined organic fractions were 
washed with brine, dried over MgS04 and solvent was removed in vacuo. The 
residue was purified by column chromatography in 20: 1 petroleum ether/ethyl 
acetate to give 150 as a clear oil, 289 mg (84%). Characterisation data for this 
compound has been described earlier. 
Synthesis of N-(1-[2-( t-butyl-diphenyl-silanyloxy)-1-propyl]-4-
hydroxymethyl-pent-4-enyl)-4-methyl-benzenesulfonamide 197 
TBDPSO~ 
N 
141 Ts 
A . 
BrMgO MgBr ~ _ ~ H OH 
.. TBDPSO"~y~~ 
195 NHTs 
197 
Preparation of Grignard Reagent: 
A 100 mL two-necked flask was charged with 1.7M n-butyllithium (14 mL, 23.84 
mmol, 4.0 eq.). Diethyl ether (17 mL) was added and the pale yellow reaction 
mixture was cooled to 0 °C. This was followed by addition of TMEDA (2.88 mL, 
17.88 mmol, 3.0 eq.) and 2-methyl-2-propen-l-01 (0.5 mL, 5.96 mmol, 1.0 eq.) 
was added dropwise resulting in a bright yellow homogenous solution. The 
reaction mixture was stirred at 0 °C for 2 h then allowed to warm to room 
temperature generating a bright orange solution. The solution was cooled to 0 °C 
and dried magnesium bromide (2.22 g, 11.92 mmol, 2.0 eq.) was added generating 
a cloudy solution. The resulting suspension was stirred at room temperature for 1 
hour. 
182 
Reaction with aziridine: 
3-(Tert-butyl-diphenyl-silanyloxypropyl)-I-( toluene-4-sulfonyl )-aziridine 141 
(270 g, 0.56 mmol, 1.0 eq) in THF (17 mL) was added to the solution of Grignard 
reagent 195 prepared above via cannula. The reaction mixture was stirred at room 
temperature for 16 h. The reaction was quenched with saturated aqueous 
ammonium chloride then extracted with ethyl acetate and the combined organic 
extracts were washed with brine. The solution was dried over MgS04 and solvent 
was removed in vacuo. The residue was purified by column chromatography in 
2:1 petroleum ether/ethyl acetate to give 197 as a clear oil, 410 mg (73%). IH 
NMR (250 MHz, CnCh): 31.01 (9H, s, C(CH3)3), 1.29-1.76 (6H, rn, CH2), 1.98 
(2H, t, J=7 Hz, =C-CH2), 2.36 (3H, s, ArCH3), 3.17-3.30 (1H, m, CH-N), 3.44-
3.53 (2H, m, TBDPSOCH2), 3.97 (2H, s, CH2-0), 4.56 (1H, d, J=8.0 Hz, NH), 
4.76 (1H, br s, C=CH), 4.99 (1H, br s, C=CH), 7.22 (2H, d, J=8.0 Hz, ArH), 7.33-
7.44 (6H, m, ArH), 7.57-7.65 (4H, rn, ArH), 7.70 (2H, d, J=8.0 Hz, ArH). 13C 
NMR (62.9 Mllz, cncIJ): 319.2, 21.5, 26.8, 28.2, 28.5, 30.9, 33.1, 53.6, 63.4, 
65.8, 105.9, 109.8, 127.0, 127.7, 129.6, 129.7, 133.7, 135.5, 143.2, 148.1. FTIR 
(CHzCIz): 3479 (br), 3277 (br), 2930 (s), 2857 (rn), 1654 (w), 1598 (w), 1428 
(m), 1323 (m), 1157 (s), 1111 (s). m/z (TOF ES): 566 (MH+). HRMS (TOF ES) 
ca led. for CJ2H44NO"SiS (MH+): 566.2760. Found: 566.2769. 
Synthesis of 2-(tert-butyl-diphenyl-silanoxypropyl)-5-methylene-1-
(toluene-4-sulfonyl)-piperidine 151 via Grignard 
1-\ ~ II 10% Pd(OAc)2 
TBDPSo""i¥~l -40%PP.~~ 
NHTs OH 25% Ti(O'Pr)4 
197 Toluene, reflux, 16 h 
TBDPSOn 
3 Ts 
151 
A flask containing 4A molecular sieves (77 rng) was flame dried in vacuo. After 
cooling, palladium acetate (10 mg, 0.04 mmol, 0.1 eq) and triphenylphosphine (45 
mg, 0.17 mrnol, 0.4 eq) were added together with toluene (2 mL). To the resulting 
yellow reaction mixture was added a solution of 197 (245 mg, 0.43 mmol, 1.0 eq) 
in toluene (2.6 rnL) via cannula followed by titanium isopropoxide (32 J..lL, 0.11 
183 
mmol, 0.25 eq). The reaction mixture was placed under reflux for 16 h. The 
reaction was quenched with 1 M HCI from pH-6 to pH-2 and extracted with 
EtOAc. The aqueous layer were basified with 1 M NaOH from pH-2 to pH-6-7 
and further extracted with EtOAc. The combined organic fractions were washed 
with brine, dried over MgS04 and solvent was removed in vacuo. The residue was 
purified by column chromatography in 20: 1 petroleum ether/ethyl acetate to give 
151 as a clear oil, 200 mg (84%). Characterisation data for this compound has 
been described earlier. 
Synthesis of N-(1-[2-( t-butyl-diphenyl-silanyloxy)-1-butyl]-4-
hydroxymethyl-pent-4-enyl)-4-methyl-benzenesulfonamide 198 
A 
TBDPSO BrMgO MgBr ~ .. TBDPSO 
. . "J 195 OH 
142 Ts 
Preparation of Grignard Reagent: 
NHTs 
198 
A 100 mL two-necked flask was charged with 2.5 M n-butyllithium (9.54 mL, 
23.84 mmol, 4.0 eq.). Diethyl ether (17 mL) was added and the pale yellow 
reaction mixture was cooled to 0 °C. This was followed by addition of TMEDA 
(2.88 mL, 17.88 mmol, 3.0 eq.) and 2-methyl-2-propen-l-01 (0.5 mL, 5.96 mmol, 
1.0 eq.) was added dropwise resulting in a bright yellow homogenous solution. 
The reaction mixture was stirred at 0 °C for 2 h then allowed to warm to room 
temperature generating a bright orange solution. The solution was cooled to 0 °C 
and dried magnesium bromide (2.22 g, 11.92 mmol, 2 eq.) was added generating a 
cloudy solution. The resulting suspension was stirred at room temperature for 1 
hour. 
184 
Reaction with aziridine: 
3-(Tert-butyl-dipheny l-silany 10xybutyl)-I-( toluene-4-sulfonyl)-aziridine 142 
(147 g, 0.29 nunol, 1.0 eq) in THF (17 mL) was added to the solution of Grignard 
reagent 195 prepared above via cannula. The reaction mixture was stirred at room 
temperature for 16 h. The reaction was quenched with saturated aqueous 
ammonium chloride then extracted with ethyl acetate and the combined organic 
extracts were washed with brine. The solution was dried over MgS04 and solvent 
was removed in vacuo. The residue was purified by column chromatography in 
2:1 petroleum ether/ethyl acetate to give 198 as a clear oil, 180 mg (99%). III 
NMR (250 MHz, CDCh): 01.03 (9H, s, C(CHj)j), 1.10-1.67 (8H, m, CH2), 1.93-
2.12 (3H, m, OH + =C-CH2), 2.34 (3H, s, ArCHj), 3.12-3.28 (IH, m, CH-N), 
3.46-3.58 (2H, m, TBDPSOCH2), 3.97 (2H, s, CHrO), 4.74 (lH, br s, C=CH), 
4.88 (IH, d, J=8.5, NH), 4.98 (IH, br s, C=CH), 7.22 (2H, d, J=8.0 Hz, ArH), 
7.32-7.47 (6H, m, ArH), 7.59-7.68 (4H, m, ArH), 7.73 (2H, d, J=8.0 Hz, ArH). 
J3C NMR (62.9 MHz, CDCh): 019.2, 21.5, 21.6, 26.9, 28.4, 30.9, 32.2, 33.0, 
53.8, 63.4, 65.8, 105.9, 109.7, 127.0, 127.6, 129.6, 133.4, 135.5, 138.4, 143.2, 
148.2. FTIR (CH2Ch): 3484 (br), 3279 (br), 2932 (s), 2859 (m), 1654 (w), 1598 
(w), 1467 (m), 1428 (s), 1323 (m), 1157 (s), 1111 (s). mlz (TOF ES): 580 (MH+). 
HRMS (TOF ES) calcd. for C33H46N04SiS (MH+): 580.2917. Found: 580.2924. 
Synthesis of 2-( tert-butyl-diphenyl-silanoxybutyl)-5-methylene-1-
(toluene-4-sulfonyl)-piperidine 152 via Grignard 
1...\ ~ II 10% Pd(OAch 
TBDPSO'\¥~l -40% Pl)~~ 
NHTs OH 25% Ti(Oipr)4 
198 Toluene, reflux, 16 h 
TBDPSO~ 
4 Ts 
152 
A flask containing 4A molecular sieves (85 mg) was flame dried in vacuo. After 
cooling, palladium acetate (11 mg, 0.05 mmol, 0.1 eq) and triphenylphosphine 
(49.6 mg, 0.19 mmol, 0.4 eq) were added together with toluene (2.1 mL). To the 
resulting yellow reaction mixture was added a solution of 198 (274 mg, 0.47 
mmoi, 1.0 eq) in toluene (2.8 mL) via cannula followed by titanium isopropoxide 
185 
(35 JlL, 0.12 nunol, 0.25 eq). The reaction mixture was placed under reflux for 16 
h. The reaction was quenched with 1 M HCl from pH-6 to pH-2 and extracted 
with EtOAc. The aqueous layer were basified with IM NaOH from pH-2 to 
pH-6-7 and further extracted with EtOAc. The combined organic fractions were 
washed with brine, dried over MgS04 and solvent was removed in vacuo. The 
residue was purified by column chromatography in 20: 1 petroleum ether/ethyl 
acetate to give 152 as a clear oil, 240 mg (90%). Characterisation data for this 
compound has been described earlier. 
7.Functionalisation 
Synthesis of 6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-3-
hydroxymethyl-1-(toluene-4-sulfonyl)-piperidin-3-01 181 and 182 
OH OH 
" .. (1 j Ts 
TSOPSO (S)-150 
OS04 cat, NMO ~"'\'OH ~OH 
AcetonelWater(4:1),RT •. l.) ,.~) 
--------II.~ " N + \' N j Ts j Ts 
TSOPSO 182 TSOPSO 181 
A solution of (S)-150 (145 mg, 0.27 nunol, 1.0 eq) in a 4:1 mixture of 
acetone:water (30 mL), was treated with NMO (96 mg, 0.82 nunol, 3.0 eq) and a 
crystal of osmium tetroxide. The reaction mixture was stirred at room temperature 
for 3 h. The reaction was quenched by addition of a saturated aqueous solution of 
Na2S03. The reaction was then evaporated to dryness in vacuo and the residue 
was extracted with DCMlMeOH (10:1). The organic phase was dried over MgS04 
and solvent was removed in vacuo. The residue was purified by column 
chromatography in 10: I DCMlMeOH to give a mixture of two inseparable 
diastreoisomers 181 and 182 in a ratio 5:1, 110 mg (71 %). The chemical shifts of 
the major diastereoisomer only are reported, since many of the peaks of the minor 
diastereoisomer were masked. In NMR (250 MHz, CDCh): BO.96 (9H, s, 
C(CHJ)3), 1.35-1.77 (6H, m, CH2), 2.26 (3H, s, ArCH3), 3.17-3.50 (4H, m, CHr 
0),3.70 (lH, d, J=13.5 Hz, C6H), 4.02 (IH, d, J=13.5 Hz, C6H,), 4.12-4.30 (lH, 
m, C2H), 7.05 (2H, d, J=8.0 Hz, ArH), 7.24-7.41 (6H, m, ArH), 7.45-7.58 (6H, m, 
186 
ArH). 13C NMR (62.9 MHz, CDCh): 019.1, 21.5, 25.7, 26.8, 28.2, 29.3, 45.1, 
49.3, 60.9, 64.3, 70.2, 126.6, 127.2, 127.7, 129.8, 133.5, 135.5, 138.1, 143.1. 
FTIR (CH2Ch): 3440 (br), 2932 (m), 1428 (w), 1333 (m), 1159 (s), 1109 (s). mlz 
(TOF ES): 590 (MNa+). HRMS (TOF ES) calcd. for C31H41NOsNaSiS (MNa~: 
590.2372. Found: 590.2366. 
Synthesis of 6-[2-(tert-butyl-diphenyl-silanyloxy)-propyl]-3-
hydroxymethyl-1-(toluene-4-sulfonyl)-piperidin-3-ol 183 and 184 
~ OS04 cat., NMO 
\,,·l.N) AcetonelWater (4:1), RT Lrs ~ 
OTBOPS 
(S)-151 
OH 
""VOH + LTS 
OTBOPS 
183 
OH 
,.U··\\'OH 
\' N LTS 
OTBOPS 
184 
A solution of (S)-151 (177 mg, 0.32 mmol, 1.0 eq) in a 4:1 mixture of 
acetone:water (36 mL), was treated with NMO (114 mg, 0.97 mmol, 3.0 eq) and a 
crystal of osmium tetroxide. The reaction mixture was stirred at room temperature 
for 3 h. The reaction was quenched by addition of a saturated aqueous solution of 
Na2S0J. The reaction was then evaporated to dryness in vacuo and the residue 
was extracted with DCMlMeOH (10: 1). The organic phase was dried over MgS04 
and solvent was removed in vacuo. The residue was purified by column 
chromatography in 10: 1 DCMlMeOH to give a mixture of two inseparable 
diastreoisomers 183 and 184 in a ratio 6:1, 156 mg (83%). The chemical shifts of 
the major diastereoisomer only are reported, since many of the peaks of the minor 
diastereoisomer were masked. III NMR (250 Mllz, CDCh): 00.94 (9H, s, 
C(CH3h), 1.05-1.20 (2H, m, CH}), 1.23-1.69 (6H, m, CH}), 2.24 (3H, s, ArCH3), 
3.32-3.43 (2H, m, CH}-O), 3.61-3.72 (2H, m, CH2-O), 3.73 (IH, d, J=13.5 Hz, 
C6H-N ), 3.80-3.92 (IH, m, C2H), 3.92 (1H, d, J=13.5 Hz, C6H'-N), 7.10 (2H, d, 
J=8.0 Hz, ArH), 7.23-7.40 (6H, m, ArH), 7.46-7.59 (6H, m, ArH). 13C NMR 
(62.9 MHz in CDCh): 019.1,21.5,23.2,24.9,25.6,28.2,29.6,45.1,47.0,60.4, 
63.3, 70.1, 126.7, 127.2, 127.7, 129.6, 133.8, 135.5, 138.3, 143.2. FTIR 
(CH2Ch): 3418 (br), 2932 (m), 2858 (m), 1428 (w), 1332 (m), 1155 (s), 1111 (s). 
187 
mlz (TOF ES): 590 (MNal. HRl\IS (TOF ES) caIcd. for C32H4JNOsNaSiS 
(MNal: 604.2529. Found: 604.2525. 
Synthesis of 2-(terl-butyl-diphenyl-silanoxyethyl)-5-hydroxymethyl-1-
(toluene-4-sulfonyl)-piperidine 186 and 187 
H?H cfH ~ 1) BH3.DMS, THF, RT 0"" : 
"""N) 2) H202, NaOH, RT \,' ",' N j Ts --------:l~~ j' ~s + j Ts 
TBDPSO (S)-150 TBDPSO 187 TBDPSO 186 
To a solution of (S)-150 (80 mg, 0.15 mmol, 1.0 eq) in THF (3.4 mL) at 0 °c was 
added borane-dimethylsulfide (42 JlL, 0.45 mmol, 3.0 eq) and the temperature 
was raised to rt over 2.5 h. After 2.5 h, an aqueous solution of NaOH (1 M, 450 
JlL, 0.45 mmol, 3.0 eq) and hydrogen peroxide (30% in water, 49 mL, 0.45 mmol, 
3.0 eq) were slowly added to the reaction mixture and stirring was continued for 1 
h. The reaction mixture was extracted with EtOAc, washed with brine, dried over 
MgS04 and solvent was removed in vacuo. The residue was purified by column 
chromatography in 3:1 petroleum ether/ethyl acetate to give a mixture of two 
inseparable diastreoisomers 186 and 187 in a ratio 6:1, 121 mg (76%). The 
chemical shifts of the major diastereoisomer only are reported, since many of the 
peaks of the minor diastereoisomer were masked. 111 NMR (250 MIIz, CnCb): 
81.02 (9H, s, C(CH3)3), 1.31-1.89 (6H, m, CH2), 2.33 (3H, s, ArCH3), 2.85 (lH, 
dd, J=2.5, 14.0 Hz, C6H), 3.26-3.65 (4H, m, CHz-O), 3.79 (IH, d, J=14.0 Hz, 
C6H), 4.17-4.30 (IH, m, C2H), 7.12 (2H, d, J=8.0 Hz, Arl-f), 7.30-7.49 (6H, m, 
Arl-f), 7.52-7.70 (6H, m, Arl-f). 13C NMR (62.9 MHz, cncIJ): 819.1, 19.8,21.5, 
23.7,26.8,31.5,34.9,40.0,50.0,61.1,61.2, 127.0, 127.7, 129.6, 129.7, 133.5, 
135.5, 138.3, 142.8. FTIR (CH2Ch): 3508 (br), 2931 (m), 1428 (w), 1329 (m), 
1162 (s), 1093 (s). mlz (TOF ES): 574 (MNa+). HRMS (TOF ES) calcd. for 
C31H41N04NaSiS (MNal: 574.2423. Found: 574.2408. 
188 
8.Natural product 
Synthesis of (2R)-amino-succinic acid dimethyl ester (R)_144107, 108, 169 
o NH2 
HO~ 
OH 
(D)-aspartic acid 
MeOH 
o °C to rt 
o NH2 .HCI Meo~O 
OMe 
(R)-144 
Thionyl chloride (3.1 ml, 42.07 mmol, 1.4 eq) was added dropwise to a solution 
of (D)-(-)-aspartic acid (4 g, 30.0S mmol, 1.0 eq) in dry methanol (40 mL) at O°C, 
the reaction was allowed to warm to room temperature and stirred for 48 h. The 
reaction was evaporated under reduced pressure to give a light yellow oil and then 
triturated with diethyl ether and filtered to give (R)-144 as a white solid (S.90 g, 
99%). [a]D22=-lS (c=l). m.p.=113-114 °c (lit. m.p.=116-117 °C)I07. In NMR 
(250 MHz, CDCh): B2.73 (IH, dd, J=7.5, 16.5 Hz, CH-H), 2.82 (IH, dd, J=4.S, 
16.S Hz, CH-H), 3.71 (3H, s, CH3), 3.7S (3H, s, CH3), 3.8S (lH, dd, J=4.S, 7.S 
Hz, CH-N). 
Synthesis of (2R)-(toluene-4-sulfonylamino)-succinic acid dimethyl 
ester (R)-145 
o NH2 HCI Meo~ 
OMe 
(R)-144 
THF, 48 h 
o °C to rt 
o NHTs 
MeoJlJyo 
OMe 
(R)-145 
A flask was charged with diester (R)-144 (S.80 g, 29.36 mmol, 1.0 eq) and THF 
(22 mL) and cooled to 0 cC. Distilled triethylamine (18 mL, 129.18 mmol, 4.4 eq) 
and then p-toluenesulfonylchloride (6.1 g, 32.23 mmol, 1.1 eq) were added and 
the mixture stirred at room temperature for 48 h. The reaction mixture was 
acidified with HCI (32%) to pH 3 and extracted with ethyl acetate. The organic 
layer was washed with saturated aqueous sodium hydrogencarbonate solution then 
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dried over MgS04 and evaporated under reduce pressure to give (R)-145 as an 
oily yellow residue (8.1 g, 87%). [aJ022= +4 (c=1.0). III NMR (250 MHz, 
CDCh): 82.41 (3H, m, CH3), 2.84 (1H, dd, J=5.0, 17.0, H-CH-C=O), 2.97 (IH, 
dd,J=5.0, 17.0, H-CH-C=O), 3.59 (3H, s, CH3), 3.66 (3H, s, CH3), 4.06-4.18 (IH, 
m, CH-N), 5.60 (1H, d, J=8.0 Hz, NJ-J), 7.30 (2H, d, J=8.0 Hz, ArJ-J), 7.73 (2H, d, 
J=8.0 Hz, Arl!). FTIR (thin film): 3849 (br), 3061 (m), 2956 (m), 1748 (s), 1599 
(m), 1440 (s), 1346 (s). 
Synthesis of N-(3-hydroxy-1-hydroxymethyl-propyl)-4-methyl-
benzenesulfonamide (R)_14S171 
?! ~HTSO 
MeO~ 
OMe 
(R)-145 
• 
THF, 48 h 
NHTs 
HO~ 
OH 
(R)-146 
A solution of the diester (R)-145 (1 g, 3: 17 mmol, 1.0 eq) in THF (15 ml) was 
added dropwise via cannula to a solution of lithium borohydride (152 mg, 6.80 
mmol, 2.2 eq) in THF (23 mL) at 0 °C and stirred for 48 h. Aqueous potassium 
carbonate solution and water were added to quench the reaction and the resulting 
mixture was extracted with ethyl acetate. The organic layer was dried over 
MgS04, evaporated under reduced pressure and then purified by flash 
chromatography to provide (R)-146 as a white powder, 1.37 g (84%). m.p.=88 °C, 
III NMR (250 Mllz, CDCIJ): 81.59-1.77 (2H, m, CH]), 1.91 (1H, br, OH), 2.43 
(3H, s, ArCH3), 3.37-3.87 (5H, m, 2 x CH] + CH-N) , 7.36 (2H, d, J=8.5 Hz, 
ArJ-J), 7.66 (2H, d, J=8.5 IIz, ArJ-J). I3C NMR (62.9 Mllz, CDCIJ): 821.6,34.4, 
53.0,58.7,64.6, 127.1, 129.8, 140.5, 143.7. 
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Synthesis of 2-hydroxyethyl-1-(toluene-4-sulfonyl)-aziridine (R)-148 
via Mitsunobu reaction 
NHTs PBu3, ADDP HO~OH ------.. [::NTS 
toluene, a °c to rt 
(R)-146 (R)-148 
A 50 mL round-bottomed-flask was charged with (R)-146 (548 mg, 2.11 mmol, 
1.0 eq), distilled tributylphosphine (840 JlL, 3.38 mmol, 1.6 eq) and toluene (20 
mL) at room temperature. The reaction mixture was cooled to 0 °c and 1,1'-
azodicarbonyldipiperidine (ADDP) (800 mg, 3.17 mmol, 1.5 eq) was added in 
small portions. The reaction mixture was stirred 2 h at 0 °c, then it was allowed to 
reach rt and stirred overnight. The reaction mixture was evaporated under reduced 
pressure, dissolved in a mixture DCMlMeOH (10:1), dried on silica and purified 
by flash column chromatography (I: I petroleum etherlEtOAc) to provide a 
colourless oil, (R)-148 411 mg (81%). III NMR (250 Mllz, CDCh): 01.36-1.53 
(lH, m, H-CH), 1.89-2.10 (lH, m, H-CH), 2.14 (lH, d, J=4.5 Hz, CHH aziridine) 
2.44 (3H, s, ArCH3), 2.64 (IH, d, J=7.0 Hz, CHH aziridine), 2.83-2.97 (IH, m, 
CH aziridine), 3.55-3.74 (2H, m, CH20H), 7.34 (2H, d, J=8.0 Hz, ArH), 7.82 (2H, 
d, J=8.0 Hz, ArH). BC NMR (62.9 Mllz, CDCIJ): 025.8, 29.6, 42.1, 55.3, 68.2, 
128.3, 131.8, 132.0, 133.3. FTIR (thin film): 3527 (br), 2925 (w), 1597 (w), 1320 
(m), 1232 (w), 1160 (s), 1092 (w) cm-I. mlz (TOF ES): 264 (MNa+). IIRMS 
(TOF ES) calcd. for CllHISN03NaS (MNa+): 264.0670. Found: 264.0666. 
Synthesis of (R)-2-( tert-butyl-di phenyl-silanoxyethyl)-1-(toluene-4-
sulfonyl)-aziridine (R)-140 
[::NTS 
~ 
f 
HO (R)-148 
TBDPSCI, Imidazole 
.. 
THF, aoc to rt, 3 h 
~ 
~ 
TBDPSO (R)-140 
Substrate (R)-148 was dissolved in THF (2.5 mL) and the solution was cooled to 
o °C. TBDPSCl (552 ilL, 2.12 mmol, 1.25 eq) and imidazole (347 rng, 5.10 rnrnol, 
191 
3.0 eq) were added. The reaction mixture was allowed to reach rt and stirred for 3 
h. The reaction mixture was diluted with EtOAc and washed with brine. The 
organic layer was dried over magnesium sulphate and concentrated under vacuum. 
Purification of the resulting oil by silica gel chromatography (10/1, 
petroleumlEtOAc) provided (R)-140 as a yellow oil (734 mg, 90%). IH NMR 
(250 MHz, CDCh): 80.96 (9H, s, C(CH3)3), 1.42-1.74 (2H, m, CH2), 2.05 (lH, d, 
J=4.5 Hz, CHH aziridine) 2.32 (3H, s, ArCH3), 2.60 (IH, d, J=7.0 Hz, CHH 
aziridine), 2.76-2.88 (IH, m, CH aziridine), 3.49 (2H, dd, J=5.5, 7.0 Hz, 
CH20TBDPS), 7.18 (2H, d, J=8.0 Hz, ArH), 7.25-7.41 (6H, m, ArH), 7.48-7.57 
(4H, m, ArH), 7.74 (2H, d, J=8.0 Hz, ArH). I3C NMR (62.9 MHz, CDCh): 
819.1,21.6,26.8,33.5,34.4,38.0,61.2, 127.7, 128.0, 129.6, 129.7, 133.5, 135.5, 
142.3, 144.4. FTIR (thin film): 3071 (w), 2930 (m), 2857 (m), 1598 (w), 1472 
(w), 1428 (m), 1326 (s), 1164 (s), 1093 (s) cm-I. m/z (TOF ES): 502 (MNa+). 
HRMS (TOF ES) calcd. for C27HJJNOJNaSiS (MNa+): 502.1848. Found: 
502.1870. 
8.1.Grignard route 
Synthesis of N-(1-[2-(t-butyl-diphenyl-silanyloxy)-1-ethyl]-4-
hydroxymethyl-pent-4-enyl)-4-methyl-benzenesulfonam ide (5)-196 
A 
(
'1 
-'\7 
N TBDPSO Ts 
BrMgO MgBr ..... ~ 
--....... TBDPSO ............... ,I,.( "-./' ............... OH 
NHTs 
(R)-140 (S)-196 
Preparation of Grignard Reagent 
A lOO mL two-necked flask was charged with 2.0 M n-butyllithium (5.96 mL, 
11.93 mmol, 4.0 eq.). Diethyl ether (8.5 mL) was added and the pale yellow 
reaction mixture was cooled to 0 cC. This was followed by addition of TMEDA 
(1.44 mL, 8.95 mmol, 3.0 eq.) and 2-methyl-2-propen-l-ol (0.25 mL, 2.98 mmol, 
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1.0 eq.) was added dropwise resulting in a bright yellow homogenous solution. 
The reaction mixture was stirred at 0 °C for 2 h then allowed to warm to room 
temperature generating a bright orange solution. The solution was cooled to 0 °C 
and dried magnesium bromide (1.11 g, 5.96 mmol, 2.0 eq.) was added generating 
a cloudy solution. The resulting suspension was stirred at room temperature for 1 
hour. 
Improved preparation of Grignard Reagent 
2.1 eq BuLi 
A ~ 2.1 eqTMEDA 1. Et20 A • • 2.2.1 eq MgBr2 
OH Et20, 24 h U OU BrMg OMgBr 
188 (cannUla) Orange gum (Filter) 0.1-0.2 M 
195 
To n-BuLi (15 mL, 10 M, 2.1 eq) at 0 °C were added anhydrous ether (114 mL) 
and TMEDA (22.6 mL, 2.1 eq). After the solution was cooled at -78°C, methallyl 
alcohol 188 was added dropwise (6.4 mL, 1.0 eq) and the reaction was stirred at-
78°C for 1 h. The bath was then removed and the resulting mixture was 
vigorously stirred for 24 h. After this time, stirring was stopped for 30 min and the 
solvent was removed via cannula filtration. Anhydrous ether (100 mL) was added 
to the remaining orange solid and the suspension was cooled to 0 cC. At this 
point, a solution of freshly prepared MgBr2 [prepared from magnesium (3.9 g, 2.1 
equiv) and dibromoethane (13.8 mL, 2.1 eq) in ether (58 mL)] was transferred 
quickly via cannula to the suspension. After addition, the bath was removed and 
the suspension was vigorously stirred for 30-45 min. At this stage, the stirring was 
stopped and the Grignard solution was separated from colorless solid via cannula. 
The Grignard solution was stored at 0 °C under argon. 
Reaction with aziridine 
A solution of Grignard reagent prepared above (0.14 M, 10 mL, 1.40 mmol, 2.5 
eq) was added to 3-(tert-butyl-diphenyl-silanyloxyethyl)-I-(toluene-4-sulfonyl)-
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aziridine (R)-140 (270 mg, 0.56 mmol, 1.0 eq) in THF (6 mL). The reaction 
mixture was stirred at room temperature for 16 h. The reaction was quenched with 
saturated aqueous ammonium chloride then extracted with ethyl acetate and the 
combined organic extracts were washed with brine. The solution was dried over 
MgS04 and solvent was removed in vacuo. The residue was purified by column 
chromatography in 2:1 petroleum ether/ethyl acetate to give (S)-196 as a clear oil, 
260 mg (85%). IH NMR (250 MHz in CDCh): 31.05 (9H, s, C(CH3)3), 1.41-1.72 
(4H, m, CH2), 2.0-2.11 (2H, m, =C-CH2), 2.40 (3H, s, ArCH3), 3.38-3.55 (2H, m, 
TBDPSOCH2), 3.60-3.72 (lH, m, CH-N) , 4.02 (2H, s, CH2-O), 4.80 (IH, br, 
C=CH), 5.01 (IH, br, C=CH), 5.42 (IH, d, J=7.5 Hz, NH), 7.22 (2H, d, J=8.0 Hz, 
ArH), 7.32-7.50 (6H, m, ArH), 7.54-7.62 (4H, m, ArH), 7.70 (2H, d, J=8.0 Hz, 
ArH). IJC NMR (125 MHz in CDCh): 319.0, 21.5,26.9,28.6,29.3, 30.9, 52.4, 
61.2, 66.0, 105.9, 109.8, 127.1, 129.9, 132.9, 133.0, 135.5, 135.6, 143.1, 148.2. 
FTIR (CH2Ch): 3475 (br), 3276 (br), 2929 (s), 2851 (m), 1657 (w), 1423 (m), 
1323 (m), 1157 (s), 1112 (s). mlz (TOF ES): 574 (MNa+). HRMS (TOF ES) 
calcd. for C31H41N04NaSiS (MNa+): 574.2423. Found: 574.2396. 
Synthesis of 2-( tert-butyl-diphenyl-silanoxyethyl)-5-methylene-1-
(toluene-4-sulfonyl)-piperidine (5)-150 via Grignard 
TBDPSO.f~·M 
NHTs OH 
(S)-196 
10% Pd(OAc)2 
-----.-
40% PPh3 
Toluene, reflux, 16 h 
TBDPS01rV 2 Ts 
(S)-150 
A flask containing 4A molecular sieves (115 mg) was flame dried in vacuo. After 
cooling, palladium acetate (IS mg, 0.065 mmol, 0.1 eq) and triphenylphosphine 
(68 mg, 0.26 mmol, 0.4 eq) were added together with toluene (2.9 mL). To the 
resulting yellow reaction mixture was added a solution of (S)-196 (356 mg, 0.65 
mmol, 1.0 eq) in toluene (3.9 mL) via cannula. The reaction mixture was placed 
under reflux for 16 h. The reaction was quenched with 1 M IICI from pH-6 to 
pH-2 and extracted with EtOAc. The aqueous layer were basified with 1 M 
NaOH from pH-2 to pH-6-7 and further extracted with EtOAc. The combined 
organic fractions were washed with brine, dried over MgS04 and solvent was 
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removed in vacuo. The residue was purified by column chromatography in 20: 1 
petroleum ether/ethyl acetate to give (S)-150 as a clear oil, 289 mg (84%). IH 
NMR (250 MHz, CDCh): 81.05 (9H, s, C(CH3)3), 1.30-1.49 (2H, m, CH2), 1.65-
1.82 (2H, m, CH2), 1.83-2.04 (2H, m, CH2), 2.37 (3H, s, ArCH3), 3.52 (IH, d, 
J=15.0 Hz, C6-H), 3.57-3.77 (2H, m, CH20TBDPS), 4.05-4.15 (1H, m, C2-H), 
4.21 (IH, d, J=15.0 Hz, C6-H'), 4.67 (1H, br s, C=CHH), 4.76 (IH, br s, 
C=CHH), 7.18 (2H, d, J=8.0 Hz, ArH), 7.32-7.47 (6H, m, ArH), 7.59-7.70 (6H, 
m, ArH). 13C NMR (62.9 MHz, CDCh): 819.2,21.5,26.9,27.3,28.0,32.9,46.5, 
50.0, 61.1, 110.3, 127.4, 127.7, 129.4, 129.6, 133.6, 135.6, 136.8, 142.3, 144.4. 
FTIR (CH2Ch): 3060 (w), 2931 (m), 2847 (m), 1466 (w), 1428 (m), 1341 (s), 
1160 (s), 1111 (s) cm-I. mlz (TOF ES): 556 (MNa+). HRMS (TOF ES) calcd. 
for CJIHJ9NOJNaSiS (MNa+): 556.2318. Found: 556.2330. 
Synthesis of 2-(tett-butyl-diphenyl-silanyloxyethyl)-5-methyl-1-
(toluene-4-sulfonyl)-1 ,2,3,4-tetrahydro-pyridine (5)-242 and 2-(tett-
butyl-diphenyl-silanyloxyethyl)-5-methyl-1-(toluene-4-suIfonyl)-
1,2,3,6-tetrahydro-pyridine (5)-241 
C1 Wilkinson Catalyst (10%), (")/ ~ ",- N ---------- ",·l.N) + ,,··l.N) j Ts DBU (0.3 eq), 4.0 °c, o.n., j Ts j Ts 
TBDPSO 4A Molecular Sieves TBDPSO TBDPSO 
(S)-150 (S)-242 (S)-241 
2 : 1 
The catalyst solution was freshly prepared as follows: a flask containing 4A 
molecular sieves (190 mg) was flame dried in vacuo. Wilkinson's catalyst (17 mg, 
0.019 mmol, 0.1 eq), DBU (9 ilL, 0.06 mmol, 0.3 eq) and ethanol (6 mL) were 
added and this solution was added to the substrate (S)-150 via cannula. The 
reaction mixture was stirred at 40°C for 16 hours. Solvent was removed in vacuo 
and the residue purified by flash chromatography (30:1 petroleum etherlEtOAc) to 
give the product as a mixture 2:1 in favour of piperidine (S)-242 (126 mg, 66%). 
(S)-242: [a]o22=-13.0 (c=0.012). 111 NMR (250 Mllz, CDCh): 81.05 (9H, s, 
C(CH3)3), 1.17-1.34 (4H, m, CH]), 1.54 (3H, s, CH3), 1.87-1.99 (2H, m, CH2), 
2.40 (3H, s, CH3Ar), 3.73 (2H, m, CHrO), 3.93-4.05 (IH, m, CH-N), 6.29 (IH, s, 
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H-C=C), 7.24 (2H, d, J=7.5 Hz, ArH), 7.32-7.49 (6H, m, ArH), 7.56-7.69 (6H, m, 
ArH). 13C NMR (62.9 MHz, CDCh): 019.2, 20.9, 21.6, 22.7, 22.8, 26.9, 34.4, 
49.3, 60.7, 118.0, 118.2, 127.1, 127.7, 129.6, 135.5, 135.6, 142.0, 143.2, 144.5. 
mlz (TOF ES): 556 (MNa l. HRM:S (TOF ES) calcd. for C31H39N03NaSiS 
(MNal: 556.2161. Found: 556.2138. 
($)-241: IH NMR (250 MHz, CDCh): 01.01 (9H, S, C(CHj)j), 1.46-1.66 (5H, m, 
CH2), 1.69 (IH, dd, J=5.0 Hz, J=17.0 Hz, HCH), 2.02-2.20 (lH, m, HCH), 2.36 
(3H, S, CHjAr), 3.16 (lH, d, J=18.0 Hz, CHH-N), 3.48-3.71 (2H, m, CHrO) 3.86 
(IH, d, J=18.0 Hz, CHH-N) , 4.13-4.25 (lH, m, CH-N), 5.19-5.31 (IH, m, H-
C=C), 7.15 (2H, d, J=8.0 Hz, ArH), 7.33-7.46 (6H, m, ArH), 7.54-7.66 (6H, m, 
ArH). 13C NMR (62.9 MHz in CDCh): 019.3, 19.7,20.5,21.4,21.9,22.3,44.6, 
51.5, 62.3, 118.3, 120.3, 121.2, 126.9, 127.7, 129.5, 129.7, 133.4, 135.6, 143.9. 
mlz (TOF ES): 556 (MNa+). HRM:S (TOF ES) ca led. for C31HJ9NOJNaSiS 
(MNa+): 556.2161. Found: 556.2138. 
Synthesis of 8-bromo-8-methyl-9-(toluene-4-sulfonyl)-2-oxa-9-aza-
bicyclo [3.3.1] nonane 246 
J" . (Y Ts 
TBDPSO 
(S)-242 
1. Na, MeOH 
• et 
. N . ~ TS6 
............". 
246 
Sodium metal (3 mg, 0.12 mmol, 1.2 eq) was dissolved in MeOH (1 mL). To this 
solution, piperidine (S)-242 (36 mg, 0.09 mmol, 1.0 eq) dissolved in MeOH (l 
mL) was added via cannula followed by bromine (7 J,1L, 0.12 mmol, 1.2 eq). After 
concentration of the solution in vacuo by one half, diethyl ether was added. This 
mixture was washed with water. The aqueous wash was extracted with ether. 
Combined organic fractions were washed with brine, dried over sodium sulphate 
and concentrated in vacuo. The residue was purified by flash chromatography (5:1 
petroleum etherlEtOAc) to give 246 as a yellow oil (95%). JH NMR (250 MHz, 
CDCh): 01.41-1.63 (3H, m, CH2), 1.85 (3H, s, CHj), 1.95-2.15 (3H, m, CH2), 
2.42 (3H, s, ArCHj), 3.62-3.90 (2H, m, CH20), 4.01-4.12 (lH, m, CH-N), 5.43 
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(1H, br, O-CH-N), 7.28 (2H, d, J=8.5 Hz, ArH), 7.84 (2H, d, J=8.5 Hz, ArH). I3C 
NMR (62.9 MHz, CDCh): 021.6, 28.2, 30.9, 33.4, 30.8, 38.2, 45.9, 59.9, 84.7, 
127.7, 129.4, 142.3, 144.4. FTIR (CH2Ch): 2928 (m), 1598 (w), 1449 (w), 1342 
(m), 1164 (5), 1141 (m), 1093 (m), 1048 (m), 1018 (m), 998 (m) cm-I. HRMS 
(TOF ES) calcd. for CISH20NOJNaS79Br (MNa +): 396.0245. Found: 396.0245. 
Synthesis of 2-[6-allyl-5-bromo-5-methyl-1-(toluene-4-sulfonyl)-
piperidin-2-yl]-ethanol 251 
cr BF3::~MS · ,.··ct~ 0 6 DCM, -78 Qc to RT j Ts 
HO 
246 251 
At -78 QC, bicycle 246 (80 mg, 0.21 mmol, 1.0 eq) was dissolved in DCM (8 mL). 
To this solution was added freshly distilled BF3.0Et2 (105 ilL, 0.85 mmol, 4.0 eq) 
followed by aIlyltrimethylsiIane (203 ilL, 1.28 mmol, 6.0 eq). The resulting 
solution was stirred at -78 QC for 2 hours and then left at room temperature for 14 
hours. Solvent was removed in vacuo and the residue purified by flash 
chromatography (l: 1 petroleum etherlEtOAc) to give piperidine 251 as a 
colourless oil and as a single diastereoisomer (71 mg, 80%). III NMR (250 Mllz, 
CDCh): 01.45-1.79 (6H, m, CH]), 1.82 (3H, s, CHj), 1.89-2.18 (2H, m, CH]), 
2.41 (3H, s, ArCHj), 2.64 (lH, br, OH), 3.53-3.70 (IH, m, H-CH-O), 3.80-3.97 
(IH, m, CH-N), 4.12-4.29 (IH, m, H-CH-O), 4.38 (IH, app t, J=7.0 Hz, CH-N), 
4.99-5.22 (2H, m, =CH]), 5.89-6.11 (lH, m, -CH=C), 7.28 (2H, d, J=8.5 Hz, 
ArH), 7.84 (2H, d, J=8.5 Hz, ArH)' 13C NMR (62.9 Mllz, CDCh): 021.6,26.1, 
31.5, 34.3, 38.0, 39.0, 48.2, 59.4, 64.8, 67.7, 114.9, 117.6, 128.1, 129.1, 142.3, 
144.4. FTIR (CII2Ch): 3518 (s), 2930 (m), 2852 (m), 1728 (w), 1599 (w), 1445 
(w), 1329 (s), 1159 (s), 1093 (m), 1048 (m), 1020 (m), 996 (m) cm-I. IIRMS 
(TOF ES) calcd. for C18H27NOJS79Br (MII+): 416.0895. Found: 416.0894. 
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Synthesis of 8-methyl-9-(toluene-4-sulfonyl)-2-oxa-9-aza-
bicyclo[3.3.1]non-7-ene 253 
et 
: N : 00 
DBU, DMF U : N : 
00 
246 253 
DBU (25 ~L, 0.1 5 mmol, 1.1 eq) was added to a solution of piperidine 246 (52 
mg, 0.14 mmol, 1.0 eq) dissolved in DMF (3 mL). The resulting solution was 
stirred at 90°C for 16 hours. The reaction mixture was then diluted with ether and 
washed with water. The aqueous was extracted twice with ether, the combined 
organic fractions were then washed with brine and dried over magnesium 
sulphate. The residue was purified by flash chromatography (1: 1 petroleum 
etherlEtOAc) to give 253 as a colourless oil (40 mg, 99%). III NMR (250 Mllz, 
CDCh): 51.38-1.64 (3H, m, CH2), 1.68 (3H, s, CH3), 1.81-2.14 (3H, m, CH2), 
2.36 (3H, s, ArCH3), 3.38-3.53 (lH, m, Cm-IO), 3.75-3.91 (lH, rn, CH-N), 3.96-
4.15 (IH, rn, Cm-IO), 5.47 (Ill, br, O-CH-N), 5.70-5.77 (IH, rn, H-C=C-CH3), 
7.22 (2H, d, J=8.5 Hz, ArH), 7.75 (2H, d, J=8.5 Hz, ArH) 13C NMR (100.0 
Mllz, CDCIJ): 520.6, 22.0, 29.3, 32.0, 46.2, 57.8, 80.4, 114.7, 125.5, 128.0, 
130.0, 138.6, 143.7. FTIR (CII2Ch): 2932 (m), 1450 (w), 1381 (w), 1344 (s), 
1252 (w), 1234 (w), 1186 (w), 1161 (s), 1106 (m), 1010 (s), 953 (m), 890 (w), 861 
(w), 815 (w) cm-I. IIRMS (TOF ES) calcd. for CISH20NOJS (MII+): 294.1164. 
Found: 294.1175. 
See Appendix 6.1 
Synthesis of 8-Methyl-9-(toluene-4-sulfonyl)-2-oxa-9-aza-
bicyclo[3.3.1]nonane 247 
:_cf
N 
; r _B_U_3S_n_H_, A_I_BN_1t 
Benzene, 80°C 
= Ts6 
-......:;; 
246 
0"'" 
: N = 0 0 
247 
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AIBN (20 mg, 0.13 mmol, 1.0 eq) was added to a solution of 246 (47 mg, 0.13 
mmol, 1.0 eq) in benzene (2.3 mL). The solution was purged with nitrogen for 15 
min then tributyltin hydride (lOO ilL, 0.38 mmol, 3.0 eq) was added and the 
resulting mixture was stirred under reflux for 16 hrs. The reaction mixture was 
cooled to room temperature and the benzene was removed in vacuo to give an oil. 
Purification by flash chromatography (5:1 petroleum etherlEtOAc) afforded the 
product 247 as white crystals (36 mg, 92%). IH NMR (250 MHz, CDCb): 00.96 
(3H, d, J=6.5 Hz, CH3-CH), 1.22-1.35 (IH, m, CH3-CH), 1.58-1.97 (6H, m, CH2), 
2.35 (3H, s, CH3), 3.33-3.45 (IH, m, CH2-CH-N), 3.84-3.97 (IH, m, CHHO), 
3.97-4.06 (lH, m, CHHO), 5.22 (lH, d, J=2.5 Hz, N-CH-O), 7.22 (2H, d, J=8.5 
Hz, Arll), 7.72 (2H, d, J=8.5 Hz, Arll). U c NMR (62.9 MHz, CDCb): 017.8, 
21.6, 26.8, 26.9, 30.9, 36.6, 46.0, 60.6, 81.6, 127.4, 129.6, 140.1, 144.3. HRMS 
(TOF ES) calcd. for CIsH22N03S (MW): 296.1320. Found: 296.1326. 
See Appendix 6.2 
Synthesis of 2-[6-allyl-5-methyl-1-(toluene-4-sulfonyl)-piperidin-2-y1]-
ethanol 248 
0""\ 
: N ~ 
~o 
.. 0 ,'\ .' ,.' "/~ j ' N ,-, Ts 
HO 
AllylTMS 
BF3.OEt2 
DCM, -78°C to RT 
247 248 
Bicycle 247 (43 mg, 0.15 mmol, 1.0 eq) was dissolved in DCM (5.5 mL) and 
cooled to -78 QC. To this solution was added freshly distilled BF3.0Eh (72 ilL, 
0.58 mmol, 4.0 eq) followed by allyltrimethylsilane (140 ilL, 0.87 mmol, 6.0 eq). 
The resulting solution was stirred at -78 QC for 2 hours and then left at room 
temperature for 14 hours. Solvent was removed in vacuo and the residue purified 
by flash chromatography (2:1 petroleum etherlEtOAc) to give piperidine 248 as a 
colourless oil and as a single diastereoisomer (35 mg, 69%). IH NMR (250 MHz, 
CDCh): 01.45 (3H, d, J=13.5 Hz, CH-CH3), 1.82 (3H, m, CH2 + CH-CH3), 1.89-
2.18 (4H, m, CH2), 2.26-2.46 (4H, m, CHH-CH=CH2 + ArCH3), 2.50-2.64 (IH, 
m, CHH-CH=CH2), 3.48-3.65 (lH, m, CH-N), 3.74-3.90 (IH, m, H-CH-O), 4.15 
199 
(IH, q, J=7.0 Hz, CH-N) , 4.32 (IH, t, J=6.5 Hz, CH-O), 4.99-5.13 (2H, m, 
=CH]), 5.84-6.05 (IH, rn, -CH=C), 7.19 (2H, d, J=8.5 Hz, ArH), 7.73 (2H, d, 
J=8.5 Hz, ArH). IJC NMR (62.9 MHz, CDCh): 019.3, 21.6, 26.1, 31.5, 33.2, 
38.0, 39.0, 48.2, 59.4, 64.8, 117.6, 128.1, 129.1, 135.8, 142.3, 144.4. FTIR 
(CH2Ch): 3533 (s), 2935 (m), 1445 (m), 1329 (s), 1159 (s), 1093 (m), 1053 (w), 
1020 (w), 996 (w), 875 (w), 814 (w) cm-I. HRMS (TOF ES) caIcd. for 
C1sH2SNOJS (MH+): 338.1790 Found: 338.1777. 
Synthesis of 4-[6-(2-hydroxy-ethyl)-3-methyl-1-(toluene-4-sulfonyl)-
piperidin-2-yl]-but-2-enoic acid methyl ester 249 
0 ", ".' N :: •• ~ j Ts 
HO 248 
Grubbs 11, 
DCM,40 DC 
Methyl acrylate (40 ilL, 0.45 mmol, 3.0 eq) was added to a solution of substrate 
248 (50 mg, 0.15 mmol, 1.0 eq) dissolved in DCM (3.1 mL) followed by addition 
of Grubbs' second generation catalyst (13 mg, 0.015 mmol, 0.1 eq). The resulting 
solution was stirred at 40 °c for 16 hours. Solvent was removed in vacuo and the 
residue purified by flash chromatography (1:1 petroleum etherlEtOAc) to give 
piperidine 249 as a colourless oil (43 mg, 72%). 
See below for characterisation 
Synthesis of 4-[6-(2-hydroxy-ethyl)-3-methyl-1-(toluene-4-sulfonyl)-
piperidin-2-yl]-but-2-enoic acid methyl ester 249 
\/ 
0.""\ 
: N : 
~o 
247 
.... Si, 
~O""""250 
• 0 ,\\ ", ::, ~ go ........ j ' N  Ts 
HO 249 
BF3.OEt2 
DCM, -78 DC to RT 
200 
Bicycle 247 (36 mg, 0.12 mmol, 1.0 eq) was dissolved in DCM (4 mL) and 
cooled to -78°C. To this solution was added freshly distilled BF3.0Et2 (70 ~L, 
0.49 mmol, 4.0 eq) followed by diene 250 (130 mg, 0.73 mmol, 6.0 eq). The 
resulting solution was stirred at -78°C for 2 hours and then left at room 
temperature for 14 hours. Solvent was removed in vacuo and the residue purified 
by flash chromatography (1: 1 petroleum etherlEtOAc) to give piperidine 249 as a 
colourless oil and as a single diastereoisomer (35 mg, 75%). IH NMR (500 MHz, 
CDCh): SO.82 (3H, d, J=6.0 Hz, CH-CHj), 1.21-1.37 (2H, m, CH2) , 1.41-1.47 
(1H, m, CHH), 1.54-1.65 (2H, m, CH2), 1.79-1.88 (2H, m, CH2), 2.36-2.53 (5H, 
m, CH2-CH= + ArCHj), 3.55-3.68 (1H, dt, J=4.0, 12.0 Hz, CH-O), 3.75 (3H, s, 
OCHj), 3.83 (IH, td, J=3.0, 12.0 Hz, CH-D), 4.14-4.21 (2H, m, CH-N), 5.83 (1H, 
td, J=1.5, 15.5 Hz, CH=CH-C02Me), 7.07-7.15 (1H, m, CH=CH-C02Me), 7.29 
(2H, d, J=8.5 Hz, ArH), 7.71 (2H, d, J=8.5 Hz, ArH). 13C NMR (62.9 MHz, 
CDCh): SI9.2, 21.5, 22.4, 28.9, 32.7, 33.6, 37.4, 48.3, 51.6, 57.0, 58.9, 122.9, 
126.7, 129.9, 138.1, 143.3, 146.9, 166.5. FTIR (CH2Ch): 3528 (s), 2953 (m), 
1722 (s), 1656 (w), 1437 (m), 1324 (m), 1160 (s), 1087 (m), 1067 (w), 999 (w), 
816 (w) cm-I. HRMS (TOF ES) calcd. for C20H30NOSS (MH+): 396.1845 
Found: 396.1849 .. 
NOESY spectrum: See Appendix 6.3 
Synthesis of (1-methoxy-buta-1,3-dienyloxy)-trimethyl-silane 250117 
1. LOA 
• 
2. TMSCI 
In a 250 mL 3-necked round-bottom flask were placed THF (75 mL) and 
diisopropylamine (14 mL, 100 mmol, 1.0 eq) under nitrogen. The solution was 
cooled to _78°C and maintained at that temperature throughout the reaction. n-
Butyllithium (50 mL, 100 mmol, 1.0 eq) was added dropwise to this solution. The 
reaction mixture was allowed to stir for 15 min. HMP A (21 mL, 120 mmol, 1.2 
eq) was added to the solution, which was allowed to stir for 10 min. Methyl 
crotonate (10.6 mL, 100 mmol, 1.0 eq) was added via syringe dropwise. The 
resulting solution was stirred for 30 min. Trimethylsilyl chloride (20 mL, 157 
201 
mmol, 1.6 eq) was added to the reaction mixture with additional stirring for 20 
min. The reaction mixture was allowed to warm to room temperature and stirred 
for an additional 2 h. The solvent was removed under reduced pressure, and the 
residue was diluted with pentane and filtered to remove LiCI salts. The filtrate was 
washed with water and dried over MgS04• Pentane was removed under reduced 
pressure, and the residue was distilled at 24 mm and collected between 50 and 60 
°c to give product 250 as a clear liquid (6.8 g, 39%). 111 NMR (400 MHz, 
CDCh): 80.25 (9H, s, CHj (TMS», 3.60 (3H, s, CHrO), 4.51 (IH, d, J=IO.5 Hz), 
4.63 (IH, dd, J=2.0, 10.5 Hz), 4.87 (lH, dd, J=2.0, 17.0 Hz), 6.51 (lH, dt, J=10.5, 
17.0 Hz). 13C NMR (62.9 MHz, CDCh): 820.3, 54.8, 80.7, 106.9, 132.5, 158.7. 
Synthesis of 2-[6-allyl-5-methyl-1-(toluene-4-sulfonyl)-1 ,2,3,6-
tetrahydro-pyridin-2-yl]-ethanol 254 
et OBU, OM: ,.ex 
",. "'I~ j" N II~ j N 90 DC Ts Ts 
HO 251 HO 254 
DBU (30 J,!L, 0.201 mmol, 1.1 eq) was added to a solution of piperidine 251 (76 
mg, 0.183 mmol, 1.0 eq) dissolved in DMF (5 mL). The resulting solution was 
stirred at 90 DC for 14 hours. The reaction mixture was then diluted with ether and 
washed with water. The aqueous layer was extracted twice with ether, the 
combined organic fractions were then washed with brine and dried over 
magnesium sulphate. The residue was purified by flash chromatography (3: 1 
petroleum etherlEtOAc) to give 254 as a colourless oil (46 mg, 75%). III NMR 
(250 MlIz, CDCh): 81.45-1.74 (6H, m, CH] + CHj), 1.75-1.93 (IH, rn, H-CH), 
2.26-2.48 (4H, m, H-CH + ArCHj), 2.52-2.68 (lH, m, H-CH), 2.79 (lH, br s, 
OH), 3.49-3.74 (IH, m, H-CH-O), 3.90-3.99 (lH, m, H-CH-O), 4.02-4.12 (IH, m, 
CH-N), 4.28-4.38 (IH, m, CH-N), 4.99-5.19 (2H, m, =CH]), 5.20-5.31 (lH, m, H-
C=C-CH3), 5.95-6.17 (IH, m, H-C=CH2), 7.26 (2H, d, J=8.0 Hz, Arl!), 7.63 (2H, 
d, J=8.0 Hz, Arl!). 13C NMR (62.9 MlIz, CDCh): 823.6,25.2, 34.3, 37.6, 39.6, 
47.6, 58.9, 67.7, 113.9, 116.6, 118.3, 120.3, 128.7, 129.0, 140.3, 145.4. FTIR 
202 
(CH2Ch): 3620 (s), 2962 (m), 2856 (m), 1744 (w), 1522 (w), 1413 (w), 1289 (s), 
1169 (s), 1073 (m), 1047 (m), 1020 (m), 990 (m) cm-I. HRMS (TOF ES) calcd. 
for C18H26N03S (MH): 336.1633. Found: 336.1650. 
COSY spectrum: See Appendix 6.4 
NOESY spectrum: See Appendix 6.5 
Synthesis of 4-[6-(2-hydroxy-ethyl)-3-methyl-1-(toluene-4-sulfonyl)-
1 ,2,5,6-tetrahydro-pyridin-2-yl]-but-2-enoic acid methyl ester 255 
,...cx~ 
) Ts 
HO 254 
Grubbs 11, 
DCM,40oC 
Methyl acrylate (43 JlL, 0.474 mmol, 3.0 eq) was added to a solution ofsubstrate 
254 (53 mg, 0.16 mmol, 1.0 eq) dissolved in DCM (3 mL) followed by addition of 
Grubbs' second generation catalyst (13 mg, 0.016 mmol, 0.1 eq). The resulting 
solution was stirred at 40°C for 14 hours. Solvent was removed in vacuo and the 
residue purified by flash chromatography (1:1 petroleum etherlEtOAc) to give 
piperidine 255 as a colourless oil (42 mg, 68%). III NMR (250 MHz, CnCh): 
01.47-1.85 (4H, m, CH]), 2.39 (3H, s, CHJ), 2.55-2.82 (2H, m, CH2), 3.52-3.67 
(IH, m, H-CH-O), 3.73 (3H, s, O-CHj ), 3.77-3.92 (lH, m, H-CH-O), 4.02-4.16 
(lH, m, CH-N), 4.30-4.40 (lH, m, CH-N), 5.28-5.36 (IH, m, H-C=C-CHJ), 5.91 
(lII, td, J=1.5 Hz, J=15.5 Hz, HC=CH-CO), 7.02-7.17 (IH, m, HC=CH-CO), 
7.25 (2H, d, J=8.0 Hz, ArJ-l), 7.63 (2H, d, J=8.0 Hz, ArJ-l). 13C NMR (62.9 Mllz, 
CnCI3): 621.5, 22.3, 32.0, 33.7, 36.5, 51.6, 55.2, 57.5, 63.1, 114.9, 121.7, 123.0, 
126.5, 129.8, 138.3, 143.5, 146.5, 166.8. FTIR (CH2Ch): 3532 (s), 2948 (m), 
1725 (s), 1645 (w), 1437 (m), 1324 (m), 1162 (s), 1088 (m), 1067 (w), 999 (w), 
816 (w) HRMS (TOF ES) caIcd. for C201128NOsS (MH+): 394.1688. Found: 
394.1700. 
203 
Synthesis of 4-[6-(2-hydroxy-ethyl)-3-methyl-1-(toluene-4-sulfonyl)-
1 ,4,5,6-tetrahydro-pyridin-2-yl]-but-2-enoic acid methyl ester 256 
cf o DBU, DMF I , .. , ... ,~ /' • ,.··~o'/ j ~s 0 90°C j Ts 
HO 252 HO 256 
DBU (30 JlL, 0.20 mmol, 1.1 eq) was added to a solution of piperidine 252 (85 
mg, 0.18 mmol, 1.0 eq) dissolved in DMF (7 mL). The resulting solution was 
stirred at 90 DC for 14 hours. The reaction mixture was then diluted with ether and 
washed with water. The aqueous was extracted twice with ether, the combined 
organic fractions were then washed with brine and dried over magnesium 
sulphate. The residue was purified by flash chromatography (1: 1 petroleum 
etherlEtOAc) to give 256 as a colourless oil (33 mg, 47%). 111 NMR (250 Mllz, 
CDCh): 81.07 (3H, s, CHj), 1.35-1.85 (8H, m, CH2), 2.43 (3H, s, CHj), 3.16 (IH, 
d, J=3.5 Hz, OH), 3.55-4.0 (3H, m, CHN + CH20), 3.72 (3H, s, OCHj), 5.81 (1H, 
d, J=15.5 Hz, CH=CH-C02Me), 6.55 (IH, dd, J=1O.5 Hz, 15.5 Hz, CH=CH-
C02Me), 7.30 (2H, d, J=8.0 Hz, Arl/), 7.70 (2H, d, J=8.0 Hz, Arl/). 13C NMR 
(100.0 Mllz, CDCh): 821.6, 22.0, 24.1, 25.2, 26.1, 32.3, 38.7, 46.1, 49.3, 51.9, 
59.4, 121.6, 127.8, 130.2, 137.2, 144.2, 147.4, 166.8. FTIR (CII2Ch): 3458 (s), 
2942 (m), 1710 (s), 1638 (m), 1439 (w), 1330 (m), 1271 (m), 1158 (s), 1094 (w), 
1017 (w), 913 (w), 814 (w) cm-I. IIRMS (TOFES) ca led. for C2oIl2sNOsS 
(MH+): 394.1688. Found: 394.1700. 
Synthesis of 2-[6-allyl-5-bromo-5-methyl-1-(toluene-4-sulfonyl)-
piperidin-2-yl]-ethanol 252 
250 O ...... TMS 
cf~< 
~ ~s; BF3.oEt2, DCM, 
"-v0 -78°C to RT 
246 252 
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Bicycle 246 (47 mg, 0.13 mmol, 1.0 eq) was dissolved in DCM (5 mL) and 
cooled to -78°C. To this solution was added freshly distilled BF3.0Eh (65 J.!L, 
0.50 mmol, 4.0 eq) followed by diene 250 (130 mg, 0.75 mmol, 6.0 eq). The 
resulting solution was stirred at -78°C for 2 hours and then left at room 
temperature for 14 hours. Solvent was removed in vacuo and the residue purified 
by flash chromatography (1: 1 petroleum etherlEtOAc) to give piperidine 252 as a 
colourless oil and as a single diastereoisomer (90%). 111 NMR (250 Mllz, 
CDCh): 81.49-1.98 (9H, m, CH2 + CH3), 2.00-2.21 (IH, m, H-CH), 2.40 (3H, s, 
ArCH3), 2.51 (IH, br s, OH), 2.59 (2H, dt, J=I.5 Hz, J=7.0 Hz, CH2-C=), 3.56-
3.89 (SH, m, O-CH3 + CHrO), 4.24 (1H, q, J=6.S Hz, CH-N), 4.39 (lH, t, J=6.5 
Hz , CH-N), 5.90 (IH, d, J=16.0 Hz, HC=CH-CO), 7.00-7.16 (IH, m, HC=CH-
CO), 7.26 (2H, d, J=8.5 Hz, ArH), 7.77 (2H, d, J=8.5 Hz, ArH). 13C NMR (62.9 
Mllz, CDCh): 821.6,25.9,31.4,33.0,37.6,38.0,48.4,51.7, 59.3, 64.1, 67.7, 
107.6, 123.4, 128.0, 129.2, 137.1, 143.4, 166.7. FTIR (CII2Ch): 3572 (s), 2950 
(m), 1722 (s), 1657 (m), 1437 (m), 1324 (m), 1159 (s), 1093 (w), l020 (w), 915 
(m). IIRMS (TOF ES) calcd. for C2oH29NOsS79nr (MH+): 474.0950. Found: 
474.0962. 
Synthesis of 4-[6-(2-hydroxy-ethyl)-3-methyl-1 ,2,5,6-tetrahydro-
pyridin-2-yl]-butyric acid methyl ester 257 
__ M_9 __ • " •• o:~o/ 
MeOH j H 
HO 257 
To a solution of Mg turnings (223 mg, 9.14 mmol, 60.0 eq) suspended in MeOH 
(1.8 mL) was added piperidine 255 (59 mg, 0.15 mmol, 1.0 eq) dissolved in 
MeOH (1.8 mL). The resulting solution was stirred for 16 hours. The reaction was 
quenched with HCl (1 M) and extracted with ethyl acetate. The aqueous phase 
was then basified with NaOH (1 M) and extracted with a mixture DCM / MeOH 
(10/1). The combined organic fractions were dried over magnesium sulphate. The 
residue was purified by flash chromatography (1: 1 petroleum etherlEtOAc) to 
give 257 as a colourless oil (14 mg, 38%).This compound was tentatively 
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characterised by IH, l3C NMR spectroscopy. III NMR (250 MHz, CDCh): 
81.49-2.09 (lIH, m, CH] + CH3), 2.27 (2H, td, J=2.5, 7.0 Hz, CH]-CO), 2.88-
3.04 (lH, m, CH-N), 3.29-3.43 (IH, m, CH-N), 3.66 (3H, s, O-CH), 3.77-3.91 
(2H, m, CH]-O), 5.47-5.55 (IH, m, CH=C-CH3). 13C NMR (62.9 MHz, CDCh): 
320.0,20.4,22.3,32.0,33.7,36.5,51.6,55.2,57.5, 63.1, 114.9, 121.7, 166.8. 
Synthesis of 4-[6-(2-Hydroxy-ethyl)-3-methyl-1 ,2,5,6-tetrahydro-
pyridin-2-yl]-butyric acid methyl ester 258 
0 ··", 0 __ M_9 __ • \\., N ""~O/ 
MeOH ) Ts 
HO 258 
To a solution of Mg turnings (190 mg, 7.80 mmoI, 60.0 eq) suspended in MeOH 
(1.5 mL) was added piperidine 249 (50 mg, 0.13 mmol, 1.0 eq) dissolved in 
MeOH (1.5 mL). The resulting solution was stirred for 16 hours. The reaction was 
quenched with HCI (1 M) and extracted with ethyl acetate. The aqueous phase 
was then basified with NaOH (1 M) and extracted with a mixture DCM I MeOH 
(lOll). The combined organic fractions were dried over magnesium sulphate. The 
residue was purified by flash chromatography (3: 1 petroleum etherlEtOAc) to 
give 258 as a colourless oil (21 mg, 42%) In NMR (250 MHz, CDCh): 30.81 
(3H, d, J=6.0 Hz, CHj-CH), 1.03-2.04 (1IH, m, CH2), 2.26-2.51 (2H, m, 
CH2C02), 2.41 (3H, s, CHj), 3.58-3.77 (IH, m, CHN), 3.66 (3H, s, CHjO), 3.84-
3.99 (2H, m, CHrOH), 4.06-4.19 (lH, m, CHN), 7.28 (2H, d, J=8.0 Hz, ArH), 
7.69 (2H, d, J=8.0 Hz, ArH). 13C NMR (62.9 MHz, CDCh): 819.6, 21.9, 22.9, 
23.0, 28.1, 29.6, 34.0, 34.1, 38.3, 48.9, 52.0, 58.4, 59.6, 127.1, 130.2, 138.8, 
143.5, 173.2. FTIR (CH2CI2): 3528 (s), 2955 (s), 2876 (m), 1735 (s), 1438 (w), 
1335 (m), 1161 (s), 1116 (w), 1088 (w), 999 (w), 866 (w), 816 (w) cm-I. HRMS 
(TOF ES) calcd. for C20HJ2NOsS (MH~: 398.2001. Found: 398.2000. 
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8.2.Buchi Grignard Route 
Preparation of the Biichi Grignard Reagent 
To a 50 mL two-necked flask fitted with a reflux condenser was added 
magnesium turnings (484 mg, 17.25 mmol, 1.7 eq) and THF (10 mL), then 2-(2-
bromo-ethyl)-[1,3]dioxolane (1.2 mL, 10.2 mmol, 1.0 eq) was added. The solution 
was allowed to cool to room temperature and the concentration of the Btichi 
Grignard solution assessed by titrationc• An aliquot was removed and placed into a 
separate flaskl74. 
Synthesis of (R)-N-(1-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-4-
[1 ,3]dioxolan-2-yl-butyl)-4-methyl-benzenesulfonamide 264 
/'" I '\7 
TBDPSO N 
Ts 
(R)-140 
261 0) 
Br~O 
Mg turnings ('II".~O) 
----..... TBDPSO NHTs 0-1 
CuBr.DMS, 
THF,-78 0 C 264 
A solution of CuBr.DMS (157 mg, 0.76 mmol, 0.4 eq) in DMS (2.3 mL) was 
added to the Btichi Grignard 261 solution (3 mL, 0.64 M, 1.91 mmol, 2.0 eq) at-
78°C and stirred for 1 hour. Then a solution of (R)-140 (458 mg, 0.96 mmol, 1 
eq) in THF (2 mL) was added at -78°C and stirred for 10 minutes. The solution 
was left stirring and allowed to warm to room temperature overnight. The reaction 
was quenched with water and the organic layer was separated. The aqueous layer 
was re-extracted with ethyl acetate (2 portions), the organic layers were combined 
and washed with brine. The solution was dried over MgS04 and concentrated 
e Titration carried out with 31 mg (D,L)-menthol, Smg I,IO-phenanthroline and 1.5 mL THF 
creating a 2.0 mmol solution. The Grignard solution was added to the solution until a red-purple 
colour persisted. The molarity was calculated by dividing 0.2 by the amount in mL used to achieve 
the colour change. 
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under reduced pressure. The residue was purified by column chromatography (4: 1 
petroleum ether/ethyl acetate) to give 264 as a white solid, 478 mg (86%). 
m.p.=79°C. [af3D=+30 (c 0.01 g/mL, CH2Ch). IH NMR (250 MHz, CDCh): 
81.02 (9H, s, SiC(CH3)3), 1.20-1.69 (8H, m, CH2), 2.39 (3H, s, ArCH3), 3.31-3.55 
(2H, m, CHNH + OCHO), 3.59-3.72 (IH, m, OCH2), 3.76-3.99 (4H, m, 
OCH2CH20 ), 4.76 (IH, t, J=4.5 Hz, OCH2), 5.30 (lH, d, J=8.0 Hz, NH), 7.21 
(2H, d, J=8.0 Hz, ArH), 7.32-7.49 (6H, m, ArH), 7.54-7.63 (4H, d, J=8.0 Hz, 
ArH), 7.70 (2H, d, J=8.0 Hz, ArH). I3C NMR (62.9 MHz, CDCh): 819.0, 19.9, 
21.5, 26.8, 33.5, 34.5, 35.4, 52.6, 61.2, 64.8, 104.3, 127.1, 127.8, 129.6, 129.9, 
133.1, 135.5, 138.2, 142.9. FTIR (thin film): 3253 (br), 2929 (m), 2856 (m), 
1472 (m), 1429 (m), 1319 (m), 1152 (s), 1113 (s), 1086 (s), 816 (m) cm-I. HRMS 
(TOF ES) ca led. for C32H43NOsNaSiS (MNa+): 604.2529. Found: 604.2504. 
Synthesis of 2-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-1-(toluene-4-
sulfonyl)-1,2,3,4-tetrahydro-pyridine 265 
TBDPSO ............... ,II.~O) 
NHTs OJ 
264 
TFA, Acetone 
r.t., 20 h 
• o 
.' 
.' N l T5 265 
OTBDPS 
Trifluoroacetic acid (100 JlL, 1.31 mmol, 5 eq) was added to a solution of 264 
(152 mg, 0.26 mmol, 1 eq) in anhydrous acetone (3 mL) at room temperature and 
left stirring overnight. Another 5 equivalents of TFA were added and the resulting 
solution was left stirring for a further 3 hours. The reaction was quenched with 
NaHC03, extracted with EtOAc. The organic layers were combined, washed with 
brine, dried over MgS04 and concentrated under reduced pressure. The residue 
was purified by flash chromatography (15:1 petroleum ether/ethyl acetate) to give 
265 as a clear oil, 120 mg, (88%). [af3D= -120 (c 0.01 g/mL, CH2Ch) III NMR 
(250 Mllz, CDCh): 81.00 (9H, s, SiC(CH3)J), 1.37-1.89 (6H, m, CH2), 2.34 (3H, 
s, ArCH3), 3.58-3.80 (2H, m, OCH2), 4.03-4.16 (lH, m, NCH), 4.87-4.98 (lH, m, 
NCH=CH), 6.48-6.56 (IH, m, NCH=CH), 7.20 (2H, d, J=8.0 Hz, Ar-H), 7.26-
7.40 (6H, rn, ArH), 7.55-7.66 (6H, m, ArH). I3C NMR (62.9 Mllz, CDCIJ): 
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317.2, 21.6, 22.6, 26.9, 29.0, 34.3, 50.0, 60.6, 109.0, 123.7, 127.1, 127.7, 129.6, 
129.9, 135.5, 135.6, 138.2, 147.8. FTIR (thin film): 3070 (w), 2929 (m), 2857 
(m), 1645 (w), 1428 (m), 1344 (s), 1167 (s), 1111 (s), 823 (w), 705 (s) cm-I. 
HRMS (TOF ES) calcd. for C30H3SN03SiS (MHl: 520.2342. Found: 520.2351. 
Dimethyldioxirane in acetone111 
A 2-necked flask equipped with an air condenser packed with glass wool and a 
solid addition funnel was charged with H20 (20 mL), acetone (13 mL) and 
NaHCO) (12.0 g). Oxone® was placed into the solid addition funnel. The top of 
the condenser was fitted with a distillation receiving bend and a receiving flask, 
which was cooled to -78°C with a C02/acetone bath. A slight vacuum was 
applied and oxone® added in one portion. A yellow liquid was collected in the 
receiving flask, and this was stirred with MgS04 for 15 min, and then filtered. The 
concentration of dimethyldioxirane in acetone was determined by iodometric 
titration: 1.00 mL of a solution of dimethyldioxirane in acetone was added to a 3:2 
mix of acetic acid and acetone (2 mL). A saturated solution of KI (2 mL) was 
added and stored in the dark for 10 min. Addition of a 0.001 M solution of 
Na2S203 determined the concentration to be 0.06 M. 
Epoxidation of 265 with dimethyldioxirane 
\\\0 \ N l Ts 
OTSDPS 
265 
DMDO, DCM, 
o DC to r.t., 16 h 
.J)o 
l Ts 
OTSDPS 
266 
A 0.06 M solution of dimethyldioxirane in acetone (5 mL, 0.30 mmol, 2.5 eq.) 
was added to a solution of265 (63 mg, 0.12 mmol, 1 eq.) in CH2Ch (12 mL) at 0 
°c via syringe. The reaction was stirred at 0 °c for 1 h and then allowed to warm 
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to room temperature overnight. The reaction mixture was then concentrated in 
vacuo to provide the crude epoxide 266 as colourless oil. No further purification 
was carried out. 
I pp m) 
Epoxidation of 265 with m-CPBA 
,,\0 
\ N l Ts 
OTBOPS 
265 
m-CPBA, OCM 
-10 QC to r.t., 16 h 
.J)o 
l Ts 
OTBOPS 
266 
To a so lution of 265 (180 mg, 0.35 mmol, 1.0 eq.) in CH2Ch (12 mL) was added 
77% m-CPBA (117 mg, 0.52 mmol , 1.5 eq.) in CH2Ch (6 mL) via cannula at -10 
Qc. The reaction was stirred at -10 QC for an hour and then allowed to warm to 
room temperature overnight. The reaction mixture was then washed with 10% 
Na2S03, saturated NaHC03 and brine, and then dried (MgS04) and concentrated. 
No further purification was carried out. 
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Epoxidation of (5)-150 with dimethyldioxirane 
() 
DMDO, DCM, 
o °c to r.t., 16 h 
", ------.. 
, N l Ts 
OTBDPS 
(S)-150 
.JJ l Ts 
OTBDPS 
243 
A 0.06 M solution of dimethyldioxirane in acetone (5 mL, 0.30 mmol, 2.5 eq.) 
was added to a solution of (S)-150 (65 mg, 0.12 mmol, 1.0 eq.) in CH2Ch (12 
mL) at 0 °c via syringe. The reaction was stirred at 0 °c for 1 h and then allowed 
to warm to room temperature overnight. The reaction mixture was then 
concentrated in vacuo to provide the crude epoxide 243 as colourless oil. The 
residue was purified by flash chromatography (5: 1 petroleum ether/ethyl acetate) 
to give product 243 as a major diastereoisomer (43 mg, 67%). III NMR (250 
Mllz, CDCh): 50.99 (9H, s, SiC(CH3)J), 1.38-1.53 (IH, m, CH]), 1.63-2.06 (5H, 
m, CH]), 2.33 (3H, s, CH3), 2.53 (IH, d, J=4.5 Hz, CHHN), 2.62 (IH, d , J=4.5 
Hz, CHHN), 3.38 (2H, s, CH]OC), 3.56-3.76 (2H, m, CH]OTBDPS), 3.99-4.01 
(IH, m, CHN), 7.18 (2H, d, J=8.0 Hz, Arl-l), 7.26-7.42 (6H, m, ArH), 7.54-7.65 
(4H, m, ArH), 7.72 (2H, d, J=8.0 Hz, ArH). BC NMR (100.0 MIIz, CDCIJ): 
519.6, 22.0, 26.0, 27.3, 32.6, 47.2, 49.7, 51.9, 61.5, 128.0, 128.1, 129.7, 130.1, 
135.2, 136.0, 138.4, 144.3. FTIR (thin film): 2931 (m), 2858 (m), 1472 (w), 
1428 (m), 1389 (w), 1337 (s), 1160 (s), 1111 (s), 1008 (w), 965 (w), 931 (w), 821 
(m) cm-I. HRMS (TOF ES) ca led. for CJIH40N04SiS (MH+): 550.2447. Found: 
550.2437. 
Synthesis of [6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-1-(toluene-4-
sulfonyl)-1,4,5,6-tetrahydro-pyridin-3-yl]-methanol 244 
, ... et j ~s 
TBDPSO 243 
DBU, DM: ,.UOH 
" N 90 QC j Ts 
TBDPSO 
244 
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DBU (9 JlL, 0.06 mmol, 1.2 eq) was added to a solution of piperidine 243 (25 mg, 
0.05 mmol, 1.0 eq) dissolved in DMF (1 mL). The resulting solution was stirred at 
90°C for 14 hours. The reaction mixture was then diluted with ether and washed 
with water. The aqueous was extracted twice with ether, the combined organic 
fractions were then washed with brine and dried over magnesium sulphate. The 
residue was purified by flash chromatography (1:1 petroleum etherlEtOAc) to 
give starting material 243 (15 mg, 60%) but none of the desired product. 
Synthesis of [6-[2-( tert-butyl-di phenyl-silanyloxy)-ethyl]-3-chloro-1-
(toluene-4-sulfonyl)-piperidin-3-yl]-methanol 245 
, ... et j ~s 
TBDPSO 243 
HCI.Et,O • • ••. &OH 
Acetone j ~s 
TBDPSO 245 
HCl in ether (1.0 M, 100 JlL, 0.1 mmol, 2.5 eq) was added to a solution of243 (21 
mg, 0.04 mmol, 1.0 eq) in anhydrous acetone (1 mL) at room temperature and left 
stirring for 16 hrs. The mixture was then concentrated under reduced pressure and 
the residue was purified by flash chromatography (5:1 petroleum ether/ethyl 
acetate) to give 245 (8 mg, 34%). IH NMR (250 MHz, CDCh): 81.03 (9H, s, 
SiC(CH3)3), 1.60-1.89 (6H, m, CH2), 2.31-2.44 (2H, m, CH2N), 2.36 (3H, s, CH3), 
2.77 (lH, m, OH), 3.40-3.54 (2H, m, CH20TBDPS), 3.72 (2H, s, CH20H), 4.19-
4.30 (1H, m, CHN), 7.18 (2H, d, J=8.0 Hz, ArH), 7.32-7.49 (6H, m, ArH), 7.54-
7.70 (6H, m, ArH). I3C NMR (100.0 MHz, CDCh): 819.2,21.9,25.4,27.2,29.2, 
31.0,47.2,50.0,51.0,61.4,69.7, 127.4, 128.1, 128.2, 130.1, 133.2, 135.9, 138.4, 
144.3. FTIR (thin film): 3503 (w), 2930 (m), 2860 (m), 2360 (s), 1457 (w), 1428 
(m), 1339 (m), 1162 (s), 1099 (s), 949 (w) cm"l. HRMS (TOF ES) ca led. for 
C31H41N04SiS35CI (MH+): 586.2214. Found: 586.2233. 
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Synthesis of 2-allyl-6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-1-
(toluene-4-sulfonyl)-piperidin-3-ol 267a 
.",Vo 1. BF3.OEt2, DCM ,,(X0H + ",(X0H • 
2. " N " l N '~ l Ts ~TMS lOT~~psl Ts OTBDPS OH 
-78°C to r.t., 16 h 
266 267a 268 
To a solution of266 (made using DMDO) (88 mg, 0.16 mmol, 1.0 eq.) in DCM (6 
mL) at -78°C, BF3.0Et2 (85 JlL, 0.66 mmol, 4.0 eq.) was added slowly. The 
resulting solution was left stirring for 15 min, then allyltrimethylsilane (155 JlL, 
0.96 mmol, 6.0 eq) was added slowly at the same temperature. The reaction 
mixture was stirred at room temperature overnight and quenched with ammonium 
chloride. The products were extracted with EtOAc and the organic phase was 
washed with sodium bicarbonate and brine. The organic layer was dried over 
MgS04, concentrated under vacuum and purified by silica gel chromatography 
(4:1 petroleum etherlEtOAc) to give 267a (65 mg, 70%) and 268 (7 mg, 10%) as 
two oils. 
267a: [afID= -6.4 (c 0.011 g/mL, CH2Ch). 111 NMR (400 MlIz, CDCh): 51.08 . 
(9H, s, SiC(CH3)3), 1.35-1.40 (lH, m, CHH), 1.48-1.52 (lH, m, CHH), 1.75-1.87 
(3H, m, CHH + CH2), 1.95-2.03 (IH, m, CHH), 2.21-2.36 (2H, m, CH2-CH=CH), 
2.41 (3H, s, ArCH3), 3.65-3.74 (2H, rn, OCH2), 3.80 (IH, br s, CHOH), 3.97-4.02 
(lH, rn, N-CH-CHOH), 4.14-4.19 (IH, m, N-CH), 4.99-5.07 (2H, m, CH=CH2), 
5.68-5.78 (IH, m, CH=CH2), 7.20 (2H, d, J=8.0 Hz, ArH), 7.26-7.40 (6H, m, 
ArH), 7.55-7.66 (6H, m, ArH). llC NMR (62.9 MHz, CDCh): 519.2,20.1,21.2, 
21.5, 26.9, 37.3, 39.3, 49.4, 58.9, 61.7, 65.5, 117.8, 127.4, 127.7, 129.5, 133.2, 
133.6, 135.5, 135.6, 136.3, 143.7. FTIR (thin film): 3530 (s), 3080 (m), 2960 (s), 
2860 (s), 1670 (w), 1470 (w), 1430 (m), 1330 (m), 1260 (s), 1160 (s), 1110 (s), 
939 (m), 816 (w) cm-I. HRMS (TOF ES) calcd. for C33H44N04SiS (MH+): 
578.2760. Found: 578.2756. 
COSY spectrum: See Appendix 6.6 
NOESY spectrum: See Appendix 6.7 
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268: [a]21o=+50 (c 0.01 g/mL, CH2Ch). IH NMR (400 MHz, CnCh): 81.11-
1.34 (2H, m, CH]), 1.42-1.53 (lH, m, CHH), 1.57-2.0 (3H, m, CH]), 2.21-2.54 
(5H, m, CH2 + Ar-CH3), 3.09 (lH, br s, CHOH), 3.57-3.72 (IH, m, N-CH-
CHOH), 3.73-3.81 (2H, m, OCH2), 4.14-4.27 (IH, m, N-CH), 4.98-5.16 (2H, m, 
CH=CH2), 5.72-5.91 (lH, m, CH=CH2), 7.29 (2H, d, J=8.5 Hz, ArEl), 7.79 (2H, 
d, J=8.5 Hz, ArEl). l3C NMR (62.9 MHz, CnC)3): 821.3,21.6, 29.7, 37.7, 39.7, 
48.5,58.7,59.4,65.3, 118.0, 127.3, 129.6, 134.8, 137.6, 143.5. FTIR (thin film): 
3407 (s), 2938 (m), 1721 (w), 1638 (w), 1441 (w), 1400 (w), 1319 (m), 1157 (s), 
1098 (m), 924 (m), 816 (w) cm-I. HRMS (TOF ES) calcd. for C17H26N04S 
(MH): 340.1583. Found: 340.1589. 
Synthesis of 2-allyl-6-[2-( tert-butyl-diphenyl-silanyloxy)-ethyl]-1-
(toluene-4-sulfonyl)-piperidin-3-01 267a 
.J)o 1. BF3.oEt2, OCM ,.(X0H • 
2. " N " l Ts ~TMS lOT~~psl OTBOPS 
266 -78°C to r.t., 16 h 267a 
To a solution of 266 (made using m-CPBA) (50 mg, 0.09 mmol, 1.0 eq.) in DCM 
(1 mL) at -78°C, BF3.0Et2 (23 JlL, 0.19 mmol, 2.0 eq.) was added slowly. The 
resulting solution was left stirring for 15 min, then aIlyItrimethylsilane (45 JlL, 
0.28 mmol, 3.0 eq) was added slowly at the same temperature. The reaction 
mixture was stirred at room temperature overnight and quenched with ammonium 
chloride. The products were extracted with EtOAc and the organic phase was 
washed with sodium bicarbonate and brine. The organic layer was dried over 
MgS04, concentrated under vacuum and purified by silica gel chromatography 
(4:1 petroleum etherlEtOAc) to give 267a (27 mg, 50%). See above for 
characterisation. 
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Synthesis of 2-allyl-6-(2-hydroxy-ethyl)-1-(toluene-4-sulfonyl)-
piperidin-3-01 268 
TBAF, THF 
loo 
To a solution of 267a (65 mg, 0.11 mmol, 1.0 eq.) in THF (2 mL), TBAF (1.0 M 
in THF, 250 J.lL, 0.25 mmol, 2.2 eq.) was added slowly. The reaction mixture was 
stirred at room temperature overnight and quenched with water. The product was 
extracted with EtOAc and the organic phase was washed with brine. The organic 
layer was dried over MgS04, concentrated under vacuum and purified by silica 
gel chromatography (1:1 petroleum etherlEtOAc) to give 268 (32 mg, 85%) an 
oil. See above for characterisation. 
Synthesis of 2-allyl-6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-1-
(toluene-4-sulfonyl)-piperidin-3-01 267a 
•• 
~"OH •• a,OH l)". TBDPSC~ imidazole 
" N " ------...... ," N " 
lOHTS ~ DMF, rt,3 hrs .lOT~~PS ~ 
268 267a 
Substrate 268 (207 mg, 0.61 mmol, 1.0 eq) was dissolved in DMF (15 mL) and 
TBDPSCI (190 J.lL, 0.73 mmol, 1.20 eq) and imidazole (50 mg, 0.73 mmol, 1.20 
eq) were added to this solution. The reaction mixture was stirred for 3 h. The 
reaction mixture was quenched with NH4CI, extracted 4 times with Et20 and 
washed with brine. The organic layer was dried over sodium sulphate and 
concentrated under vacuum. Purification of the resulting oil by silica gel 
chromatography (10/1, petroleumlEtOAc) provided 267a as a colourless oil (286 
mg, 81 %). See above for characterisation. 
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Synthesis of 2-allyl-6-[2-( tert-butyl-di phenyl-silanyloxy)-ethyl]-1-
(toluene-4-sulfonyl)-piperidin-3-01 267a 
NaSH4 ,MeOH ,.UOH + ,.O~:'OH 
.. " N " "N" 
ooe to RT,2 hrs l Ts l:: l Ts l:: 
OTSDPS OTSDPS 
267a 267b 
Substrate 269 (37 mg, 0.06 mmol, 1.0 eq) was dissolved in MeOH (15 mL) and 
sodium borohydride (2.4 mg, 0.06 mmol, 1.0 eq) at 0 QC. The reaction mixture 
was stirred for 2 h at room temperature. The reaction mixture was poured into 
aqueous 10% HCI solution, extracted with EtOAc. The organic layer was washed 
with aqueous saturated NaHC03 solution and brine, dried over Na2S04, and 
solvent was removed to give a 2.5:1 mixture of the 2 diastereoisomers (35 mg, 95 
%) in favour of 267b. Purification of the resulting oil by silica gel 
chromatography (4/1, petroleumlEtOAc) provided pure samples of 267a (5 mg, 
14 %) and 267b (5 mg, 14 %) as colourless oils. 
267a : see above for characterisation. 
267b: III NMR (500 MlIz, CDCh): 81.05 (9H, s, SiC(CH3)3), 1.21-1.36 (2H, m, 
CH]), 1.45-1.62 (2H, m, CH]), 1.76-1.85 (IH, m, Cl/H), 1.92-2.00 (IH, m, CHH), 
2.20-2.30 (IH, m, Cl/H), 2.38 (3H, s, ArCH), 2.53-2.61 (lH, m, CHH), 3.54 
(IH, br s, CHOH), 3.60-3.69 (2H, m, OCH]), 4.06-4.13 (lH, m, N-CH-CHOH), 
4.27-4.33 (lH, m, N-CH), 4.01-5.08 (2H, m, CH=CH2), 5.84-5.95 (IH, m, 
CH=CH2), 7.20 (2H, d, J=8.0 Hz, ArH), 7.34-7.45 (6H, m, ArH), 7.61-7.70 (6H, 
m, ArH). I3C NMR (100.0 MHz, CDCh): 819.4, 20.3, 21.0, 22.5, 26.5, 37.6, 
39.1,49.4,59.0,61.5,65.5,117.2,127.3,127.1,129.3, 133.9, 134.6, 135.4, 135.6, 
136.3, 144.7. FTIR (thin film): 3533 (s), 3076 (m), 2952 (s), 2864 (s), 1674 (w), 
1470 (w), 1419 (m), 1332 (m), 1260 (s), 1157 (s), 1112 (s), 939 (m) cm-I. lIRMS 
(TOF ES) calcd. for CJJH44N04SiS (MH+): 578.2850. Found: 578.2843. 
COSY spectrum: See Appendix 6.8 
NOESY spectrum: See Appendix 6.9 
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Synthesis of 2-allyl-6-[2-( tert-butyl-diphenyl-silanyloxy)-ethyl]-1-
(toluene-4-sulfonyl)-piperidin-3-one 269 
1. (COCI)2. DMSO 
DCM. -7SoC 
Oxalyl chloride (60 f.lL, 0.66 mmol, 2.25 eq) was added to DCM (5 mL) at -78°C 
then DMSO (95 f.lL, 1.32 mmol, 4.5 eq) was added and the reaction stirred for 5 
minutes. A solution of alcohol 267a (170 mg, 0.29 mmol, 1.0 eq) in DCM (2.5 
mL) was added to the mixture. After 1 hour, Et3N (280 f.lL, 1.99 mmol, 6.75 eq) 
was added and the mixture was allowed to wann to room temperature. The 
reaction was quenched with water and the product was extracted with DCM. The 
combined organic layers were washed with brine then dried over MgS04, filtered 
and concentrated under reduced pressure. The resulting oily residue was purified 
by by silica gel chromatography (l0:1 petroleum etherlEtOAc) to give 269 (135 
mg, 80%). [a]2ID=+42 (c 0.005 glmL, CH2Ch). III NMR (400 MHz, CDCh): 
Bl.08 (9H, s, SiC(CHJ)J), 1.20-1.29 (lH, m, CHH-C=O), 1.46-1.56 (IH, m, 
CHH), 1.68-1.77 (lH, m, CHH), 1.97-2.04 (lH, m, CHH), 2.04-2.10 (lH, rn, 
CHH), 2.30-2.46 (2H, m, CHH + CHH), 2.40 (3H, s, ArCHJ), 2.52-2.59 (IH, m, 
CHH), 3.67-3.74 (lH, m, CHH-OSi), 3.77-3.83 (IH, m, CHH-OSi), 3.98-4.06 
(IH, m, N-CH), 4.37-4.42 (lH, m, N-CH), 5.05-5.15 (2H, m, CH=CH2), 5.78-5.88 
(IH, m, CH=CH2), 7.24 (2H, d, J=8.0 Hz, ArH), 7.36-7.46 (6H, m, ArH), 7.61 
(2H, d, J=8.0 Hz, ArH), 7.64-7.69 (4H, d, J=8.0 Hz, ArH). Uc NMR (62.9 Mllz, 
CDCh): BI9.3, 21.5, 25.0, 26.9, 35.5, 39.2, 40.9, 51.2, 60.9, 63.7, 118.4, 127.0, 
127.8, 129.8, 129.9, 133.3, 133.5, 135.6, 136.0, 143.7, 208.5. FTIR (thin film): 
2939 (m), 2858 (m), 1730 (s), 1428 (w), 1360 (w), 1327 (w), 1167 (s), 1111 (s), 
980 (w), 949 (w), 821 (w) cm-I. IIRMS (TOF ES)calcd. for C331142N04SiS 
(MH+): 576.2604. Found: 576.2589. 
COSY spectrum: See Appendix 6.10 
NOESY spectrum: See Appendix 6.11 
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Synthesis of 4-[6-[2-( tert-butyl-di phenyl-silanyloxy)-ethyl]-3-oxo-1-
(toluene-4-sulfonyl)-piperidin-2-yl]-but-2-enoic acid methyl ester 270a 
a O ~C02Me ""(X~C02Me + ,.ao " I, .. ... \ N I, " N I, l Ts ~ Grubbs 11 cat. l T5 lOT~~PS lvC02Me OTBOPS ~ OCM,40 Qc OTBOPS 
269 270a 270b 
To s aolution of 269 (134 mg, 023 mmol, 1.0 eq) in DCM (4 mL), was added 
methyl acrylate (65 JlL, 0.70 mmol, 3.0 eq) followed by Grubbs' second 
generation catalyst (20 mg, 0.02 mmol, 0.1 eq). The reaction mixture was stirred 
at reflux for 16 hours and then concentrated by rotary evaporation. The resulting 
oily residue was purified by silica gel chromatography (6: 1 petroleum 
etherlEtOAc) to give 270a (l15 mg, 78%) and 270b (26 mg, 18%). 
270a: [a]2Io=+34 (c 0.011 glmL, CH2Ch) III NMR (400 Mllz, CDCh): cS1.11 
(9H, s, SiC(CH3)3), 1.24-1.75 (4H, m, CH2), 2.03-2.18 (lH, m, CmI), 2.29-2.40 
(IH, m, CHH), 2.44 (3H, s, ArCH3), 2.46-2.56 (IH, m, CHH), 2.65-2.76 (IH, m, 
CHH), 3.66-3.74(IH, m, CHH-OSi), 3.77 (3H, s, OCH3), 3.78-3.86 (IH, m, CHH-
OSi), 4.06 -4.17 (lH, m, N-CH), 4.44-4.53 (IH, m, N-CH-CO), 5.89 (IH, d, 
J=15.5 Hz, CH=CH-C02CH3), 6.94 (lH, td, J=7.5 Hz, J=15.5 Hz, CH=CH-
C02CH3), 7.28 (2H, d, J=8.0 Hz, ArH), 7.38-7.50 (6H, m, ArH), 7.66 (2H, d, 
J=8.0 Hz, ArH), 7.67-7.72 (4H, m, Arl-/). IJC NMR (62.9 Mllz, CDCh): cSI9.2, 
21.6, 25.0, 26.9, 29.7, 35.5, 37.6, 51.2, 51.6, 60.7, 62.6, 124.2, 127.1, 127.8, 
129.8, 130.0, 133.5, 135.6, 136.0, 143.1, 144.0, 166.0, 207.8. FTIR (thin film): 
2928 (m), 2845 (m), 1727 (s), 1426 (w), 1343 (w), 1164 (s), 1111 (5), 980 (w), 
819 (w) cm-I. IIRMS (TOF ES) ca led. for C3s1144N06SiS (MH+): 634.2659. 
Found: 634.2667. 
270b: [a]21 0=+42 (c 0.014 g/mL, CH2Ch) III NMR (400 Mllz, CDCIJ): cS1.ll 
(9H, s, SiC(CH3h), 1.23-1.37 (lH, m, CHH), 1.54-1.82 (2H, m, CHH), 1.93-2.05 
(HI, m, Cmf), 2.08-2.19 (IH, m, CHH), 2.37-2.51 (4H, m, CHH + ArCH3), 3.02-
3.15 (lH, m, CHH), 3.17-3.30 (IH, m, CHH), 3.62-3.74 (4H, rn, CHH + OCH3), 
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3.78-3.89 (lH, m, CHH-OSi), 4.06-4.17 (lH, m, N-CIl), 4.44-4.53 (lH, m, N-
CH-CO), 5.96 (lH, d, J=I1.5 Hz, CH=CH-C02CH3), 6.44 (IH, td, J=7.0 Hz, 
J=I1.5 Hz, CH=CH-C02CH3), 7.28 (2H, d, J=8.0 Hz, Arll), 7.37-7.51 (6H, m, 
Arll), 7.64 (2H, d, J=8.0 Hz, Arll), 7.67-7.77 (4H, m, Arll). I3C NMR (62.9 
MHz, CnCh): 319.7, 22.0, 23.1, 27.3, 30.1, 34.2, 35.8, 51.2, 51.6, 61.2, 63.3, 
122.1, 127.4, 128.2, 130.2, 130.4, 134.1, 136.0, 136.5 144.3, 145.0, 166.3,208.1. 
FTIR (thin film): 2924 (m), 2853 (m), 1721 (s), 1462 (w), 1431 (w), 1361 (w), 
1166 (s), 1112 (s), 821 (w) cm-I. HRMS (TOF ES) calcd. for CJSH44N06SiS 
(MW): 634.2659. Found: 634.2644. 
Synthesis of 4-[6-[2-( tert-butyl-diphenyl-silanyloxy)-ethyl]-3-oxo-1-
(toluene-4-sulfonyl)-piperidin-2-yl]-but-2-enoic acid methyl ester 273a 
"~,aD ~ -C02Me , N ,,,r """ l Ts 
OTBDPS 
270a 
o 
,0, 
" \ Brzl jnBr 
Zn ~ 
-------.... "l.)". ~ -C02Me \' N I,l'" ~ l Ts 
OTBDPS 
TiCI4 , THF, 0 °C to rt 
273a 
To a solution of Nysted reagent (570 JlL, 0.29 mmol, 3.0 eq) in THF (1 mL) at 0 
cC, was added titanium tetrachloride (32 JlL, 0.29 mmol, 3.0 eq) dropwise. The 
resulting dark brown solution was stirred at 0 °c for 20 min. To this mixture was 
then added a solution of substrate 270a (62 mg, 0.10 mmol, 1.0 eq) at rt for 16 
hrs. The solution was quenched by addition of HCI (1 M) and the product was 
extracted with EtOAc. The organic phase was washed with brine and dried over 
MgS04. The resulting oily residue was purified by silica gel chromatography (5:1 
petroleum etherlEtOAc) to give 273a (32 mg, 52%) and starting material 270a (28 
mg, 45%). [afID=+30 (c 0.01 g/mL, CH2Ch). )11 NMR (400 Mllz, CnCIJ): 
31.08 (9H, s, SiC(CH3h), 1.18-1.31 (2H, m, CH2), 1.80-1.93 (2H, m, CH2), 2.08-
2.27 (2H, m, CH2), 2.41 (3H, s, ArCH3), 2.45-2.67 (2H, m, CH2), 3.68-3.83 (5H, 
m, OCH3 + CH2-0Si), 4.02-4.10 (lH, m, N-CH), 4.55-4.61 (IH, m, N-CH), 4.65 
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(IH, br s, C=CHH), 4.76 (IH, br s, C=CHH), 5.84 (IH, d, J=15.5 Hz, CH=CH-
C02CH3), 6.86 (IH, td, J=7.5 Hz, J=15.5 Hz, CH=CH-C02CH3), 7.23 (2H, d, 
J=8.0 Hz, ArH), 7.36-7.49 (6H, m, ArH), 7.62-7.73 (6H, m, ArH). 13C NMR 
(62.9 MHz, cncIJ): 019.2, 21.5, 24.5, 26.9, 27.8, 37.9, 39.8, 50.0, 51.5, 58.9, 
61.6, 111.5, 120.2, 123.4, 127.0, 127.7, 129.6, 133.6, 135.6, 137.8, 142.5, 142.9, 
144.9, 166.6. FTIR (thin film): 3050 (w), 2937 (m), 2854 (m), 1721 (s), 1659 
(w), 1426 (w), 1332 (w), 1161 (s), 1104 (s), 922 (w), 813 (w) cm". HRMS (TOF 
ES) ca led. for C36H4sNOsNaSiS (MNa+): 654.2685. Found: 654.2706. 
Synthesis of 4-[6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-3-
methylene-1-(toluene-4-sulfonyl)-piperidin-2-yl]-but-2-enoic acid 
methyl ester 273b 
Nysted's reagent, TiCI... "ex 
" N ,.~ 
THF, 0 DC to rt l Ts -I 
OTBDPS C02Me 
273b 
To a solution of Nysted reagent (610 J.lL, 0.32 mmol, 3.0 eq) in THF (I mL) at 0 
QC, was added titanium tetrachloride (35 J.lL, 0.32 rnrnol, 3.0 eq) dropwise. The 
resulting dark brown solution was stirred at 0 °c for 20 min. To this mixture was 
then added a solution of substrate 270b (67 mg, 0.11 mmol, 1.0 eq) at rt for 16 
hrs. The solution was quenched by addition of HCI (1 M) and the product was 
extracted with EtOAc. The organic phase was washed with brine and dried over 
MgS04• The resulting oily residue was purified by silica gel chromatography (5: I 
petroleum etherlEtOAc) to give 273b (41 mg, 61%). [a]2'D=-60 (c 0.01 g/mL, 
ClhCh) In NMR (400 MHz, cncIJ): 01.09 (9H, s, SiC(CH3)3), 1.15-1.26 (IH, 
rn, CHH), 1.47-1.56 (2H, rn, CH2), 1.72 (IH, dt, J=4.5, 15.0 Hz, CHH), 1.87-1.97 
(I H, rn, CHH)' 2.11-2.2 I (1 H, rn, CHH-CH2-OSi), 2.26-2.36 (1 H, rn, CHH-CHr 
OSi), 2.42 (3H, s, ArCH;), 3.00-3.22 (2H, rn, CH2), 3.64-3.81 (2H, rn, CH2-OSi), 
3.69 (3H, S, CH30), 4.03-4.10 (IH, rn, N-CH), 4.66 (IH, br s, C=CHH), 4.78 (IH, 
br s, C=CIUI), 5.91 (1H, td, J=1.5, J=I 1.5 Hz, CH=CH-C02CH3), 6.41-6.50 (IH, 
rn, Cf{=CH-C02CH3), 7.24 (2H, d, J=8.0 Hz, ArH), 7.37-7.48 (6H, rn, ArH), 
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7.65-7.74 (6H, m, Arll). 13C NMR (400 MHz, CnCIJ): SI9.2, 21.5, 24.8, 26.9, 
27.2, 36.3, 37.8, 50.1, 51.1, 59.0, 61.3, 110.6, 120.7, 123.0, 127.2, 127.7, 129.6, 
133.8, 135.6, 137.6, 142.9, 143.9, 146.6, 166.6. FTIR (thin film): 3050 (w), 2937 
(m), 2854 (m), 1721 (s), 1659 (w), 1426 (w), 1332 (w), 1161 (s), 1104 (s), 922 
(w), 813 (w) cm-I. HRMS (TOF ES) ca led. for C36H4sNOsNaSiS (MNa): 
654.2699. Found: 654.2708. 
Synthesis of 4-(6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-3-oxo-
piperidin-2-ylidene)-but-2-enoic acid methylester 271 
""(X~C02Me l Ts 
OTBDPS 
270a 
® e 
H3C-PPh3 Br 
tBuOK, Benzene ("'f0 
• ····l..N~co2Me 
THF, rt l H 
OTBDPS 
271 
A mixture of anhydrous potassium tert-butoxide (30 mg, 0.27 mmol, 5.6 eq) and 
methyltriphenylphosphonium bromide (84 mg, 0.24 mmol, 5.0 eq) in anhydrous 
benzene (12 mL) was allowed to stir at room temperature for 75 min. The 
substrate 270a (30 mg, 0.05 mmol, 1.0 eq) in THF (5 mL) was then added into the 
resulting yellowish solution dropwise at rt. The mixture was stirred at rt overnight. 
The solution was quenched with water, diluted with EtOAc and the aqueous phase 
was extracted with EtOAc. The organic phase was washed with brine and dried 
over Na2S04. The resulting oily residue was purified by silica gel chromatography 
(5:1 petroleum etherlEtOAc) to give 271 (14 mg, 52%). IH NMR (400 MlIz, 
CnC)J): S1.11 (911, s, SiC(CH3h), 1.67-1.91 (4H, m, CH]), 1.99-2.09 (lH, m, 
CIIII), 2.43-2.54 (Ill, m, CIUl), 2.66 (lH, td, J=4.5 Hz, J=17.5 Hz, N-CH), 3.69 
(311, s, OCH3), 3.82-3.87 (211, m, CH]-OSi), 5.08 (lH, br s, NH), 5.94 (lH, d, 
J=I4.5 IIz, C=CH-ClI=CH-C02CH3), 6.02 (IH, d, J=13.0 Hz, C=CH-CH=CH-
C02CIb), 7.32 (111, dd, J=13.0 Hz, J=14.5 Hz, C=CH-CH=CH-C02CH3), 7.39-
7.51 (611, m, Arll), 7.66-7.72 (411, m, Arll). FTIR (thin film): 3364 (w), 2949 
(m), 2854 (m), 1691 (s), 1588 (s), 1426 (m), 1337 (w), 1306 (w), 1249 (w), 1135 
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(s), 1112 (s), 818 (w) cm-I. HRMS (TOF ES) ca led. for C2sH36N04Si (MH+): 
478.2414. Found: 478.2411. 
Synthesis of 4-(6-[2-( tert-butyl-diphenyl-sila nyloxy)-ethyl]-3-
methylene-piperidin-2-yl)-butyric acid methyl ester 274 
•••. (:(~C02Me l Ts 
OTBDPS 
273a 
Mg. MeOH. , •• (tjco2:e 
sonication L' N I 
Ts 275 
OTBDPS 
.,.,(t.jC02Me 
l H 274 
OTBDPS 
To a solution of 273a (37 mg, 0.06 mmol, 1.0 eq) in methanol (2 mL) was added 
powdered magnesium (42 mg, 1.75 mmol, 30.0 eq) and the resulting suspension 
sonicated at room temperature for 40 minutes. Additional powdered magnesium 
(42 mg, 1.75 mmol, 30.0 eq) was then added and the reaction mixture sonicated 
for a further 30 min. The solution was quenched by addition of HCl (1 M) and the 
product was extracted with EtOAc. The organic phase was washed with brine, 
dried over MgS04, filtered and concentrated under reduced pressure. The 
resulting oily residue was purified by silica gel chromatography (gradient from 
5:1 petroleum etherlEtOAc to 10:1 DCMlMeOH) to give 274 (15 mg, 52%) and 
275 (6 mg, 16%). 
274: III NMR (400 Mllz, CDCIJ): S1.08 (9H, s, SiC(CH3)3), 1.57-1.84 (8H, m, 
CH]), 2.08-2.18 (2H, m, CH2), 2.32-2.42 (IH, m, NCH), 2.35 (2H, t, J=7.5 Hz, 
ClhC02Me), 2.89-3.02 (IH, m, NCH), 3.68 (3H, s, OCH3), 3.74-3.84 (2H, m, 
Clh-OSi), 4.72 (111, br s, C=CHH), 4.77 (IH, br s, C=CHH), 7.37-7.46 (6H, m, 
Arll), 7.65-7.72 (4H, m, ArH). I3C NMR (400 MHz, CDCh): 019.6,22.0,22.6, 
26.9, 27.3, 32.1, 34.2, 35.1, 51.5, 55.0, 59.0, 61.8, 110.9, 127.7, 129.6, 135.6, 
143.1, 144.8, 174.0. FTIR (thin film): 2928 (s), 2854 (m), 1734 (s), 1456 (w), 
1428 (m), 1385 (w), 1257 (w), 1194 (w), 1169 (w), 1111 (s), cm-I. HRMS (TOF 
ES) calcd. for C291142N03Si (MH+): 480.2922. Found: 480.2934. 
275: III NMR (400 Mllz, CDCI3): 01.09 (9H, s, SiC(CH3)3), 1.45-1.55 (2H, m, 
CH]), 1.67-1.80 (4H, m, CH2), 1.83-1.94 (2H, m, CH2), 2.13-2.28 (2H, m, CH2), 
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2.34-2.44 (5H, m, ArCHJ + CH2-C02Me), 3.63-3.82 (5H, m, OCHJ + CH2-0Si), 
3.97-4.05 (1H, m, N-CH), 4.48 (1H, t, J=7.5 Hz, N-CH), 4.65 (1H, br s, C=CHH), 
4.76 (IH, br s, C=CHH), 7.23 (2H, d, J=8.0 Hz, ArH), 7.36-7.49 (6H, m, ArH), 
7.63-7.74 (6H, m, ArH). l3C NMR (400 MHz, CDCh): 319.6, 21.9, 22.6, 25.2, 
27.3, 27.9, 33.9, 36.9, 38.5, 50.5, 51.9, 60.1, 61.9, 110.9, 127.1, 127.5, 128.1, 
129.8,134.1, 136.0, 138.3, 143.1, 144.8, 174.0. FTIR (thin film): 3071 (w),296 
(s), 2855 (s), 1737 (s), 1462 (m), 1428(m), 1334 (m), 1162 (s), 1111 (s), 999 (w), 
916 (w), 822 (w) cm'l. HRMS (TOF ES) calcd. for C36H47NOsNaSiS (MNa+): 
656.2842. Found: 656.2840. 
Synthesis of 4-(6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-3-
methylene-piperidin-2-yl)-butyric acid methyl ester 274 
, ..,(:(jCO,Me 
er l Ts 275 
,.,.(XjC02Me 
l H 274 
Mg OTSOPS 
".' N '",~C02Me ---~. l Ts MeOH reflux 
OTSOPS 
OTSOPS 
273a 
Magnesium turnings (93 mg, 3.84 nunol, 30.0 eq) were flame dried in a 2 neck 
flask fitted with a condenser. The flask was cooled under nitrogen then methanol 
(1 mL) was added followed by dropwise addition of a solution of the ester 273a 
(81 mg, 0.13 mmol, 1.0 eq) in methanol (1.5 mL). The solution was left stirring 
for 16 hours and another 30 equivalents of magnesium turnings were added and 
the reaction mixture was heated at reflux for 3 hours. The solution was quenched 
by addition of HCI (1 M) and the product was extracted with EtOAc. The organic 
phase was washed with brine, dried over MgS04, filtered and concentrated under 
reduced pressure. The resulting oily residue was purified by silica gel 
chromatography (gradient from 5:1 petroleum etherlEtOAc to 10:1 DCMlMeOH) 
to give 274 (32 mg, 51 %),275 (14 mg, 17%) and 276 (14 mg, 24%). 
274: see above for characterisation. 
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275: see above for characterisation. 
276: IH NMR (400 MHz, CDCI3): 01.03 (9H, s, SiC(CH3)3), 1.53-1.76 (8H, rn, 
CH2), 1.87-1.95 (2H, rn, CH2), 2.39-2.48 (2H, m, CH2), 3.63-3.73 (2H, m, CHr 
OSi), 3.88-3.93 (lH, m, N-CH), 4.40-4.45 (lH, m, N-CH), 4.94 (lH, br s, 
C=Clffi), 4.97 (IH, br s, C=CHH), 7.33-7.44 (6H, m, ArH), 7.60-7.68 (4H, rn, 
ArH). I3C NMR (400 MHz, CDCh): 019.1, 20.0, 22.7, 26.0, 26.8, 27.0, 32.3, 
34.9,49.1,55.7,62.1, 110.2, 123.4, 127.6, 129.5, 135.5, 144.8, 169.5. FTIR (thin 
film): 3062 (w), 2937 (s), 2856 (s), 1726 (s), 1630 (s), 1605 (s), 1427 (w), 1332 
(w), 1161 (m), 1106 (s), 823 (w) cm"l. HRMS (TOF ES) calcd. for C2sH3SN02Si 
(MW): 448.2672. Found: 448.2678. 
Synthesis of 4-(6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-3-
methylene-piperidin-2-yl)-butan-1-ol 278 
~ LiAIH4 ""l.N)""~C02Me _____ • l H THF, 0 °c to rt 
OTBDPS 
274 
.. ··(X~OH lOT~DPS 
278 
LiAIH4 (7 mg, 0.18 mmol, 5.0 eq) was added to a solution of 274 (17 mg, 0.04 
rnrnol, 1.0 eq) in THF (2 mL) at 0 QC. The solution was left stirring for 16 hours at 
room temperature. The solution was quenched by addition of potassium carbonate 
and the product was extracted with EtOAc. The organic phase was washed with 
brine, dried over Na2S04, filtered and concentrated under reduced pressure. The 
desired product 278 was obtained without further purification (15 mg crude, 
95%). III NMR (400 MlIz, CDCh): 01.08 (9H, s, SiC(CH3)3), 1.32-1.69 (6H, m, 
CH2), 1.75-1.89 (4H, m, CH2), 2.11-2.22 (2H, m, CH2), 2.41-2.48 (IH, m, NCll), 
3.06-3.20 (IH, m, NCH-C=CH2), 3.64 (2H, t, J=6.0 Hz, CH2-0H), 3.75-3.88 (2H, 
m, CHrOSi), 4.78 (lH, br s, C=CHH), 4.84 (lH, br s, C=CHH), 7.38-7.48 (6H, 
rn, ArH), 7.65-7.71 (4H, rn, ArH). I3C NMR (250 MlIz, CDCh): 019.4, 22.2, 
23.6, 26.9, 27.4, 32.3, 34.2, 35.8, 51.7, 55.2, 59.4, 61.8, 111.3, 128.2, 130.3, 
136.0, 143.4, 145.8. FTIR (thin film): 3336 (br), 2930 (s), 2846 (s), 1464 (w), 
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1423 (m), 1388 (w), 1103 (s) cm"I. HRMS (TOF ES) ca led. for C2sH42N02Si 
(MH+): 452.2985. Found: 452.2983. 
Synthesis of 4-[2-( tert-butyl-diphenyl-silanyloxy)-ethyl]-1-methylene-
octahydro-quinolizine 277 
Cd .. "" N Et3N. MeCN o °c to RT TBDPSOJ 
277 
Carbon tetrabromide (28 mg, 0.08 mmol, 1.25 eq) was added to a solution of 
substrate 278 (30mg, 0.07 mmol, 1.0 eq) in DCM (1 mL) at 0 cC. When all the 
CBr4 had dissolved, triphenylphosphine (26 mg, 0.1 mmol, 1.5 eq) was added to 
the reaction mixture at 0 cC. The solution was left stirring for 1 hour at 0 °c then 
triethylamine (152 JlL, 1.09 mmol, 16.5 eq) was added. The solution was 
concentrated under reduced pressure and the resulting white solid was purified by 
silica gel chromatography (200:1 CHChlMeOH) to give the desired bicycle 277 
(26 mg, 91%). IH NMR (400 MHz, CDCIJ): Bl.07 (9H, s, SiC(CH3)3), 1.20-2.45 
(ISH, m, CH2), 3.03-3.19 (1H, m, N-C!-/), 3.75 (2H, t, J=7.5 Hz, CH2-0Si), 4.77 
(2H, br s, C=CH2), 7.37-7.49 (6H, m, Ar!-/), 7.65-7.72 (4H, m, Ar!-/). BC NMR 
(250 MHz, CDCh): BI9.2, 20.0, 22.7, 26.9, 28.9, 29.7, 35.0, 36.8, 49.1, 50.2, 
55.7, 61.6, 110.2, 123.4, 127.6, 129.5, 135.5, 144.8 FTIR (thin film): 2928 (s), 
2855 (s), 1472 (m), 1428 (m), 1388 (w), 1257 (w), 1186 (w), 1112 (s), 898 (w) 
cm"I. HRMS (TOF ES) calcd. for C2sH4oNOSi (MH): 434.2879. Found: 
434.2885. 
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Synthesis of 4-[2-( tert-butyl-di phenyl-silanyloxy)-ethyl]-1-methylene-
octahydro-quinolizine 277 
277 
LiAlH4 (6 mg, 0.14 mmol, 5.0 eq) was added to a solution of 276 (25 mg, 0.06 
mmol, 1.0 eq) in THF (3 mL) at 0 °C. The solution was left stirring for 16 hours at 
room temperature. The solution was quenched by addition of potassium carbonate 
and the product was extracted with EtOAc. The organic phase was washed with 
brine, dried over Na2S04, filtered and concentrated under reduced pressure to give 
the desired product 277 (23 mg, 90%). No further purification was carried out. 
The spectroscopic data matches that described earlier. 
Synthesis of 4-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-1-methyl-
octahydro-quinolizine 279a and 279b 
279a 279b 
1:1 
To a solution of 277 (67 mg, 0.23 mmol) in methanol (2.3 mL) was added 
palladium on 10% carbon (16 mg) and the mixture was stirred under an 
atmosphere of hydrogen overnight. The reaction mixture was filtered over Hyflo 
Super Cel and washed with methanol. The solvent was removed under reduced 
pressure to give an inseparable mixture of the two diastereoisomers 2793 and 
279b. No further purification was carried out. III NMR (400 Mllz, CDCh): 
80.S5 (3H, d, J=6.0 Hz, C-CH3), 0.95 (3H, d, J=7.0 Hz, C-CH3), 1.06 (ISH, s, 
SiC(CH3)3), 1.12-2.11 (32H, m, CH2), 3.06-3.21 (2H, m, N-CH), 3.73 (4H, m, 
CH2-0Si), 4.77 (2H, br s, C=CH2), 7.32-7.50 (l2H, m, ArH), 7.60-7.77 (SH, m, 
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ArH). 13C NMR (250 MHz, CDCh): 313.4, 19.2, 19.3, 22.1, 25.0, 26.3, 26.0, 
26.6, 26.9, 28.9, 31.6, 31.8, 32.0, 33.3, 33.8, 36.8, 45.0, 46.9, 51.5, 51.6, 52.9, 
61.6,62.0,62.1,66.2, 127.6, 129.6, 134.0, 134.1, 134.8, 135.6. FTIR (thin film): 
2930 (s), 2856 (s), 1459 (w), 1428 (m), 1388 (w), 1112 (s), 1083 (s), 823 (m), 737 
(m), 701 (s) cm-I. HRMS (TOF ES) calcd. for C2sH42NOSi (MH+): 436.3036. 
Found: 436.3026. 
Synthesis of 2-(1-methyl-octahydro-quinolizin-4-yl)-ethanol 280a and 
280b 
I'ca + , •• (~ 
TBDPSO TBDPSOJ-O 
279a 279b 280a 
1 :1 1:1 
280b 
To a solution of 279a and 279b (25 mg, 0.06 mmol) in THF (2 mL) was added 
TBAF (1.0M in THF, 90 ilL, 0.09 mmol, 1.5 eq) and the resulting mixture was 
stirred at rt overnight. The reaction was quenched with water and the product 
extracted with ethyl acetate. The organic phase was then dried over Na2S04 and 
concentrated under reduce pressure. Purification of the oily residue by silica gel 
chromatography (20: 1, CHChlMeOH) provided an inseparable mixture of the two 
diastereoisomers 280a and 280b (7 mg, 69%). A clean sample that was free from 
contamination by Et3N could not be obtained. So the sample was used directly in 
the subsequent step. HRMS (TOF ES) calcd. for C12H24NO (MHl: 198.1858. 
Found: 198.1854. 
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8.3.Model Substrate 
Synthesis of 3-piperidin-1-yl-propan-1-ol 281 147,148 
8r~OH o /281 
HO 
o 
H KI, Acetone reflux 
3-Bromopropan-1-01 (1.3 mL, 14.39 mmol, 1.0 eq) was added to a solution of 
piperidine (2.84 mL, 28.78 mmol, 2.0 eq) and potassium iodide « 5 mg) in 
acetone (30 mL) and the resulting mixture was stirred under reflux for 16 hours. 
The solution was concentrated by rotary evaporation and the product 281 was 
obtained by distillation under reduced pressure b.p.: 110°C, 10-15 mmHg (646 
mg, 31 %) (lit147, 148: b.p. 94-95°C, 0.5 mmHg). IH NMR (400 MHz, CDCh): 
B1.36-1.49 (2H, m, CH2), 1.56 (4H, q, J=5.5 Hz, CH2), 1.66-1.73 (2H, m, CH2), 
2.33-2.52 (4H, m, CH2-N), 2.55 (2H, t, J=5.5 Hz, N-CH2), 3.79 (2H, t, J=5.5 Hz, 
CHrOH), 5.87 (lH, br s, OH). 
Synthesis of 3-piperidin-1-yl-propan-1-01 281 147, 148 
o Br~OH 
H 
• o /281 
HO 
3-Bromopropan-l-01 (3 mL, 34.32 mmol, 1.0 eq) was added to a solution of 
piperidine (3.60 mL, 36.03 mmol), 1.05 eq) and potassium carbonate (4.08 g, 
29.52 mmol, 0.86 eq) in acetonitrile (70 mL) and the resulting mixture was stirred 
under reflux for 16 hours. The solution was filtered, concentrated by rotary 
evaporation and the product 281 was obtained by distillation under reduced 
pressure. 
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Synthesis of hexahydro-pyrido[1 ,2-c][1 ,3]oxazine 285150 
HO~ 
H 
283 
HCHO 
AcOH 
NaCNBH3 
MeCN c9 o 285 
To a solution of 283 (504 mg, 3.90 mmol, 1.0 eq) in acetonitrile (58 mL) was 
added formaldehyde (37% aq, 18.2 mL, 223.0 mmol, 57.0 eq), AcOH (1.3 mL) 
and NaCNBH3 (1.35 g, 21.5 mmol, 5.5 eq) and the resulting solution was left 
stirring overnight. The dark solids were removed by filtration, washed with 
dichloromethane and acetonitrile and the solution was concentrated under reduced 
pressure. The resulting oily residue was distilled under vacuum to give 285 (440 
mg, 80%) as a clear oil (h.p.: 90°C, -10 mmHg). (lit. ISO b.p.: 114-115°C, 15 
mmHg). I3C NMR (250 MHz, CDCh): 023.6, 25.2, 31.6, 32.0, 48.8, 60.4, 67.9, 
86.8. 
Synthesis of hexahydro-pyrido[1 ,2-c][1 ,3]oxazine 285149 
HO~ 
H 
283 
c9 
o 285 
Substrate 283 (504 mg, 3.90 mmol, 1.0 eq) was mixed with formaldehyde (37% 
aq, 1.6 mL) and formic acid (2 mL) cautiously. The mixture was kept at 70°C in 
an oil bath for 24 h. Water was added and then 50% aq. NaOH was used to adjust 
the pH to 14. The solution was saturated with NaCI and extracted with DeM. The 
combined organic extracts were dried over Na2S04. Filtration and concentration 
afforded a crude oil which was subjected to distillation to give 285 (254 mg, 89%) 
as a liquid (b.p.: 90°C, 10 mmHg). 
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Synthesis of 2-(1-methyl-piperidin-2-yl)-ethanol 284151 
ex LiAIH4 ) N -T-H-F-, r-ef-Iu-~ o 285 
To a solution of substrate 285 (254 mg, 1.80 mmol, 1.0 eq) in THF (110 mL) was 
added LiAI~ (683 mg, 18.0 mmol, 10.0 eq) and the resulting mixture was heated 
under reflux for 16 hrs. The reaction was quenched with NaOH (20%) and then 
with water at 0 °C. The lithium salts were removed by filtration, washed with 
DCM and the aqueous phase was extracted with DCM. The combined organic 
extracts were dried over Na2S04. The crude product 284 (220 mg, 85%) was pure 
enough to be carried through directly the next step. III NMR (400 MlIz, eDCh): 
81.20-1.34 (lH, m, CHH), 1.43-1.62 (5H, m, CH2), 1.68-1.77 (lH, m, CHRN) , 
1.92-2.08 (2H, m, CH2), 2.15-2.23 (lH, m, CHHN), 2.32 (3H, s, CH3), 2.86 (IH, 
ddt, J=1.5, 3.5, 11.5 Hz, CRN), 3.63-3.70 (IH, m, CHHOH), 3.86-3.94 (IH, m, 
CHHOH). 13e NMR (250 MHz, CDCh): 824.1, 25.0, 28.9, 32.4, 43.2,56.6,60.7, 
62.6. 
Synthesis of 2-(2-oxoethyl)-1-piperidinecarboxylic acid tert-butyl 
ester 286152 
~ Boc,O, Et,N. ~ 
HO N DCM aoc to rtHO N * H, J 
283 286 O-::?'-O . 
To a solution of substrate 283 (229 mg, 1.60 mmol, 1.0 eq) in DCM (2.6 mL) at 0 
°c was added Et3N (270 !-tL, 1.92 mmol, 1.2 eq) followed by a solution of Boc-
anhydride (352 mg, 1.61 mmol, 1.01 eq) via cannula and the resulting mixture 
was left stirring at rt for 16 hrs. The reaction was quenched with NaHC03 and the 
product was extracted with DCM. The combined organic extracts were dried over 
MgS04. The crude product 286 (360 mg, 98%) was pure enough to be carried 
through directly the next step. JII NMR (400 MHz, CDCI3): 81.36-1.67 (6H, m, 
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CH2), 1.48 (9H, s, CH3), 1.70-1.82 (IH, m, CHH), 1.89-2.05 (1H, m, CHH), 2.69 
(1H, td, J=2.70 Hz, 13.0 Hz, CHHN), 3.28-3.47 ( IH, br s, OH), 3.57-3.68 (1H, 
m, CHHN), 3.80-4.10 (2H, m, CH20H), 4.36-4.54 (1H, m, CHN). llC NMR (250 
MHz, CDCh): BI9.2, 25.5, 28.4, 29.2,32.4,40.0,48.2,59.4,80.0, 155.3. 
Synthesis of hexahydro-pyrido[1 ,2-c][1 ,3]oxazine 284 
.. cY 
OH 
THF, reflux 
286 284 
A solution of substrate 286 (360 mg, 1.57 mmol, 1.0 eq) in THF (25 mL) was 
added dropwise to a solution of LiAIH4 (365 mg, 9.60 mmol, 5.9 eq) in THF (25 
mL), the resulting solution was stirred at rt for 30 min and then was heated under 
reflux for 16 hrs. The reaction was quenched with NaOH (20%) and then with 
water at 0 cC. The lithium salts were removed by filtration, washed with DCM 
and the aqueous phase was extracted with DCM. The combined organic extracts 
were dried over Na2S04. The crude product 284 (192 mg, 85%) was pure enough 
to be carried through directly the next step. 
Synthesis of (1-methyl-piperidin-2-yl)-acetaldehyde 287 
c9 OH 284 
1. (COClh, DMSO 
DCM,-7S0C R 
" NI 2. Et3N 
H 0 287 
Oxalyl chloride (175 ilL, 1.99 mmol, 2.25 eq) was added to DCM (14.5 mL) at-
78°C then DMSO (285 ilL, 4.01 mmol, 4.5 eq) was added and the reaction stirred 
for 5 minutes. A solution of alcohol 284 (127 mg, 0.89 mmol, 1.0 eq) in DCM 
(2.5 mL) was added to the mixture. After 2 hours, Et3N (840 ilL, 6.01 mmol, 6.75 
eq) was added and the mixture was allowed to warm to room temperature. The 
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reaction was quenched with water and the product was extracted with DeM. The 
combined organic layers were washed with brine then dried over MgS04, filtered 
and concentrated under reduced pressure. The resulting oily residue 287 (92 mg) 
was not purified further. 
(pp m) 
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Synthesis of 4-(6-[2-(tert-butyl-diphenyl-silanyloxy)-ethyl]-3-oxo-
piperidin-2-ylidene)-but-2-enoic acid methylester 288 
'-O BrO 
PPh3 
!BuOK 
THF, RT ~ ~ ~ 
A mixture of anhydrous potassium tert-butox ide (90 mg, 0.79 mmol, 1.5 eq) and 
propargyItriphenylphosphonium bromide (360 mg, 0.79 mmol , 1.5 eq) in dry THF 
(8 mL) was allowed to stir at room temperature for 75 min . The substrate 287 (74 
mg, 0.52 mmol , 1.0 eq) in THF (7 mL) was then added into the resulting yellow 
solution dropwise at rt. The mixture was stirred at rt overnight. The solution was 
quenched with water, diluted with EtOAc and the aqueous phase was extracted 
with tOAc. The organic phase was washed with brine and dried over Na2S04. 
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The compound appeared to decompose after attempted purification by silica gel 
chromatography (A crude 'H NMR spectrum is given below). 
3 . 1 1 . 8 1 ~ lO 1 . 6 Il 08 
(pp m) 
Synthesis of (1-methyl-octahydro-quinolizin-4-yl)-acetaldehyde 
Ices + Ices 
HO HO 
1. (COC1h, DMSO ca'" ca 
DCM, -78 Qc • f'" N " H + f "  N H 
2. Et3N ~ ~ 
o 0 
280a 280b 289a 289b 
1:1 
Oxalyl chloride (7 ilL, 0.08 mmol , 2.25 eq) was added to DCM (I mL) at -78 QC 
then DMSO (12 ilL, 0.16 mmol , 4.5 eq) was added and the reaction stirred for 5 
minutes. A solution of alcohols 280a and 280b (7 mg, 0.04 mmol , 1.0 eq) in DCM 
(2 mL) was added to the mixture. After 2 hours, EtJN (33 ilL, 0.24 mmol , 6.75 eq) 
was added and the mixture was allowed to warm to room temperature. The 
reaction was quenched with water and the product was extracted with DCM. The 
combined organic layers were washed with brine then dried over MgS04 , filtered 
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and concentrated under reduced pressure. The resulting oily residue was used 
directly in the next step. 
Synthesis of 1-methyl-4-pent-2-en-4-ynyl-octahydro-quinolizine 291a 
and 291b 
ca
,' 
TMS \ TMS~, (. N "H 
TBS ~ 
tBuLi, TieOPr)4 291a 
THF TMS~~"'C6 289a 289b 
291b 
A solution of tert-butyllithium (27 ~L, 0.046 mmol, 1.7 M solution in pentane, 1.3 
eq) was added to a solution of 3-(tert-butyldimethylsilyl)-1-(trimethylsilyl)-I-
propyne (7.6 mg, 0.0.034 mmol, 0.96 eq) in dry THF (1.0 mL) at -78 °C. After 1 
h, titanium tetraisopropoxide (14 ~L, 0.046 mmol, 1.3 eq) was added to the 
mixture. After 10 min, a solution of the crude aldehydes 289a and 289b (0.035 
mmol, 1.0 eq) in dry THF (1.0 mL) was added to the organotitanium reagent and 
the resulting mixture was held at -78 °C for 1 h, -40 °C for 2 h, -20 °C for 1 h, and 
room temperature for 2.5 h, after which saturated NH4CI was added and the 
mixture was extracted with ethyl acetate. The combined organic phases were dried 
(Na2S04) and concentrated. Purification of the crude reaction mixture by column 
chromatography did not provide the desired products. 
Synthesis of 3-( terf-butyl-dimethyl-silanyl)-1-trimethylsila nyl-propyne 
29095,146 
1. tBuli, ether, _5°C 
• 
2. TBSCI, rt, on 
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To a solution of 1-(trimethylsilyl)propyne (1.2 mL, 13.54 mmol, 1.0 eq) in ether 
(20 mL) was added t-butyllithium (1.7 M in pentane, 8 mL, 13.54 mmol, 1.0 eq) 
at _5°C. After stirring for 30 min, t-butyldimethylsilyl chloride (2.04 g, 13.54 
mmol, 1.0 eq) was added and the mixture was stirred for 12 hrs. The resulting 
mixture was poured into ice-cooled water and the product was extracted with 
ether. The combined extracts were dried and concentrated. The residue was 
distilled under reduced pressure to give 3-(tert-butyl-dimethyl-silyl)-I-
trimethylsilyl-propyne 290 (1.53 g, 50%), b.p.=80 QC, 15 mmHg (lit95, 146: 
b.p.=106-107 QC, 31 mmHg). IH NMR (400 MHz, CDCh): 80.08 (6H, s, CH3), 
0.14 (9H, s, CH3), 0.93 (9H, s, CH3), 1.58 (2H, s, CH2). 
Synthesis of tris(triphenylphosphine)chlororhodium (1)175,176 
To a solution of freshly recrystallised PPh3, (870 mg, 3.32 mmol, 4.8 eq) in 
ethanol (25.5 ml) at 78°C, was added a solution of rhodium trichloride trihydrate 
(145 mg, 0.69 mmol, 1.0 eq) in boiling ethanol (9.3 ml.) and the solution was 
heated under reflux for 30 min. The hot solution was filtered and the burgundy-
red crystals of the complex were washed with degassed ether (2 x 15 ml) and 
dried in vacuo. Yield (375 mg, 59%), m. p. 155°C (lit. 175 m.p.=157-158 QC). 
Synthesis of acetic acid 3-chloro-2-hydroxy-propyl ester 20583• 84 
~ HOAc ?H 
Cl ~ • ("I 
o FeCI3• 65-70 oC OAc Cl 
203 205 
Epichlorohydrin 203 (8.5 mL, 108.7 mmol, 1.0 eq) was slowly added to a solution 
of iron trichloride (18 mg, 0.11 mmol, 0.001 eq) in glacial acetic acid (6.55 g, 
108.9 mmol, 1.0 eq). The mixture was heated at reflux for 24 hours. The solvent 
was removed under reduced pressure and the product 205 was not further purified 
but used directly in the next step. III NMR (250 Mllz, CDCh): 52.02 (3H, s, 
CH3C=O), 3.49-3.57 (2H, rn, CH2CI), 4.01 (IH, q, J=5.5 Hz, CH-OH), 4.12 (IH, 
d, J=5.5 Hz, CH2-0). 
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Synthesis of cetic acid 3-chloro-2-(1-ethoxy-ethoxy)-propyl ester 
20683,84 
;; ~O~ lo~ ~ 
Ok Cl p-TsA cat. OAc Cl 
. 205 206 
p-Toluenesulfonic acid monohydrate (105 mg, 0.54 mmol, 0.005 eq) was added to 
crude 205 (1.66 g, 108.7 mmol, 1.0 eq) and ethyl vinyl ether (11.8 mL, 122.9 
mmol, 1.13 eq) was added dropwise with stirring. The mixture was cooled to 
maintain a reaction temperature of 35-37 °c. After the addition was completed, 
the mixture was heated at reflux for 16 hrs. The excess of ethyl vinyl ether was 
removed under reduced pressure and the product 206 was not further purified but 
used directly in the next step. IH NMR (250 MHz, CnCIJ): 81.14 (3H, t, J=7.0 
Hz, CH3), 1.33 (3H, d, J=5.5 Hz, CH3CH), 2.02 (3H, s, CH3C=O), 3.37-3.76 (SH, 
m, CH2CI + CH2-0 + CHO), 3.88-4.25 (3H, m, O-CH-O + CHrOAc). 
Synthesis of 3-(1-ethoxy-ethoxy)-oxetane 20783,84 
O,.lO~ 
~ 
OAc Cl reflux 
206 207 
Crude 206 (2.44 g, 108.7 mmol, 1.0 eq) was added dropwise with stirring to a 
solution of aqueous sodium hydroxide (12 g, 298.9 mmol, 2.75 eq) in water (12 
mL) at 105°C, and the reaction mixture was heated under reflux for an additional 
4 hour period. The mixture was cooled and was washed with water. The aqueous 
layer was washed with DCM and the combined organic phases were stripped of 
solvent to give crude 207 (10 g, 63%). The product was not further purified but 
used directly in the next step. III NMR (250 MHz, CnCll ): 81.05-1.45 (6H, m, 
CH3), 3.31-3.76 (6H, m, CH20), 3.79-4.04 (IH, m, OCH), 4.59-4.91 (1H, m, 
OCH). 
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Synthesis of oxetan-3-ol 20883, 84 
pTsA dOH 
Me OH, NaHC~3 0 
207 208 
Methanol (6 mL) was added to compound 207 (10 g, 68.4 mmol, 1.0 eq) and the 
mixture was cooled to 15°C. p-Toluenesulfonic acid monohydrate (80 mg, 0.41 
mmol, 0.006 eq) was added with stirring. The reaction temperature increased 
slightly and then decreased to room temperature. The mixture was stirred for 
another 45 min and then solid sodium bicarbonate (40 mg, 0.48 mmol, 0.007 eq) 
was added. The reaction mixture was then distilled between 120-150 °c (20 mm 
Hg) but no desired oxetane 208 was isolated, the product appeared to polymerise. 
Synthesis of acetic acid 2-acetoxymethyl-allyl ester 21285 
~ AcOH,DBU A 
Cl Cl Benzene reflux, 72 h OAc OAc 
211 212 
A stirred solution of acetic acid (6.9 g, 115 mmol, 2.8 eq) in benzene (25 mL) was 
treated at rt with a solution of DBU (16.4 g, 108 mmol, 2.6 eq) in benzene (25 
mL). The yellow mixture was then added slowly to a solution of 3-chloro-2-
(chloromethyl)-I-propene 211 (5.1 g, 40.8 mmol, 1.0 eq) in benzene (50 mL) and 
the mixture was warmed at 60°C for 72 h. A white precipitate was then removed 
by filtration and washed with benzene and the combined benzene phases were 
washed with water and dried. Evaporation of solvent under reduced pressure left a 
yellow oil. Distillation of this residue under vacuum (85-90 QC, 15 mmHg) gave 
pure product 212 (6.73 g, 96%). (lit.8s b.p.=148 °c (70 mmHg)). III NMR (250 
Mllz, CDCh): 52.02 (6H, s, CHrC=O), 4.58 (4H, s, CH20), 5.32 (2H, s, 
CHrC). 
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Synthesis of 2-methylene-propane-1 ,3-diol 20985 
A NaOMe, MeOH A 
OAc OAc 0 °C to rt, 48 h OH OH 
212 209 
A stirred solution of substrate 212 (6.73 g, 39.1, mmol, 1.0 eq) in methanol (24 
mL) was treated at O°C with a solution of sodium methoxide (660 mg, 11.73 
mmol, 0.3 eq) in methanol (10 mL). The mixture was kept at 0 °c for 2 h and then 
at rt for 48 h. Solvent was removed by evaporation under reduced pressure, and 
distillation (110 QC, -15 mmHg) of the residue offered product 209 as a colourless 
liquid (2.75 g, 80%) (lit.85 b.p.=156 °c (63 mmHg). IH NMR (250 MHz, CDCh): 
84.25 (4H, s, CH]O), 5.21 (2H, s, CHrC). 
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Appendices 
6.1.X-Ray data for 253 
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Crystal data for CI5HI9N03S; M = 293.37. Crystallises from petroleum ether as 
colourless needles; crystal dimensions 0.14 x 0.12 x 0.03 mm3. Orthorhombic, a = 
7.404(2) A, b = 11.268(3) A, c = 17.150(5) A, a= 90°, J3 = 90°, Y = 90°, U= 
1430.8(7) A3, Z = 4, Dc = 1.362 Mglm3, space group P212121, Mo-Ka radiation 
(A. = 0.71073 A), J.l(Mo-Ka) = 0.233 mm-I, P(OOO) = 624. 
Data collected were measured on a Bruker Smart CCD area detector with Oxford 
Cryosystems low temperature system. Cell parameters were refined from the 
setting angles of 2506 reflections (9 range 2.16 < 24.98°). 
Reflections were measured from a hemisphere of data collected of frames each 
covering 0.3 degrees in omega Of the 10920 reflections measured, all of which 
were corrected for Lorentz and polarisation effects and for absorption by semi 
empirical methods based on symmetry-equivalent and repeated reflections 
(minimum and maximum transmission coefficients 0.9681 and 0.9930), 3259 
independent reflections exceeded the significance level IFl/cr(lPI) > 4.0. The 
structure was solved by direct methods and refined by full matrix least squares 
methods on p2. Hydrogen atoms were placed geometrically and refined with a 
riding model (including torsional freedom for methyl groups) and with Uiso 
constrained to be 1.2 (1.5 for methyl groups) times Ueq of the carrier atom. 
Refinement converged at a final R = 0.0585 (wR2 = 0.1531, for all 2506 data, 184 
parameters, mean and maximum Ma 0.000, 0.000) with allowance for the thermal 
anisotropy of all non-hydrogen atoms. Minimum and maximum final electron 
density -0.372 and 0.810 e.A-3• A weighting scheme w = 1I[s2(P02) + (0.0590*p)2 
+ 2.3795"'P] where p=(F02+ 2'" Fc2)/3 was used in the latter stages of refinement. 
Complex scattering factors were taken from the program package SHELXTL Y as 
implemented on the Pentium computer. 
Reference Y SHELXTL version, An integrated system for solving and refining 
crystal structures from diffraction data (Revision 5.1), Bruker AXS L TD 
Supplementary material 
anisotropic thermal vibrational parameters with e.s.d.s 
hydrogen atom position parameters 
observed structure amplitudes and calculated structure factors. 
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Table 1. Crystal data and structure refinement for sandonl_Om. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 24.98° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(l)] 
R indices (all data) 
Absolute structure parameter 
Extinction coefficient 
Largest diff. peak and hole 
sandonl Om 
C15H19N03S 
293.37 
150(2) K 
0.71073 A 
Orthorhombic 
P212121 
a = 7.404(2) A 0.= 90°, 
b = 11.268(3) A p= 90°, 
c= 17.150(5) A y = 90°, 
1430.8(7) A3 
4 
1.362 Mg/m3 
0.233 mm-I 
624 
0.14 x 0.12 x 0.03 mm3 
2.16 to 24.98°. 
-7<=h<=8, -8<=k<=13, -20<=1<=20 
10920 
2506 [R(int) = 0.0816] 
100.0 % 
Semi-empirical from equivalents 
0.9930 and 0.9681 
Full-matrix least-squares on F2 
2506/0/184 
1.038 
RI = 0.0585, wR2 = 0.1304 
RI = 0.1 074, wR2 = 0.1531 
-0.06(18) 
0.0063(18) 
0.810 and -0.372 e.A-3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (A2x 103) for sandonl_0m. U(eq) is defined as one third of the 
trace of the orthogonalized Uij tensor. 
x y z U(eq) 
S(1) 4006(2) 1661(1) 8196(1) 30(1) 
N(I) 2012(5) 2107(3) 8455(2) 29(1) 
0(1) 5235(5) 2555(3) 8476(2) 35(1) 
0(2) 4186(5) 460(3) 8455(2) 35(1) 
0(3) 787(5) 3740(3) 7752(2) 33(1) 
C(I) 4144(7) 1650(4) 7176(3) 28(1) 
C(2) 4278(7) 2707(4) 6768(3) 34(1) 
C(3) 4337(8) 2699(4) 5962(3) 36(2) 
C(4) 4248(7) 1647(5) 5537(3) 33(1) 
C(5) 4120(8) 579(4) 5954(3) 34(1) 
C(6) 4077(7) 577(4) 6759(3) 29(1) 
C(7) 393(6) 1365(4) 8321(3) 30(1) 
C(8) -532(7) 1778(4) 7573(3) 32(1) 
C(9) -870(7) 3104(4) 7573(3) 32(1) 
C(10) 1554(7) 3358(4) 8479(3) 30(1) 
C(11) 314(7) 3556(4) 9165(3) 27(1) 
C(12) -783(9) 2681(5) 9402(3) 37(1) 
C(13) -758(7) 1467(4) 9065(3) 32(1) 
C(14) 355(10) 4772(5) 9510(3) 52(2) 
C(15) 4264(9) 1639(5) 4655(3) 46(2) 
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Table 3. Bond lengths [A] and angles [0] for sandonl_Om. 
S(I)-0(2) 1.431(3) 
S(I)-O(1) 1.440(3) 
S(I)-N(1) 1.621(4) 
S(1)-C(1) 1.753(5) 
N(1)-C(10) 1.450(6) 
N(1)-C(7) 1.480(6) 
0(3)-C(10) 1.435(6) 
0(3)-C(9) 1.453(6) 
C(I)-C(2) 1.385(6) 
C(I)-C(6) 1.406(6) 
C(2)-C(3) 1.384(7) 
C(2)-H(2) 0.9500 
C(3)-C(4) 1.394(7) 
C(3)-H(3) 0.9500 
C(4)-C(5) 1.403(7) 
C(4)-C(15) 1.513(7) 
C(5)-C(6) 1.380(7) 
C(5)-H(5) 0.9500 
C(6)-H(6) 0.9500 
C(7)-C(8) 1.527(7) 
C(7)-C(13) 1.538(7) 
C(7)-H(7) 1.0000 
C(8)-C(9) 1.516(7) 
C(8)-H(SA) 0.9900 
C(8)-H(8B) 0.9900 
C(9)-H(9A) 0.9900 
C(9)-H(9B) 0.9900 
C(1 O)-C(1I) 1.509(7) 
C(10)-H(1O) 1.0000 
C(11)-C(12) 1.341 (7) 
C(11)-C(14) 1.493(7) 
C(12)-C(13) 1.485(7) 
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C(12)-H(12) 0.9500 
C(13)-H(13A) 0.9900 
C(13)-H(13B) 0.9900 
C(14)-H(14A) 0.9800 
C(14)-H(14B) 0.9800 
C(14)-H(14C) 0.9800 
C(15)-H(15A) 0.9800 
C(15)-H(15B) 0.9800 
C(15)-H(15C) 0.9800 
0(2)-S(1 )-O( 1) 120.0(2) 
0(2)-S(1)-N(I) 107.0(2) 
O(I)-S(1)-N(I) 105.5(2) 
0(2)-S(1 )-C(1) 107.3(2) 
0(1 )-S(I)-C(I) 107.5(2) 
N (1 )-S(1 )-C( 1) 109.2(2) 
C(1 O)-N(1 )-C(7) 111.3(4) 
C(10)-N(1)-S(I) 121.4(3) 
C(7)-N(1)-S(1) 121.4(3) 
C(10)-0(3)-C(9) 111.7(4) 
C(2)-C(I)-C(6) 119.1(4) 
C(2)-C( 1 )-S( 1) 120.1(4) 
C( 6)-C( 1 )-S( 1 ) 120.8(4) 
C(3)-C(2)-C(1 ) 120.1(5) 
C(3)-C(2)-H(2) 120.0 
C(I)-C(2)-H(2) 120.0 
C(2)-C(3)-C(4) 121.8(4) 
C(2)-C(3)-H(3) 119.1 
C(4)-C(3)-H(3) 119.1 
C(3)-C( 4)-C(5) 117.7(4) 
C(3)-C( 4)-C(15) 121.8(5) 
C(5)-C( 4)-C(15) 120.4(5) 
C(6)-C(5)-C(4) 120.9(4) 
C(6)-C(5)-H(5) 119.5 
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C( 4 )-C( 5)-H( 5) 119.5 
C( 5)-C( 6)-C(1 ) 120.4(4) 
C(5)-C(6)-H(6) 119.8 
C(1 )-C( 6)-H( 6) 119.8 
N (1 )-C(7)-C(S) 108.S(4) 
N(I)-C(7)-C(13) 106.2(4) 
C(8)-C(7)-C( 13) 115.2(4) 
N (1 )-C(7)-H(7) 108.S 
C(8)-C(7)-H(7) 108.8 
C(13)-C(7)-H(7) 108.S 
C(9)-C(S)-C(7) 112.0(4) 
C(9)-C(8)-H(8A) 109.2 
C(7)-C(8)-H(8A) 109.2 
C(9)-C(S)-H(SB) 109.2 
C(7)-C(S)-H(SB) 109.2 
H(8A)-C(S)-H(8B) 107.9 
0(3 )-C(9)-C(8) 110.3(4) 
0(3)-C(9)-H(9A) 109.6 
C(8)-C(9)-H(9A) 109.6 
0(3)-C(9)-H(9B) 109.6 
. C(8)-C(9)-H(9B) 109.6 
H(9A)-C(9)-H(9B) 108.1 
0(3)-C(1 O)-N(1) 111.1(4) 
0(3)-C(1 0)-C(11) 113.1(4) 
N(I)-C(10)-C(II) 107.9(4) 
0(3)-C(1 O)-H(1 0) 108.2 
N(1 )-C(1 O)-H(1 0) 108.2 
C(11)-C(10)-H(10) 108.2 
C(12)-C(11)-C(14) 124.6(5) 
C(12)-C(II)-C(10) 119.8(4) 
C(14)-C(II)-C(10) 115.6(5) 
C(11)-C(12)-C(13) 123.5(5) 
C(11)-C(12)-H(12) l1S.3 
C(13)-C(12)-H(12) 118.3 
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C(12)-C(13)-C(7) 1 13.S(4) 
C(12)-C(13)-H(13A) 108.9 
C(7)-C(l3)-H(l3A) 108.9 
C(12)-C(13)-H(13B) 108.9 
C(7)-C( 13)-H( 13 B) 108.9 
H(13A)-C(l3)-H(13B) 107.7 
C(11)-C(l4)-H(l4A) 109.S 
C(11)-C(14)-H(14B) 109.S 
H(14A)-C(l4)-H(14B) 109.S 
C(ll)-C(14)-H(14C) 109.S 
H(14A)-C(14)-H(14C) 109.S 
H(14B)-C(14)-H(14C) 109.S 
C(4)-C(lS)-H(1SA) 109.S 
C(4)-C(lS)-H(lSB) 109.S 
H(lSA)-C(lS)-H(lSB) 109.S 
C(4)-C(lS)-H(lSC) 109.S 
H(lSA)-C(lS)-H(lSC) 109.S 
H(lSB)-C(lS)-H(lSC) 109.5 
Symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacement parameters (A2x l03)for sandonl_Om. The 
anisotropic displacement factor exponent takes the form: -27t2[ h2a*2Ull + ... + 
2 h k a* b* Ul2] 
S(I) 29(1) 23(1) 37(1) 0(1) -2(1) 4(1) 
N(1) 24(2) 22(2) 39(3) -1(2) -1(2) -1(2) 
0(1) 22(2) 38(2) 45(2) -7(2) -8(2) 1(2) 
0(2) 40(2) 28(2) 37(2) 4(2) -1(2) 11(2) 
0(3) 41(2) 22(2) 36(2) 2(1) 7(2) 0(2) 
C(l) 21(3) 25(2) 38(3) 0(2) 3(2) 8(3) 
C(2) 36(3) 23(3) 41(3) 1(2) 1(3) 3(3) 
C(3) 41(4) 16(3) 50(4) 7(2) 6(3) 3(3) 
C(4) 30(3) 29(3) 40(3) 0(2) 6(3) 1(3) 
C(5) 41(3) 24(3) 39(3) -6(2) 1(3) 4(3) 
C(6) 28(3) 18(2) 40(3) 2(2) -3(3) 0(2) 
C(7) 32(3) 16(2) 41(3) 2(2) 1(2) -2(2) 
C(8) 31(3) 31(3) 34(3) -3(2) -2(2) 2(3) 
C(9) 34(3) 26(3) 36(3) 1(2) -7(3) 2(3) 
C(lO) 35(3) 26(3) 30(3) -7(3) -3(2) 5(2) 
C(ll) 29(3) 28(3) 25(3) -3(2) -5(2) 9(3) 
C(12) 40(4) 41(3) 31(3) 4(2) 6(3) -1(3) 
C(13) 35(3) 27(3) 32(3) 5(2) 3(3) 3(3) 
C(14) 65(5) 46(4) 45(4) -23(3) 9(3) -11(4) 
C(15) 64(4) 36(3) 38(3) 6(3) 6(3) -6(4) 
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (A2x 103) for sandonl_Om. 
x y z U(eq) 
H(2) 4329 3439 7042 40 
H(3) 4442 3431 5691 43 
H(5) 4061 -152 5679 41 
H(6) 4001 -155 7032 35 
H(7) 779 521 8256 35 
H(8A) 235 1568 7121 39 
H(8B) -1698 1356 7515 39 
H(9A) -1321 3353 7055 38 
H(9B) -1804 3301 7965 38 
H(IO) 2689 3819 8570 36 
H(l2) -1621 2846 9808 45 
H(l3A) -2012 1226 8942 38 
H(13B) -282 908 9460 38 
H(14A) -263 5327 9160 79 
H(14B) 1612 5024 9579 79 
H(14C) -256 4764 1001779 
H(l5A) 3739 2380 4460 69 
H(15B) 3554 965 4464 69 
H(15C) 5511 1568 4469 69 
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6.2.X-Ray data for 247 
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Crystal data for C15 H21 N 03 S; M = 295.39. Crystallises from petroleum ether 
as colourless needles; crystal dimensions 0.14 x 0.12 x 0.03 mm3• Orthorhombic, 
a = 7.7722(4) A, b = 11.0799(6) A, c = 17.1162(9) A, ex = 90°, P = 90°, Y = 90°, U 
= 1473.96(13) A3, Z = 4, Dc = 1.331 Mg/m3, space group P21212J, Mo-Ka 
radiation (A. = 0.71073 A), J.1(Mo-Ka) = 0.227 mm-I, F(OOO) = 632. 
Data collected were measured on a Bruker Smart CCD area detector with Oxford 
Cryosystems low temperature system. Cell parameters were refined from the 
setting angles of3890 reflections (9 range 2.19 < 28.97°). 
Reflections were measured from a hemisphere of data collected of frames each 
covering 0.3 degrees in omega Of the 28817 reflections measured, all of which 
were corrected for Lorentz and polarisation effects and for absorption by semi 
empirical methods based on symmetry-equivalent and repeated reflections 
(minimum and maximum transmission coefficients 0.9540 and 0.9777), 3890 
independent reflections exceeded the significance level IFl/cr(lF!) > 4_0. The 
structure was solved by direct methods and refined by full matrix least squares 
methods on p2. Hydrogen atoms were placed geometrically and refined with a 
riding model (including torsional freedom for methyl groups) and with Viso 
constrained to be 1.2 (1.5 for methyl groups) times Veq of the carrier atom. 
Refinement converged at a final R = 0.0369 (wR2 = 0.0933, for all 3890 data, 183 
parameters, mean and maximum '6/cr 0.000, 0.000) with allowance for the thermal 
anisotropy of all non-hydrogen atoms. Minimum and maximum final electron 
density -0.340 and 0.516 e.A-3• A weighting scheme w = l/[s2(F02) + (0.0590*pi 
+ 2.3795*P] where P=(P02+ 2 • Pc2)/3 was used in the latter stages of refinement. 
Complex scattering factors were taken from the program package SIIELXTL Y as 
implemented on the Pentium computer. 
Reference Y SHELXTL version, An integrated system for solving and refining 
crystal structures from diffraction data (Revision 5.1), Bruker AXS L TD 
Supplementary material 
anisotropic thermal vibrational parameters with e.s.d.s 
hydrogen atom position parameters 
observed structure amplitudes and calculated structure factors. 
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Table 1. Crystal data and structure refinement for ns363. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 25.00° 
Absorption correction 
Max. and min. transmission 
Refinement method 
Data 1 restraints 1 parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(l)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
ns363 
C15 H21 N03 S 
295.39 
150(2) K 
0.71073 A 
Orthorhombic 
P2}2}2} 
a= 7.7722(4) A a= 90°. 
b = 11.0799(6) A p= 90°. 
c = 17.1162(9) A y = 90°. 
1473.96(13) A3 
4 
1.331 Mg/m3 
0.227 mm·1 
632 
0.21 xO.21 xO.lOmm3 
2.19 to 28.97°. 
-1O<=h<=lO, -14<=k<=15, -23<=1<=23 
28817 
3890 [R(int) = 0.0612] 
100.0 % 
Semi-empirical from equivalents 
0.9777 and 0.9540 
Full-matrix least-squares on f2 
389010/183 
1.022 
RI = 0.0369, wR2 = 0.0876 
RI = 0.0470, wR2 = 0.0933 
0.01(7) 
0.516 and -0.340 e.A·3 
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (A2x 103) for ns363. U(eq) is defined as one third of the trace of 
the orthogonalized Vii tensor. 
x y z U(eq) 
S(I) 960(1) 7698(1) 8134(1) 23(1) 
N(1) 2961(2) 7827(1) 8387(1) 23(1) 
0(1) 127(2) 8800(1) 8350(1) 30(1) 
0(2) 364(2) 6577(1) 8457(1) 29(1) 
0(3) 4967(2) 6389(1) 7901(1) 29(1) 
C(I) 848(2) 7602(2) 7107(1) 23(1) 
C(2) 601(2) 8644(2) 6668(1) 30(1) 
C(3) 592(2) 8557(2) 5858(1) 31(1) 
C(4) 828(2) 7463(2) 5483(1) 31(1) 
C(5) 1038(3) 6429(2) 5936(1) 31(1) 
C(6) 1061(2) 6495(2) 6747(1) 27(1) 
C(7) 4031(2) 6780(2) 8567(1) 24(1) 
C(8) 5105(2) 7104(2) 9292(1) 27(1) 
C(9) 5999(3) 8332(2) 9258(1) 32(1) 
C(10) 4958(2) 9325(2) 8850(1) 30(1) 
C(II) 4005(2) 8874(1) 8128(1) 24(1) 
C(12) 5141(3) 8481(2) 7440(1) 29(1) 
C(13) 6078(2) 7299(2) 7580(1) 30(1) 
C(14) 848(3) 7384(2) 4604(1) 44(1) 
C(15) 6361(3) 6099(2) 9493(1) 37(1) 
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Table 3. Bond lengths [A] and angles [0] for ns363. 
S(1)-O(1) 1.4303(13) 
S(I)-O(2) 1.4361(13) 
S(1)-N(1) 1.6198(14) 
S(I)-C(I) 1.7646(16) 
N(I)-C(7) 1.460(2) 
N(1)-C(II) 1.484(2) 
O(3)-C(7) 1.419(2) 
O(3)-C(13) 1.437(2) 
C(I)-C(6) 1.382(2) 
C(I)-C(2) 1.391(2) 
C(2)-C(3) 1.389(2) 
C(2)-H(2) 0.9500 
C(3)-C(4) 1.383(3) 
C(3)-H(3) 0.9500 
C(4)-C(5) 1.394(2) 
C(4)-C(14) 1.507(2) 
C(5)-C(6) 1.390(2) 
C(5)-H(5) 0.9500 
C(6)-H(6) 0.9500 
C(7)-C(8) 1.538(2) 
C(7)-H(7) 1.0000 
C(8)-C(15) 1.520(3) 
C(8)-C(9) 1.529(3) 
C(8)-H(8) 1.0000 
C(9)-C(10) 1.534(3) 
C(9)-H(9A) 0.9900 
C(9)-H(93) 0.9900 
C(10)-C(11) 1.525(2) 
C(l 0)-11(1 OA) 0.9900 
C(10)-1I(103) 0.9900 
C(11 )-C(12) 1.535(2) 
C(11 )-11(11) 1.0000 
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C(12)-C(13) 1.518(3) 
C(12)-H(12A) 0.9900 
C(12)-H(12B) 0.9900 
C(13)-H(13A) 0.9900 
C(13)-H(13B) 0.9900 
C(14)-H(14A) 0.9800 
C(14)-H(14B) 0.9800 
C(14)-H(14C) 0.9800 
C(15)-H(15A) 0.9800 
C(15)-H(15B) 0.9800 
C(15)-H(15C) 0.9800 
0(1 )-S(1 )-0(2) 119.49(7) 
0(1 )-S(1 )-N(I) 106.89(8) 
0(2)-S(1)-N(I) 106.48(8) 
0(1 )-S(1 )-C( 1) 106.63(8) 
0(2)-S(I)-C(I) 108.39(8) 
N(1)-S(1)-C(1) 108.60(7) 
C(7)-N(I)-C(11) 111.86(13) 
C(7)-N(1)-S(1) 122.20(11) 
C(11)-N(I)-S(I) 120.95(11) 
C(7)-0(3 )-C( 13) 113.66(12) 
C( 6)-C(1 )-C(2) 120.82(15) 
C( 6)-C( 1 )-S( 1) 119.45(12) 
C(2)-C(1 )-S(1) 119.69(13) 
C(3)-C(2)-C(I) 118.79(16) 
C(3)-C(2)-H(2) 120.6 
C(1 )-C(2)-H(2) 120.6 
C( 4)-C(3)-C(2) 121.59(16) 
C(4)-C(3)-H(3) 119.2 
C(2)-C(3)-H(3) 119.2 
C(3)-C( 4)-C(5) 118.49(16) 
C(3 )-C( 4 )-C(14) 121.08(16) 
C( 5)-C( 4 )-C( 14) 120.42(17) 
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C( 6)-C( 5)-C( 4) 120.91(16) 
C(6)-C(5)-H(5) 119.5 
C(4)-C(5)-H(5) 119.5 
C( 1 )-C( 6)-C( 5) 119.38(15) 
C(1 )-C( 6)-H( 6) 120.3 
C(5)-C(6)-H(6) 120.3 
O(3)-C(7)-N(I) 111.43(12) 
0(3)-C(7)-C(8) 116.16(15) 
N(1 )-C(7)-C(8) 107.11(13) 
0(3 )-C(7)-H(7) 107.2 
N(I)-C(7)-H(7) 107.2 
C(8)-C(7)-H(7) 107.2 
C(15)-C(8)-C(9) 111.63(15) 
C( 15)-C(8)-C(7) 111.12(15) 
C(9)-C(8)-C(7) 115.04(13) 
C(15)-C(8)-H(8) 106.1 
C(9)-C(8)-H(8) 106.1 
C(7)-C(8)-H(8) 106.1 
C(8)-C(9)-C( 10) 114.57(15) 
C(8)-C(9)-H(9A) 108.6 
C(10)-C(9)-H(9A) 108.6 
C(8)-C(9)-H(9B) 108.6 
C(10)-C(9)-H(9B) 108.6 
H(9A)-C(9)-H(9B) 107.6 
C(11 )-C(1 0)-C(9) 113.02(14) 
C(II)-C(10)-H(lOA) 109.0 
C(9)-C(1 O)-H( lOA) 109.0 
C(11)-C(10)-H(10B) 109.0 
C(9)-C(1 O)-H(l OB) 109.0 
H(1 OA)-C(1 O)-H(1 OB) 107.8 
N(I)-C(II)-C(10) 106.23(14) 
N(I)-C(11)-C(12) 108.80(13) 
C(10)-C(11)-C(12) 115.79(15) 
N(I)-C(11)-H(11) 108.6 
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C(10)-C(11)-H(11) 108.6 
C(12)-C(II)-H(lI) 108.6 
C(13)-C(12)-C(11) 113.58(14) 
C(13)-C(12)-H(l2A) 108.9 
C(11)-C(12)-H(12A) 108.9 
C(13)-C(12)-H(12B) 108.9 
C(II)-C(l2)-H(12B) 108.9 
H(12A)-C(12)-H(12B) 107.7 
O(3)-C(13)-C(12) 112.15(15) 
O(3)-C(13)-H(13A) 109.2 
C(12)-C(13)-H(13A) 109.2 
O(3)-C(13)-H(13B) 109.2 
C(12)-C(13)-H(13B) 109.2 
H(13A)-C(13)-H(13B) 107.9 
C( 4)-C(14)-H(14A) 109.5 
C( 4)-C(l4)-H(14B) 109.5 
H(14A)-C(14)-H(14B) 109.5 
C( 4 )-C(14)-H( 14C) 109.5 
H(14A)-C(14)-H(14C) 109.5 
lI(14B)-C(14)-H(14C) 109.5 
C(8)-C(15)-H(15A) 109.5 
C(8)-C(l5)-H(15B) 109.5 
H(l5A)-C(15)-H(15B) 109.5 
C(8)-C(l5)-H(15C) 109.5 
H(15A)-C(15)-H(15C) 109.5 
H(15I3)-C(15)-H(15C) 109.5 
Symmetry transformations used to generate equivalent atoms: 
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Table 4. Anisotropic displacement parameters (A2X l03)for ns363. The 
nisotropic displacement factor exponent takes the form: _21t2[ h2a*2UIl + ... + 
2 h k a * b * un ] 
S(1) 21(1) 23(1) 25(1) 0(1) 0(1) 0(1) 
N(I) 23(1) 21(1) 25(1) 2(1) -2(1) -2(1) 
0(1) 28(1) 27(1) 35(1) -3(1) 4(1) 6(1) 
0(2) 27(1) 28(1) 31(1) 5(1) 1(1) -7(1) 
0(3) 35(1) 24(1) 27(1) -4(1) 1(1) 2(1) 
C(I) 21(1) 24(1) 25(1) 1(1) -3(1) -2(1) 
C(2) 33(1) 23(1) 33(1) 1(1) -5(1) 2(1) 
C(3) 36(1) 26(1) 33(1) 7(1) -6(1) -1(1) 
C(4) 31(1) 35(1) 27(1) 4(1) -5(1) 0(1) 
C(5) 37(1) 26(1) 32(1) -4(1) -4(1) -1(1) 
C(6) 30(1) 21(1) 29(1) 2(1) -5(1) 0(1) 
C(7) 24(1) 22(1) 26(1) 3(1) -1(1) -1(1) 
C(8) 26(1) 34(1) 22(1) 2(1) 0(1) 1(1) 
C(9) 28(1) 42(1) 25(1) -6(1) -2(1) -4(1) 
C(10) 30(1) 28(1) 32(1) -8(1) 2(1) -7(1) 
C(ll) 26(1) 19(1) 27(1) 1(1) 1(1) -1(1) 
C(12) 33(1) 31(1) 24(1) 3(1) 3(1) -4(1) 
C(13) 30(1) 35(1) 25(1) -4(1) 5(1) 1(1) 
C(14) 60(1) 44(1) 27(1) 2(1) -6(1) 1(1) 
C(IS) 32(1) 44(1) 35(1) 10(1) -6(1) 5(1) 
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (AZx 103) for ns363. 
x y z U(eq) 
H(2) 442 9402 6917 36 
H(3) 418 9264 5555 38 
H(5) 1168 5667 5687 38 
H(6) 1221 5787 7051 32 
H(7) 3240 6108 8719 28 
H(8) 4275 7148 9738 33 
H(9A) 7110 8237 8982 38 
H(9B) 6254 8597 9798 38 
H(IOA) 4113 9661 9224 36 
H(10B) 5746 9984 8695 36 
H(l1) 3210 9524 7944 29 
H(12A) 4413 8399 6968 35 
H(12B) 5999 9121 7336 35 
H(13A) 6560 7005 7079 36 
H(13B) 7049 7440 7943 36 
H(14A) 1185 6567 4445 66 
H(14B) 1675 7968 4394 66 
H(14C) ·302 7564 4400 66 
H(15A) 7273 6069 9098 56 
H(15B) 5750 5325 9503 56 
H(15C) 6869 6254 1000756 
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6.3.NOESY spectrum for compound 249 
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6.4.1H-IH Cosy NMR data for compound 254 
H3 ' HB 
H2 H5 HI H6 H6 ' H9 H9 ' 
I 
2 
. 
, . 
3 
• 
D 
/ , 4 . .. 
f' , 
/ 5 ,. 
~ 6 , 
7 
· f ' 
.' 
I, 
.A • 
8 
9 
8 7 6 5 4 3 2 I ppl1l 
26 1 
6.5.NOESY spectrum for compound 254 
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6.6.1H-IH Cosy NMR data for compound 267a 
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6.7.NOESY spectrum for compound 267a 
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6.8.IH-IH Cosy NMR data for compound 267b 
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6.9.NOESY spectrum for compound 267b 
HIO 
H7 ' 
H7 
HI 
ppm 
• 
1 
• • 
• ~ 2 
~ 
• 
... 
• 
3 
,~o , . . . I 
~. . . • 4 
o· • + 
, 
.f 5 , 
a 
a ~ 6 
Hg Hs 
OH 
266 
6.10.1H-IH Cosy NMR data for compound 269 
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6.11.NOESY spectrum for compound 269 
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